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Abstract
Atomic resolution structures of protein-protein interactions were initially limited to X-ray
crystallography; with unnatural buffers, pHs and forced lattice structures. NMR extended
investigations to be able to determine solution based structures of small complexes, but
proteins of any size or high dynamicity remain problematic, whilst ab initio investigation
remains almost impossible.
Using site-directed spin labelling (SDSL) across both docking partners, in combination with
the electron paramagnetic resonance (EPR) technique pulsed electron-electron double res-
onance (PELDOR) allows for the precisemeasurement of intermolecular distances. Produc-
ingmanymutant proteins with spin label sites across the protein allows for a 3-dimensional
map to be built. Each EPR distance measurements is incorporated as a distance restraint
into existing docking protocols with an aim to provide better quality docking models.
Themethod outlined in this investigation presents EPR as a technique with immense poten-
tial. EPR only measures paramagnetic species, in this case introduced nitroxide spin labels,
making it applicable to water-soluble and membrane proteins, without the protein size lim-
itations as with NMR. Furthermore, incorporation with freeze-quench apparatus could yield
future time-dependent modelling in a way unavailable to traditional biomolecular structural
techniques.
Using the well-characterised system of the DNase domain of colicin E9 and its inhibitor,
colicin E9 immunity protein, Im9, a combination of structural NMR models and EPR long
range distance restraints were able to present a structural solution with comparible resolu-
tion to high resolution NMR or X-ray crystallography. Looking forward, this method could be
extended to molecules that have previously been available to study such as large proteins,
proteins with high dynamicity, membrane proteins in lipids or even to build a structure in
combination with in silico techniques.
1

Part I.
Background
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1. Fundamentals of electron paramagnetic
resonance
1.1. Introduction to electron paramagnetic resonance
Zavoisky published the first articles on paramagnetic resonance in 1945, quickly followed
by a further 2 papers in the following year [111, 113, 112, 114]. The first paper entitled
``Spin-magnetic resonance in paramagnetics'', described how hydrated cupric chloride in
the presence of applied radiation and magnetic field gave resonance of a particular applied
electromagnetic radiation / magnetic field ratio. From these results it was later possible to
determine that the spin quantum number of cupric chloride as S = 1/2. Only one year later
did the initial work on nuclear magnetic resonance (NMR) begin to appear in the literature.
The nuclei of atoms are made up of protons and neutrons. A proton in elementary particles
is composed of up, up, down quarks strongly held together by gluon force, giving an overall
positive charge. The slightly heavier neutron consisting of up, down, down quarks yields a
positive core ~ 0.3 fm in diameter negated by a negatively charged radius of 2 fm. As a
result of this quark build up, each nucleon has an intrinsic quantum property of spin. With
NMR it is clear that the nuclear moment is a result of the total nuclear spin.
Electrons, however, are negatively charged subatomic point particles [21], which is to say
are zero dimensional in any relevant context [24]. Despite this an electron still has mass (~
1/1836 that of a proton), energy, spin (S = 1/2) and electrical charge. Spin is a unique degree
of freedom fundamental to all elementary particles and, in the case of electrons, it is the
directional spin of the particle upon its own axis. As the electron is charged and is moving,
it also has a magnetic moment, closely related to the angular momentum or spin of the
particle due to the gyromagnetic ratio (ie. the faster a charged particle is spun the greater the
magnetic field). This spontaneousmagnetization of spinning objects is governed according
to the Barnett effect [3].
In the case of the electronic magnetic moment, the orbital angular moment of the charged
electron moving through space contributes as well as the spin of the electron. As a result,
the technique formly known as electron spin resonance (ESR) has slowly been renamed to
electron paramagnetic resonance (EPR).
From a methodological view the main difference between NMR and EPR is the size of these
magnetic moments. The electron moment is 660 times that of a proton, which lends EPR
to a much higher sensitivity at a given spin concentration. The greater magnetic moment
and intrinsic time sensitivity allows for the observation of spin-spin interactions over much
larger distances and to molecular motions on a much shorter time scale.
From an applied perspective almost all molecules contain magnetic nuclei and are thus ac-
cessible to NMR spectroscopy, whilst very few molecules contain unpaired electrons and
5
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are thus inaccessible to EPR spectroscopy. In fact biologically, nature goes to extraordinary
lengths to stop the natural occurence of unpaired electrons as these often result in highly
reactive species. A naturally occuring EPR signal is thus often related to an area of enhanced
reactivity such as transition metal complexes in enzyme cores or free radicals.
1.2. Site directed spin labelling
In the absense of paramagnetism, as is common in biological systems, an artifical source
is required. Paramagnetic spin probes have been routinely used in NMR paramagnetic re-
laxation enhancement (PRE) experiments since the 1950s [85]. Commonly metal ions have
been used, but for these paramagnetic sources to be of any use theymust be in an oxidation
state that is inert with respect to reaction with water and amino acids. Consequently, exam-
ples usingMn2+, Fe2+, Co2+,Ni2+, Cu2+, and most of the lanthanide series ions appear in
the literature [70]. Historically, paramagnetic metalloproteins kick-started the development
of protein NMR spectroscopy as the paramagnetism shifted protons in such a way that they
could be resolved in (what is now considered) low fields.
Many new EPR techniques developed as researchers became more aware that a paramag-
netic centre could yield information as to the atoms that surround it, harnessing the con-
siderable increase in spectral resolution over NMR. Particularly since the development of
pulsed and high field/high frequency spectrometers [89]. Whilst some estimate up to half of
proteins contain a metal [88], most of these will be diamagentic and of those that are para-
magnetic, still fewer will have the paramagnetic centre near an area of interest. For these
reasons it has long been commonplace to introduce paramagnetic labels into proteins for
study by EPR.
The use of metal based labels is becoming more prevalent, particularly in high field appli-
cations [79], but for the most part, by far and away the most common paramagentic labels
introducted to protein systems utilise nitroxide radicals. Pioneered by the McConnell group
in the early 1960s [86], the nitroxide group of compounds consists of a radical delocalised
across a nitrogen-oxygen bond. Often to stabilise the radical, to temperatures over 400K ,
the immediate neighbouring carbons have branching methyl groups. The nitroxide radicals
do however remain suspectible to low pHs and oxidation to hydroxylamines by weak reduc-
ing agents such as ascorbic acid. The most common of these compounds; IA-PROXYL,
MTSL, TOAC and TEMPO are now commerically available at moderate cost and can be ob-
tained in various isotopically enriched forms. Typically, nitroxides have the nitrogen of the
NO cyclised into a 5 or 6membered ring with the ring tethered to a sulphate or other leaving
group. Through the use of sulphur chemistry a disulphide or thioester bond can be formed
to cysteine sulphurs, as demonstrated in figure 1.1.
The natural abundance of cysteine in proteins is only 1.2 % (though it constitutes 5.6 % of
catalytic residues) [4]. The chance that a cysteine is present in any given protein, at a site that
could be spin labelled and at a site of interest, is low. Therefore, genetic engineering is used
and, through modification of only a few DNA bases, cysteines can be introduced at desired
positions in the protein. These provide anchoring points to which extrinsic spin labels can
be attached, the combined process is known as site directed spin labelling (SDSL).
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Figure 1.1 Labelling mechanisms of common nitroxides to cysteine's S
In the case of poly-cysteine proteins it is common to first mutate all cysteines to alanines to
present a simplemodel and then systematicallymutate back the cysteines. Care needs to be
takenwhenmutating away naturally occuring cysteines, as they often formdisulphide bonds
which can be key to protein structure, or are used at catalytic sites in metal coordination.
Equally, adding cysteines to proteins that previously had none requires care. Surface ex-
posed cysteines can easily generate intermolecular disulphide bonds forming poly-protein
chains. Mutating, sometimes previously unknown, key residues to binding or activity can
render the mutant inactive and sometimes the mutation will produce much reduced yields
or will not express at all. After mutations have been performed full biochemical analyses are
required to confirm that fully formed and functional proteins are used in the investigation.
1.3. Basic EPR theory
EPR as a technique for studying materials with unpaired electrons has much of its funda-
mental theory within quantum physics. In Schrödinger's equation, electrons assume pre-
defined electron orbitals with certain levels of energy. Electrons will always occupy the low-
est possible energy state unless an external influence is applied. Once the low energy or-
bitals have been filled then electrons will enter the next lowest orbital, this was known and
7
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used from as early as 1920 (before quantum theory) by Bohr and others in the Aufbau prin-
ciple [105] and later formalised into the Pauli Exclusion Principle [74] and Hund's rules.
Electrons strive to find theminimal orbiting energy, however as a result of the Pauli Exclusion
Principle (as electrons are fermions and thus must obey Fermi-Dirac dynamics), electrons
cannot have the same quantum number and will often occupy the same energy level with
opposite spins. The resulting spin pair, with opposing spins means that the paramagnetism
on each electron is negated leaving the atom diamagnetic.
An unpaired electron, however, remains paramagnetic, that is to say it is attracted to and
influenced by a magnetic field.
An electron will occupy the lowest possible energy state, however, through the application
of energy, the electron can be excited from the ground state to an excited state. This is
most commonly achieved by irradiation with photons (light) of a particular frequency. With
time, the energy will be lost as an emission of a photon and the electron will return back to
the ground state. Absorption of visible light gives rise to colours and has been exploited in
science in colorimetry, luminescence and fluorescence experiments amongst many others,
where absorption/emission intensity, frequency or decay times are measured.
In an EPR experiment numerous different factors will affect the electron's magnetic proper-
ties which will in result in differentiation in the total energy of the system. The total energy of
a spin system can be described by a Hamiltonian, H^ , where total energy the formal term for
the combined kinetic and potential energies of a system. The spin Hamiltonian formalism
considers the energy of an electron to be determined by its spin only. For an electron in the
absense of an applied photon energy the spin Hamiltonian is given as
H^ = H^EZ + H^HF + H^NQ + H^ZFS + H^EI (1.1)
where the Hamiltonian is the sum of the electron Zeeman (EZ), hyperfine interaction (HF),
nuclear quadrupole (NQ), zero field splitting (ZFS) and exchange interaction (EI). Each term
in the spin Hamiltonian will be described in greater detail in the following sections.
1.3.1. Electron Zeeman
When considering the simplest system, that of a single electron in a hydrogenic orbital, the
application of an external magnetic field splits the electron ground state. With intrinsic spin
and charge, the electron also has a magnetic property known as a magnetic moment (turn-
ing force). The magnetic moment creates a directionality to the electron's magnetism. As
a result, when the electron is placed within a magnetic field it can aligned with the field in
either a parallel or antiparallel manner. Opposing the external magnetic field requires more
energy than aligning parallel to the field, this creates the splitting of the ground state into two
distinct energy levels. The energy difference between the two energy levels creates a Boltz-
mann distribution between the two states in the unperturbed system. The splitting energy
between states is directly proportional to the size of the applied magnetic field.
With the application of energy, in the form of electromagnetic radiation, the Boltzmann dis-
tribution is distorted and greater spin density is found in the the higher energy ground state.
With time, electrons in the higher energy state will relax to the lower energy ground state by
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emission of a photon. Whilst the Boltzmann distribution no longer applies, a difference in
populations between energy states is required to maintain a signal.
EPR is a resonance technique, in which the transitions of electrons between split ground
states are measured by the aborption of photons. Detection is made by disruption of a
standing wave causing reflections of microwaves from the sample cavity.
The relationship between energy spin levels and photon frequency is stated by Planck's law.
Whereby the change in energy,E , is related to the frequency of the absorbed electromag-
netic radiation
E = h (1.2)
where h is Planck's constant and  is the frequency of the radiation. Many different spec-
troscopies utilise the same principle using different frequencies of radiation, for example;
NMR uses 106Hz (radio frequencies - corresponding to nuclear resonance), terahertz spec-
troscopy uses 1012 Hz, infra-red spectroscopy uses 1012 14 Hz (corresponding to covalent
bonds), ultra-violet/visible spectroscopy uses 1015 16 Hz, to name but a few. EPR uses 109
Hz radiation, commonly referred to as microwaves. The most common EPR spectroscopy
is conducted at X-band corresponding to approximately 9 GHz (3.3 cm wavelength). In
EPR, unlike other spectroscopies, for experimental reasons it is more convenient to keep the
frequency static and sweep the magnetic field through resonance positions.
An EPR spectrum is a graphical representation of the absorption of energy (electromagnetic
radiation, in themicrowave frequency range) against the strength of themagnetic field. This
ultimately can give information that can elucidate the environment of the paramagnetic elec-
tron, including interactions to other paramagnetic centres and sample dynamics reported by
the orbital angular momentum that are otherwise lost in the spin Hamiltonian formalism.
The largest influence to the electron in an EPR experiment is usually that of the electron inter-
acting with the magnetic field, this is called the Zeeman effect. The electron has a magnetic
moment, , which as discussed previous results in the lowest energy state to result when
the electron polarity is aligned with the field.
The two energy levels are labelled according to the direction of their spin,ms relative to the
direction of the magnetic field. For a simple single electron, spin half system the parallel
state is designatedms =  1/2 and the antiparallel state is designatedms = +1/2. From this
the primary EPR equation can be deduced:
E = ge B B0ms = 1/2 ge B B0 (1.3)
where ge is the electron g-factor, a proportionality constant (2.002319304). B is the Bohr
magneton (~9:27  10 24 J:T 1), the natural unit of an electronic magnetic moment, the
moment that would be expected if an electron was a spinning charge according to classi-
cal physics (universal constant). B0 is the external magnetic field. In figure 1.2 it can be
seen that with no magnetic field the ground state is degenerate, but as the magnetic field
increases the energy difference between the two spin projections increases.
Formally however, themagnetic field is a vector giving it directionality aswell as amagntiude.
When considering the magnetic field as a vector the spin Hamiltonian becomes:
9
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Figure 1.2 An energy diagram representing electron Zeeman splitting in the presence of a magnetic field. The
stronger the magnetic field the greater the degree of separation
θ
Φ
y
x
z
Figure 1.3 Definition of angles in a spherical co-ordinate system used in equations 1.5 and 1.6, when z is defined
as the external magnetic field, B0,  is from the z-axis and  the projection in the xy plane
H^ =
B
~
~B0 g S^ (1.4)
where B is the Bohr magneton, ~ is the reduced Planck's constant (h/2  1:0510 34 J:s),
~B0 the transpose of themagnetic field vector ~B0 = (B0x; B0y; B0z), g the g tensor (not strictly
a tensor as it connects two independent spaces; that of the spin and that of the laboratory)
and S^ the electron spin vector (S^x; S^y; S^z).
When in the principal axis system of the g tensor the magnetic field can be written as:
~B0 = B0(sin  cos; sin  sin; cos ) (1.5)
where  and  are polar angles that characterise the direction of the magnetic field within
the principal axis system (see figure 1.3). Combining equations 1.4 and 1.5 yields:
H^EZ =
B
~
B0(gx sin  cos S^x + gy sin  sin S^y + gz cos  S^z) (1.6)
When the g tensor is anisotropic the direction of the effective magnetic field to the principal
axis system is dependent upon the orientation of the molecule within the magnetic field.
As the electron spin system is not necessarily parallel to the magnetic field and could have
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different orientations, each with differently directed effective magnetic fields, the effective g
tensor is given as:
geff =
q
g2x sin2  cos2 + g2y sin2  sin2 + g2z cos2  (1.7)
At highmagnetic fields the electron Zeeman interaction dominates over all other interactions
and the contribution is proportional to the combination of the magnetic quantum number
of the electron spin and the effective g tensor. The resonance condition for this orientation
then becomes:
B0;res =
hmw
geffB
(1.8)
The effective g tensor will deviate slightly from that of the free electron g value, ge, as a re-
sult of the orbital angular momentum which otherwise would not exist. Perturbation theory
can resolve this deviation accurately but can be approximated as occupied electron oribitals
making a negative difference (increase in field) whilst empty p-, d- or f- orbitals increase the
g tensor (low field shift). The g tensor is therefore a complicated function that can act as a
fingerprint to the electron orbitals of a paramagnetic centre since small nuclei elements will
have a small spin-orbit coupling and the g tensor deviation from ge will be small whilst first
row transition metals with extended electron orbitals will show greater deviations from ge.
1.3.2. Hyperfine interaction
Whilst the paramagentic electron's g factor yields much information, it mainly reports only
upon the electron, it speaks little of the environment surrounding the electron. Fortunately,
the same paramagnetic electron is very sensitive to the immediate area. A large number
of naturally abundant nuclei have a non-zero nuclear spin, resulting in their own magnetic
momenta and thus magnetic fields. This nuclear magnetic field interacts with the electron
magnetic field with the electron energy reflecting the interaction, an effect known as the
hyperfine interaction.
The magnetic field resulting from the nucleus, B1, can either add to or oppose the external
magnetic field which in turn raises or lowers the energy required to fulfil the resonance con-
dition. In the case of a nucleus with spin I = 1/2, the single resonance line at B0 is split in
two representing the B0  B1 and B0 +B1 conditions.
The hyperfine interaction term of the spin Hamiltonian for a S = 1/2 is given by
H^HF =
X
k
S^ Ak I^k (1.9)
where k represents every magnetic nuclei (Ik > 0) in the molecule that has hyperfine cou-
plings, I^k are vector operators for each nuclei and Ak are hyperfine tensors.
The hyperfine coupling of the electron spin to the nuclear spin comes about by a through-
space dipole-dipole coupling of the two magnetic moments and by the Fermi contact inter-
action as a result of the non-zero probability that the electron is in the nucleus. The Fermi
11
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Figure 1.4 The magnetic moment of a I 6= 0 nucleus can also be thought of in classical physics as a small bar
magent. The resulting magnetic field, B1 that can either add to or oppose the external magnetic field.
contact interaction can only occur when the electron is in a s orbital and yields a purely
isotropic coupling, H^HF = aiso S^ I^ with
aiso = s:
2
3
20
~
ge B gn n j 0(0)j2 (1.10)
where s the spin density in the s-orbital, gn the nuclear g value and n the nuclearmagneton
(~5:0510 27 J:T 1). j 0(0)j2 is the probability that an electron in the ground state ( 0) has
a displacement of zero from the nucleus.
Paramagnetic electrons in p-, d- or f- orbitals do not have a Fermi contact interaction as
these orbitals have a node at the nucleus and so the electronwill never be found there. How-
ever, as these orbitals are non-spherical in shape and symmetry, couplings between these
orbitals and nuclei do not average. The spin density in this case gives purely anisotropic
hyperfine couplings. The total anisotropic hyperfine coupling tensor, T of matrix, Ti;j in this
case can be calculated from the ground state wavefunction:
Ti;j =
0
4~
ge B gn n

 0
3rirj   @ijr2r5
 0 (1.11)
In special cases, such as a proton or alkaline metal which have no significant spin density in
p-, d- or f- orbitals the anisotropy can only occur from through-space dipole-dipole coupling
to other spin density centres, though this is not significant to this investigation. For protons
a good approximation is to assume only spin density at the central ion.
As with the electron Zeeman, orbital angular momentum has a small contribution to the
dipole-dipole coupling in hyperfine coupling. As a result a small correction factor for the
dipole-dipole hyperfine tensor is required
Add =
g T
ge
(1.12)
Yielding the final hyperfine tensor Ak in equation 1.9 as
12
1.3. Basic EPR theory
Ak = aiso;k  1 +
g T k
ge
(1.13)
1.3.3. Nuclear quadrupole interaction
With nuclei of spin Ik > 1/2 there are 2 or more centres of magnetism within the nucleus.
Whilst each sourcewill behave as a dipole and yield a dipolar field in isolation, the close prox-
imity of the centres dampens the dipole moment and yields a quadrupole moment. Typi-
cally the nuclear quadrupole interaction does not contribute significantly to the EPR signal
unless it is of the same order of the hyperfine coupling to the nucleus. Usually, this only
occurs in heavy elements in the third row of the periodic table. However, in electron-nuclear
double resonance (ENDOR), electron spin echo envelope modulation (ESEEM) and hyper-
fine sub-level correlation (HYSCORE) spectroscopy investigations the nuclear quadrupole
effect needs to be considered. In EPR the nuclear quadrupole Hamiltonian for a single spin
is written as
H^NQ = I^ P I^ (1.14)
where the principle values of the nuclear quadrupole tensor are given as
Pz =
e2 q Q
2I(2I   1)~ ; (1.15)
Px   Py =  Pz ; (1.16)
and
Px + Py + Pz = 0 : (1.17)
In the high field approximation the nuclear Zeeman ismuch larger than the quadrupole inter-
action energies. This allows the evaluation of the nuclear quadrupole as the product of the
square of nuclear spin quantum number and the effective nuclear quadrupole interaction.
1.3.4. Zero field splitting / fine structure
In the case of many electrons about a nucleus the electrons will distribute degenerately
first singly occupying each orbit according to Hund's rule as electron pairing is a higher
energy state. In the presence of a ligand field that removes orbital degeneracy to the extent
that orbital seperation is greater than spin pair repulsion, then spin pairing will be favoured.
Depending upon the strength of the ligand field several electrons may be unpaired in high
spin states or paired as far as possible in the low spin state.
In the case of transition metals all unpaired electrons stay mostly with the metal, the elec-
trons remain so close in space and coupled such that they cannot be individually excited.
In this case it is appropiate to consider the many electrons as a single collective group. For
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example Fe3+with electron configuration 3d5, with weak ligands assumes a S = 5/2 high
spin state (5 unpaired electrons, 3 low spin, 2 high spin), whilst in a strong ligand field with
4 electrons coupled has a low spin state of S = 1/2 (4 paired electrons, 1 unpaired, all low
spin). Note that a transitionmetal does not have to be high spin to exhibit zero field splitting.
In the case of a 3d4 system, a S = 1 state can occur from all electrons being low spin, with
2 electrons pairing and 2 remaining unpaired.
In the case of the high spin Fe3+ (S = 5/2) and other S > 1/2 cases, the d-orbitals are not
symmetricalwhich creates a small distortion not entirely dissimilar to the nuclear quadrupole,
a magnetic effect which would be present even in the absense of an external magnetic field.
The spin Hamiltonian for zero field splitting is
H^ZFS = S^
T D S^ (1.18)
whereD is the zero field splitting tensor. In the principle axes frame of this tensor the Hamil-
tonian can be written as
H^ZFS = Dx S^
2
x +Dy S^
2
y +Dz S^
2
z (1.19)
1.3.5. Exchange coupling
When two unpaired electron spins, S1 and S2, of S = 1/2, such as two nitoxide radicals, are in
close proximity up to approximately 15 A there is a significant overlap of the singly occupied
molecular orbitals, which allows the electrons to exchange [48]. The exchange interaction
allows for a splitting between the singlet (S = 0) and triplet (S = 1) states. If this splitting is
small then transitions between singlet and triplet state can be excited in the EPR experiment,
but it is oftenmore convenient, especially at longer distances, to consider the system as two
individual spins.
The exchange term of the spin Hamiltonian is given as
H^EI = J S^1 S^2 = J(S^1xS^2x + S^1yS^2y + S^1zS^2z) (1.20)
This term describes a purely isotropic coupling, whilst anisotropic contributions to the ex-
change coupling can occur, this only occurs for heavy elements and can be neglected for
the purposes of this investigation.
The high field approximation of the energy contribution of the exchange interaction is pro-
portional to the product of spin quantum numbers of both spins and J . However, a more
practical approximation for nitroxide systems is that the exchange interaction decays ex-
ponentially with distance between the spins subject to the magnetic conductivity of the
medium. In systems where J is significant, such as copper acetate, this approximation
cannot be made.
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1.3.6. Dipole-dipole coupling
In systems with large g anisotropy or where the sample is derived from a frozen solution,
as is the case in biological systems, the magnetic coordinate frames are highly unlikely to
be parallel to the external magnetic field. When 2 spins are considered then, neither will be
aligned with the field or with each other. The energy between spins and the spin Hamilto-
nian describing that energy will therefore be a product of the angles between the spins, ,
the angle of each spin to the magnetic field, , and the distance between the spins. This
interaction is shown graphically in figure 1.5 and mathematically derived as:
E =  0
4
: 1 2 :
1
r3
: (2 cos 1 cos 2   sin 1 sin 2 cos) (1.21)
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Figure 1.5 Coupling between two magnetic moments, ~1 and ~2 in a general orientation to the magnetic field
with angles, 1, 2 and 
with the dipole-dipole coupling term in the Hamiltonian becoming:
H^dd = S^1D S^2 =
1
r3
:
0
4~
: g1 g2 B

S^1 S^2   3
r2
(S^
1
\
r
)(S^
2
\
r
)

(1.22)
In the special case when anisotropy is so small that orientation can be neglected when cal-
culating H^dd, as in two organic radicals when S = 1/2 and gxy  gxz  gyz , the dipole-dipole
tensorD has the principal values  !dd, !dd and 2!dd where
!dd =
1
r3
:
0
4~
: g1 g2 
2
B (1.23)
Whereupon the orientation of the molecule can be characteristed using a single angle, ,
between the magnetic field and spin-spin vector, shown in figure 1.6
d() = (3 cos2    1)!dd (1.24)
When the g tensors for each spin are approximately equal to ge an approximation of the
coupling in frequency units is
dd =
52:04MHz
r3 nm
(1.25)
when
dd =
!dd
2
(1.26)
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Figure 1.6 Coupling between two isotropic magnetic moments, 1 and 2 in a single orientation to the magnetic
field with angle, 
With typical transverse relaxation times in electrons being in the order of a fewmicroseconds
dipole-dipole couplings can be measured to around 100 kHz, corresponding to a distance
of 8 nm [102, 103].
1.4. Continuous wave versus pulsed EPR
For a long time, due to the technological demands of such small time scales and difficult
electromagnetic radiation frequencies, EPR had been a continuous wave (cw) spectroscopy.
AswithNMR the field has received substaintial gains in sensitivity and shortened experiment
time by moving from a continuous application of radiation to a pulsed Fourier transforma-
tion (FT) process. Bymeasuring in the time domain and usingmulti-dimensional techniques
more data than could ever have been previously imagined can be obtained. However, un-
like in NMR, continuous wave EPR techniques still provide invaluable information and looks
unlikely to be replaced.
In the most basic setup, pulsed-EPR involves using a short (nanosecond) and intense (hun-
dreds of Watts) burst of microwaves to excite the sample and move the Boltzmann distri-
bution from thermal equilibrium. After a brief delay, the subsequent relaxation back to the
lower thermodynamic energy Boltzmann distributed ground state is recorded. This gives
data in the time domain which can be Fourier transformed into the frequency domain.
The most common analogy for the differences between cw and pulsed EPR is that of tuning
a bell. If given an unknown bell and assigned to finding the frequency spectrum of the bell,
one approachwould be to apply a low power frequency generator to the bell and slowly scan
through all the frequencies and listening. Any sound detected is as a result of acoustic res-
onances in the bell; this is analogous with cw-EPR. This approach takes a long time to scan
through the frequency range if a reasonable resolution is desired. The second approach
would be to strike the bell with a hammer and a large amount of energy. The bell will imme-
diately resonate to disperse the energy. The ringing noise is an overlay of all the acoustic
resonances at multiple frequencies. Recording the decaying noise, digitizing the sound and
performing a Fourier transformation gives the frequency spectrum of the bell. In one short
experiment the whole spectrum can be acquired, this is called themultiplex advantage. This
was not possible with EPR until the development of fast desktop computers as performing
Fourier transformations of complex signals is computationally difficult.
By extending the metaphor a few technical problems become apparent. The detector (in
this case a microphone) cannot record resonances at the point in time when the hammer
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strikes the bell, otherwise all that is heard is the noise of the application of the hammer and
not the bell. The hammer noise will also be much louder (single event energy transfer) than
the desired resonances to be recorded, typically this would overload a detector optimised for
listening to the resonances. Secondly, because frequencies are being measured the collec-
tion time needs to be as long as possible, however, with time each oscillation is dampened
and amplitude is lost. By increasing the experiment lifetime the number of observed oscil-
lations is increased, which reduces uncertainty in the wavelength, but this is not compatible
with fast relaxing species. Finally, the experiment cannot be repeated until the bell has re-
turned to equilibrium with its environment, something which is incompatible with extended
lifetime experiments.
1.5. Continuous wave EPR
1.5.1. EPR characteristics of nitroxides
The unpaired electron of the nitroxide radical is located mainly in a  bond formed by the
nitrogen and oxygen atoms' pz orbitals. Some characteristic s orbital spin density can be
seen from sp hybridisation of the N-O bond, but very little further delocalisation onto the
carbon atoms is seen. The g tensor for nitroxides differs slightly from the ge as a result
of the spin orbit coupling of low lying excited states that have unquenched orbital angular
momenta upon the oxygen atom. The greatest deviation is seen in the gx, along the N-O
bond, with some in gy and almost none in gz . By contrast the greatest hyperfine coupling to
the 14N is seenwhen the externalmagnetic field is aligned parallel with the pz orbitals, whilst
hyperfine coupling in molecular x and y directions is small. A typical nitroxide will therefore
have tensors such gxx = 2.0090, gyy = 2.0060, gzz = 2.0030,Axx =Ayy = 18MHz andAzz = 96
MHz. In a nitroxide with very fast motion, ie. free in solution or bound to a mobile location
of a small protein then some hyperfine coupling to surrounding carbons can be seen but
usually the motion is too slow and the carbons contribute only to line broadening.
The EPR spectrum of a nitroxide in a single orientation or undergoing fast rotation yields 3
equally sized lines. The electron Zeeman splitting in a magnetic field yields 2 energy levels.
The 14N nuclear Zeeman further splits each energy level into 3 (I = 1, where 2I + 1 = 3).
However, considering only electron and nuclear Zeeman contributions the allowed energy
transitions are degenerate, as each is the same energy difference and would yield only a
single line spectrum. The hyperfine coupling of the electron spin to the 14N nuclear spin
results, when spins are parallel (aligned), spin repulsion results in an increase in the energy
level, as can be seen in figure 1.7. However, when spins are anti-parallel (of opposite sign)
there is an energy drop. This creates three transitions, the ms =  1/2; mI = +1 to ms =
+1/2; mI = +1 now has a larger difference in energy, the ms =  1/2; mI =  1 to ms =
+1/2; mI =  1 is reduced in energy and the ms =  1/2; mI = 0 to ms = +1/2; mI = 0
remains unchanged. With a different energy for each of the three transitions, there are now
three resonance conditions resulting in a three line spectrum. In analysis of the fast regime
spectra, the centre line corresponds to isotropic g value (giso = (gxx+gyy+gzz)/3) with the two
additional lines split according to the isotropic A tensor (2Aiso = (Axx+Ayy+Azz)/3).
At the other extreme, the single crystal spectrum of a nitroxide shows the centre line at the g
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Figure 1.7 Energy level diagram of electron Zeeman, nuclear Zeeman and 14N hyperfine interactions in a contin-
uous wave EPR spectrum of a nitroxide radical
value positioned along the magnetic field direction in the molecular frame, with the splitting
determined by the hyperfine coupling in this direction. In the case of a powder, or frozen
solution, with multiple spins the resulting spectrum is the superposition of all orientations
with proper weighting, such that there are 3 peaks corresponding to each g value and the 2
outer peaks are split by 2Azz .
1.5.2. Mobility
Rotational motion can best be thought of in nitroxides as a multi-stage process between
different orientations where the exchange rate is related to the rotational diffusion time, R,
through
R =
1
6r
(1.27)
where r is the rotational correlation time. In slow exchange the spectrum is broadened, but
as the motion becomes faster, exchange between orientations results in averaging of the
resonance frequencies resulting in an apparent reduction of 2Azz , visually seen experimen-
tally as the 2 outer peaks moving closer to the central peak.
By analysing the line shapes of the spectra, information canbegathered about themobility of
nitroxide. In the fast regime, thewidths of the three lines are identical as a result of averaging
toward giso. In the slow regime a powder spectrum is obtained. However, in the intermediate
regime the linewidths are different. The central line withmI = 0 has the smallest linewidth
as a result of having the smallest difference in resonant frequencies. The high field line, with
mI =  1, is the broadest as it has the largest range exchange interactions and therefore
in resonant frequencies. Only at very fast motion (> 10 ps) do the line shapes and widths
become equal as other factors become the major contributers to line broadening. Using
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Kivelson theory it is possible to calculate the relaxation time for the central line using analysis
of line shapes and width [52].
1.5.3. Accessibility
The g and hyperfine tensors of the nitroxide depend upon the spin distribution of the elec-
tron across the bond and atoms. This distribution will depend upon the polarity of the en-
vironment. In a hypothetical polar environment the oxygen could exist in the charged O 
state and be stabilised by the polar environment whilst the electron could be located upon
the positively charged nitrogen atom, N+. In a non-polar environment, the charged polar
states cannot be stabilised by the environment and thus the nitroxide atoms will preferen-
tially sit in an uncharged state and so the electron will reside mostly upon the oxygen, O,
with an uncharged nitrogen.
In a polar environment with the electron contributing most spin density to the nitrogen, N ,
the isotropic hyperfine coupling from the 14N increaseswith the increased spin density in the
pz orbital (Azz). As the hyperfine tensor increases the g tensor decreases from ge, as spin
density has been withdrawn from the high energy excited states upon the oxygen, which
further changes the g tensor as the energy levels between the lone electron and the lone
pairs on the oxygen changes. Furthermore, hydrogen bonding to the lone pairs on the oxygen
causes a small amount of delocalisation of the lone pair orbitals and an adjustment in the
gxx tensor.
By placing paramagnetic quenchers near a nitroxide spin label, Heisenberg exchange of un-
paired electrons can occur between the nitroxide and the quencher. The quench rate will be
directly proportional to the concentration of the quencher. A common laboratory quencher
is diatomic oxygen that exists as a triplet in the ground state. Diatomic oxygen has two elec-
trons in degenerate orbitals, which the exchange interaction splits into 1 singlet state (S = 0)
and 3 triplet states (S = 1); Hund's rule states that the singlet state will be higher in energy
than the triplet states, giving oxygen a non-zero spin in the ground state so it is paramag-
netic. Diatomic oxygen is more soluble in apolar environments such as lipid bilayers than
in polar environments such as water. Water soluble quenchers usually consist of transition
metals stabilised in soluble ligands such as the uncharged Ni(II) ethylendiaminediacetic
acid (EDDA)(NiEDDA) or negatively charged Cr(III) tris-oxalate ([Cr(C2O4)3]3 ). At high
concentrations the quenchers will cause line broadening through excessive exchange in-
teraction. At lower concentrations the relaxation influence can be quantified using power
saturation experiments.
In a saturation experiment the microwave power is increased where the amount of spins
exciting and contributing to resonance increases in a linear fashion, yielding an increase in
signal intensity. Approaching the saturation point, the amount of microwave energy being
applied to the sample increasingly matches the rate of excitation with the rate of decay,
yielding no net increase in resonance. Any further increase in microwave power begins to
saturate the sample, whereby the rate of excitation exceeds the rate of decay to the ground
state resulting in a loss of signal.
The rate of relaxation is purely through collisions of the quencher with the nitroxide. If the
longtitudinal relaxation time of the quencher is shorter than the lifetime of quencher/nitrox-
ide complex then the exchange rate,Wex, can be expressedly as follows
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=Wex = kexC (1.28)
where kex is the exchange rate constant and C is the quencher concentration. In the case
that the quencher concentration is kept low the exchange rate can be assumed to be much
less than 1/T2. Wex can be determined from the saturation curves by measuring the first
derivative peak-to-peak amplitude, A, of the central line of the nitroxide spectrum (mI = 0)
against the applied microwave power, P using
A(P ) =
I
p
Ph
(1+(21/ 1))P
P1/2
i (1.29)
with I the power independent amplitude factor, P1/2the power at half saturation and  the in-
homogeneity paramater, typically 1.5, but can be as low as 0.5 for inhomogeneous samples.
More correctly, P1/2 is the microwave power when the peak-to-peak amplitude is reduced to
half of its unsaturated maximum. Given by
P1/2 =
3
p
4  1
2e 
2 T1 T2
(1.30)
where = B1/pP is the conversion efficiency of the spectrometer resonator. When quencher
concentration is low, exchange broadening is small and T2 is constant despite the presense
of the quencher. Thus the change in P1/2 can be simplified to
P1/2 =
 
3
p
4  1Wex
2e 
2 T2
(1.31)
To remove the spectrometer dependency on  and sample dependency on T2, the P1/2 is
converted into a dimensionless accessibility parameter, , defined as:
 =
[P1/2/Bpp]sample
[P1/2/Bpp]reference
= Wex (1.32)
where  is a constant derived experimentally by comparison of line broadening and satu-
ration values, Bpp is the change in peak to peak width (in the magnetic field), where the
denominator is obtained by the measurement of a known standard such as a magnetically
dilute diphenylpicrylhydrazyl (DPPH) solution in the same spectrometer.
The fundamentals of these experiments were extensively investigated by Altenbach of the
Hubbell group on T4 lysozyme [1, 81]. Later work particularly in the implementation of power
saturation experiments on transmembrane and membrane-interacting proteins has been
conducted on colicin A by the Steinhoff group [72].
1.5.4. Multiple frequency EPR
The majority of nitroxide based EPR study remains at X-band (9-10 GHz, 0.3 T ), however
experiments conducted at high field/frequency such as at W-band (~94GHz, 3.4 T ) allows
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the opportunity to offer new quantitative and qualitative data. The main transformations
in line spaces occur around 1.1 T , above this point the magnitude of Zeeman anisotropy
dominates over the 14N hyperfine coupling in the spin Hamiltonian. With further increases
in field/frequency the g tensors are better resolved. At X-band, the nitroxide spectrum is
dominated by axial hyperfine coupling and signal averaging from molecular motion. At W-
band as the rhombic Zeeman term becomes dominant new information on protein structure
and dynamics becomes accessible. At higher fields, the Larmor frequency is also higher
which can be used to deconvolute label motion from labelled small proteins [106].
Developments in high field EPR were long hampered by technological issues, but recently
has seen adramatic increase in development thanks to improvements in quasi-optical bridges,
digital electronics engineering and microwave technologies (thanks to mobile telecommu-
nication industry demand). At the same time improvements in cooling such as cryogen-free
superconductingmagnets have significantly reduced the operating costs of such spectrom-
eters.
One notable feature of nitroxide spin-label EPR is the ability to provide detailed information
upon the complex rotational motion of the spin-labelled molecule. In a molecule that has
been spin labelled, the paramagnetic centre is undergoing random motion and therefore is
undergoing stochastic reorientation of the molecule relative to the external magnetic field.
Thus, the polar  and  angles between the external magnetic field and molecular coorid-
inate system are constantly changing in a time-dependent fashion. As a result, the spin
Hamiltonian becomes time-dependent as the magnetic properties of the system vary such
that g = g(t) and A = A(t). It is easiest to consider the time dependent spin Hamiltonian in
isotropic,H0, and anisotropic,H1(t), parts, such that
H = H0 +H1(t) (1.33)
Where the anisotropic part is given as
H1(t) =
h
B ~B : [g(t)  giso] : S^
i
+
h
hS^ : [A(t) Aiso] : I^
i
(1.34)
where S^ and I^ are the electron and nuclear spin operators. The isotropic parameters are
defined as
giso =
gxx + gyy + gzz
3
(1.35)
Aiso =
Axx +Ayy +Azz
3
(1.36)
If the time dependency arises solely from molecular motion the isotropic part will not fluc-
tuate with time but the anisotropic part will. Fluctuations in the anisotropic part will cause
modulations in the energy levels and therefore the resonance frequencies, giving rise to a
single EPR transition line occuring at multiple positions and generating line broadening.
Notice that the first term in the time-dependent Hamiltonian (equation 1.34) reflecting the
electron spin is proportional to the magnetic field. Whilst the second term, reflecting the
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hyperfine interaction is field independent. By increasing the magnetic field we would there-
fore expect the contribution from the anisotropic Hamiltonian to increase causing protein
motion to appear in the slow motion regime. The increased anistropy also has the result of
broadening the spectral width and enhancing sensitivity to molecular motion. Conversely,
by decreasing the magnetic field the contribution from the time-dependent Hamiltonian is
reduced, dropping the spectral width, resulting in the collapse of g tensors toward giso.
1.5.5. Line broadening
The first derivative absorbance spectrum of a nitroxide spin label at the rigid limit typically
has a linewidth of 0.4 mT (11.2 MHz). A broadening of upto half this width from dipole-
dipole interactions can be measured with confidence without distortion. Using equation
1.25, this corresponds to an upper detection limit of 21 A. In special circumstances when
each of the spin labels are in near identical environmental conditions, and line broadening
contributions are largely unresolved hyperfine couplings to methyl carbons, the limit can be
slightly extended and with deuteration of the spin label distances upto 25 A can be resolved.
In hydrogen bonding or polar environments, when the spin labels have different tensors,
additional broadening of the signal occurs and the detection limit drops to approximately 16
A.
The interspin distance can only be deconvoluted when a high precision spectrum for each
individual label as well as the combined spectrum exists. The doubly labelled spectrum is
fitted by convolution of the sum of the singly labelled spectra. Thismethodworks best when
both labelling sites are completely labelled though underlabelling can be compensated for
this can be relaxed using a superposition of the diploar broadened and unbroadened spec-
tra, however it is less accurate and more computationally expensive. In extreme situations
simulated spectra can be used in place of one of the singly labelled species.
1.6. Pulsed EPR theory
1.6.1. Magnetization in the laboratory frame
In order to describe electron position and motion accurately requires the use of an axis sys-
tem. Most people are familiar with the Cartesian or laboratory frame that uses the standard
x, y, z system of 3 perpendicular axes. The laboratory frame in EPR is described such that
themagnetic field,B0 is parallel to the z-axis (horizontal in the lab), themicrowavemagnetic
field, B1 is parallel to the x-axis (vertical in the laboratory), whilst the y-axis is orthogonal to
the x and z-axis (also horizontal in the laboratory, but into space not the magnet).
According to classical physics, an electron having mass and spin has angular momentum
(ie it would require energy to stop it), a product of its mass and velocity. When this electron
is put into a magnetic field, a torque (turning force) is exerted which causes the electron to
precess about the z-axis. Think of a wheel spinning with its axis tied to a piece of string. If
there were no gravity then the wheel would be free to spin in any direction, with the inclusion
of gravity the wheel hangs by the piece of string (axis pointing down, wheel spin horizontal)
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aligned parallel with the field (gravity). By moving the axis by a few degrees the wheel can
be seen to be rotating about the z-axis (this is always true, it is just that at very small angles
this cannot be seen). This rotation about the z-axis is called precession, and is independent
of the angle from z. The speed, or more correctly the frequency, of this precession is called
the Larmor frequency and is related to the magnetic field by
!L =   B0 (1.37)
Where !L is the Larmor frequency,  is the proportionality constant known as the gyromag-
netic ratio and B0 is the magnetic field. A free electron has a gyromagnetic ratio of ~ 2.8
MHz/G, which given a typical X-band experiment at 9.75 GHz, yields a magnetic field of
3480 G.
Figure 1.8 Diagram explaining the variations in angular momentum a) shows in 2 dimensions the effect of mass
in a circular path; r is radius, , the angle from x, v the velocity b) shows that spin when parallel to the
force of external magnetic field c) shows spin at an angle that is not along the z-axis d) shows that the
torque (as of a result of the forces in c) cause a precession around the z-axis. The actual position of an
electron can be anywhere around the edge of the top of the cone, it is simply more convenient to show
this as a solid cone.
In any given sample there is not simply one molecule, there are several hundreds of thou-
sands. In the classical model, an electron is treated as a single sphere which is not sufficient
to explain all phenomena that arise frommagnetic resonance. To consider the full situation
a quantum model is needed in which the magnetic spins of the elementary particles can
be considered to have 2 different spin axes pointing either up or down. In the absence of
an external field these spins are identical in energy and are at thermal equilibrium with ex-
actly half the population in either state. However, upon the application of a magnetic field
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the up energy state is aligned with the external magnetic field and as a result experiences
a drop in energy. Alternatively, the particle can align against the external field (down) and
rises in energy to an excited energy state. As this phenomenon is quantum in nature there
are no possible intermediate states. The energy difference between the two states is directly
proportional to the strength of the external magnetic field.
The number of electrons in either state follows Boltzmann distribution dynamics, but as
the aligned, parallel state is lower in energy this will be the most populated state. The net
magnetization, the sum of all the magnetic moments in the sample, will therefore be along
the z-axis as the majority of electrons whilst randomly scattered about the xy plane will be
precessing around the positive z-axis cancelling any net effect.
1.6.2. Magnetization in the rotating frame
Magnetization of a sample can result in incredibly complicated incurrent motion, with mo-
tions happening in three dimensions whilst rotating (think narrowing corkscrew). A useful
technique to simplify the mathematics and to allow understanding is to switch from a static
frame to a rotating one. The classic analogy of this effect involves a carousel and two peo-
ple trying to have a conversation, whilst one is on the carousel and the other is not. In a
static frame example, the observer is stationary and so meaningful conversation can only
be held as only a few brief words exchanged per revolution. If the observer now walks at the
same speed as the carousel is rotating then the two people can talk continously as if they
were not rotating at all. Of course this setup has more benefits, if the observer was trying
to measure the riders speed (given they knew their own speed) or how often the carousel
horse moved up and down this is much easier from a rotating frame (when the observers
frame is approximately equal to the carousels precession and so appears static within the
frame of reference).
EPRexperiments use linearly polarizedmicrowaves designed to produce amagnetic field,B1
perpendicular to the appliedmagnetic field,B0. Linearly polarized electromagnetic radiation
can be thought of in one of two ways. First it can be considered as an oscillating magnetic
field (sine wave). Alternatively, and perhaps far more usefully, it can be thought of as two
separate magnetic fields rotating in opposite directions to each other at the same rate. If
both have a value of 1/2 then when they both align they give a value of 1, 45 later in the
sine wave the total magnetization value is 1/2 as both fields have both dropped to 1/4, at 90
through the sine wave each field is opposing and negates the magnetization to give a value
of 0 and so on.
To simplify the mathematics of looking at a constantly moving coordinate system the coor-
dinate system is moved at the same rate to create a rotating frame of reference when
!L = !O (1.38)
where!O is themicrowave frequency. Bymaking the coordinate system rotate at the Larmor
frequency,!L, one component ofB1 appears stationary (the other components now rotate at
an apparent 2!O and thus can be neglected). The rotating frame also makes magnetization
components rotating at the Larmor frequency appear stationary.
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Equation 1.37 showed that with a magnetic field the magnetization precesses around the
direction of magnetic field. Thus we can extend this to B1
!1 =  B1 (1.39)
Where !1 is also known as the Rabi frequency. If we assume that B1 is parallel to the x-
axis then the magnetic field will now rotate along the +x axis for as long as microwaves are
applied.
The angle with which the bulk magnetization,M0, is rotated (away from the z-axis) is equal
to
 =   jB1jtp (1.40)
Where  is the angle from z,  is the gyromagnetic ratio and tp is the length of the pulse.
Pulses are often labeled by their resulting tipping of the bulk magnetization vector, the most
common of which are /2 (90) and  (180). However, the tip angle of a pulse varies both
with the length of the pulse and the magnitude of B1.
Note that when the bulk magnetization lies along the z-axis and a field, B1 is applied along
the x-axis, the resultingmagnetization lies along the y axis (Fleming's left hand rule). Also,
as B1 is applied parallel to the x-axis it is known as a+x pulse. By shifting the phase of the
microwaves by 90 B1 would lie along the+y axis and the magnetization would lie upon the
+x axis, hence pulses are labelled by both their tip angle and which axis they lie parallel to.
1.6.3. Free induction decay and off resonances
It is important to remember that whilst in the rotating frame that after a pulse, the bulk mag-
netization lies along the -y axis and is stationary, whilst in the laboratory frame this is actually
rotating through the xy plane at the Larmor frequency. This rotation of charge creates cur-
rents and voltages in the resonator, using the same principles as a generator, and is called
the free induction decay (FID)
Thus far we have only considered the conditions behind exact resonance; when the mi-
crowave frequency exactly matches the Larmor frequency. However, in any given sample
there will be many different frequencies, of which not all can be tuned to be on-resonance
at once, making it necessary to consider what happens to off-resonance signals.
Let us first consider the rotating frame of magnetization, with frequency ! following a 90
pulse. At the end of the pulse the magnetization will be aligned to the -y axis. However, as
the frequency does not equal the Larmor frequency the magnetization will appear in the xy
plane, rotating faster or slower than the microwave magnetic field. The apparent rotation
rate will be equal to the difference
! = !   !0 (1.41)
When ! = 0 the rotation rate is zero appears stationary in the rotating frame, which is
exactly what is expected for on resonance. If ! > 0 the magnetization is gaining and will
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rotate in an anticlockwise direction, similarly if ! < 0 the magnetization is losing and will
rotate in a clockwise direction within the rotating frame.
This behaviour of rotating faster or slower than the reference frame gives detail toward how
the free induced decay is encoded as each individual resonance frequency will appear as
a magnetization component rotating in the xy plane according to !. By measuring the
magnetization in the rotating frame and knowing the rotating frame frequency, the frequency
components can be extracted and used to construct the EPR spectrum.
Earlier, it was stated that in an on resonance state that B0 disappears. However, in off res-
onance conditions B0 cannot be ignored and as a result the microwave magnetic field, B1,
tips the magnetization into the xy plane differently.
! =   B0 (1.42)
Now the magnetization is not tipped by B1 alone, instead by the vector sum of both B0 and
B1, the effective magnetic field,Beff . AsBeff is the combination of two fields it follows that
the precession frequency is the faster sum of precessions
!eff =
p
(!1)2 + (!)2 (1.43)
Beff is a combination of vectors in the z and x-axis, resulting in the magnetization not lying
in the xy plane as B1 does but, instead, its motion is that of a cone as shown in figure 1.9.
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Figure 1.9 The effective microwave magnetic field in the rotating frame
Themagnetization tipped toward thexy plane actuallymoves in an oscillatingmannerwhich
decreases as the precession frequency increases (which is expected if we think back to the
classicalmodel, a spinning top that spins fast enoughwill always right itself). This oscillation
is defined such:
M y =M0  1r
1 +

!
!1
2  sin
0@s1 + !
!1
2
 
2
1A (1.44)
In the case of a broad EPR spectrum from a wide range of frequencies (! > !1) the signal
is greatly diminished as the tip from the /2 pulse will align fewer spins to be coherent in the
xy plane and thus be detectable. For this reason it is important to maximise !1 for broad
signals to maximise the detectable signal. This is experimentally acheived by using short
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Figure 1.10 The effect of varying the pulse length in pulsed-EPR, these spectra show the same sample of peri-
naphthenyl radical. Shorter pulses maximise spectra resolution. Adapted from Elexsys E580 User's man-
ual
pulse lengths (see figure 1.10) and a significant technological hurdle in the development of
pulsed EPR techniques was the accurate generation of pulses of such small lengths.
1.7. Pulsed EPR applications
1.7.1. Relaxation times
Thus far it has been assumed that a /2 pulse transfers the bulk magnetization from the
z-axis into the xy plane. In reality the electrons are constantly interacting with their environ-
ment. To maintain magnetization in the xy plane is a higher energy state than to align with
the laboratory magnetic field. As a result magnetization about the xy plane will decay and
slowlymove back toward the z-axis. This process, called relaxation, is governed by two con-
stants. T1, the spin lattice relaxation time which describes how quickly the magnetization
returns to the Boltzmann distribution about the z-axis and T2, the transverse relaxation time
which describes how quickly the coherence in magnetization in the xy plane dissippates.
The result of the /2 pulse is an immediate Fourier induced decay of the electronmagnetiza-
tion of frequency corresponding to the microwave pulse bandwidth. As almost all samples
exhibit inhomogeneous broadening that extends beyond the pulse bandwidth a small num-
ber of spins are excited and relax very quickly.
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Figure 1.11 Upon the application of the pulse, all magnetization lies along -y (as shown left diagram). With time
fanning out about xy occurs (right diagram, faster spin shown lighter), decreasing the magnetization
1.7.1.1. Transverse relaxation
The transverse relaxation time, T2, corresponds to the decay of magnetization about the xy
plane. Typically, this constiutes two types of broadening mechanism: homogeneous and
inhomogeneous broadening.
Inhomogeneous broadening is a result of several unresolved couplings overlapping one an-
other. Spins across a sample will experience a number of different magnetic fields arising
from unresolved hyperfine interactions. The difference between each interaction is so small
that each coupling overlaps and gives a Gaussian distribution of spins.
The Gaussian shape can be explained when considering that the local fields will produce a
large number of electrons in the xy plane all precessing at various, non-zero frequencies. All
electrons will only be approximately equal to the Larmor frequency, !, causing a fanning of
the net magnetization (as thermal equilibrium is seeked); the Gaussian shape appears from
the average frequency. Summing all the spin packets together results in a cancellation of
terms (see figure 1.11). This characteristic time decay constant is called T 2 (T two star)
Homogeneous broadening is a result of each spin packet experiencing the same magnetic
field. The resulting spin packets interact with each other causing mutual or random flipping
of one or both spins. This induced flip-flopping between spin states contributes to a faster
fanning action (loss of coherence) via a normal general exponential Fourier induced decay
(FID):
M y(t) = e
  t
T2 (1.45)
Where T2 is often called the spin-spin relaxation time. This form of line broadening results in
Lorentzian shaped broadening as opposed to typical inhomogeneous broadening that gives
Gaussian shaped broadening. This is a result of the Fourier transformation, where a quickly
decaying signal in the time domain gives a broad peak in the frequency domain and slowly
decaying signal in time gives a narrow frequency domain peak.
Typically an echo detected pulse sequence (/2----echo, figure 1.12) is used but a 2/3-
-2/3--echo can occassionally give better signal intensity. In this sequence the /2 pulse
excites coherence with amplitude cos  on the two allowed transitions and coherence with
amplitude sin  on the two forbidden transitions. During the first time delay,  , coherence
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π
2 π
τ1τ1
Figure 1.12 Echo detected EPR pulse sequence
evolves and decays with the transverse relaxation times T2a or T2f . The  pulse inverts the
phase of all coherences and refocuses themagnetization such that after another time delay,
 , the spins converge to coherence to give an echo that smoothly decays with respect to the
relaxation rate.
2π
3
2π
3
τ1 τ1
Figure 1.13 Moving pulse 2 pulse ESEEM experiment pulse sequence
To experimentally measure the transverse relaxation, a modified 2 pulse ESEEM pulse se-
quence, shown in figure 1.13, is used. Stepping the second pulse, as well as the detection
point allows the decay to be recorded and analysed.
The  pulse changes the nuclear spin state with a probability of sin2  corresponding to a
transfer in coherence between the different phase transitions. Each transferred coherence
will experience a phase inversion and will oscillate with the difference of the transition fre-
quency, allowing for the nuclear frequency to be seen in the free induced decay. A simple
Fourier transformation of the decay trace will reveal the nuclear frequency of the atom on
which the electron is located.
1.7.1.2. Inversion recovery
When electrons are placed inside amagnetic field, quantummechanics allows for two states
to be occupied; aligned parallel or anti-parallel to the field. Themoments of the electronswill
be distributed randomly with a slight majority in the lower energy, parallel to the magnetic
field. The system obeys Boltzmann distribution statistics; whereby the system will find the
lowest energy state of thermal equilibrium through a mix of enthalpy and entropy. The ratio
of the two states can thus be defined as
nanti parallel
nparallel
= e 
E
kT (1.46)
Where n represents the populations of the two states,E is the energy difference between
the two energy states, k the Boltzmann's constant and T the temperature (in Kelvin).
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Figure 1.14 Inversion recovery experiment pulse sequence
The bulkmagnetization so far discussed is actually the net vector of parallel and anti-parallel
states. At equilibrium more electrons will be aligned parallel, the bulk or average magnetic
moment of the sample is therefore parallel with the field. The magnetic moment is propor-
tional to the populations of both states; with greater numbers of electrons aligned paral-
lel yields a larger magnetic moment. Thus, a more concentrated sample (a sample with a
higher number of total spins) providesmore signal, so long as it remainsmagnetically dilute.
However, achieving a larger magnetic moment requires distorting the Boltzmann distribu-
tion and requires the application of energy.
The difference in the physical number of electrons between states is not required to be very
high as spectroscopy measures the transitions between states and not the population of
the states. A typical X-band EPR experiment at room temperature (300 K) has 50.04% of
the electrons aligned parallel and 49.96% anti-parallel, a difference of 1 in 125.
By applying a /2 pulse, what actually occurs is that the populations in the two energy states
(parallel and anti-parallel) are equalled giving no net magnetization in +z or -z. However, the
movement of electrons between states creates a magnetic moment in the xy plane, such
that the bulk magnetization is considered to be in the xy plane. Using equation 1.46 we
could find that T = 1, which whilst counter-intuitive is thermodynamically allowed as the
system is in a non-equilibrium state. Through interactions with the environment the system
will eventually return to thermal equilibrium about the z axis through a process called the
spin-lattice relaxation, T1.
By applying a  pulse the Boltzmann distribution is inverted with more electrons now lying
anti-parallel (commonly referred to as an ``inversion pulse''). Equation 1.46 in this instance
reports a negative temperature, which is thermodynamically allowedbut unfavourablewhich
drives the system back to equilibrium. The rate constant at whichMz recovers to thermal
equilibrium is the spin-lattice relaxation time, T1. The magnetization vector behaves for a 
pulse according to:
Mz(t) =M0 
h
1  e tT1
i
(1.47)
or for a /2 pulse:
Mz(t) =M0 
h
1  2e tT1
i
(1.48)
A  pulse would generate an inverted Fourier induced decay as magnetization returns to
equilibrium. Experimentally, the inversion recovery time from a single  pulse is very difficult
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to record, due to pulse imperfections and a delay between pulse application and ability to
turn on the receiver amplifier. To overcome this experimental restraint, a 2 pulse ESEEM
pulse sequence is applied to the decaying signal as a reporter sequence, shown in figure
1.14. The reporter sequence allows the detection of a Hahn echo well away from the pulses
so that the entire decay can be accurately recorded.
1.7.2. Field swept electron spin echo
By using the 2 pulse ESEEM sequence introduced in figure 1.12 and scanning through the
magnetic field, a field dependent response of the sample can be detected. This is analogous
to an absorbance scan in continuous wave EPR, but with detection being made using an
electron spin echo (ESE). This technique is frequently referred to as a field swept ESE or field
swept echo (FSE).
As with the 2 pulse ESEEM experiment for some samples, a 2/3  2/3 pulse sequence can
yield greater signal intensity than a /2  .
2π
3
2π
3
τ1 τ1
Figure 1.15 FSE experiment pulse sequence
1.7.3. Electron-electron double resonance
Pulsed electron-electron double resonance (PELDOR) also knownasdouble electron-electron
resonance (DEER) is a pulsed EPR technqiue for measuring the dipole-dipole interaction be-
tween spins across distances above 15 A. By utilising 2 differentmicrowave frequencies the
PELDOR experiment seeks to excite each spin individually. This is possible, even in the case
of 2 nitroxides, as the excitation bandwidth of each microwave pulse is significantly smaller
than the width of the nitroxide spectrum. Each frequency therefore can excite a different ori-
entation or different spin state of the 14N in each nitroxide, as the probability of both being
in identical conditions is extremely low.
π
τ1 τ1 τ2
νObserve
νPump
π
2 π
π
τ2
Figure 1.16 4 pulse PELDOR pulse sequence
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The PELDOR pulse sequence consists of several parts. One of the spins is selected as the
observer spin and a 2 pulse ESEEM sequence is used to generate a reporter Hahn echo -
/2-1--1-echo (where 1 is a delay time). To this a second part is added 2--2-echo,
where after a second delay, 2 an additional  pulse is added to refocus the Hahn echo into
a second echo. The observer  pulses excite only the subpopulation of A spins with linearly
orientated operators (electron Zeeman and hyperfine interactions) as well as the dipole-
dipole interaction between spin A and spin B.
The second microwave frequency applies only a single  pulse which exclusively excites B
spins. The excitation of the B spins by the ``pump pulse'' inverts the state of the B spins and
yields a change in the resonant frequency of the nearby A spins through the dipole-dipole
interaction dependent on distance.
The time delays of the observer sequence (1 and 2) are kept constantwhilst the pumppulse
is slowly stepped by variable t through the first Hahn echo and echo decay. As the pump
pulsemoves through the echo signal, the echo is modulated by the effect of B spin inversion
with !dd as a function of time. Using !dd and equations 1.25 and 1.26, the distance between
the spins can be calculated. Themodulation itself is not dampened by relaxation as the total
time of the experiment never changes. However, the number of observable modulations is
dependent upon the detectable time of the echo, as is the maximum detectable distance.
Thus the maximum observable time, tmax, is approximately equal to the T2 relaxation time.
In classical physics an analogy can bemade to two barmagnets aligned side by side so that
their magnetic fields are coupled. If one of the bar magnets is moved with an external force
we would expect the movement to be induced in the other. The degree of movement will
be proportional to the strength of the coupling, in this case primarily the distance between
them. By analysing the induced movement the distance between the magnets could be
calculated.
To give observable echo times experiments are routinely conducted at cryogenic tempera-
tures so as to increase the transverse relaxation time to that detectable by the spectrom-
eter. At these temperatures the transversal relaxation is mainly driven by fluctuations in
the hyperfine fields from weakly coupled neighbouring protons, hence the dropping of pro-
ton concentration, typically by deuteration of the solvent, improves signal resolution and the
observation window.
As the pump pulse has only a limited excitation bandwidth, it will excite only a small fraction
of the B spins, . It is only these spins that will contribute to echo intensity modulation, the
remaining B spins (1   ) remain independent and not contributing to the spin pair. The
PELDOR signal form factor for a given time at a spin vector angle from the magnetic field,
F (t; ) can be given as
F (t; ) = F (0) f1  () [1  cos(d()t]g (1.49)
With the final form factor, for a disordered sample being the sum of powder average, such
that
F (t) =
/2
0
V (t; ) sin d (1.50)
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A small proportion of A spins will also be inverted by the pump pulse as a result of their
interactions with neighbouring molecules. Assuming that these neighbours are distributed
homogeniously in space then they can be subtracted using a background factor:
B(t) = exp

2 g2 2B 0NA
9:
p
3~
ct

(1.51)
where the average modulation depth  is the fraction of spins excited by the pump pulse,
g is the average g value and c is the concentration of spins. When combined this gives the
final PELDOR signal as:
V (t) = F (t)B(t) (1.52)
By combination of the Fourier induced decay and the PELDOR signal form factor, V (t) the
experimental trace is given.
Due to the flexibility inherent in biologicalmolecules and nitroxide linker chains, the spin-spin
distance is not a sharply defined distance but rather a distribution. Extraction of the distri-
bution of distances, p(r), from the form factor, F (t), is an ill-posed problem where small
errors in fitting the form factor can generate large errors in the distance distribution. Er-
rors occurring from noise in the raw data and inaccurate background subtraction cannot
be avoided. One method to stabilise the solution is with additional constraints. These are
defined to be non-negative p(r) (as a distance cannot be negative) and must give a smooth
distribution. The deviation of this new constraint from the experiment can be evaluated to
give a second constraint. Using matrix algebra and a Tikhonov regularisation the subspace
can be scanned to give data that is smooth, without being over-smoothed which still yields
a good fit to the original data. This method is implemented in the software package Deer-
Analysis developed by Prof. Dr. G. Jeschke of ETH Zurich (Switzerland), which plots the log
of each parameter in the result of the Tikhonov regularisation to form a characteristically
shaped L-curve. At the steep section of the curve a small increase in the smoothing param-
eter yields a large increase in the quality of the fit. In the flat section of the curve the data is
over-smoothed and results in a poor fit to the original data. The best compromise then is at
the discontinuity of the L-curve [49].
The setup of a PELDOR experiment requires careful optimisation of parameters. Typically a
field swept echo is first performed to select optimumpositions for the pumpand observation
pulse sequences. Following the field swept echo, a tranverse relaxation time experiment
is performed to determine the maximum observation window for the echo. An inversion
recovery experiment shows the time required for the system to return to thermal equilibrium
after a pulse has been applied, this allows for the setting of the pulse shot repetition time
- the time between experiments in signal averaging. The spectrometer is then calibrated
such that the 2 pulse ESEEM reporter sequence gives the maximum signal intensity without
overloading the detector.
Spectrometer design is such that the secondmicrowave channel is completely independent
of the first in frequency, power and phase. Each of these need to be adjusted to the sample
to give maximum inversion in the PELDOR experiment. First, a modified inversion recovery
pulse sequence, shown in figure 1.17, is applied where the ELDOR channel is set to the same
frequency as the normal channels and initiates the sequence with a  pulse. This allows for
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Figure 1.17 ELDOR pulse power optimisation sequence
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Figure 1.18 ELDOR nutation experiment pulse sequence
the optimisation of the ELDOR pulse power (with zero power the echo should be entirely
positive) to achieve maximum inversion.
As the ELDORchannel uses different electronics, whilst the frequency andpower arematched
as far as possible there may still be some variation in channels. To ensure equal inversion
of  pulses in both channels an ELDOR nutation experiment is performed, shown in figure
1.18. With the ELDOR channel power optimised and frequency matched, the ELDOR pulse
begins very short and is incremented up in size whilst the inversion of the echo ismonitored.
Again maximum inversion is sought and should be approximately equal to the  pulse in the
observer channel. When the pulse is too short, not enough energy is supplied to sufficiently
move the bulk magnetisation into the xy plane; when the pulses are too long the magneti-
sation will be moved past the xy plane.
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2.1. Organisms and cells
From the 7 characteristics of life; homeostasis, organisation, metabolism, growth, adaption,
response to stimuli and reproduction [66], Linnaean taxonomy defines 3 distinct domains
that of archaea, bacteria and eukarya. Traditionally, these domains are split into the 6 king-
doms of eubacteria, archaebacteria, protista, fungi, planae and animalia [42].
The cell is the basic biological, structural and functional unit of life, common to all living
organisms and often referred to as the building block of life. The number and complexity
of cells vary greatly between species from unicellular Amoeba protea (290 billion base pair
genome) up to species such as Homo sapiens having an estimated 100 trillion cells (from a
2.9 billion base pair genome)1. The word cell comes from the Latin cellula, meaning small
room and first coined by Robert Hooke in 1665 when he observed that cork under a micro-
scope looked similar to the small rooms that monks of the time lived in [61]. However, it was
not until 1839 when it was hypothesised that cells were produced by pre-existing cells [57].
Cells have since been classified into 2 classes. The first, prokaryotic cells, are usually in-
dependent, smaller, simpler and typically classed by their cytoplasmic DNA (no membrane
encapsulated nucleus) and flagella for motility (though not always required). The second,
eukaryotic cells, are typically part of a multicellular organism, approximately 15x the size
of a typical prokaryotic cell. Characteristically, with membrane bound organelles such as
mitochondria, and DNA is formed into linear chromosomes inside a nuclear envelope.
Bacteria are further divided into Gram-positive and Gram-negative historically dependent
upon their reaction to Gram staining, named after its inventor, Hans Christian Gram [78].
Gram staining differentiates bacteria by the chemical and physical characteristics of their
cell walls by detecting the presense of peptidoglycan. Gram-positive bacteria have a single
cellular membrane surrounded by a thick peptidoglycan layer. Gram-negative bacteria have
a thin peptidoglycan layer that is sandwiched between two cellular membranes, having 2
membranes requires more elaborate transport systems with the outer membrane having
many different porins for transport of materials.
2.2. Bacteria and colicins
Bacteria such as Escherichia coli, amongst other Gram-negative enterobacteriaceae often
find themselves in less than favourable environmental conditions. At this time essential
nutritional factors quickly become scarce.
1Database of Genomic Sizes, the Growth of GenBank http://www.cbs.dtu.dk/databases/DOGS/GBgrowth.php
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Figure 2.1 Expression, entry and action of colicin E9 from host cell to target cell. The ColE9 plasmid starts ex-
pression in response to SOS signalling and expresses the colicin E9; subdivided into the 15 kDa DNase
domain (red) and the 45 kDa receptor binding and translocation domain (blue). The ColE9 Plasmid also
expresses the 9 kDa colicin immunity protein, Im9 to stop the DNase activity inside the host cell. The
E9/Im9 complex is released from the host and binds to sensitive bacteria via the BtuB receptor.
One response to biological stress is that of the SOS response pathway which allows the
DNA repair protein RecA to bypass lesions and base pair mismatches in the DNA. RecA
and other SOS response proteins are negatively regulated by LexA protein dimers binding to
DNA at SOS box sequences (~ 20 bp in length). DNA damage increases in the amount of
single stranded DNA (ssDNA) at replication forks where DNA polymerase has been blocked.
RecA forms a filament around the ssDNA region, while with activation by ATP, allows RecA
to interact with LexA's repressor domain and trigger self-cleavage from SOS boxes, allowing
the expression of other SOS response system proteins [59]. Colicins are plasmid encoded
antibacterial toxins (expressed by E. coliwith the appropiate Col plasmid) that are one group
of proteins that are expressed as a result of the SOS response. By delivering them into the
extracellular environment gives themacompetitive edge in nutritionally restrictive times [32].
Colicins are composed of three protein domains [15]. The first domain is responsible for the
recognition of specific receptors on the target cell, such as the BtuB receptor for the E-group
colicins [108]. The second domain is responsible for the translocation of the colicin across
the cell membrane after binding by co-opting the machinery of the target cell. The third
domain is the killing domain with either cytotoxic or pore formation activity which ultimately
leads to death of the target cell. Colicins usually exhibit a ``1-hit'' kill kinetic by which only
a very small number of molecules are required to successfully kill a target cell. Based upon
the cytotoxicity method, colicins are divided into 4 groups:
 The ion channel formers; colicins E1 (reviewed by Cramer et al. [23]), A, B Ia [58], Ib
and N - these form voltage dependant ionic channels in the cell membrane causing
membrane depolarisation and stopping the cell producing energy.
 The cell wall inhibitor, colicin M - that inhibits the synthesis of the cell wall, eventually
causes cell lysis, seen typically through initial cell blebbing [41]
 The RNases, colicins E3 [12], E4, E6 - typically cleaving the 16S ribosomal RNA, mak-
ing RNA-to-protein translation impossible, colicin E5 is a RNase but instead targets
36
2.3. Domains and structures of E-type colicins
H2N CO2HT domain R domain C domain
Im9
47,093 Da 14,456 Da
Colicin E9
61,549 Da
Im9
9,583 Da
Figure 2.2 A schematic repesentation of the colicin E9 domains; the translocation T domain, receptor R domain
and cytotoxic C domain as well as Im9, with included masses.
transfer RNA [68].
 The DNases, colicins E2, E7, E8, E9 [97] - cleave the DNA in both singly and doubly
stranded fashion.
2.3. Domains and structures of E-type colicins
E-type colicins (molecular weight ~61 kDa) are composed of three domains, each designed
for a specific function in assisting to the overall lethal toxicity. Due to colicins being such
potent antibacterial agents their structure and activity has been well studied. Proteolytic
digestion and deletion analysis revealed that there is linearity to the domains in the amino
acid sequence, giving common structural function to all colicins [73].
The first colicin domain, the N-terminal T domain is involved in the translocation of the col-
icin across the target's outer cell membrane. The second domain, the R domain, is respon-
sible for receptor recognition; namely the BtuB cell surface receptor protein. The cytotoxic
activity is carried by the third C-terminal cytotoxic ``killing'' domain.
Colicinswithin a class (such as the E group colicins) have been shown to have high sequence
homologywithin their T and R domains. The difference between each colicin in a class lies in
their C domains, where only those colicins with similar cytotoxic action show any sequence
homology [20, 90, 25, 30]. For example within the DNase E colicins (E2, E7, E8 and E9), an
80% sequence homology in the C domain is seen [46].
Colicin production is executed with simultanious coexpression of colicin specific immu-
nity proteins (molecular weight ~10 kDa). Amongst the E group, DNase colicin immunity
proteins there is a sequence homology of approximately 50% [46]. Each immunity protein
specifically binds its partner colicin, referred to as its cognate partner. The immunity pro-
tein tightly binds to the colicin C-terminal DNase domain thereby blocking the DNA binding
region and thus protecting the host cell from the affect of DNase activity.
This pairing means that each immunity protein (Im) is named according to its cognate part-
ner, for example E9-Im9, E7-Im7, etc. Sequence homologies between the colicin E activity
domains as well as the immunity proteins is high. This allows for some amount of cross
protection of colicin expressing cells from other colicins, even if the attack does not have
explicit immunity to that colicin. This is a complex interaction that is as yet not fully under-
stood as cross protection works well in vitro yet is rarely seen in vivo.
Since the first discovery of colicin DNases [82] and RNases [66] it has been found that the
corresponding immunity proteins form a very tightly bound complex with the colicin, that is
only chemically breakable through the use of strong denaturation agents.
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Wallis et al [96, 97, 98] were the first to measure the binding affinities for colicin E9 to Im9;
as well as a number of other noncognate immunity proteins. The dissociation constant
(Kd) for the cognate pairing was found to be one of the highest measured affinities for a
protein-protein interaction even to this date (figure 2.3). The outcome of these experiments
both in vivo and in vitro gave an order to cross reactivity affinity for colicin E9 as Im9 
Im2 > Im8, with Im7 offering no detectable binding to colicin E9 in the methods employed
by Wallis et al (figure 2.4), but later using other methods found to have a Kd of 1  10 4
M . The non-cognate immunity proteins, whilst binding colicin E9 showed binding affinities
(concentration of immunity protein required for half the population to be complexed) in the
range of 10 8 to 10 4 M . The kinetic experiments however, show that the association rate
constants (the speed at which the complex forms) are similar amongst cognate and non-
cognate pairs. The differences are only really pronounced in the dissociation rate constants
(strength of binding, ie how difficult it is to seperate the complex) where the cognate pair is
over six orders of magnitude slower than non-cognates. Most interestingly, these experi-
ments showed that whilst non-cognate of different immunity proteins to the same colicin
varied by four orders of magnitude, the non-cognate pairing of the same immunity protein
to different E group colicins varies little.
10-910-5 10-710-3 10-11 10-13 10-15 10-17
Kd / M
Respiratory electron
transfer protein
Antigen - antibody
complex
Peptide hormone
receptor complex
Protease - inhibitor
complex
RNase - inhibitor
complex
Cognate colicin
complex
Non-cognate colicin
complex
Figure 2.3 A comparison of dissociation constants for E9 DNase-Im protein complexes with a number of other
well studied protein-protein interactions. Exact figures are not given but instead an approximate range as
colicin E9-Im protein interaction is salt concentration dependant. Figure adapted from Figure 6 of [96].
ot
Wallis et al additionally showed that the dissociation constant for Im9 binding to full length
colicin E9 or the E9 DNase domain was near identical, suggesting that the immunity protein
makes no contacts with the T and R domains of any energetic significance.
Homologue-scanning mutagenesis was conducted whereby the key secondary structures
of Im9 were systematically mutated to those of Im2 allowing for the elucidation of the sec-
ondary structures responsible for binding to colicin E9 [55]. With further investigation using
nuclear magnetic resonance (NMR) [69] it was found that a single, 14 residue helix (helix II)
wasmostly responsible for colicin specificity. The neighbouring 6 residue helix III was found
to be important in binding (see figure 2.5). Helix III remains conserved amongest the immu-
nity protein family. Later investigation by alanine scanning mutations (where the 6 residues
of helix III are systematicallymutated to alanine) confirmed that helix III was indeed themain
DNase binding site and contributed over 2/3 of the binding energy to colicin E9 [96].
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Figure 2.4 A diagram comparing the affinity of 3 different immunity proteins with the E9 colicin, the cognate Im9
and the non-cognates Im2 and Im8. As each immunity protein is different they bind the E9 in slightly
different ways giving rise to different binding affinites.
Figure 2.5 A cartoon representation of Im9 bound to the E9 DNase domain, with Im9's helices highlighted from
PDB 2K5X. E9 is shown in grey, Im9 in cyan with helix II in dark blue and helix III in blue
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2.4. Extracellular release of colicins
During times of environmental stress LexA dimers are removed from SOS boxes as a result
of ssDNA replication forks, a classic example of DNA damage. The removal of inhibition
allows for the resulting translated SOS reponse proteins to activate SOS boxes and start
transcription of downstream genes. However, the LexA inhibition system is not completely
effective, as there is always a small amount of the downstream genes transcribed into pro-
tein. This results in a very small background level of colicins in any cell containing the Col
vector. Upon SOS box activation colicin production is positively upregulated but the acti-
vation system results in a lag time of approximately 60 to 90 minutes between stress and
observable increases in colicin production. After the inital lag colicin levels increase expo-
nentially to around 1000 times that of pre-induction [96] as a result of a very strong promoter
and multicopy plasmids.
The release of colicins into the extracellular environment is very different to other bacterial
extracellular proteins and is still thought to be largely unique [96]. Most extracellularly re-
leased proteins use a specific signal sequence, typically an encoded amino acid sequence
(in much the same way as eukaryotes) or posttranslational modification (such as glycosy-
lation), to bind the chaperone SecB. SecB binds the membrane bound SecA, an ATPase that
delivers the protein to the translocation complex consisting of SecY, E and G. This SecA and
SecYEG complex translocates the protein stepwise, 20 residues at a time, with each step
powered by the hydrolysis of an ATP molecule [66]. There are 4 other, less common, meth-
ods of extracellular release by bacteria reviewed by Nikaido [67] and Thanassi and Hultgren
[87].
Instead, colicins are secreted by a method that requires no signal sequence but rather the
expression of only one genewhich encodes the colicin lysis protein, also known as the killing
(kil) protein or bacteriocin release protein (BRP). Colicins are released non-specifically after
an arbitrary amount of time after synthesis with an amount of additional cytoplasmic and
periplasmic proteins. The reason for such erratic release comes from the colicin lysis pro-
tein gene being located proximally to the immunity protein gene with a weak transcription
terminator between them. Transcription then is reliant upon transcriptional read-through
from the colicin promoter across the entire operon. Under normal (non-SOS) conditions
very little lysis protein is produced as the chance of read-through on an inhibited gene is
very low. With SOS activation, inhibitors are removed and there is increased reading of the
entire operon, which results in greater colicin lysis protein production, but still at a low and
random rate.
Thuswhen a cell activates colicin production, the process is usually irreversible. With in vitro
studies artificial colicin induction immediately causes a drop in the number of viable cells
within a colony. This cell death is as a result of lysis protein coexpression with colicin and
not from the colicins themselveswhich the cell is protected fromwith the immunity proteins.
The exact method by which cell death is caused still remains unknown but it seems to be
linked to the shutting down of chromosomal protein synthesis [60].
Many studies have been conducted upon the effectiveness of the colicin lysis protein and
the operators surrounding the colicin genes. In the event of the lysis gene being removed or
having base mutations, insertions or deletions, release of colicins from the cell is inhibited.
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Whilst cloning of the lysis gene and induction provokes protein release and cell death even
in non-colicinogenic cells [15].
Ultimately, cells that underproduce or are slower to initiate a response are favoured for sur-
vival in a colony environment. However, switching the mechanism off or having it respond
too slowly would also be detrimental to the population in a mixed environment. As a con-
stant turnover of immunity protein is required to protect the host cell from its neighbour's
colicin production.
In vivo experiments have shown that colicin producing strains of E. coli actively promote
microbial diversity and E. coli colonies exist in a constant state of rock-paper-scissors be-
tween colicin producing, colicin sensitive and colicin resistent. As resistent outcompetes
producing, producing kills sensitive and sensitive outcompetes resistent strains [37, 51].
2.5. Receptor binding and membrane translocation
2.5.1. Initial binding
Whilst once thought to be a simple method of the colicin binding a transmembrane pro-
tein and then a simple translocation across the cell membrane. It was found not to be the
casewith the characterization of several colicin insensitivemutants. Initially colicin resistant
mutants, which did not bind the colicins were found more recently to be ``tolerant'' mutants,
which bind the colicins but were unaffected were discovered. Following experimentation the
colicin targetted transmembrane proteinswere called ``Tol'' for their tolerance of colicin, with
the most abundant protein being TolC. These mutants were found to inhibit colicin activity
via one of two methods. Classification of tolerant cells to colicins into groups A or B was
made by whether the colicin was translocated via the Tol or Ton systems respectively.
Both A and B group colicins target E. coli cells by interacting with specific outer membrane
proteins. Group B colicins such as colicin B, D, M, Ia, Ib use the Ton system; almost exclu-
sively a single TonB-dependant transporters in the outer membrane, only group B colicins 5
and 10 have been shown to use two outer membrane proteins [13].
Group A colicins largely target the TonB-dependent vitamin B12 transporter BtuB for binding
(including colicins A and E1 to 9, whilst colicin K binds Tsx and U binding OmpA) These
colicins also require a second outer membrane protein for translocation (OmpF in all cases
except colicin E1 which uses TolC, note that the TolC pore is twice the size of OmpF's). This
two step translocation has lead many researchers to believe that the initial binding event
serves to orientate the colicin into position on the cell surface before translocation. This
is not necessarily a requirement as BtuB can be bypassed by the pore forming colicin A
proteins when cells are incubated in low osmotic conditions suggesting that OmpF can be
used as a sole receptor [18]. Cramer et al. have recently proposed a controversial fishing pole
mechanism where the strong binding event of colicin to BtuB allows the colicin T domain to
search the outer membrane whilst still being tethered to the membrane [109].
The actual binding event between colicins (both groups A and B) and receptor is now quite
well characterised through genetic, biochemical and biophysical approaches, as well as ex-
tensive X-ray crystallography andNMR investigation (reviewed extensively by Cascales et al.
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[15]). Interestingly, colicins despite their size exhibit the same type of receptor specificity to
that of the small molecule ligand of the receptor. Immunity to colicin attack can be given to
cells if a surplus of ligand is added to the extracellular environment, this competition differs
greatly depending upon the natural ligand the individual colicin [17].
2.5.2. Colicin cleavage at cell surface
Many different laboratories working with different colicins (A, E1 to E4, Ia and Ib) have char-
acterised cleavage of the killing domain at the outer membrane. Most groups attributed
this cleavage to the outer membrane protease OmpT fragmenting the colicin into smaller
products at the cell surface. Further investigation using ompT deletion mutants showed no
fragmentation of colicins but remained sensitive to colicin kill domains and died [16].
This proteolytic cleavage seems to be essential for the effectiveness of some nuclease act-
ing colicins [18], whereas ompT deletion mutants are killed with the same efficiency as wild
type by colicin Ia.
Recently at the University of Oxford using a combination of cysteine trapping, mass spec-
trometry and X-ray crystallography, colicin E9 has been shown to move across the outer
membrane using OmpF [43]. The cleavage question of E group colicins remains hotly de-
bated, with some claiming that the Oxford trapping method artifically creates the results
they want to see.
2.5.3. Release of immunity protein
Colicin expression in cell requires coexpression with an immunity protein to prevent autoin-
duced apoptosis. Due to the importance of this inhibition, the immunity protein is bound
very tightly. In the case of colicin E9 with its immunity protein, Im9 the complex displays a
Kd of 10 17M. This immunity protein needs to be removed at the target cell in order to be
an effective cytotoxic protein, but such a tight binding presents a problem.
Studies have shown that the colicin is unfolded or at least goes through a large conforma-
tional change during the translocation process. This could explain the release of the im-
munity protein; however, isothermal titration calorimetry combined with structural studies
have shown that colicin E9 does not unfold on binding. Instead the colicin E9-Im9 complex
is able to bind BtuB and recruit OmpF forming the BtuB-OmpF-colicin E9 translocon without
displacing Im9 [44]. The exact mechanism by which the immunity protein is shed remains
unknown and is likely different for each colicin-immunity protein complex.
2.5.4. Colicin import
Colicin import is the term used for the movement by which parts of the colicin (N and C
domains) reach their final target including recognition and binding to the outter membrane
of target cells. To avoid complication only the E colicins (group A)(nucleases) shall be dis-
cussed further.
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Figure 2.6 The binding event and recruitment of host cell proteins by colicin E9. The multi-domained colicin ini-
tially binds to the BtuB cell surface receptor. The translocation domain's tail (shown as a red and blue
twist) binds TolC which further recruits OmpF. Together BtuB, TolC, OmpF and colicin from a translocon.
The colicin tail is fed through TolC which brings the colicin C domain into close proximity to OmpF allow-
ing for transport across the membrane and binding to TolB. Colicin E9 here shown using the colicin E3
homology model.
Whilst the exact translocation mechanism of colicins across the outer membrane remains
poorly understood, it is plain that two proteins are required; a cell surface receptor (BtuB)
and a cell penetrator (TolC) [44]. The latter also requires a co-transporter usually in the form
of OmpF (an outtermembrane tri-pored protein). The naturally disordered tail of the colicin's
translocation domain binds the complex and forms a BtuB-OmpF-colicin translocon. The
tail of the translocation domain is then fed into the cell via one of the OmpF's pores and then
recruits TolB (a periplasmic protein). The colicin's cytotoxic domain is now in close proximity
to another of OmpF's pores and is thought to probably enter this way [110].
Transport across the periplasmic space and final import, whilst being widely researched for
many years remains speculative. What is clear is that TolA, B, Q and R are required for the
translocation of colicins A, E2 to E9 and K (colicin E1 does not require TolB) [5]. Further
investigation has shown that each Tol protein level increased proportionally to the amount
of colicin that the cell was exposed to [38] and that the number of translocation events was
similar to the number of TolA molecules on the cell surface [54].
Despite all of this research the exact release mechanism of the immunity protein from the
colicin during binding and translocation remains unknown. It has been shown with colicin
E2-Im2 that the binding event with receptor did not provide enough energy to separate the
cognate complex [29]. Through fluorescence assays it has been shown that the energy
for separating the colicin E9-Im9 complex must come from the cytoplasmic proton motive
force, using the tol system. A crucial role in energy transfer is played by TolA, whilst sepera-
tion can only occur when the first few residues of the colicin E9 translocation domain have
bound TolB [93].
2.6. Cytotoxic activity of Colicin E9
Colicin E9 is known to be an enzymatic colicin that targets the phosphodiester bonds of
DNA. Colicin E9 must first cross the outer cell membrane. The inner cell membrane and the
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nuclear envelope, before acting upon the DNA. Debate still remains whether the transport
within the cell is actively mediated (``self-propulsion'') or by a system possibly at the end of
the Tol/Ton system yet to be identified (``retrotranslocation''); or by a combination of both.
What is known from planar lipid bilayer experiments is that colicin E9 binds membrane sur-
faces (such as the nuclear envelope) and creates specific channels. The E9 DNase channels
are short lived with lifetimes in the order of milliseconds and are not voltage dependant.
Whilst these channels are not affected by DNA or metal ion binding, they are completely
blocked when the E9 DNase is complexed with Im9 [62].
Colicin E9, as well as three other DNase colicins (E2, E7 and E8), have all had their structures
elucidated, with the DNase domains holding an ~65% sequence homology. The DNase do-
main of colicin E9 consists of 3 antiparallel -sheets surrounded by helices, with a concave
active-site cleft for DNA binding (see figure 2.7). Interestingly most of the differences be-
tween the family of DNase colicins is confined to the immunity protein binding site, adjacent
to the active site [53].
The core of the colicin DNase activity comes from the H-N-H motif, a ~34 amino acid se-
quence at the C-terminus of the DNase domain (and thus the protein) constructed of 2 -
strands and an -helix sandwiched between a metal co-factor, which in all colicins resem-
bles a distorted zinc finger structure.
The motif contains 4 histidine residues, conserved across all colicin DNases. The most
important of these is the N-terminal histidine of the H-N-H motif which serves as a gen-
eral base for the hydrolysis of the DNA backbone. The central asparagine (H-N-H) plays a
structural role stabilizing an hydrogen bond across the motif, whilst the C-terminal histidine
(H-N-H) is a metal binding residue.
Colicin DNases have been shown to destroy bacterial genomes through producing random
nicks in dsDNA. Since nicks are a common occurrence in ordinary cell biology, repair mech-
anisms exist to protect the cell. However, cell death is likely to occur as a result of a double
strand break caused by the repeated cutting of DNA, preferentially at thymine bases [76]. It
has also been shown that colicin E9, like most H-N-H motif proteins, shows a dependence
for high levels of Mg2+ or Ca+2, a high optimum pH (pH 8-9) and is inhibited by monovalent
cations. Colicin E9 can readily bind and use many first row transition metals such as Ni2+,
Co2+, Cu2+ and Zn2+although these metals influence substrate specificity and typically tar-
get ssDNA instead of dsDNA [50].
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Figure 2.7 Colicin E9 DNase bound to dsDNA. Image manipulated from X-ray crystalography structure (PDB
1V14). E9 DNase shown in grey with binding residue side chains highlighted in ball and stick, DNA back-
bone in orange, DNA bases in green.
Figure 2.8 Colicin E9 DNase active site with H-N-H motif and metal. The H-N-H motif's -helix and -sheets
are highlighted in blue, with bound magnesium ion in green, and dsDNA (backbone in orange). Image
manipulated from X-ray crystalography structure (PDB 1V14)
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3. Aims and objectives
Atomic resolution structures of protein-protein interactions were initially limited to x-ray
crystallography; with unnatural buffers, pHs and forced lattice structures. NMR extended
investigations to be able to determine solution based structures of small complexes, but ab
initio information remains a constantly developing field.
Here it is hoped to express several mutant proteins of the colicin E9 DNase - Im9 complex.
Eachmutant will contain at least one cysteine which will be targeted by a nitroxide spin label
in order to make it paramagnetic and detectable by EPR.
Each spin labelled protein will be fully characterised by various EPR techniques to deter-
mine the labelling efficiency, spin label motion, spin label accessibility and position in space
relative to other labelling positions.
Using the EPR technique, pulsed electron-electron double resonance (PELDOR) it is hoped to
be able to measure the interspin distances between spin labels across the colicin E9 DNase
- Im9 complex.
Current docking models using NMR ambiguous interaction restraints based upon chemical
shift perturbations from HSQC titrations give two potential binding sites of Im9 upon the
colicin E9 DNase surface. The EPR experimentally derived interspin distances will be added
as restraints to the protein-protein docking simulation to see if the quality of the model can
be enhanced.
To introduce spin label to spin label distance constraints into the docking software will re-
quire:
 simulation of spin labels upon the protein structure
 generation of the protein coordinate file inclusive of spin labels
 creation of parameters for spin labelled cysteine residues, such that the software con-
siders the residue to be an unnatural but allowed amino acid residue
 creation of restraint files based upon EPR data
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4. Protein production, purification and
performance
The purpose of this chapter is not to extensively describe every technique and step involved
in the production of samples, this information canbe found in themolecular biologymethods
chapter, chapter 10 (page 195). Instead this chapter seeks to highlight the typical output of
a protein grow up and purification for each different production method.
Initial plans were to use genes previously generated at the University of East Anglia (UEA) by
previous members of the colicin research group. However, it quickly became apparent that
there were problems with these, detailed below, and other arrangements had to be sought.
As a result, this investigation uses 3 basic types of protein grow up procedures, dependent
upon the gene source.
First, the immunity protein Im9, which since the very earliest work has been expressed with
a terminal His6 tag; allowing for a single step crude purification method using immobilised
metal affinity chromatography (IMAC) as poly-histidine sequences are known to favourably
bind metal 2+ cations.
Second, in existing DNA stocks of colicin E9 DNases the DNase activity remains requiring
co-expression with the immunity protein. Since in the in natura vector the immunity protein
overlaps the E9 DNase domain, but in a different reading frame, this is not a problem and the
2 genes are co-expressed with the immunity protein (coming second in the gene) labelled
with an His6 tag. The crude purification then consists of binding the protein to an IMAC
column then washing the columnwith buffer to remove weakly associated proteins. A wash
with a denaturant to remove the colicin E9 DNase from the immunity protein Im9 follows,
before finally removing the Im9 from the column.
Third, for newly created mutants where the existing DNA stocks had irrevocably been dam-
aged or for new mutants, recent developments could be exploited whereby introducing a
H127A mutation allowing the binding of colicin E9 DNase to DNA but inhibits the cleaving
ability. These colicin mutants could be safely overexpressed in E. coli cells without the need
for an immunity protein and could also be expressed with an His6 tag allowing purification
in a similar manner to that of the immunity protein Im9.
4.1. DNA stocks
4.1.1. Naturally derived mutants
At the start of the investigation an extensive library of colicin E9 DNase mutants existed
frompreviousNMRand X-ray crystallography studies. These libraries were cloned copies of
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the colicin gene from the wild-type Col plasmid, with mutants being produced using primer
based site directed mutagenesis. The libraries were stored in plasmid DNA stocks as well
as cell gylcerol stocks, where the plasmid had been tranformed into E. coli BL21 (DE3) cells.
Test expressions were initially made for mutants colicin E9 DNase S3C, S30C, S80C, E66C
and D20C/E66C as well as immunity protein Im9 from the glycerol stocks. The results of
which showed that none expressed protein at a suitable molecular weight.
As no record of when the glycerol stocks had been made, a fresh transformation from the
plasmid library for each was made and test expression repeated. Here the colicin E9 DNase
E66C, D20C/E66C and immunity protein Im9 showed good expression. Whilst the cells with
plasmids containing the colicin E9DNaseS3C, S30CandS80Cmutations showedweakened
antibiotic resistance and no protein expression.
The freshly transformed cells were split and mini-prepped to yield a large enough plasmid
amount for DNA sequencing. DNA sequencing was conducted by The Genome Analysis
Centre, Norwich, UK.
Mutant Correct amino acid sequence
E9 DNase S3C MECKRNKPGK ATGKGKPVGD KWLDDAGKDS GAPIPDRIAD KLRDKEFKSF
DDFRKAVWEE VSKDPELSKN LNPSNKSSVS KGYSPFTPKN QQVGGRKVYE
LHHDKPISQG GEVYDMDNIR VTTPKRHIDI HRGK HHHHHH
E9 DNase S30C MESKRNKPGK ATGKGKPVGD KWLDDAGKDC GAPIPDRIAD KLRDKEFKSF
DDFRKAVWEE VSKDPELSKN LNPSNKSSVS KGYSPFTPKN QQVGGRKVYE
LHHDKPISQG GEVYDMDNIR VTTPKRHIDI HRGK HHHHHH
E9 DNase S80C MESKRNKPGK ATGKGKPVGD KWLDDAGKDS GAPIPDRIAD KLRDKEFKSF
DDFRKAVWEE VSKDPELSKN LNPSNKSSVC KGYSPFTPKN QQVGGRKVYE
LHHDKPISQG GEVYDMDNIR VTTPKRHIDI HRGK HHHHHH
Table 4.1. Sequencing results from the UEA non-yielding mutants. Black text shows residues in the correct
reading frame. Green text indicates a 1 base frame shift. Blue text indicates a 2 base frame shift. Red text
indicates a 3 base frame shift.
The results of sequencing (shown in table 4.1) showed that each non expressing mutant
had several frame shifts in the DNA within the protein encoding region, each is usually a
very rare occurance. At best these shiftsmade nonsensical amino acid sequences or simply
halted transcription through stop sequences. Upon further investigation it was found that
these plasmidswere constructed before at least 1992-1994, where they first appeared in the
literature [100, 99, 101], with no record of theirmaintenance. Whilst holdingDNAat cryogenic
temperatures should preserve it indefinitely, even at these temperatures enzymes can turn
over, only at a much reduced rate. It is common practice to not hold DNA in cell glyercol
stocks for more than a year, and sequence DNA stocks every 5 years to ensure quality.
Communication with colicin research groups at the Universities of Nottingham and York
sought to find replacement DNA for the colicin E9 DNase S3C, S30C and S80C mutants.
Dr. M. Vankemmelbeke, University of Nottingham, UK was able to provide DNA for each, but
confessed that these were old clones of UEA stocks and had no recent experience with them
and had not had them sequenced.
The Nottingham DNA stocks were transformed into E. coli and split. Half going to a small
scale test expression and half to mini-prepping for sequencing. E9 DNase S3C yielded good
amounts of protein in the test expression andwas confirmedby sequencing. E9DNaseS30C
and S80C performed poorly in the test expressions and the sequencing showed frame shifts
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in the protein encoding region, albeit to a lesser extent than the DNA stocks from UEA.
4.1.2. Synthetically derived mutants
As a result of poor sequencing results and test expressions it was decided that the mutants
of colicin E9 DNase S30C and S80C were unusable. Synthetic gene companies, such as
Eurofins MWG Operon, offer synthetic genes cloned into vectors at prices comparible to
that of cloning in the laboratory.
Whilst creating genes it was decided that investigating doublemutants (mutants with 2 spin
label sites) would give the investigation an added dimension allowing for triangulation of
three distances within one complex. Through in silico analysis the possibility of a colicin
E9 S3C/S30C was ruled out as the spin labels would be too close in space to give effective
PELDOR distances. However the double mutants colicin E9 S3C/S80C, S30C/S80C and Im9
S6C (with a natural cysteine at position 23) could also be commissioned.
4.2. Protein expression
All mutants were grown in E. coli BL21 (DE3) cells transfected with the plasmid of interest.
These cells were grown from a single colony overnight in antibiotic loaded growth media as
a selection pressure (as per section § 10.4.1 on page 200). A proportion of the overnight
growth was used to propogate a large scale growth medium.
Every half an hour the optical density of the growth media (Luria broth) was measured to
monitor cell growth. At an OD600nm of 0.6 an E. coli population is considered to be in the
middle of its log growth phase and was induced such that the cells are converted from cell
growth to protein expression.
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Figure 4.1 A typical large scale overexpression. Shown here, a growth profile , started from 20ml taken from the
overnight culture of E. coli BL21 (DE3) cells transformed with the colicin E9 DNase S3C plasmid. Here the
cells were added to LB broth (500 ml) with ampicillin (500 l, 100 mg/ml) and incubated with shaking
(37 C , 180 rpm) until reaching an optical density (less LB) at 595 nm of approximately 0.6, at which
time induction occured (3 h) with IPTG (5 ml, 100 mM ). Samples were taken regularly and run upon a
SDS-PAGE gel to confirm the presense or absense of colicin E9 DNase.
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4.3. Crude purification
The aim of crude purification is to separate the desired, over-expressed protein from the
vast majority of other soluble cytoplasmic proteins contained in the cell lysate. To this end,
an IMAC column charged with Ni2+ was used, as it is routinely used for the purification of
proteins containing a poly-histidine tail. The poly-histidine tail reversibly coordinates around
the metal cation and can easily be dissociated from the column with the use of imidazole.
The crude soluble, filtered, cell lystate is passed over the column bed with a low level (50
mM ) of imidazole to prevent non-specific binding. A long wash of several column volumes
preceeds the removal of the desired protein from the column.
4.3.1. Naturally derived colicin E9 DNases
Colicin E9 DNase mutants S3C, E66C and D20C/E66 are functionally active as DNases and
required co-expressionwith the immunity protein Im9, which contains the poly-histidine tag.
Due to the high affinity between the complex it was practical to separate the complex in place
on the column using guanidine hydrochloride before titrating in the imidazole to remove the
immunity protein Im9 from the column.
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Figure 4.2 A typical crude purification with a GdnHCl unfolding in situ step before the imidazole titration. Shown
here the supernatant of the spun down and sonicated cell lysate of the colicin E9 DNase S3C grow up
was added to a 5 ml GE Healthcare Life Sciences HisTrap HP column activated with Ni2SO4 (50 M ).
The protein was directly loaded onto the column with low concentration imidazole (50mM ) to stop non-
specific binding. After a 10 column volume wash, GdnHCl was titrated in to a final concentration of 6M
to unfold the colicin E9 DNase from the immunity protein Im9. The GdnHCl was titrated away, before the
imidazole was increased to a final concentration of 500mM to dissociate the immunity protein Im9 from
the column. Samples were taken at each stage and run upon a SDS-PAGE gel to confirm the presense or
absense of colicin E9 DNase.
4.3.2. Synthetically derived colicin E9 DNases and immunity
protein Im9s
The synthetically derived colicin E9 DNases of S30C, S80C, S3C/S80C and S30C/S80C were
all synthesised with the additional H127A mutation making them DNA binding but not DNA
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cutting and thus not a threat to the host cell during expression. This meant that these mu-
tants could also be synthesised directly with the poly-histidine tag, allowing for a one step
crude purification.
The synthetic colicinmutants cell lysate, aswith the immunity proteinmutants, were passed
onto a Ni2+IMAC column with low level imidazole to prevent non-specific binding. The col-
umn was then extensively washed before the imidazole concentration raised to dissociate
the protein from the column bed.
Often therewould be such a large quantity of protein that the SDS-PAGE gels showed leaking
across lanes and the flow through from the columnalso shows the desired protein as a result
of there being too much protein to bind to the column. In this case the flow through was run
again over the column and the excess protein collected.
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Figure 4.3 A typical crude purification with a one step imidazole titration. Shown here the supernatant of the
spun down and sonicated cell lysate of the colicin E9 DNase S3C/S80C grow up was added to a 5ml GE
Healthcare Life Sciences HisTrap HP column activated with Ni2SO4 (50 M ). The protein was directly
loaded onto the column with low concentration imidazole (50mM ) to stop non-specific binding. After a
10 column volume wash, the imidazole was increased to a final concentration of 500mM to dissociate
the protein from the column. Samples were taken at each stage and run upon a SDS-PAGE gel to confirm
the presense or absense of the protein of interest. a) shows the chromatogram with only a single, large
peak b) shows the associated SDS-PAGE gel showing a huge amount of colicin E9 DNase.
4.4. Polishing purification
After the crude purification almost all contaminants are removed from the sample, but to
ensure as high purity as possible a second purification step was used. In this investigation
the second purification used was a gel filtration, size exclusion chromatography step. The
assumption that the probability that any naturally occuring, soluble protein within the E. coli
cell lysate that showed affinity to the IMAC column also having a similar molecular weight
would be very small.
There was no difference in method at this stage between proteins or between the origins of
the DNA.Most of the proteins here did however show2 peaks during the size exclusion chro-
matography. When samples were taken of the 2 peaks and tested by SDS-PAGE they gave
2 bands at the samemolecular weight (as seen in figure 4.4). When a native SDS-PAGE test
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was conducted (one in which no reducing agent is present), the first peak was found to be
twice the apparent molecular weight of the monomer protein suggesting exposed cysteines
were producing homo-dimers.
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Figure 4.4 A typical polishing purification using size exclusion chromatography. After dialysis and concentration
the protein in question, shown here colicin E9 DNase S3C, would be loaded into the injection loop of a
GE Health Life Sciences Äkta Explorer FPLC system, connected to a 350 ml bed volume, GE Health Life
Sciences Superdex 200, 26/60 column. Samples were taken at each stage and run upon a SDS-PAGE
gel to confirm the presense or absense of the protein of interest. a) shows a characteristic size exclu-
sion chromatogram showing two distinct peaks b) shows the accompanying SDS-PAGE gel showing that
under normal reducing conditions used in SDS-PAGE that both peaks contain a protein band associated
with monomer colicin E9 DNase.
4.5. Protein confirmation
4.5.1. Optical spectroscopy
All samples after purification were tested using a wide spectrum UV/visible absorbance
spectroscopy. As none of the proteins here contain metal cofactors, a single peak at 280
nmwas expected in the UV/visible spectrum resulting mainly from tryptophan, tyrosine and
cysteine residues.
All samples also had their circular dichroism spectrum recorded. The naturally derived col-
icin E9mutants which were unfolded in the crude purification step were recorded before and
after dialysis to ensure that correct folding was achieved. It was expected that for unfolded
proteins a random noise like signal would be seen before dialysis and for the folded protein
therewould be a strong negative peak in the far-UV range (<250nm). In the example given in
figure 4.5.b performing estimation of protein secondary structure from CD spectra using the
online web tool K2D2 [75], colicin E9 DNase S3C in the presense of a denaturant shows 5.4
% predicted -helical structure and 4.3 % predicted -strand structure. After dialysis, K2D2
gives 60.4 % predicted-helical structure and 4.7 % predicted -strand structure. This com-
pareswell with the published X-ray crystallography structure (PDB entry 1FSJ) that reports 8
-helices (65 residues, 48 %) and 4 short -strands (10 residues, 7 %). CD is only an used as
a prediction of secondary structure and that with the facilities measurement only to 220 nm
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was possible, whereas for more accurate predictions of secondary structure require further
measurement into the far-UV to 190 nm.
All proteins behaved as expected in this tests. All mutants, even those of synthetically de-
rived mutants gave comparible traces.
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Figure 4.5 A typical optical spectroscopy profile. Shown here colicin E9 DNase S3C. Blue shows the folded protein
after dialysis. Red shows the unfolded protein taken directly after the crude purification. Folded protein
traces before and after size exclusion are identical.
4.5.2. Mass spectrometry
All samples, after purification and lypophilisation, had a small amount taken (~ 1 mg, far
more than required for a ), desalted and sent for MALDI-MS (matrix assisted laser des-
orption ionisation mass spectrometry) analysis at the National Mass Spectroscopy Centre,
Swansea, UK. 1mg of protein is far more than required for a typical MS sample, but allowed
the service to properly optimise experimental conditions for clean spectra. MALDI-MS was
selected over ESI-MS (electrospray ionisation mass spectrometry) as it uses a much softer
ionisation process, resulting in lower charge ions which evolve at lower energies, ideal for
proteins with untested stabilities. MALDI-MS is also more robust to the salt concentrations
expected in biological buffers.
All samples showed a strong intensity at a mass to charge ratio (m/z) corresponding to the
molecular weight of the protein with a +1 charge. A second, weaker peak could be seen at
exactly half the m/z corresponding to the mutant with a +2 charge.
4.6. Yields
Yields are given as an averagemg of protein yielded per litre of growthmedia. Asmutants are
of approximate equal weight direct comparison is possible. The average yield also reflects
that lower yielding mutants were grown in multiple batches to yield a total of greater than
100mg required for all further experiments.
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Figure 4.6 Typical MALDI mass spectrometry profiles for a colicin E9 DNase and immunity protein Im9.
Protein, labelling position Yield /mg:l 1
E9 DNase S3C 64.2
E9 DNase S30C 2.7
E9 DNase S80C -
E9 DNase S3C / S80C 34.3
E9 DNase S30C / S80C 31.2
E9 DNase E66C 32.4
E9 DNase D20C / E66C 19.9
Im9 C23 36.1
Im9 C23S / S6C 11.6
Im9 S6C 12.8
Table 4.2. The yields of each protein's grow up and purification.
4.7. Binding activity
Many of proteins in this investigation are synthetically derived such that they ultimately have
the same amino acid sequence. This however does not mean that each mutant uses the
same DNA base sequence, as each mutant underwent a codon optimisation process based
upon the NCBI-GenBank Codon Usage Database [65]. This process both ensures that only
the most common codons for each amino acid for the selected species are used whilst
avoiding excessive use of similar codons in close proximity, as well as avoiding bad motifs -
such as restriction enzyme target sites, hairpinmotifs, etc. It was therefore important to test
each synthetically derived mutants' biological activity matched that of the the naturally de-
rived mutants, thereby ensuring that each mutation was structurally and functionally active
as desired.
Free tryptophan in solution shows a fluorescence emission at 350 nm when irradiated with
radiation at 295 nm. In unfolded proteins where each amino acid has little interaction with
others the fluorescence of tryptophan residues reflect that of the free state. As a protein
folds the amino acid side chains of other residues surround the typtophan residue and their
interaction influences the fluorescene behaviour.
Pommer [77] (amore in depth discussion ofWallis et al. [100]) showed that the 2 tryptophans
(W22 and W58) within colicin E9 DNase domain show an emission maximum at 332 nm
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Figure 4.7 Fluorescence enhancement as a result of addition of immunity protein Im9 to colicin E9 DNase. 10
M colicin E9 DNase was added to a 1010mm quartz cuvette at 298K. Scans were conducted using
continuous excitation mode with excitation at 295 nm, with detection between 300 and 500 nm with a
scan rate of 100 nm/min. For each titration a small amount of 100 M immunity protein Im9 was added
to minimise dilution effects.
indicative of at least 1 of these tryptophans being buried. When the colicin E9 DNase is
denatured by pH, the fluorescence emission shifts to 354 nm. The immunity protein Im9,
with no natural tryptophans shows no significant fluorescence from excitation at 295 nm.
However, as Im9 is titrated into a colicin E9 DNase solution a fluorescence enhancement
is seen until an equimolar stoichiometry is reached. The fluorescence emission maximum
upon excitation at 295nm shifts to 334nm, as both tryptophans are very close to the binding
interface of the immunity protein Im9.
Thus, if a fluorescence enhancement and shift is seenwhen titrating in immunity protein Im9
to a colicin E9 DNase solution then it can be shown that the synthetically derived mutants
are forming a complex comparible to the naturally derived mutants.
Figure 4.7 is typical for all the mutants tested and shows that the synthetically derived pro-
teins behave experimentally as the naturally derivedmutants, which in turnmatch the results
seen by Wallis et al. [100, 101].
4.8. Enzymatic activity
As stated at the start of this chapter, naturally derived colicin E9 DNasemutants still possess
DNase activity and required co-expression with the immunity protein Im9, to stop the killing
of the host cell during expression. The synthetically derivedmutants were all expressedwith
an additional H127A mutation following the work of Garinot-Schneider et al. [34]. This work
showd that on full length colicin E9 a H575A mutation knocked out DNase activity whilst
still being able to enter target cells. However, the activity of isolated DNase domain with this
mutation was previously untested. Whilst the first indication that DNase activity had been at
least inhibited was given when cells transformed with the new plasmid did not immediately
die; the extent of DNase activity inhibition required testing.
Likewise, the synthetically derived immunity protein Im9 (S6C) needed its biological rele-
vance to be tested to ensure that it inhibits the enzymatic activity of the colicin E9 DNase
domain.
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For this experiment 2 types of cell were used, non-transformed E. coli BL21 (DE3) cells and
E. coli BL21 (DE3) cells transformedwith the Col plasmid for colicin E9 DNase S3C. The cells
without the plasmid should be sensitive to the cytotoxic activity of colicin E9 whilst those
containing the plasmid contain a gene encoding for the immunity protein Im9. However, on
the addition of colicin E9 DNase complexed with the immunity protein Im9 neither cell line
should be adversely affected.
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Figure 4.8Growth curves of E. coli BL21 (DE3) cells in culture with the addition of colicin E9 DNase. Black squares
show normal cell growth. Red circles, cells with colicin E9 DNase S3C added at 2 hours. Blue upward
triangles, cells colicin E9 DNase S3C and Im9 added at 2 hours. Dark cyan downward triangles, colicin E9
DNase S3C and Im9 S6C added at 2 hours.
Figure 4.8 shows that cells lacking the Col plasmid when exposed to colicin E9 DNase with-
out the H127A mutation show a drop in optical density and no further growth. If however
the colicin is added complexed with Im9 irrespective of whether it is naturally derived or the
synthetically produced Im9S6C then cells survive. There is a distinct slowing of population
growth as inevitably some cells will not respond in time to prevent death, but both Im9s
show near identical results.
0 1 2 3 4 5
0 . 0
0 . 5
1 . 0
1 . 5
2 . 0
2 . 5  N o  a d d i t i o n E 9  D N a s e E 9  D N a s e  +  I m 9
 
 
OD
595
 / A
.U.
T i m e  /  h
(a)With colicin E9 DNase S3C/S80C/H127A
0 1 2 3 4 5
0 . 0
0 . 5
1 . 0
1 . 5
2 . 0
2 . 5  N o  a d d i t i o n E 9  D N a s e E 9  D N a s e  +  I m 9
 
 
OD
595
 / A
.U.
T i m e  /  h
(b)With colicin E9 DNase S30C/S80C/H127A
Figure 4.9 Growth curves of E. coli BL21 (DE3) cells in culture with the addition of synthetic colicin E9 DNase.
Black squares show normal cell growth. Red circles, cells with colicin E9 DNase added at 2 hours. Blue
upward triangles, cells colicin E9 DNase and Im9 added at 2 hours.
In figures 4.9.a and 4.9.b the addition of synthetic colicin E9 DNases with the additional
H127A mutation show no distinct difference to population growth. If wild type colicin E9
DNase with DNase activity is complexed with Im9, when administered there appears to be
some minor slowing, presumbaly from a few free molecules of colicin E9.
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Figure 4.10 Growth curves of E. coli BL21 (DE3) cells with Col plasmid in culture with the addition of colicin E9
DNase. Black squares show normal cell growth. Red circles, cells with colicin E9 DNase S3C added at 2
hours. Blue upward triangles, cells colicin E9 DNase S3C and Im9 added at 2 hours. Dark cyan downward
triangles, colicin E9 DNase S3C and Im9 S6C added at 2 hours.
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Figure 4.11 Growth curves of E. coli BL21 (DE3) cells with Col plasmid in culture with the addition of synthetic
colicin E9 DNase. Black squares show normal cell growth. Red circles, cells with colicin E9 DNase added
at 2 hours. Blue upward triangles, cells colicin E9 DNase and Im9 added at 2 hours.
Cells with the Col plasmid upon the addition of colicin E9 DNase from either source does
not kill population growth, but, slows it slightly. Again, the presense of Im9 with colicin E9
DNase slows population growth more than simply colicin E9 DNase alone. This could be
due to some unknown positive feedback mechanism whereby the presense of Im9 in the
cell makes the cell produce more Im9 to protect itself, as naturally the only time that Im9
would be produced is during co-expressionwith colicin E9 and free Im9 suggests free colicin
within the cell.
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5. Spin label characterisation
With proteins successfully expressed and verified, next was to attach a spin label so an EPR
signalwas produced. A full cw-EPRcharacterisationwas then conducted to analyse the spin
label's properties before moving forward to the more technical pulsed EPR methods. Spin
labelled proteins are denoted by the PDB modified residue ID assignment, in superscript
to the residue, where IA1 is IA-PROXYL and R1A is MTSL. The spin labelling procedure is
discussed on §10.5.
5.1. Spin label efficiency
Spin label efficiency was calculated by deriving the double integral of the room tempera-
ture, X-band cw-EPR spectrum (the spin count). This was compared against a standard
curve constructed of spin counts of free spin label at concentrations around the estimated
protein concentration. The attached spin label concentration by spin count determination
was compared to the protein concentration by UV/visible absorbance to give a labelling ef-
ficency. Labelling efficency is stated as a percentage for the total label attachment sites.
Protein concentration was measured using absorbance at 280 nm (detailed in §10.4.1.8)
and the Beer-Lambert Law (eq. 10.1). Where more than one cell culture was used the aver-
age labelling efficiency is given.
Protein, labelling position Labelling efficiency / %
E9 DNase S3C 33.6IA1 / 1.6R1A
E9 DNase S30CR1A 19.2
E9 DNase S80CIA1 N/A
E9 DNase S3CIA1 / S80CIA1 84.7
E9 DNase S30CIA1 / S80CIA1 95.9
E9 DNase E66CIA1 38.9
E9 DNase D20CIA1 / E66CIA1 1.4
Im9 C23IA1 5.3
Im9 C23S / S6CIA1 14.1
Im9 S6CIA1 / C23IA1 16.5
Table 5.1. Spin labelling efficiency summary
In this investigation, a large amount of time was spent fully optimising labelling efficiency to
the highest possible level. It was known from the outset that low labelling efficiencies would
be punishing in the later PELDOR investigation, for example if two proteins with labelling
efficiency of 10 % are complexed then only 1 % of the sample will contain a complex where
both proteins are labelled and can contribute to the PELDOR signal.
In the first instance, a thorough literature search was conducted. As some colicin E9 mu-
tants had been previously reported [106] this protocol was replicated. This method (detailed
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in §10.5.1) involved in a low oxygen environment (glove-box) adding a small amount of DTT
to the protein sample to reduce any protein homodimers and ensure that cysteines were in
theS  state. ExcessDTTwas removed using a PD-10 desalting column, such that the newly
formed label-protein bond would not be reduced. The protein was mixed with a 5 fold molar
excess solution of MTSL, wrapped in foil (as the reaction is light inhibited) and left for 3 h
with stirring. In the paper, labelling efficiencies of >95%were reported [106], compared to the
obtained results of <5 %. After personal communications with Dr. G White, a labelling pro-
cedure was attempted together in identical conditions to those reported previously. Again,
the resulting labelling efficiency was <5 %.
So began a spin label trial in whichmany conditions were investigated. Namely, oxygenation
of the environment (atmospheric versus low oxygen environment), with and without DTT,
labelling time (3, 16 and 56 h), labelling excess (2, 5, 10, 20, 100 fold molar excess of label),
pH (5.0, 7.0 and 9.0) and labelling temperature (277 and 298 K). With optimisations in all
of these variables typical labelling efficiencies were increased to low teen percentages for
colicin E9 mutants, with Im9 samples not reaching over 8 %. Note that samples requiring
unfolding showed an inhibited labelling efficiency by the denaturant and typically required
10 the labelling excess.
It was at this point, the newly reported IA-PROXYL was tested, as its reaction chemistry
is irreversible and uses a good iodo leaving group instead of weak sulphur chemistry. The
results listed in table 5.1 are the result of a small spin labelling trial with the IA-PROXYL label,
in which it was found that the best labelling conditions could be obtained using a 5molar
excess, without DTT, pH 7.0, at 277K with incubation overnight with stirring (16 h, 30 rpm).
Using IA-PROXYL the synthetically derived colicin E9 DNase mutants immediately jumped
from 10-15 % to 84-96 %. Some naturally derived colicin E9 DNasemutants (S3C and E66C)
saw an increase of around 30 % in labelling efficiency. All Im9 labelling sites remained very
low efficiency, but approximately double that seen with MTSL.
5.2. Continuous wave EPR characterisation
Each spin label site was characterised at room (298K) and cryogenic (80K) temperatures,
at S, X and Q-band, with some also characterised at W-band. Each sample was run under
identical conditions for each temperature and frequency (§11.1), allowing direct comparison
between samples.
Q-band spectra, particularly at low temperatures are not phased well, due to the spectrom-
eter in question having no feedback regarding phasing and thus each spectrum had to be
phased by hand using a trial-and-error process.
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5.2.1. Colicin E9 DNase S3CIA1
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Figure 5.1 cw-EPR results for colicin E9 DNase S3CIA1 at S, X and Q - band
5.2.2. Colicin E9 DNase S30CR1A
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(b) High temperature (298K , W-band at 200K)
Figure 5.2 cw-EPR results for colicin E9 DNase S30CR1A at S, X, Q and W - band
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5.2.3. Colicin E9 DNase S3CIA1 / S80CIA1
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Figure 5.3 cw-EPR results for colicin E9 DNase S3CIA1 / S80CIA1at S, X and Q - band
5.2.4. Colicin E9 DNase S30CIA1 / S80CIA1
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Figure 5.4 cw-EPR results for colicin E9 DNase S30CIA1 / S80CIA1at S, X and Q - band
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5.2.5. Colicin E9 DNase E66CIA1
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Figure 5.5 cw-EPR results for colicin E9 DNase E66CIA1 at S, X and Q - band
5.2.6. Colicin E9 DNase D20CIA1 / E66IA1
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Figure 5.6 cw-EPR results for colicin E9 DNase D20CIA1 / E66CIA1at S, X and Q - band
67
5. Spin label characterisation
5.2.7. Im9 C23IA1
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Figure 5.7 cw-EPR results for Im9 at S, X, Q and W - band
5.2.8. Im9 C23S / S6CIA1
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Figure 5.8 cw-EPR results for Im9 C23S / S6CIA1 at S, X and Q - band
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5.2.9. Im9 S6CIA1 / C23IA1
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Figure 5.9 cw-EPR results for Im9 S6CIA1 / C23IA1 at S, X and Q - band
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5.3. Spin label properties
Having collected each cw-EPR spectrum, each experiment was loaded into MatLab and fit-
ted with the EasySpin package to extract its spin properties. Normal nitroxide spin label
conditions were assumed as the starting point of the fitting and to optimise this fitting pro-
cess the MatLab package EasyRefiner was written which allowed for the queuing of experi-
ments and through an iterative refining of parameters process minimised fitting time whilst
maintaining a high degree of accuracy (§ 12.1.2 on page 214) .
Table 5.2 on the facing page shows the resulting g-factors and hyperfine constants for all
colicin E9 DNase and Im9 samples from the EasySpin/EasyRefiner process. It can be seen
that most spin label sites give very similar results, typical of that for nitroxide spin labels.
Moreover, there is even less variation in g or A values for the same sample at different fre-
quencies, reinforcing that both experimental and fitting methods are sound.
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5.4. Spin label accessibility
The g and hyperfine tensors of the nitroxide depend upon the spin distribution of the elec-
tron across the bond and atoms. This distribution will depend upon the polarity of the en-
vironment. In a hypothetical polar environment the oxygen could exist in the charged O 
state and be stabilised by the polar environment whilst the electron could be located upon
the positively charged nitrogen atom, N+. In a non-polar environment, the charged polar
states cannot be stabilised by the environment and thus the nitroxide atoms will preferen-
tially sit in an uncharged state and so the electron will reside mostly upon the oxygen, O,
with an uncharged nitrogen.
In a polar environment with the electron contributing most spin density to the nitrogen, N ,
the isotropic hyperfine coupling from the 14N increaseswith the increased spin density in the
pz orbital (Azz). As the hyperfine tensor increases the g tensor decreases from ge, as spin
density has been withdrawn from the high energy excited states upon the oxygen, which
further changes the g tensor as the energy levels between the lone electron and the lone
pairs on the oxygen changes. Furthermore, hydrogen bonding to the lone pairs on the oxygen
causes a small amount of delocalisation of the lone pair orbitals and an adjustment in the
gxx tensor.
At equilibrium within a magnetic field there exists a Boltzmann distribution between spins
aligned with the field and those against the field. At room temperature and magnetic fields
associated with X-band frequencies, the distribution lies such that 50.04 % of the spin pop-
ulation is parallel with the external magnetic field. 49.96 % of the spin population is aligned
anti-parallel to the field. Without this distribution of spins magnetic resonance would not be
possible. With applied radiation of the correct frequency transitions between the two energy
levels occur. The absorption from the lower energy state of photons is typically detected in
EPR by disturbance in a standing wave.
At low microwave powers spins the probability of a transition between energy levels is low.
As the microwave power is increased the probability of transition increases in a linear fash-
ion, thus the amount of spins abosrbing photons at any given point increases yielding an
increase in signal. That is until the saturation point, at which time the spin populations of
both levels and the transition rate between each is equalled resulting and there is no net
change in of microwave power being applied to the sample matches the rate of excitation
with the rate of decay. Any further increase in microwave power ``saturates'' the sample
whereby the rate of decay exceeds the rate of excitation and results in a loss of signal.
By placing paramagnetic quenchers near a nitroxide spin label, Heisenberg exchange of un-
paired electrons can occur between the nitroxide and the quencher. The quench rate will
be directly proportional to the concentration of the quencher. Thus by introducing different
forms of relaxation agent that preferentially adopt hydrophoic or hydrophilic environments
and observing the change nitroxide spin label saturates can yield information as to its envi-
ronment.
Typically a control experiment is performedwhereby the sample is tested in a nitrogen atmo-
sphere. Then the experiment is repeated again in the presense of oxygen, air is sufficiently
oxygenated. Diatomic oxygen, with its 3 triplet states, preferentially sits inside of a lipophilic
environments such as a phospholipid bilayer of a cell wall and will quench nitroxides sitting
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in or near membranes. A third experiment with aqueous relaxation agents such as consist
of transition metals stabilised in soluble ligands such as the uncharged Ni(II) ethylendi-
aminediacetic acid (NiEDDA) or negatively chargedCr(III) tris-oxalate ([Cr(C2O4)3]3 ). At
high concentrations the quenchers will cause line broadening through excessive exchange
interaction. At lower concentrations the relaxation influence can be quantified using power
saturation experiments. By comparing the peak-to-peak linewidth broadening and intensity
of the centre peak in the 3 experiments against a standard such as DPPH (2,2-diphenyl-1-
picrylhydrazyl) the accessibility of the spin label to an aqueous or lipid environment can be
calculated.
Briefly, the rate of relaxation is purely through collisions of the quencher with the nitroxide. If
the longtitudinal relaxation time of the quencher is shorter than the lifetime of quencher/ni-
troxide complex then the exchange rate,Wex, can be expressedly as follows


1
T1

= 

1
T2

=Wex = kexC (5.1)
where kex is the exchange rate constant and C is the quencher concentration. In the case
that the quencher concentration is kept low the exchange rate can be assumed to be much
less than 1/T2. Wex can be determined from the saturation curves by measuring the first
derivative peak-to-peak amplitude, A, of the central line of the nitroxide spectrum (mI = 0)
against the applied microwave power, P using
A(P ) =
I
p
Ph
(1+(21/ 1))P
P1/2
i (5.2)
with I the power independent amplitude factor, P1/2the power at half saturation and  the in-
homogeneity paramater, typically 1.5, but can be as low as 0.5 for inhomogeneous samples.
More correctly, P1/2 is the microwave power when the peak-to-peak amplitude is reduced to
half of its unsaturated maximum. Given by
P1/2 =
3
p
4  1
2e 
2 T1 T2
(5.3)
where = B1/pP is the conversion efficiency of the spectrometer resonator. When quencher
concentration is low, exchange broadening is small and T2 is constant despite the presense
of the quencher. Thus the change in P1/2 can be simplified to
P1/2 =
 
3
p
4  1Wex
2e 
2 T2
(5.4)
Experimentally, this is simplified by plotting the square root of microwave power against
the peak-to-peak amplitude of the central line of the nitroxide spectrum (mI = 0) at that
power. By replicating this across a range of microwave powers a saturation curve can be
constructed. At low powers, an increase inmicrowave power yields a linear increase in peak-
to-peak amplitude. Nearing saturation the linear relationship tails off to a peak, after which
any further increase in microwave power results in an exponential decay in peak-to-peak
amplitude. This gives a characteristic power saturation profile which can easily be fitted
using
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Y 0 =
"
a 
p
P  1 + ((2
1/b   1)  P 2)
P1/2
# b
(5.5)
Where Y 0 is the peak-to-peak amplitude of the central line of the nitroxide spectrum (mI =
0), a and b are fitting variables, P the microwave power and P1/2 the power at half saturation.
P1/2 values are obtained for the sample under control, lipophilic and hydrophilic quencher
conditions as well as for the reference sample (DPPH) under the same conditions.
To remove the spectrometer dependency on  in equation 5.4 and sample dependency on
T2, the P1/2 is converted into a dimensionless accessibility parameter, , by comparison to
the reference sample (DPPH), such that
 =
[P1/2/Bpp]sample
[P1/2/Bpp]reference
= Wex (5.6)
Where  is a dimensionless accessibility parameter (easily converted to a percentage) and
Bpp is the peak-to-peak broadening effect of saturation.
This technique was extensively developed by Dr. C. Altenbach of the Hubbell group on T4
lysozyme [81] and further extensively tested and implemented by the Steinhoff group with
particular focus on transmembrane and membrane-interacting proteins [72].
Automated analysis of power saturation experiment data through to accessibility parame-
ters using the equations and methods detailed by Altenbach [81] were implemented into a
graphical user interfaceMatLab package, PowerSat (§ 12.1.3 on page 215). PowerSatwhilst
automatically calculating P1/2 and values also generates and exports a visual representa-
tion of the peak-to-peak intensity against the square root of microwave power - the power
saturation profile.
The numerical accessibility of each labelling position is presented in tables 5.3 and 5.4 for
aqueous and lipid accessibility respectively. In each table addition columns are given show-
ing the results of an MMM site scan analysis of the labelling position upon the PDB entry
2K5Xmodel. MMM takes amolecular dynamics derived rotamer library based upon allowed
bond angle and energies and calculates how many of these rotamers would be allowed
without substantial steric hinderance from the protein structure. The higher the number of
rotamers, then the greater the amount of freedom to the site, which in the case of a sur-
face residue means more solvent accessibility. Obviously an internalised residue may have
freedom to move within a pocket but not necessarily have solvent accessibility. Futher-
more, MMM then calculates the distance that the nitroxide N-O bond covers amongst all
of the allowed rotamers. A small value here shows that the nitroxide bond is restricted and
is predicted to move very little, whilst a large distance corresponds to high flexibility of the
nitroxide corresponding to high solvent accessibility.
In figure 5.10.a the centre line of the nitroxide spectrum has been plotted in 3 dimensional
space with increasing microwave power shown in the z direction. An increase in microwave
power can be seen to yield a large increase in signal intensity, up until saturation at 5.0mW .
The increase in signal intensity also allows the satelite peaks of hyperfine coupling to 13C to
be seen on the shoulders.
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Protein, labelling position Accessibility MMM
P1/2/mW 1/2 Aqueous / % No. rotamers
Distribution
size / nm
E9 DNase S3CIA1 27.6 63.6 50 0.69
E9 DNase S30CR1A 14.8 79.4 46 0.49
E9 DNase E66CIA1 15.9 5.9 37 0.51
Im9 C23IA1 33.6 60.2 3 0.18
Im9 C23S / S6CIA1 12.6 2.8 46 0.57
Table 5.3. Spin labelling aqueous accessibility summary frompower saturation experiments for colicin E9DNase
and Im9 labelling positions with comparison to their MMM predicted labelling statistics.
Protein, labelling position Accessibility MMM
P1/2/mW 1/2 Lipid / % No. rotamers
Distribution
size / nm
E9 DNase S3CIA1 8.8 16.6 50 0.69
E9 DNase S30CR1A 41.3 14.5 46 0.49
E9 DNase E66CIA1 15.4 4.5 37 0.51
Im9 C23IA1 12.6 0.1 3 0.18
Im9 C23S / S6CIA1 12.5 2.5 46 0.57
Table 5.4. Spin labelling lipid accessibility summary from power saturation experiments for colicin E9 DNase
and Im9 labelling positions with comparison to their MMM predicted labelling statistics.
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(a) Spectral profile of the nitroxide central peak in the
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Figure 5.10 Power saturation profile of colicin E9 DNase S3CIA1 a) shows each microwave power slice of the
central nitroxide peak in the oxygen experiment b) shows the power saturation profiles of samples of
colicin E9 DNase S3CIA1 in the presence of a nitrogen atmosphere (blue circles), atmospheric oxygen
(red squares) and a nitrogen atmosphere with 1 mM NiEDDA (green triangles). Lines are coloured to
each experiment and show the fit of data using equation 5.5 and PowerSat's Lorentzian derivative fitting
mode. 100 M protein, 298K.
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As this spin label position is verymuch solvent exposed theNiEDDAcurve in figure 5.10.b can
be seen to be of less intensity due to the presence of a strong relaxant in solution stopping
the maximum signal increase from microwave power. But, as the nitroxide spins relax that
much faster the amount of power required to achieve saturation is much higher at 25.2
mW . This change can be seen in the P1/2 values as when oxygen is used saturation occurs
at a low value of 8.8mW 1/2, but with NiEDDA the P1/2 vastly increases to 27.6mW 1/2. This
corresponds to 16.6 % accessibility to a lipophilic environment and 63.6 % accessibility to a
aqeuous environment. These numbers align well with the large numbers of expected MMM
rotamers and the large sample space that these rotamers cover.
In figure 5.11 the other single cysteine spin labelledmutants are shown. Figure 5.11.a shows
colicin E9 DNase S30CR1A, another solvent exposed site and as with the colicin E9 DNase
S3CIA1 the oxygen andNiEDDA curves are above the nitrogen control, with theNiEDDAcurve
never becoming as intense as the oxygen, but saturating at a higher power with aP1/2 of 41.3
mW 1/2.
It is interesting to note that the aqueous accessibility of colicin E9 DNase S30CR1A is higher
than that of colicin E9 DNase S3CIA1. This is despite the MTSL label having one less atom
in the linker chain between nitroxide and protein backbone, and the nitroxide ring being
more rigid than IA-PROXYL due to the double bond between C3 and C4 (see figure 8.5 on
page 149). The MMM accessment of this position also predicts for their to be fewer ro-
tamers and for those rotamers to have a smaller spread of the NO position than the S3CIA1
label.
Figure 5.11.c shows Im9 C23IA1, again a solvent exposed site and the curves show a similar
tale but are not as far removed from the nitrogen control curve. This suggests that whilst
being solvent exposed it is not as accessible as the colicin E9 DNase S30CR1A position.
This is reflected in the calculated aqueous accessibility being only 60.2 % for Im9 compared
to the colicin E9 DNase S30CR1A position's 79.4 % accessibility (table 5.3). Perhaps most
shockingly, MMM predicts this to be a very restricted site with only 3 rotamers being viable,
these having a very small 0.18 nm distribution of the NO bond. This predicted restriction
could explain the low (5.3 %) labelling efficiency seen previously.
Meanwhile, in figure 5.11.b the saturation profiles for colicin E9 DNase E66CIA1 can be seen.
This site from X-ray crystallography and NMR structures is an internal residue and is ex-
pected to have low aqueous accessibility. This was reflected during labelling when this pro-
tein could only be successfully spin labelled in strong denaturing conditions. As a result
the saturation curves look almost identical in the presense of either relaxant to the nitrogen
control, implying a low accessibility to either, which when calculated was less than 6 %. The
MMM analysis for this site does show a reasonable number of rotamers and NO distance
distribution. This is as a result of a small pore inside the protein in which the label could
reside, open inspection the NO bond distribution is artifically as a result of the label being in
close proximity to the other side of the pore, forcing the label to sit in two opposing positions.
Figure 5.11.d shows the Im9 S6CIA1 labelling position. This positionwas chosen as it is near
the flexible end of protein and from published structures should be solvent accessible to
provide good labelling efficency. As a result, this position shows a large rotamer distribution
in MMM analysis with a good spread of distances of the NO bond. However, the power
saturation profile would suggest otherwise. Each experimental curve can almost be overlaid,
corresponding to calculated accessibilities of less than 3 %. Whilst, this site was originally
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Figure 5.11 Power saturation profiles of other labelling sites. Each shows the power saturation profiles of the
sample in the presence of a nitrogen atmosphere (blue circles), atmospheric oxygen (red squares) and a
nitrogen atmosphere with 1 mM NiEDDA (green triangles). Lines are coloured to each experiment and
show the fit of data using equation 5.5 and PowerSat's Lorentzian derivative fittingmode. 100M protein,
298K.
selected as a predicted good site for labelling the accessibility measurements suggest a site
with little accessibility. If this is the case, it could explain the low (14.1 %) labelling efficiency
of this site.
In addition to lone protein power saturation experiments, each experiment was repeated
with with unlabelled cognate binding partner complexed. None of the experiments showed
any significant change in accessibility suggesting that each labelling position is away from
the docking interface.
5.5. Summary and discussion
From this investigation it has been found that several sites across the colicin E9 DNase - Im9
complex can be successfully spin labelled with nitroxide spin labels. Most of the labelling
sites in the proteins expressed in the previous chapter were found to be able to be labelled
with either MTSL or IA-PROXYL. However, the majority of this investigation quickly moved
from using the more traditional spin label, MTSL to the IA-PROXYL label. The reason for
the change in label primarily came only after exhaustive testing of MTSL and the very poor
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labelling efficiency of the proteins. In most cases with MTSL, the spin labelling efficiency
was in the range of 10-20 %. By moving to the IA-PROXYL label in for all sites, except the
colicin E9 DNase S30C, the labelling efficiency drastically improved. In the most dramatic
cases such as the colicin E9 DNase double mutants (S3C/S80C and S30C/S80C) the spin
label efficiency increased from around 10 - 20% to 80 - 90%. The labelling efficiencies using
MTSL simply were not suitable for most sites to continue with in this investigation.
The notable exception was E9 DNase S30C mutant, which preferentially labelled with MTSL
giving a spin labelling efficiency of 19.2 % with MTSL as opposed to being unable to give
reliable results at all with IA-PROXYL. Given the poor yield and resulting very limited amounts
of this protein available, it was decided to continue with MTSL for this mutant.
As most of these sites were selected for their solvent accessibility, and resulting expected
high labelling efficiency it is unsuprising that these cw-EPR experiments atmultiple frequen-
cies and temperatures show little variation, due in large part to the short correlation times.
Some sites, particularly on the Im9, show some slight restriction and a slightly longer cor-
relation time with the high field peak broadening slightly. The high solvent accessibility was
confirmed by power saturation experiments, with some labelling positions as high as 80 %
water accessible.
The suprises here were the colicin E9 DNase E66CIA1 , which despite the difficultly in la-
belling and predicted internalised position, showed low solvent accessibility but retained
a low correlation time associated with high mobility. The other suprise was the Im9 S6C
position which, whilst predicted to be very solvent exposed and a low correlation time asso-
ciated with high label motility, showed very low solvent accessibility in the power saturation
experiment. Though this could merely be representing the fact that colicin E9 DNase in so-
lution shows some amount of intrinsically disordered protein characteristics, this molecular
movement artificially decreases the rotational correlation time.
The largest problem that was encountered in spin labelling was the proteins themselves.
Many of the spin labelling positions were that of solvent exposed positions. These posi-
tions whilst designed to allow access of free spin label to react with the exposed cysteine
side chains, in such small, globular proteins also allowed the formation of homo-dimers.
The only way to remove the disulphide linked homo-dimers was with the use of a reducing
agent, but this reducing agent would indiscriminately reduce the cysteine - spin label bond
we were trying to form. Alternative stratergies such as low protein concentrations, anaer-
obic environments, pH shifts, reaction time did little to increase the labelling efficiency with
MTSL. IA-PROXYL with its iodo leaving group however, reacts with the exposed cysteine
sulphur atom in a non-reversible manner and greatly increased the labelling efficiency.
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It is possible to use pulsed EPR methods to elucidate distances between spin labels by ex-
ploiting the dipolar coupling between them. In order to do this it is required to pulse one of
the spin labels and observe the induced reaction on the other. Due to the rapid relaxation,
sample size and small difference in spin populations it is necessary to repeat the experi-
ment many times and average the results to ensure high resolution data. Furthermore, as
the electron is highly sensitive to its environment, the quality of the data obtained relies upon
the correct experimental conditions.
For this reason it is necessary to optimise the conditions to maximise the transverse (T2)
relaxation time, the main contribution to echo longevity. Echoes which last longer before
decoherence yield more observable data with each scan, which in turn, greatly reduces ex-
periment time. Too short a transverse spin relaxation time yields echoes shorter than the
periodicity of electron-electron dipolar oscillations and render the PELDOR experiment use-
less. This is not to say that spin-lattice (T1) relaxation times and other factors were ignored,
but they were not the primary focus of this investigation.
In this investigation the assumption was made that the optimisation of conditions and ex-
perimental parameters for one spin label site of colicin E9 DNase would be applicable to all
the spin label sites due to their high solvent accessibility. Therefore optimum conditions
were found using colicin E9 DNase S3CIA1.
6.1. Spectra fitting
Using particular techniques and in this case, pulse sequences allows for the collection of
raw data that contains information regarding to the relaxation of the system. To extract the
relaxation times from each raw spectrum requires fitting the raw data to idealised relaxation
models. As a relaxation is being measured it is important to ensure that the experiment
is sufficiently long such that the system is completely relaxed, fitting data that has yet to
reach thermal equilibrium could artifically generate false fitting results. To ensure accuracy
a zero-filling method can be employed where the fit is compared to a second fitting of a
dataset with an addition data points at later time points all with zero intensity.
In the case of transverse relaxation times, relaxation follows an exponential decay. By fitting
the data to a single parameter exponential decay:
y = a(1  b)x (6.1)
Where, y, is the decaying quantity, a, the original signal intensity before decay, b, the decay
rate and x, time. In the case, of a transverse relaxation experiment the decay rate reflects
the transverse relaxation.
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Complexity arises in these experiments as the electron is not isolated from the environment.
Commonly in nitroxide samples a strong hyperfine interaction is seen with the solvent. The
hyperfine coupling results in an oscillation of the relaxation with a periodicity related to the
Larmor frequency of the nuclei. With this modulation in the relaxation fitting can be con-
ducted using different approaches.
In the first approach the spectrum is considered as a single dataset and fitting is conducted
with all data points using the assumption that the integral of positive modulations from the
fit will equal the integral of negative modulations from the fit.
The second approach uses all of the dataset towards the end of the experiment, but uses
only the maxima peaks of the hyperfine modulations to calculate the decay. The benefit of
this method is that it will underestimate the relaxation time as a result of the rate of decay
being effectively higher. This can be benefical when later experiments rely upon the experi-
mentally derived relaxation time as it gives the shortest usable time.
The third method, advocated by Eaton and Eaton [REF] is fit an exponential decay to only the
data after the hyperfine modulations. Hyperfine oscillations typically relax away before the
sample reaches thermal equilibrium. This gives the advantage that the hyperfine interaction
does not interfere with the data analysis. However, in order to detect hyperfine interaction
free signal requires strong, long lived signals but also allows for larger margains for error as
the signal intensity used in the fitting process is only a small percentage of the total signal
of the receiver.
When these three different methods are used on experimental data the difference between
them quickly becomes apparent as shown in figure 6.1. Here the T2 relaxation experiment of
colicin E9 S3CIA1 in water at 4K is shown. The data, as would be expected, shows obvious
hyperfine modulations with a periodicity corresponding to the proton Larmour frequency.
The hyperfine modulations decay faster than the overall signal and as a result the signal
without detectable hyperfine modulations (>2 s) can be fitted. Fitting a single parameter
exponential decay to this data (shown in red) results in a transverse relaxation time of 471.6
ns ( 20.2 ns) and a relative signal amplitude of 179000. Clearly, whilst this fit corresponds
well to data at later times it in no way reflects the experimental situation at the start, when
the data is most significant. Using the assumption that hyperfine modulations average to
give a consistent signal yields a much better fit to the experimental data (shown in green).
Here the transverse relaxation time is calculated to be 511.6 ns ( 7.3 ns) with a relative
signal amplitude of 511000. Finally, the method in which only the maxima of the hyperfine
modulations are used for fitting initially and once they have decayed the rest of the data is
used (shown in blue) results in a transverse relaxation time is calculated to be 507.7ns ( 2.7
ns) with a relative signal amplitude of 570000. Here the fit is good to the data (that is being
considered) and yields a relaxation time that is both reasonable as it reflects accurately the
data, but it also gives the lowest possible value reflecting the fastest relaxing species within
the sample.
As a result, this investigation uses the hyperfine maxima method of fitting for transverse
relaxation time measurement, where only the maxima data points of each hyperfine modu-
lation are considered. In doing so the obtained relaxation times give a lower limit to the real
transverse relaxation time which is more beneficial when setting the observation window in
the later PELDOR experiments.
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Figure 6.1 Possible fitting methods of the T2 relaxation time, shown here E9 DNase S3C in water at 4 K . For
visual clarity, this figure has been cropped at 4.0 s but fitting was conducted with data up to 8.5 s.
Shown in navy is the raw data, in red the fitting line associated with only fitting data free from hyperfine
modulations (data after 2.0 s), in green the fitting line associated with considering all data points and in
blue the fitting line associated with only taking the maxima of each hyperfine modulation as well as all
data after the hyperfine modulations cannot be detected. 32 scans, 4 shots/point, 1024 points, 15000 s
shot rep. time, 3438 G, 9.6635 GHz, 5.8 dB attenuation, 200MHz video bandwidth, 66 dB video gain.
100 M protein inH2O.
In the case of longitudinal relaxation experiments, each spectrum is considered as a com-
plete data set. As an inversion recovery methodology was used to observe the relaxation
time is fitted to an inverse exponential decay where the data set is inverted by multiplication
of -1 before being fitted to a single parameter exponential decay, again of form:
y = a(1  b)x (6.2)
Fitting of spectra results in the determination of two variables; the relaxation time (the rate
of change with respect to time) and the relaxation intensity (the rate of change with respect
to the initial intensity at time zero). The relaxation time for each spectrum is plotted with the
relaxation times of the other spectra in a single plot. The relaxation intensity measurement
for each spectra, being of arbitary unit, is normalised against the largest signal amplitude
before being plotted. In all cases the fitting procedure records the 95% confidence bands
and these are present as error bars on associated plots.
By showing both the relaxation time as well as the fitted and normalised signal intensity al-
lows for the determination of not only ideal relaxation times but signal. A desirable relaxation
time, with little signal is not preferential to a less desired relaxation time with a larger inten-
sity as the required extended signal averaging time to obtain a sufficient signal-to-noise
ratio, far exceeds the benefit of the relaxation time.
6.2. Temperature optimization
Temperature is a key component to optimise. As the sample is cooled, energy is removed
which reduces the molecular motion, of not only the bonds of the spin label, but the protein
backbone aswell. Asmotion is reduced an increase in the relaxation timewould be expected
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as energy is not dissipated through motion. At low temperatures, certain conformations of
the folding landscape begin to be eliminated as their energy level is no longer supported.
Approaching absolute zero it is expected that all other conformations are eliminated leaving
only the lowest possible energy state, which may or may not reflect the biological solution.
Further it is known that the signal-to-noise ratio in echo experiments varieswith temperature
as a result of the temperature dependence to the polarisation of the spins. At temperatures
when kB T > hmw polarisation is inversely proportional to temperature [49].
6.2.1. T2 relaxation time
The experiment was started at 4 K , as the lowest feasible stable temperature to absolute
zero with the experimental setup. The temperature was then raised to 10K with further 10
K increments until an echo could not be measured.
As expected, the lowest temperature with the lowest energy gave the longest transverse
relaxation time as all relaxation mechanisms slow. This had the additional advantage of
giving the greatest amplitude signal. At 4 K , with no other experimental optimization, a T2
of 507.8 ns was acheived with a large intensity, and very low signal-to-noise (SNR) after
32 scans. Subtraction of the background and Fourier transformation of the peaks of this
experiment (figure 6.3), reveals two distinct peaks. The peak at 14.7MHz matches that of
the proton Larmour frequency (42.6 MHz/T [104, 6]) at the experimental magnetic field.
The second peak at 7.3MHz is exactly twice the Larmour frequency and is largely a result
of the background subtraction method .
Between 4 and 80 K there is a near linear relationship between diminishing transverse re-
laxation time and increased temperature. The amplitude of the echoes vary little between
10 and 80K before dramatically increasing at 4K. Suggesting a shift in the Boltzmann dis-
tribution of spins approaching very cold termperatures, allowing for the excititation of many
more electron spins, seen experimentally as an increase in signal.
The 90K data point at first glance appears erroroneous. After the data point was repeated
in triplicate it was concluded to be significant. In this instance the fitting gives values that
are artifically distinct from the others in the temperature assay. The transverse relaxation
time at this temperature is much higher than the series would expect, at 507.7 ns and is only
0.1 ns lower than the relaxation time shown at 4 K . However, the intensity is very low as
displayed in figures 6.2.a and 6.2.c. The very shallow decay in the first 500 ns of this curve
gives a very low signal amplitude (ie. rate of decay), but this artifically creates an incredibly
long relaxation time. Realistically, despite the long calculated relaxation time this would be
a terrible experimental to select as the signal intensity is so low that the experiment would
require huge experimental times to achieve a reasonable signal-to-noise ratio.
Upon further investigation of the 90 K data point, it was found that this temperature at
atmospheric pressure coincides with a phase transition of ice. Whereby, as the ice warms
it moves from ice XI (an orthorhombic structure) to ice Ic (a metastable cubic crystalline
structure) [2, 33, 64]. It is likely that the coexistence of two phases at equilibrium negates the
signal from the echo as any energy put into the sample at this point shifts the equilibrium
and the energy is used in the phase transition, rather than in emission of photons to the
receiver.
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Figure 6.2T2 temperature optimization of E9DNaseS3C inwater. a) echodecay traces showing key temperatures
b) fitted T2 times plotted against temperature c) fitted echo amplitude plotted against temperature. In b
and c error bars show 95 % confidence bands of the fitting. 32 scans, 4 shots/point, 1024 points, 15000
s shot rep. time, 3438G, 9.6635GHz, 5.8 dB attenuation, 200MHz video bandwidth, 66 dB video gain.
100 M protein inH2O.
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Figure 6.3 A Fourier transformation of the 4 K experiment shown in 6.2.a. 100 M colicin E9 DNase S3C in
H2O. a) the fitting subtracted data centred about the fitting line (zero). b) the Fourier transformation of
the relaxation experiment.
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After the 90 K data point the T2 relaxation time continues to drop as the temperature is
increased. However both the relaxation time and signal intensity drop away faster than the
experiments below 90K .
At 130K the signal intensity begins to level, but the transverse relaxation time approaches
a minimum and begins to increase again with increased temperature. This can again be
explained with phase transition chemistry of ice. At approximately 130K and atmospheric
pressure, ice transitions from ice Ic (metastable cubic crystalline) to ice Ih (hexagonal crys-
talline - common ice). The new phase of ice generates longer relaxation times as the rate
of decay in the signal decreases, but this comes at the cost of less and less signal intensity,
reflected in the signal-to-noise ratio and increasing error bars on the signal intensity plot.
The final data point shown at 160 K (figure 6.2.a), shows little intensity. This intensity ar-
tifically gives a high T2 relaxation time when fitted. At 170 and 180 K no echo could be
detected.
As a result of this experiment, it is clear that the lower the temperature that the experiment
is conducted the better in terms of both the observed T2 relaxation time and signal intensity,
though good data is achievable at 80K or below.
6.2.2. T1 relaxation time
Again beginning at 4K , as the nearest feasible temperature to absolute zero theT1 relaxation
time was measured. The temperature was then raised to 10K and further increased in 10
K increments until an echo could not be measured.
The T1 relaxation time is more sensitive to temperature increases than the T2 relaxation
times and it proved only possible to measure up to 80K , though measurements at 90 and
100K were attempted in light of the T2 relaxation time data.
In figures 6.4.b and 6.4.c a near exponential increase in both the T1 relaxation time and echo
intensity as the temperature is dropped. At temperatures of 60K and above it can be seen
in figure 6.4.a that there is very little signal intensity from the inversion above that of the
noise. This creates some uncertainty in the fitting seen in the error bars of figures 6.4.b and
6.4.c. However, having short longitudinal relaxation is preferential in that it means that the
system returns to thermal equilibrium quickly and allows for faster experiment repetition.
If long longitudinal relaxations are desired then these experiments again show that colder
temperatures are preferential.
From this experiment the ideal temperature for further investigation was concluded to be
around 40-50K . At these temperatures the T1 relaxation time is significantly reduced when
compared to lower temperatures, for instance it is less than than a fifth of the relaxation time
and intensity of that seen at 4K.
6.3. pH optimization
Proteins have a biologically finite range of operation often within a narrow pH spectrum re-
lated to their function. Moving outside of the natural pH range can result in the loss of enzy-
matic function followed by a loss in secondary structure. Whilst most proteins will function
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Figure 6.4 T1 temperature optimization of E9 DNase S3C. a) echo decay traces showing key temperatures b)
fitted T1 times plotted against temperature c) fitted echo amplitude plotted against temperature. In b and
c error bars show 95 % confidence bands of the fitting. 1 scan, 2 shots/point, 4000 points, 60496 s shot
rep. time, 3439 G, 9.6642 GHz, 4.4 dB attenuation, 200MHz video bandwidth, 63 dB video gain. 100
M protein inH2O.
across a range of pHs there is usually an ideal pH at which rate and binding coefficients
are much higher. For this reason most experiments with proteins are carefully buffered to
ensure the sample does not move far from the desired pH thereby remaining in the most
active state.
Previous studies [91] have shown that colicin E9 is typically biologically active at pH 7.4 (in
vivo) but still has activity as low as pH 4.9 (in vitro). Obviously, whilst in this case the protein
may continue to show activity at extreme pHs the spin label can be reduced to theO  state
or oxidised to the OH state, rendering it EPR silent. For this reason it was essential to test
the bound spin label across the biological pH spectrum to ensure that an EPR signal could
be seen, and that no particular pH gave a marked increase in signal.
Figure 6.5.a shows that there is no significant change in the echo decays between pH 5.0
and 9.0. This suggests that the pH change has little effect upon the environment around
the spin label. As previous studies have shown there is still biological activity in this range,
we would expect no loss or significant change in the colicin E9 DNase domain secondary
structure.
When the echo decays are fitted (as in figure 6.5.b) a minimal change in the T2 relaxation
times is seen across the in vitro pH rangewith a difference of only 40 ns between the longest
(at pH 7.5) and shortest (at pH 5.0). There is a definite optimum between pH 7.0 (494.0 ns)
and pH 7.5 (494.5 ns), matching the in vivo optimal pH with a slight deterioration to the
acidic and a faster deterioration to the basic pH regimes. The signal amplitude matches the
T2 relaxation times but shows that pH 7.0 is preferential to pH 7.5.
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6.4. Deuteration optimization
Due to the non-linear relationship between the frequency of the observed signal derived
from the spin-spin coupling and the spin-spin distance, the maximum range of distance
measurements is often quoted as 80 A requiring up to 10s to obtain a full dipolar oscillation
[49], whilst a distance of 100 A would require at least 20 s and remains unobtainable in
biological systems [103].
Echo dephasing in spin labelled protein systems is largely caused by the hyperfine coupling
of the electron to protons in the surrounding environment and the consequent spin diffusion.
It has been shown that by removing protons in solution andmethyl groupswithin the protein
via deuteration vastly increases the T2 relaxation time [56].
It was therefore expected that as the sample becamemore deuterated that the T2 relaxation
time would increase whilst the 1H hyperfine modulations seen in the oscillations would be
replaced with 2H ESEEMmodulations as a result of the much larger quadrupole coupling in
a deutereon. It is hypothesised that complete deuteration of sample and buffer may be able
to extend the maximum PELDOR detection range to 100 - 130 A [11].
In figure 6.6 colicin E9 DNase without deuteration shows a normal echo decay as seen in all
of the previous experiments with hyperfine oscillations inside each echo oscillation. At 40
% deuteration the ESEEM effect can be seen to be appearing, with the third and fourth os-
cillations being higher than expected for an exponential decay. As the deuteration is further
increased the 2H ESEEM effect becomes more pronounced, but the 1H hyperfine splitting
of oscillations remains until 80 % deuteration; showing just how strong this effect is.
With every increase in deuteration level from 0 % an almost exponential increase in T2 relax-
ation time is seen at the cost of some singal intensity. That is until 70% deuteration which
shows an interesting, and repeatable, effect whereby the majority of signal intensity is lost
which when fitted gives a high T2 relaxation time in keeping with the trend, but could be artif-
ically high as a result of fitting. It is likely that at 70 % there is a situation of where there is the
highest level of both hyperfine and ESEEM relaxation resulting in relaxing the spin population
so quickly as to remove most of the signal.
With further investigation of this experiment (shown in figure 6.7) it can be seen that the
way the data is handled can make a large difference to calculated results. In red, is the
single parameter exponential decay fit of the entire dataset, yielding a T2 relaxation time of
1376.1  19.8 ns with signal amplitude 87500. In green, is the fitting curve used in figures
6.6.b and 6.6.c where only the maxima of the proton hyperfine modulations are used in the
fitting, where hyperfinemodulations still exist in the signal. This yields a T2 relaxation time of
1116.1 32.7 nswith signal amplitude 102000, this fitting whilst having a shorter relaxation
time has an increased amplitude which means that it appears closer to the experimental
data even if the confidence range is larger. Finally, the line in blue shows the fitting when
only the maxima of proton and deuteron modulations are included, in this instance no data
points below 380 ns are used. The result of this fitting is a T2 relaxation time of 978.3 26.6
nswith signal amplitude 198000. Using the fitting parameters that consider both relaxation
methods results in the large spike in figures 6.6.b and 6.6.c being reduced to little more than
the 60 and 80 % points on either side.
Above 70%deuteration themain contribution to theT2 relaxation time is ESEEMand thus the
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Figure 6.5 T2 pH temperature optimization of E9 DNase S3C. a) echo decay traces showing every pH unit b) fitted
T2 times plotted against pH c) relative echo amplitude plotted against pH. In b and c error bars show 95
% confidence bands of the fitting. 15 K , 32 scans, 4 shots/point, 512 points, 15034 s shot rep. time,
3438G, 9.6645GHz, 5.5 dB attenuation, 200MHz video bandwidth, 42 dB video gain. 100 M protein
inH2O.
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Figure 6.6 T2 buffer deuteration optimization of E9 DNase S3C. a) echo decay traces showing buffer deuteration
b) fitted T2 times plotted against buffer deuteration c) fitted echo amplitude plotted against buffer deuter-
ation. In b and c error bars show 95 % confidence bands of the fitting. 15K , 32 scans, 4 shots/point, 512
points, 15034 s shot rep. time, 3438G, 9.6648GHz, 5.5 dB attenuation, 200MHz video bandwidth, 48
dB video gain. 100 M protein inH2O/D2O.
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fitting is conducted to the ESEEMmodulations only. As a result the relaxation time remains
constant around 800 ns, but with further deuteration of the buffer shows a marked increase
in signal intensity.
From this it can be seen that, conforming with the literature, increased levels of deuteration
yields a longer transverse relaxation time. With increased echo coherence comes greater
intensity echoes, so long as 70 % deuteration is avoided.
6.5. Glyercol optimization
Glyercol increases the viscosity of the sample which, given constant temperature, has been
shown to linearly increase the molecular tumbling correlation time in proteins [39, 80]. The
correlation time is a key factor to the relaxation time with fast molecular tumbling causing
an averaging in the g and A anisotropiesmaking it difficult to detect between the pulsed spin
and the observed induced spin.
Glycerol slows the molecular motion of neighbouring methyl groups to which the unpaired
electron is coupled, therefore further reducingmethods bywhich the echo can rapidly decay.
It was expected, prior to the investigation, that even a small addition of glycerol would vastly
increase the relaxation time and that it would continue to increase with more glycerol until
a maximum was reached.
As figure 6.8 shows there is a large increase of 33.9% in theT2 relaxation time on the addition
of 10 % glycerol from 2.77 to 3.71 s. With further additions of glycerol the T2 relaxation time
continues to increase but at a much slower rate, until 70 % glycerol where the T2 relaxation
time levels out and reaches a maximum of 4.11 s at 80 % glycerol.
The amplitude of the signal appears to vary wildly in figure 6.8.c but this is as a result of the
fitting and presentation. All glycerol concentrations gave approximately equal intensities
which when normalized to the highest and lowest decay, gives the spread an appearance of
being much more diverse than when compared to the actual curves seen in figure 6.8.a.
A final sample preparation of 50 % glycerol was decided upon. Whilst, even the smallest
addition of glyercol showed a large increase in the T2 relaxation time, it is clear that as much
glyercol as is possible is optimal. However, high glycerol sample preparations have a very
high viscousity making them almost unmanageable to work with. It also requires a very
concentrated aqueous protein sample to achieve a suitable protein concentration after the
addition of glycerol. For this reason 50 % glycerol gave the optimum comprimise between
sample preparation and experimental result.
6.6. Glyercol deuteration optimization
In previous sections it has been shown that for optimal T2 relaxation times, high levels of
deuteration (§6.4) andglycerol concentration (§6.5) are required. However, glycerol (CH2(OH)
CH(OH)CH2OH) as a simple polyol can bedeuterated to different levels, completely (glyercol-
d8), through non-labile protons (glycerol-d5) or through the labile protons of the alcohols
(glycerol-d3).
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Figure 6.7 T2 relaxation time determination of E9 DNase S3CIA1 at 70 % deuteration of the buffer. In navy is the
raw data trace, cropped to show only the first 4.0 s. The red line is the fitting line obtainedwhen the entire
dataset is considered. The green line is the fitting line obtained if all of the dataset is considered but only
themaxima peaks from proton hyperfinemodulation are used in the fitting. The blue line shows the fitting
line obtained when only the maxima hyperfine modulations of both proton and deuteron are used. 15K ,
32 scans, 4 shots/point, 512 points, 15034 s shot rep. time, 3438 G, 9.6648 GHz, 5.5 dB attenuation,
200MHz video bandwidth, 48 dB video gain. 100 M protein inH2O/D2O.
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Figure 6.8 T2 glycerol conentration optimization of E9 DNase S3C. a) echo decay traces showing key temper-
atures b) fitted T2 times plotted against glycerol concentration c) fitted echo amplitude plotted against
glycerol concentration. In b and c error bars show 95 % confidence bands of the fitting. 15K , 32 scans,
4 shots/point, 1024 points, 15031 s shot rep. time, 3445 G, 9.7070 GHz, 7.5 dB attenuation, 20MHz
video bandwidth, 68 dB video gain. Sample made from 200 M protein in H2O to give final sample as
100 M protein.
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As discussed in §6.4 proton concentration is inversely related to T2, namely, [H+] / 1/T2 [56].
Thus, if a sample were made of 50:50 D2O:glycerol then, as the labile glycerol hydrogens
exchange, then the concentration of free protons would increase.
To show the effect of glyercol and deuteration upon the sample and to highlight the contri-
butions from the spin label and the protein, this investigation was conducted first upon free
spin label before the label was attached to colicin E9 DNase S3C.
6.6.1. IA-PROXYL
Figure 6.9 confirms that the addition of glyercol is of paramount importance to achieve long
T2 relaxation times. Figure 6.9.b clearly shows that the addition of glycerol increases the
T2 relaxation time from 0.40 s to 2.10 s to 2.54 s with glycerol-d8. When the proton
concentration is further reduced by using a deuterated solvent (D2O) then the T2 relaxation
time sharply increases from 0.40 s to 3.32 swith glycerol-d3 and 8.34 swith glycerol-d8.
The combination of deuteration and glycerolisation yields a 17.5 increase in T2 relaxation
time 8.7 increase in modulation signal intensity.
Figure 6.9.a perhaps best shows the difference between 1H hyperfine coupling (best seen
in Glycerol in H2O) and 2H ESEEM oscillations (best seen in glycerol-d8 in D2O). On close
inspection of figure 6.9.a the oscillations in the first few s of the D2O curve appears er-
roneous as it contains no ESEEM modulations, only some hyperfine. Whilst, the hyperfine
modulations are understandable as the protein is still protonated, the ESEEM modulations
simply cannot be seen as without the presence of glyercol the relaxation is so fast that the
system has all but relaxed before the first ESEEM modulation.
Note that the glycerol-d3 in D2O echo despite a very low proton concentration still shows
hyperfine oscillations upon the much longer ESEEM oscillations.
6.6.2. Colicin E9 DNase S3C
Given the results of the IA-PROXYL experiment, the spin labelled protein experiment was ex-
tended so that each solvent (H2O/D2O) saw every level of glycerol deuteration. Figure 6.10
shows a that combined deuterated solvent and glycerol medium yields longer T2 relaxation
times and signal intensities, but to a lesser extent than in the case of the free label (7.8 T2
relaxation time, 3.0 intensity).
Figure 6.10.a whilst initially appear noisier than previous spectra, note that the abscissa is
now 8 s, double that shown at the beginning of this chapter. Again the main contribution
to relaxation from hyperfine and ESEEM effects as the sample becomes more deuterated
is apparant, with the reduction in hyperfine relaxation lengthening the T2 relaxation times
(figure 6.10.b).
6.7. Sample cooling
EPR samples want to be in a frozen solution, a glass, not a solid. In order to achieve a good
glass it is common practice for a sample to be mixed with glycerol and flash frozen in liquid
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Figure 6.9 T2 glycerol deuteration optimization of IA-PROXYL. a) echo decay traces b) fitted T2 times plotted
against glyercol deuteration c) fitted echo amplitude plotted against glyercol deuteration. In b and c error
bars show 95 % confidence bands of the fitting. 50K , 32 scans, 4 shots/point, 1024 points, 499.8 s shot
rep. time, 3464G, 9.7389GHz, 2.8 dB attenuation, 20MHz video bandwidth, 63 dB video gain. 100 M
IA-PROXYL.
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Figure 6.10 T2 glycerol deuteration optimization of E9 DNase S3C. a) echo decay traces b) fitted T2 times plotted
against glycerol deuteration c) fitted echo amplitude plotted against glycerol deuteration. In b and c error
bars show 95 % confidence bands of the fitting. 50 K , 64 scans, 4 shots/point, 1024 points, 15031 s
shot rep. time, 3450 G, 9.7120 GHz, 5.0 dB attenuation, 20 MHz video bandwidth, 69 dB video gain.
100 M protein at 33 % labelling efficiency.
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nitrogen. This serves to both capture a ``snapshot in time'' of the sample and by creating
a glass, there is low order in the lattice which minimising lattice relaxation pathways. In
contrast, a slowly frozen sample in water should have a near perfect lattice with a high level
of order, allowing for higher loss ofmagnetization via lattice relaxation. Additionally, aswater
freezes and forms the crystal lattice its volume increaseswhich can create distortionswithin
the protein structure.
The work of Dr. G. Smith and co-workers (University of St. Andrews, UK) using a specialised
spectrometer, HIPER, where microwaves approach the sample in a top-down fashion have
found that the quality of the sample glass surface greatly affects their signal-to-noise (SNR)
ratio.
Here the T1 and T2 relaxation times of colicin E9 DNase S3CIA1 were measured under 3
conditions in 3 different environments. Colicin E9 DNase S3CIA1 samples were produced in
water, in a 50% glyercol solution and a 50% glyercol-d8 in D2O. Ice sampleswere produced by
slowly freezing the sample in the cryostat from 298K to 50K at 2K/min. Glass samples
were produced by flash freezing the sample in liquid nitrogen and being transferred to a cold
cryostat at 50 K. Reannealed samples were produced by flash freezing the sample, and
once inside the cryostat the temperature were raised at 5 K/min to just below the glass
transition point (140K [63]) and held for 20min before being returned to 50K at 2K/min.
Liquid nitrogen is a poor thermal conductor and the samples at 100 l are still relatively
large, even with flash freezing any high density water area will see crystal lattice formation.
By raising the sample to just below the glass transition (the maximum temperature that the
glass can exist) amolten glass state is reachedwhere the glass can freelymovewith almost
liquid-like properties minimising any areas of high water concentration. The slow reduction
in temperature ensures that the sample cools in a consistent manner so that no one area
cools faster allowing lattice formation.
As expected, the longitudinal relaxation (T1) (figure 6.11) vastly increaseswith the addition of
glyercol. However, there is little difference between the deuteration level of the sample when
the sample is slowly or flash frozen. In a protonated environment reannealingmakes a small
but unsubstantial change to the relaxation. However, in a fully deuterated environment the
T1 drops almost in half. We can only assume that the deuteration somehow affects the
ability of hydrogen bonding in lattice formation.
Considering the transverse relaxation (T2) (figure 6.12) we can again see that the addition
of glyercol (a glass former) increases the relaxation time by ~ 8 fold regardless of the cool-
ing method. Here we can also see that in a protonated environment there is little change
to the relaxation time between cooling methods. However, in a deuterated environment a
glass yields an increase in relaxation time over the ice, whilst the reannealed glass shows a
significantly increased T2 time of 1 s.
For samples where relaxation is very fast, this increase could prove vitally important. How-
ever, in this investigation the additional 2 hours required to reanneal each sample yields no
gain. Most PELDOR distances under 8 nm can see sufficient oscillations in under 3 s, thus
an increase in T2 time from 5 s to 6 s simply increases the experiment time, where an
additional 2 hours of sample averaging would be more beneficial.
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Figure 6.11 Effect of T1 relaxation by different sample cooling methods of E9 DNase S3C. Error bars show 95 %
confidence bands of the fitting. 50K , 2 scans, 4 shots/point, 1024 points, 50000 s shot rep. time, 3455
G, 9.6903 GHz, 20MHz video bandwidth, 60 dB video gain. 100 M protein.
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Figure 6.12 Effect of T2 relaxation by different sample cooling methods of E9 DNase S3C. Error bars show 95 %
confidence bands of the fitting. 50K , 4 scans, 4 shots/point, 1024 points, 10000 s shot rep. time, 3455
G, 9.6903 GHz, 20MHz video bandwidth, 51 dB video gain. 100 M protein.
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Figure 6.13 T2 /2 pulse length optimization of E9 DNase S3C. a) echo decay traces b) fitted T2 times plotted
against /2 pulse length c) fitted echo amplitude plotted against /2 pulse length. In b and c error bars
show 95 % confidence bands of the fitting. 50K , 4 scans, 4 shots/point, 1024 points, 10000 s shot rep.
time, 3454.5 G, 9.6846 GHz, 20MHz video bandwidth, 48 dB video gain. 100 M protein.
6.8. Pulse length optimization
With high levels of deuteration it is expected to have 2H ESEEM modulations with greater
than 10 % modulation depth [94]. It was investigated whether a softening of pulses would
create a decrease in the severity of the 2H ESEEMmodulation depth [83]. For this, a standard
Hahn echo sequencewasused (/2 -  - -  - echo), with  kept at an optimum380ns, whilst
the /2 length was varied. The  pulse was adjusted accordingly and the power optimised
to give the largest echo.
Using the standard Bruker spectrometer configuration a 10 ns /2 pulse was the shortest
achieveable (89.3 mW ), at 8 ns there was not enough power to fully invert the spin popu-
lation, seen in 6.13.a, whereby the echo modulations have a distorted frequency to all the
pulse lengths. This results from uncertainty within the electronics and the ability to accu-
rately measure such short times.
A 16 ns /2 pulse (20mW ) gave a good T2 relaxation time and experimental amplitude whilst
maintaining a narrow Hahn echo of 140 ns. Moving to an 18 ns /2 pulse there was a broad-
ening of the echo to 160 ns, which corresponds to a dropping of the T2 time and amplitude.
Pulses of 30 and 36 ns saw an increase in the signal amplitude which, when fitted, also gave
a marked increase in the T2 time. Unfortunately, the echo at this point increases to 200 ns
in width. At a 48 ns /2 pulse the echo width increases to 250 ns and at 66 ns /2 pulses the
Hahn increase to over 300 ns.
The increase in Hahn echo width is not a problem, for a simple collection of transverse re-
laxation time where the integral of the whole echo can be taken, however, for more complex
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experiments this becomes a problem. As the pulse length increases more spins are excited
but fewer of them are within the xy plane, instead there is a cloud ofmagnetisation about xy.
For an experiment, such as PELDOR that has a level of orientation selectivity, a high degree
of coherence in magnetisation is essential. Removing the orientation dependence can be
achieved with strong samples by only integrating a small portion at the centre of the Hahn
echo, rather than the entire echo encompassing all orientations and off-resonances.
Most interestingly, with all /2 pulse lengths the first oscillation depth is 36.1  1.1 % (1
standard deviation) of the total signal. The aim of this investigation was to see whether soft
pulses would decrease the 2H ESEEMmodulation effect, but upon this sample no effect can
be seen. For this reason a 16 ns /2 pulse remained the best option, yielding good transverse
relaxation times, signal amplitude and goodpolarisation homogeneity in spinmagnetisation.
6.9. Summary and discussion
All data in this section, aside from the temperature assays, were collected at 50K. Through-
out the timeperiod of these experiments the laboratorywas installing closed circuit cryostats,
with 15K representing the lowest, reliable temperaturewith rapid cool down time this equip-
ment could achieve at the time. At timeswhen the closed circuit cryostats could not be used,
such as to achieve temperatures below 15 K in the temperature assays a traditional flow
cryostat was used.
In a PELDOR experiment the system must return to magnetic equilibrium before initiating
the next pulse sequence for the next scan. The experiment repition time is there fore typi-
cally set to five times greater than the longest relaxation time. Equally the dipolar coupling
oscillations that are observed in a T2 dependent relaxing echo. To capture the highest quality
data and asmany as dipolar oscillations as possible requires selecting a temperature to that
maximise the T2 relaxation time but minimise the much longer T1 relaxation time. The best
compromise then allows for the longest persistent echo with the highest scan rate, resulting
in the most signal capture and thus, best possible data set.
In figures 6.2 and 6.4 (page 83) at 30 K the T2 relaxation time is 94.2 % of the maximum,
seen at 4K. The T1 relaxation timemeanwhile has beenmuch reduced to only 27.2 % of the
maximum, seen at 4K . At 20K a small T2 relaxation time increase of 3.1 % (relative to the
maximum at 4 K) is seen, but also an increase in T1 relaxation time of 40.9 %. Raising the
temperature further to 40 or 50K results in a drop in T2 relaxation time (of 88.1 % and 86.1
% respectively, relative to the intensity at 4K) with no real gain in T1 relaxation time (25.6 %
and 25.1 % respectively). Whilst these numbers reflect the situation of a pure relaxation ex-
periment, the actual PELDOR experiments quickly showed it were far preferable to continue
at 50 K as the echo duration with glyercol and other parameter optimisation showed little
variation, however the experiment replication time could safely be dropped a further 10ms.
The pH of the experiment showed little bearing on the experiment in terms of T2 relaxation
time, though a small maximum is seen around pH 7.5. As the cytosolic pH of E. coli is 7.6
[10] and the optimum conditions for colicin E9 activity is pH 7.4 [91] an experimental pH 7.5
is most desirable for spectroscopic and biological relevance. Had the colicin E9 shown a
strong pH dependence outside of this range then a compromise would have been needed to
bemade between protein structure and function with still having functional detection times.
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Individually, the deuteration and glycerolisation optimization experiments showed that in-
creases in both gave better T2 relaxation times and signal intensities. The deuteration as-
say showed an almost exponential increase in T2 relaxation times using the standard fitting
method up until 70 % deuteration (figure 6.6). However, on closer analysis it was found that
the 70%deuteration point was likely to be a quirk of environmental parameters and fitting. At
70 % deuteration of the solvent a large amount of modulations from both hyperfine coupling
and ESEEM can be seen, allowing the sample to relax quickly via twomethods. The relatively
small amount of signal combined with inexact fitting methods artifically generated a high
T2 relaxation time. With data points above 70 % solvent deuteration any further increase in
deuteration yields no significant increase in T2 relaxation time, however, an increase in sig-
nal amplitude is seen. These observations made it clear that full deuteration of all samples
was desirable.
Working with high glyercol concentrations is difficult as it requires that the protein be con-
centrated to very high levels nearing saturation before being added to the glycerol or require
the difficult process of resuspending freeze-dried protein in glycerol. The high viscosity so-
lutions associated with high glyercol concentrations also generate sample handling prob-
lems when requiring small volumes to be accurately measured and placed inside narrow
bore sample tubes. The increase from a 50 % glycerol solution to 90 % glycerol solution
yielded only a further increase of 0.1 s in the T2 relaxation time (a 5.3 % relative increase
(figure 6.8)). With this in mind, the combined deuteration and glyercol experiments were
conducted using 50 % glycerol, as very much a practical handling compromise over a best
experimental result.
With individual assays of glyercol and deuteration complete, it was already known that the
most desirable conditions were with high glycerol concentrations and deuteration. To in-
vestigate the effect of deuteration of the glycerol itself two experiments were conducted.
In the first (figure 6.9) free in solution IA-PROXYL was placed in several combinations of
solvent and glycerol deuteration. The addition of glycerol as before had marked increase
on the effect of T2 relaxation time, from 0.40 to 2.10 ms in protonated solvent and 0.40 to
3.32 ms in deuterated solvent. Deuteration of the glyercol in either solvent showed again
a marked increase in the T2 relaxation time. Most significantly the fully deuterated sample
showed a 17.5 fold increase in T2 relaxation time than the protein in water alone. Glycerol
deuteration was further shown to be beneficial to signal amplitude. The increased viscosity,
and thusmolecular tumbling time as well as the reduced relaxation via solvent 1H hyperfine
couplings, yield large experimental gains.
With the results of free in solution IA-PROXYL showing such drastic results, it was hoped
that similar results could be achieved with the spin label attached to protein. In figure 6.10,
the original IA-PROXYL experiment was extended slightly such that each solvent (protonat-
ed/deuterated) saw each level of glycerol deuteration. In protonated solvent environments
the addition of glyercol increased the T2 relaxation time but to a lesser extent than free IA-
PROXYL. As the glycerol was deuterated the T2 relaxation time increased, only slightly with
glycerol-d3, but glycerol-d8 showed a relaxation time almost exactly double that of glyc-
erol. With deuterated solvent, the T2 relaxation time almost matches that of the protonated
solvent with glycerol-d8. When the deuterated solvent has glycerol added the T2 relaxation
time actually drops as the addition of protons and associated hyperfine coupling relaxation
is more detrimental to relaxation than the increase in viscousity and associated molecular
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tumbling time. As with IA-PROXYL, further deuteration of the glyercol in the deuterated sol-
vent results in longer T2 relaxation times but to a lesser extent than seen with IA-PROXYL
free on solution. Overall, with glyercol and deuteration a 7.8 fold increase in T2 relaxation
time was seen with a near doubling of signal amplitude.
With infinite resources, it would be desirable that the proteins be grown in deuteratedmedia,
ensuring that the entire protein was completely deuterated, with samples using deuterated
labels and being resuspended directly into 100%glycerol-d8 for the experiments. Deuterated
grow ups are prohibitively expensive for all of the required mutants. As a result, all samples
were grown in normal, protonated, media and later buffer exchanged intoD2O. Deuterated
spin labels in the quantity required for this investigation also proved prohibitively expensive.
All experiments were conducted using the much easier to handle but similarly behaving 50
% glycerol-d8. This gave much of the benefit of deuteration and glycerolisation without ex-
treme expense and difficulty in sample preparation.
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7. Pulsed Investigation
With protein expressed, spin labelled and characterised, and all conditions optimised the
PELDOR experiments could begin. This investigation includes 7 spin label sites across the
E9 DNase domain and immunity protein Im9. This yields a binding cross of 42 possible
distances. Mutations for every possible distance were not prudent, giving an experimental
investigation of 18 PELDOR experiments.
Each PELDOR experiment was individually optimised to yield the best possible data. This
meant that before each PELDOR run several experiments were conducted; a T2 experiment
to gather the maximum PELDOR observation window as well as the optimum 1 time (see
chapter 1), a T1 experiment to determine theminimum time between shots in an experiment,
a field swept echo experiment to locate the spin resonance location and an ELDOR nutation
experiment to determine both ELDOR pulse power and length.
In addition, PELDOR experimental background experiments were conducted in which the
PELDOR experiment was repeated under identical conditions and parameters but the sam-
ple is replaced with a sample where only one of the binding partners is spin labelled and a
further experiment where one of the binding partners is completely removed. By subtracting
the experimental background of a spin label in the same position and environment with no
PELDOR effect from the real experiment, the resulting trace can be attributed entirely as a
result of a dipolar coupling.
This amounts to 18 PELDOR experiments each with; 4 PELDOR backgrounds, a T2 exper-
iment, a T1 experiment, a field swept echo, an ELDOR nutation as well as experimental
background subtracted PELDOR traces and PELDOR derived distance distributions. This
amounts to a substantial amount of data, far more than would be appropiate to be show
here in full. As a result the results of the T 1 and T 2 experiments are briefly summarised in
§7.1, whist full parameter setup experiment examples can be found in appendix D.
7.1. T 1 and T 2 measurements
Following optimization of echo parameters, each spin labelling site was investigated to en-
sure a level of consistency between the different positions. As each sample was run with
near identical conditions, near equivalent solvent accessibility of label sites (with the expec-
tions of colicin E9 D20C/E66C and E66C) and given that the protein size and weight should
be of the same order, even between colicin and immunity protein, a large difference was not
expected.
However, this experiment established the maximum acquisition time from the T 2 time for
the PELDOR experiment and the minimum required shot repetition from the T 1 time. As
seen from table 7.1 the maximum acquisition time for any sample was around 3 s with
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Figure 7.1 Relaxation times of each labelled protein in the E9 DNase - Im9 bindind complex under optimised con-
ditions from chapter 6. All proteins shown here use the IA-PROXYL label except E9 DNase S30C which
uses MTSL. All experiments: 50 K , 4 scans, 4 shots/point, 1024 points, T2 experiments used 6.0 dB at-
tenuation, 20MHz video bandwidth, 45 dB video gain and 10000 s shot rep. time. T1 experiments used
9.0 dB attenuation, 20MHz video bandwidth, 51 dB video gain and 50000 s shot rep. time. Frequency
and magnetic field were optimised on a per experiment basis typically around 9.70GHz and 345.70mT
respectively. Protein concentration 100 M inD2O and 50 % glycerol-d8.
most sitting between 1.8 and 2.6 s. Whilst the T 1 times sit at approximately 4ms, so as to
ensure that the system is completely relaxed the shot repetition time was set at two and a
half times this value (10ms).
Protein, labelling position T 1 /ms T 2 / s
E9 DNase S3C 3.81 2.37
E9 DNase S30C 3.39 2.67
E9 DNase S3C / S80C 3.90 3.03
E9 DNase S30C / S80C 3.87 2.52
E9 DNase E66C 4.04 1.98
Im9 C23 4.22 1.80
Im9 C23S / S6C 4.06 1.51
Im9 S6C 4.36 1.87
Table 7.1. The T 1 and T 2 relaxation times of each labelled protein within the E9 DNase - Im9 binding complex
under optimised conditions, at 50K.
7.2. Distance measurement
Each PELDOR experiment samplewasmade according to the conclusions of previous chap-
ter. Namely, samples were buffer exchanged into 100 % D2O and further washed with D2O
to ensure that any labile protons on the protein had been exchanged with deuterons and
combined with glyercol-d8, so that the final solution was 50 % glyercol.
Samples requiring the mixing of two proteins were mixed such that the protein stoichiom-
etry remained 1:1 to avoid any free protein distorting the PELDOR trace. Any difference in
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concentration was adjusted with the addition of further D2O. A short mixing time of a few
minutes was allowed before addition of the glycerol. The addition of glyercol yielded an
80 l total sample volume, which required agitation to stop formation of a biphasic system.
Protein concentration was kept as high as possible tomaintain signal but on occasion in un-
buffered D2O protein precipitation was unavoidable and at much lower concentration than
expected for the sample protein in normal, protonated, buffered solution.
Each PELDOR experiment figure presented here shows an approximate 20 hour data collec-
tion and is presented with 4 subfigures. The first subfigure shows a cartoon model of the
colicin E9 DNase - Im9 complex from PDB 2K5X. IA-PROXYL spin labels have been added to
each labelling site (with the aid of MMM, with the calculated most populated rotamer) being
displayed in ball and stick representation. Each label has been coloured uniquely and the
near-solid line representing the PELDOR vector is coloured to match the first label in each
pair. For example, as the colicin E9 DNase S3CIA1 label is black and by convention is the
first label listed any distance involving this label is coloured black. This subfigure is included
to aid the reader's perception of each experiment in relation to the others.
The second subfigure shows the raw data of the PELDOR experiment, including the brief
rise before time zero. Whilst most experiments are kept with similar parameters it is worth
noting the difference that the acquisition time for some experiments does vary.
The third subfigure shows the raw data PELDOR trace subtracted from the background and
renormalized in navy. For particularly noisy spectra the raw trace passed through a Fourier
transform noise filter to remove high frequency noise associated with very short distances,
which would be below detection by PELDOR. When this technique was used it has been
noted in themain text. The red line shows the fit to the experimental data fromDeerAnalysis.
Finally, the last subfigure shows the distance distribution fromDeerAnalysis after a Tikhonov
regularisation L-curve analysis. In navy is the experimental data, plotted against the dis-
tance prediction, made from MMM rotamer population analysis, based upon the NMR min-
imised average complex (PDB: 2K5X) in red. In cases where the experimental and predicted
distance distribution vary substantially, the experimental data is loaded into MMM and a
rotamer analysis is performed to see if varying the rotamer populations could better fit the
predicted distribution to the experimental. Where this is the case, the adjusted distribution
is presented in maroon.
In addition to the figures shown in the body text here for each experiment a L-curve analysis
plot of the Tikhonov regularisation is shown in appendix D.2 on page 317. Whilst the theory
behind Tikhonov regularisation is not the focus of this investigation the resulting L-curve
shows the quality of the regularisation and thus reflects the quality and confidence of the
final distance distribution.
Additionally, appendix D.2 shows a superimposing of the 4 pulse PELDOR experimental data
and background trace from which the experiment is subtracted. With this additional figure
it can help visualise the quality of the experiment by highlighting how strong the dipolar
oscillations vary from a simple decay.
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7.2.1. Colicin E9 DNase S3CIA1/S80CIA1
(a) Protein structure
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(c) Background subtracted PELDOR trace
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Figure 7.2 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1. a) shows the PELDOR experiment
distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin labels are
highlighted in coloured ball and stick representation showing highest populated MMM rotamer. S80C
position in the middle, S3C position at the right b) shows the raw 4 pulse PELDOR data. c) shows the
PELDOR experiment after background subtraction in navy with the fitting made by DeerAnalysis is red. d)
Shows the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted distance
distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 276 points, 6.0 dB attenuation,
20MHz video bandwidth, 57 dB video gain and 10000 s shot rep. time, ~9.70 GHz, 345.70 mT . 1=
380 ns, 2= 2200 ns, ELDOR pulse step 4 ns, no nuclear modulation suppression. Protein concentration
100 M inD2O and 50 % glycerol-d8.
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The colicin E9 DNase S3CIA1/S80CIA1 sample clearly shows a mix of 2 distinct distances
in the distance distribution. The peak at 3.91 nm shows good agreement with the MMM
prediction in position but is much less broad. Perhaps suggesting that one or both of the
sites is more restricted than predicted, thus not allowing the full motion of the rotamer cloud
predicted by MMM. The second peak at 5.31 nm however is not predicted by MMM but can-
not necessarily be discounted due to its high probability. Considering both peaks together
could suggest that one or both of these positions must be more restricted than expected
and jumps between 2main conformations, resulting in two narrow distribution peaks rather
than a single broad peak as expected.
When the MMM rotamer distributions of these two labelling sites are visualised, as in figure
7.3, both of these sites can be seen to be largely mobile on the surface of the protein. The
colicin E9 DNase S3CIA1 is very mobile and shows an almost equal sampling across the
entire rotamer cloud. The colicin E9 DNase S80CIA1 is more restricted and shows a smaller
sampling than the colicin E9 DNase S3CIA1 position and appears to have a slight split into
twopopulations at the top and bottomof figure 7.3.b. It is likely that the shoulder of theMMM
distance distribution trace (red line in figure 7.2.d) appears as a result of this split. However,
this small split would not account for the distinct difference of populations seen in figure
7.2.d. The colicin E9 DNase S80C position lies upon a short  helix between a flexible hinge
and the main, flexible DNA binding region. It is therefore not unreasonable to expect some
molecular motion of this helix that could result in a two state conformation interchange,
particularly in the absense of the immunity protein to stabilise the DNA binding region. This
could explain the difference in experimental and calculated distance distributions.
(a) Colicin E9 DNase S3CIA1 (b) Colicin E9 DNase S80CIA1
Figure 7.3 Rotamer comparison of colicin E9 DNase S3CIA1 and S80CIA1. MMM computed rotamers are shown
superimposed onto the cartoon structure of colicin E9 DNase/Im9 complex (PDB: 2K5X). Each individual
rotamer's transparency relates to that rotamer's population, with solid rotamers being statistically more
relevant. The magenta sphere represents the nitroxide radical position of each rotamer, with sphere size
relating to rotamer population.
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7.2.2. Colicin E9 DNase S30CIA1/S80CIA1
(a) Protein structure
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Figure 7.4PELDOR experiment results for colicin E9DNase S30CIA1/S80CIA1. a) shows the PELDOR experiment
distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin labels are
highlighted in coloured ball and stick representation showing highest populated MMM rotamer. S80C
position in themiddle, S30C position at the bottom right b) shows the raw 4 pulse PELDOR data. c) shows
the PELDOR experiment after background subtraction in navy with the fitting made by DeerAnalysis is
red. d) Shows the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted
distance distribution in red. 50 K , 20 hours collection (~ 2500 scans), 4 shots/point, 193 points, 10.0
dB attenuation, 20 MHz video bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.69 GHz,
346.00mT . 1= 380 ns, 2= 4160 ns, ELDOR pulse step 4 ns, no nuclear modulation suppression. Protein
concentration 100 M inD2O and 50 % glycerol-d8.
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The colicin E9 DNase S30CIA1/S80CIA1 sample again shows a mix of 2 distinct distances
in the distance distribution. The peak at 3.86 nm shows good agreement with the prediction
fromMMM, suggesting that the rotamer population fromMMMdiffers only slightly from the
case in vivo.
As with the colicin E9 DNase S3CIA1/S80CIA1 a significant second peak at 5.33 nm can
be seen which is not predicted by MMM. Further analysis of this peak was conducted (see
appendix D.2.2), to determine whether this peak results is simply a ghost peak, a truncation
artefact from background subtraction or significant. By using DeerAnalysis' validation tool
the fitting window was moved through 2.5 and 3.5 s at the same regularisation parameter.
It was found that the oscillation after 2.0 s in the background subtracted PELDOR trace
(figure 7.4.c) remains significant and fits the data well. This had little effect upon the shorter
distance peak, varying only a little in the low distance tail. With the longer distance peak the
validation process added significance to 5.40 nm as a significant distance.
The common element between this and the previous experiment is the colicin E9 DNase S3C
site. When viewed in combination there is a suggestion that the colicin E9 DNase S3C site
is more restricted than predicted and jumps between 2 conformations. One pointing into
the colicin and giving the shorter distances and one pointing out and away from the protein
giving rise to the longer distance. This could perhaps explain the slightly lower spin labelling
efficiency and aqueous accessibility than that of the colicin E9 DNase S30C site, seen earlier
in this investigation.
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7.2.3. Im9 S6CIA1/C23IA1
(a) Protein structure
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Figure 7.5 PELDOR experiment results for Im9 S6CIA1/C23CIA1. a) shows the PELDOR experiment distance su-
perimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin labels are highlighted
in coloured ball and stick representation showing highest populated MMM rotamer. C23 shown in or-
ange, S6C shown in red b) shows the raw 4 pulse PELDOR data. c) shows the PELDOR experiment after
background subtraction in navy with the fitting made by DeerAnalysis is red. d) Shows the DeerAnalysis
Tikhonov derived distance distribution in navy with the MMM predicted distance distribution in red. 50K ,
20 hours collection (~ 2500 scans), 4 shots/point, 254 points, 8.0 dB attenuation, 20MHz video band-
width, 69 dB video gain and 10000 s shot rep. time, ~9.69 GHz, 345.60mT . 1= 380 ns, 2= 1800 ns,
ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100 M in D2O and
50 % glycerol-d8.
106
7.2. Distance measurement
Unfortunately, this Im9 mutant was incredibly prone to precipitation and could only be used
at concentrations around 25 M . The low (16 %) labelling efficiency, with both sites indi-
vidually labelling poorly (S6C 14 %, C23 5 %) meant that the proportion of spins contributing
to electron-electron dipolar oscillations were going to be small. Initially looking at the raw
PELDOR trace, whilst being virtually noise free this experiment appears to be little more than
a straight decay. However if the data between 1.0 and 1.5 s (in figure 7.5.b) is extrapolated
a slight rise can be seen. This is made more apparent in appendix D.2.3, where the PELDOR
trace is shown with the Im9 C23IA1 relaxation run with the same experimental parameters.
An optimistic fit can be made with DeerAnalysis yielding a distance distribution with 3 short
distances, though the L-curve (appendix D.2.3) is very shallow. MMM initially predicts a
single, relatively narrow peak reflecting the slightly restricted labelling sites (red). This pre-
dicted peak matches well with the longest experimental distance at 3.2 nm, after loading
the resulting DeerAnalysis distance distribution into MMM the rotamer population can be
adjusted whereby the population of each rotamer is adjusted to see if the prediction and ro-
tamers canmatch the experiment data. This experimentally adjusted prediction is given the
maroon line distribution, which aligns not too dissimilarly from the experimental result. Nev-
ertheless, this is a somewhat optimistic result and still yields an overall distance distribution
of over 2.0 nm.
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7.2.4. Colicin E9 DNase S3CIA1 - Im9 C23IA1
(a) Protein structure
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Figure 7.6 PELDOR experiment results for colicin E9 DNase S3CIA1 - Im9 C23IA1. a) shows the PELDOR ex-
periment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin
labels are highlighted in coloured ball and stick representation showing highest populated MMM rotamer.
E9 DNase S3C shown in yellow, Im9 C23 in orange b) shows the raw 4 pulse PELDOR data. c) shows the
PELDOR experiment after background subtraction in navy with the fitting made by DeerAnalysis is red. d)
Shows the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted distance
distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 414 points, 5.5 dB attenuation,
20MHz video bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.69 GHz, 345.60 mT . 1=
380 ns, 2= 3440 ns, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration
100 M inD2O and 50 % glycerol-d8.
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This experiment proved troublesome and was repeated no less than 4 times. In the first
instance the effective label concentration was far too low to achieve a good SNR echo. The
second experiment increased the protein concentration virtually to the point of precipitation.
After still no PELDOR being seen the individual proteins were taken and protein concentra-
tion accurately confirmed with a nanodrop spectrophotometry and spin label attachment
confirmedwith room temperature X-band cw-EPR followed by a repeated spin labelling pro-
cedure repeated.
Figure 7.6 shows the result of the fourth PELDOR attempt with maximum possible protein
concentration and both proteins having been spin labelled twice. Figure 7.6.b shows a clear,
linear decay, which when subtracted from the background, in figure 7.6.c, gives a straight
line distorted by noise. If the PELDOR experiment trace is plotted with the single colicin E9
DNase S3CIA1 PELDOR decay (as in appendix D.2.4) it can be seen that there are no dipolar
oscillations present in this sample.
This experiment clearly showing no dipolar contributions when analysed with DeerAnalysis,
unsuprisingly gives non-sense results. The background subtracted trace shows less than
0.2 % intensity - little more than noise (figure 7.6.c). The Tikhonov L-curve (appendix D.2.5)
and distance distribution (figure 7.6.d) give, expected, terrible data. The L-curve is not the
expected shape and the distance distribution includes below zero probabilites of certain
distances.
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7.2.5. Colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23S
(a) Protein structure
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Figure 7.7 PELDOR experiment results for colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23S. a) shows the PELDOR
experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin
labels are highlighted in coloured ball and stick representation showing highest populated MMM rotamer.
E9 DNase S3C shown in yellow, Im9 S6C in red b) shows the raw 4 pulse PELDOR data for 3 different
experiments (described in the text). c) shows the PELDOR experiment after background subtraction in
navywith the fittingmade by DeerAnalysis is red for each of the 3 experiments. d) Shows the DeerAnalysis
Tikhonov derived distance distributions in navy with the MMM predicted distance distribution in red. 50
K , 20 hours collection (~ 2500 scans), 4 shots/point, 20MHz video bandwidth and 10000 s shot rep.
time, ~9.69GHz, ELDOR pulse step 8 ns, no nuclear modulation. Data points, magnetic field, attenuation,
video gain and delay times were optimised on a per experiment basis suppression. Protein concentration
100 M inD2O and 50 % glycerol-d8.
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This experiment again due to the very low concentration and labelling efficiency of colicin E9
DNase S3CIA1 proved troublesome. However, unlike colicin E9 DNase S3CIA1 - Im9 C23IA1
some trace of information can be gleaned from each experiment. For this experiment the
extent of difficultly has been highlighted by showing the initial experiment (top spectrum
in each panel), after protein concentration to precipitation point (middle spectrum in each
panel) and after protein concentration and a second attempt at spin labelling with a 100 fold
excess of label (bottom spectrum in each panel).
Comparing the bottomspectrumof figure 7.7.awith a background decay of colicin E9DNase
S3CIA1 (appendix D.2.5) shows only a slight raise in signal intensity in the first microsecond.
After background subtraction (figure 7.7.c) fitting shows some oscillations, of which some
are clear amongst at least one trace.
The MMM prediction for colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23S is shown in red in
figure 7.7.d. Many of the peaks predicted by MMM appear in at least one of the experimen-
tal distributions. Key to notice is that peaks at 3.0 and 3.5 nm appear in all 3 experimental
distributions, whilst a peak around 4.2 nm appears in both low noise spectra. Perhaps, it
is to be expected to have such an array of peaks in the experimental distance distribution
when the predicted distribution clearly is very broad and is a complex built up of many small
populations. Consulting the Tikhonov L-curve of the final spectrum (appendix D.2.5), a dis-
continuity is evident but both lengths of the curve are far from the desired straightness or
steepness. It is possible that in each experiment, conditions were varied sufficiently that dif-
ferent rotamers were isolated and contributed to different peaks; however with such weak
signals these peaks could be fitting artifacts from such a weak signal.
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7.2.6. Colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23IA1
(a) Protein structure
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Figure 7.8 PELDOR experiment results for colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23IA1. PELDOR experiment
results for colicin E9 DNase S3CIA1 - Im9 C23IA1. a) shows the PELDOR experiment distance super-
imposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin labels are highlighted in
coloured ball and stick representation showing highest populated MMM rotamer. E9 DNase S3C shown
in yellow, Im9 C23 in orange, S6C in red b) shows the raw 4 pulse PELDOR data. c) shows the PELDOR
experiment after background subtraction in navy with the fitting made by DeerAnalysis is red. d) Shows
the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted distance distri-
bution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 602 points, 3.5 dB attenuation, 20
MHz video bandwidth, 63 dB video gain and 10000 s shot rep. time, ~9.74 GHz, 347.30mT . 1= 380
ns, 2= 2580 ns, ELDOR pulse step 4 ns, no nuclear modulation suppression. Protein concentration 100
M inD2O and 50 % glycerol-d8.
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This 3 distance experiment is predicted byMMM to have distances of 2.70, 3.48 and 3.83nm
so any broadness in rotamer population was expected to broadening distance distribution
peaks and hide data.
The raw trace, shown in 7.8.b is peculiar in that it appears an almost linear decaywith a slight
wobble, and dramatic dip at 0.4 s. The sudden drop off in signal at 2.0 s corresponds to
a mirrored increase in signal in the imaginary channel (not shown), suggesting a loss of
phase in the echo toward the end of the experiment. To compensate for this the end point
of the experiment was moved up to 1.5 s so that analysis was only conducted on reliable
data. Background subtractionwas conductedwith colicin E9DNase S3CIA1 complexedwith
unlabelled Im9, when the background experimentwas conductedwith identical the dramatic
dip at 0.4 swas not seen (appendix D.2.6) andwas considered as significant after repetition
of the PELDOR experiment in the background subtracted data (figure 7.8.c). The dramatic
dip at 0.4 s remains, but has been lessened and once again we see a very poor modulation
depth associated with low labelling efficiencies, meaning that few of the molecules in the
sample are contributing to the PELDOR signal.
The experimental distance distribution, with multiple distance DeerAnalysis ghost supres-
sion applied, gives 3 clear peaks at 3.0, 3.5 and 4.2 nm, with a low probability and distance
ghost peak at 2.3 nm. The Tikhonov L-curve (appendix D.2.6) shows an obvious discontinu-
ity, though the curve is not strong, likely reflecting the weak oscillation depths. The resulting
distances are a little longer than the distances predicted byMMMhighest populated rotamer
distances but are a little shorter than the MMM rotamer ensemble average shown in red in
figure 7.8.d. Overall, despite the very weak oscillation depth and very unusual, unexplained
dip the resulting distances have a high level of confidence in this data set.
However, after further analysis whereby the fitting window is moved with a width of a deu-
terium ESEEM modulation the distance distribution (as shown in appendix D.2.6) collapses
down to a single, sharp distance just below 3.0 nm - where the black line is the average
distance probability with red and blue representing upper and lower fitting bounds (2 stan-
dard deviations). As a result, it can be concluded from the very weak oscillation depth and
Tikhonov validation test that this experiment is showing little more than deuterium ESEEM
oscillations and should be disregarded from further investigation. The additional peaks seen
in figure 7.8.d are evidentally fitting artifacts from the choice of fitting window and resemb-
lence to the predicted MMM distance distribution is coincidental.
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7. Pulsed Investigation
7.2.7. Colicin E9 DNase S30CR1A - Im9 C23R1A
(a) Protein structure
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Figure 7.9 PELDOR experiment results for colicin E9 DNase S30CR1A - Im9 C23R1A. a) shows the PELDOR
experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin
labels are highlighted in coloured ball and stick representation showing highest populated MMM rotamer.
E9 DNase S30C shown in blue, Im9 C23 in orange b) shows the raw 4 pulse PELDOR data. c) shows the
PELDOR experiment after background subtraction in navy with the fitting made by DeerAnalysis is red. d)
Shows the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted distance
distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 253 points, 4.0 dB attenuation,
20MHz video bandwidth, 60 dB video gain and 10000 s shot rep. time, ~9.66 GHz, 344.70 mT . 1=
380 ns, 2= 3000 ns, ELDOR pulse step 12 ns, no nuclear modulation suppression. Protein concentration
100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
This experiment uses the scarce colicin E9 DNase S30C protein and is the only PELDOR
experiment to useMTSL instead of IA-PROXYL. MTSL has a shorter linker between nitroxide
radical and protein backbone, but at the expense of having slightly more flexibility in the
linker. MTSL is still expected to have a narrower distance distribution than IA-PROXYL in
the same positions.
Here despite the low concentrations of sample, a clean PELDOR trace is obtained, which
when background subtracted against colicin E9 DNase S30CR1A complexed with unlabelled
Im9 (appendix D.2.7) yields a good fit (figure 7.9.c). The experimental distance distribution
after a very clean Tikhonov regularisation (appendix D.2.7) shows an obvious main peak at
3.8 nm with a secondary ghost peak at 5.3 nm. Furthermore, this experiment shows an
almost flawless agreement with the predicted distance distribution from MMM.
115
7. Pulsed Investigation
7.2.8. Colicin E9 DNase E66CIA1 - Im9 C23IA1
(a) Protein structure
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Figure 7.10 PELDOR experiment results for colicin E9 DNase E66CIA1 - Im9 C23IA1. a) shows the PELDOR
experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin
labels are highlighted in coloured ball and stick representation showing highest populated MMM rotamer.
E9 DNase E66C shown in magenta, Im9 C23 in orange b) shows the raw 4 pulse PELDOR data. c) shows
the PELDOR experiment after background subtraction in navy with the fitting made by DeerAnalysis is
red. d) Shows the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted
distance distribution in red. 50 K , 20 hours collection (~ 2500 scans), 4 shots/point, 352 points, 6.0
dB attenuation, 20 MHz video bandwidth, 60 dB video gain and 10000 s shot rep. time, ~9.71 GHz,
348.00mT . 1= 380 ns, 2= 2600 ns, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein
concentration 100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
This experiment is very curious, in that a clear oscillation can be seen in the raw spectrum
shown in 7.10.b. These oscillations have a tiny modulation depth, but are incredibly regular
yielding the very narrow distance distribution seen in figure 7.10.d.
In the case of colicin E9 DNase E66CIA1 there was not enough sample to run a background
experiment of colicin E9 DNase E66CIA1 with unlabelled Im9 as the refocussed echo was
so small that the experiment could not be accurately setup. As a result a 3 dimensional
homogenious background was employed in DeerAnalysis to give a near straight line back-
ground (shown in appendix D.2.8).
The resulting Tikhonov L-curve and distance distribution from these very regular modula-
tions gives a single, very sharp line at just below 3.0 nm - a distance that corresponds to
the oscillation frequency of deuterium ESEEM effects. The only other possible explaination
would be that both spin label positions are almost completely rigid and that despite the low
labelling efficiencies of both proteins almost every labelled protein contributes to the dipolar
oscillations. This scenario is highly unlikely statistically and would be in stark contrast to
the earlier accessibility experiments where the Im9 C23IA1 position was found to have 60.2
% aqueous accessibility.
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7. Pulsed Investigation
7.2.9. Colicin E9 DNase E66CIA1 - Im9 S6CIA1/C23S
(a) Protein structure
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Figure 7.11PELDOR experiment results for colicin E9DNase E66CIA1 - Im9S6CIA1 / C23S. a) shows the PELDOR
experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan). Spin
labels are highlighted in coloured ball and stick representation showing highest populated MMM rotamer.
E9 DNase E66C shown in magenta, Im9 S6C in red b) shows the raw 4 pulse PELDOR data. c) shows the
PELDOR experiment after background subtraction in navy with the fitting made by DeerAnalysis is red. d)
Shows the DeerAnalysis Tikhonov derived distance distribution in navy with the MMM predicted distance
distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 500 points, 5.5 dB attenuation,
20MHz video bandwidth, 60 dB video gain and 10000 s shot rep. time, ~9.71 GHz, 348.00 mT . 1=
380 ns, 2= 4160 ns, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration
100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
Unfortunately, during this experiment there were hardware issues overnight and so only the
autosave of the first 500 scans could be usedwith confidence compared to the >2000 scans
most of these other experiments have collected. Accounting for poor SNR in this experiment,
oscillations can still be seen in the raw data.
A high frequency Fourier transformation filter to remove noise corresponding to distances
less than 1.00 nm was applied. A background was constructed in DeerAnalysis using a 3
dimensional homogenious model as again the background experiment of colicin E9 DNase
E66CIA1with unlabelled Im9 yielded unusable results. The backgroundwas subtracted after
the Fourier transformation filter to yield a still noisy, but a clear single oscillation, as shown
in figure 7.11.c (and appendix D.2.9).
Tikhonov regularisation of this single, weak oscillation yielded a poor L-curve but one still
with a discontinuity. MMM rotamer analysis predicted a single, broad peak, centred at 5.2
nm. However, the experimental distance distribution shows a clear splitting of the broad
peak into two peaks at the 4.4 and 5.1 nm with an additional small probability peak at 6.8
nm. This longer range peak is likely attributed errors in the fitting of such weak, single os-
cillation experimental data. However, when the experimentally derived distance distribution
is loaded into MMM and is analysed using the rotamer population adjustment tool, the two
main, experimentally observed peaks fit easily into allowed rotamers (MMM experimentally
adjusted rotamer distance distribution is omitted in figure 7.11.d for the sake of clarity).
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7. Pulsed Investigation
7.2.10. Colicin E9 DNase E66CIA1 - Im9 S6CIA1/C23IA1
(a) Protein structure
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Figure 7.12 PELDOR experiment results for colicin E9 DNase E66CIA1 - Im9 S6CIA1 / C23IA1. a) shows the
PELDOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in
cyan). Spin labels are highlighted in coloured ball and stick representation showing highest populated
MMM rotamer. E9 DNase E66C shown in magenta, Im9 C23 in orange, S6C in red b) shows the raw 4
pulse PELDOR data. c) shows the PELDOR experiment after background subtraction in navy with the
fitting made by DeerAnalysis is red. d) Shows the DeerAnalysis Tikhonov derived distance distribution
in navy with the MMM predicted distance distribution in red. 50 K , 20 hours collection (~ 2500 scans),
4 shots/point, 428 points, 10.0 dB attenuation, 20 MHz video bandwidth, 66 dB video gain and 10000
s shot rep. time, ~9.71 GHz, 348.00 mT . 1= 380 ns, 2= 3200 ns, ELDOR pulse step 8 ns, no nuclear
modulation suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
Again, here is a very weak PELDOR trace with dipolar oscillations of modulation depth less
than 0.3 % of the initial signal. As a result the raw data can hardly be differentiated from a
straight linear decay (highlighted in appendix D.2.10). Again a background was constructed
in DeerAnalysis using a 3 dimensional homogenious model as the background experiment
of colicin E9 DNase E66CIA1 with unlabelled Im9 yielded unusable results. Once the back-
ground is subtracted (figure 7.12.c) the modulation depth is very small indeed. After a high
frequency noise filter had been applied to remove noise associated with distances less than
1.00 nm a noisy oscillation can been seen. With such a noisy spectrum, with such small
modulation depth, it was important to ensure that the correct zero time was selected. To
ensure as such the first 500 ns of data was taken, normalised and zero filled on either side
to double the number of data points. The resulting data set was fitted to a Gaussian distri-
bution to find the maxima, and this was used as the zero time. This method was found to
be more reliable than simply using a moving point average smoothing function that, noise
depending, could distort the starting position.
Tikhonov regularisation was conducted using ghost suppresion for 3 spin label distances,
but due to the very poor data quality yielded a near straight line L-curve (appendix D.2.10).
With 3 spin labels in this sample, 3 distances are expected, 2 short distances (between the
E9 DNase E66CIA1 - Im9C23IA1 and the intramolecular Im9 distance S6CIA1-C23IA1) and 1
longer distance (E9 DNase E66CIA1 - Im9 S6CIA1). In the experimental distance distribution
we see the longer, broad distance split into 2 peaks at 4.65 and 5.55 nm. However, the
shorter distances relying upon Im9 C23IA1 position cannot be seen. The Im9 C23 position
was shown in the earlier continuous investigation to label very poorly. This investigation is
again not surprising when considered with figures 7.11 and 7.12 where the colicin E9 DNase
E66CIA1 to Im9 C23IA1 shows no result but the experiment to Im9 S6CIA1 shows some
suggestion of dipolar oscillations.
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7. Pulsed Investigation
7.2.11. Colicin E9 DNase S3CIA1/S80CIA1 - Im9 C23IA1
(a) Protein structure
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Figure 7.13 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1 - Im9 C23IA1. a) shows the PEL-
DOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in cyan).
Spin labels are highlighted in coloured ball and stick representation showing highest populated MMM
rotamer. E9 DNase S3C shown in yellow, S80C in black, Im9 C23 in orange b) shows the raw 4 pulse PEL-
DOR data. c) shows the PELDOR experiment after background subtraction in navy with the fitting made
by DeerAnalysis is red. d) Shows the DeerAnalysis Tikhonov derived distance distribution in navy with
the MMM predicted distance distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point,
428 points, 10.0 dB attenuation, 20 MHz video bandwidth, 69 dB video gain and 10000 s shot rep.
time, ~9.68 GHz, 342.60 mT . 1= 380 ns, 2= 3200 ns, ELDOR pulse step 8 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
With an additional spin label in the system an additional distance is introduced. If each of
these distances is of a suitably narrow distribution and the distances are suitably different
then the distance distribution should resolve to only contain 3 peaks.
This sample is noisy and shows only very small oscillations, that only become apparent after
using a high frequency Fourier transformation filter to remove noise corresponding to dis-
tances less than 1.00 nm. Only again, the modulation depth is only around 3 %, suggesting
very few molecules in the signal are contributing to the dipolar oscillations.
Using, the rotamer cloud average from MMM this experiment should resolve to a single
short distance (E9 DNase S80CIA1- Im9 C23IA1 at 1.71 nm) and a likely convolution of two
similar distances between E9DNaseS3CIA1- S80CIA1 (3.19nm) and E9DNaseS3CIA1- Im9
C23IA1 (3.48 nm). Earlier in this investigation (§7.2.1) experimentally it was been shown that
the E9 DNase S3CIA1- S80CIA1 measurement has 2 distinct distances at 3.80 and 5.40 nm,
of which peaks can be seen at 3.50 and 5.00 nm in figure 7.13.d.
Knowing that at least one of these positions exists in two states takes the total number of
expected distances to at least 6. Given the weak nature of the signal it is difficult to say
with any certainly whether the peaks seen here are true representations of the sample and
the distances between the spin labels and which peaks are artifacts of fitting. The number
of peaks is within what is expected, but the short E9 DNase S80CIA1- Im9 C23IA1distance
appears to be too long and there are peaks covering the 2.00 to 3.00 nm range that would
not be expected from MMM predictions.
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7. Pulsed Investigation
7.2.12. Colicin E9 DNase S3CIA1/S80CIA1 - Im9 S6CIA1/C23S
(a) Protein structure
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Figure 7.14 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1 - Im9 S6CIA1/C23S. a) shows
the PELDOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9
in cyan). Spin labels are highlighted in coloured ball and stick representation showing highest populated
MMM rotamer. E9 DNase S3C shown in yellow, S80C in black, Im9 S6C in red b) shows the raw 4 pulse
PELDOR data. c) shows the PELDOR experiment after background subtraction in navy with the fitting
made by DeerAnalysis is red. d) Shows the DeerAnalysis Tikhonov derived distance distribution in navy
with the MMM predicted distance distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/-
point, 428 points, 11.0 dB attenuation, 20MHz video bandwidth, 69 dB video gain and 10000s shot rep.
time, ~9.71 GHz, 346.30 mT . 1= 380 ns, 2= 3200 ns, ELDOR pulse step 8 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
Here again we see a poor PELDOR trace, but once the background is subtracted and noise
filter applied a better trace can be seen than with Im9 C23IA1 labelling position. Once again
with 3 spin label sites, 3 distances would be expected, except that the E9 DNase S3CIA1-
S80CIA1 has been shown experimentally to have 2 distances at around 4 and 5 nm.
Using the highest populated MMM rotamer from each site we could expect 3 distances in
this experiment at 3.19, 3.83 and 4.09 nm which align reasonably well to the experimental
peaks at 2.90, 3.50 and 4.20 nm.
The overall MMM analysis with at least two of the spin label sites being very mobile shows
a large rotamer cloud spread which collapses the predicted distance distribution to a single,
broad peak spanning 2 nm.
Whilst this experiment shows a clear single osillation (highlighted in appendix D.2.12), the
experiment still yields a poor PELDOR trace. However, when a Tikhonov regularisation anal-
ysis is conducted with ghost suppresion for a three spin system a reasonable L-curve is
yielded (appendix D.2.12) with a clear discontinuity. The result is a distance distribution that
matches the predicted distance distribution surprisingly well, one which would suggest that
the distances are more resolved than predicted.
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7. Pulsed Investigation
7.2.13. Colicin E9 DNase S3CIA1/S80CIA1 - Im9 S6CIA1/C23IA1
(a) Protein structure
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Figure 7.15 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1 - Im9 S6CIA1/C23IA1. a) shows
the PELDOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9
in cyan). Spin labels are highlighted in coloured ball and stick representation showing highest populated
MMM rotamer. E9 DNase S3C shown in yellow, S80C in black, Im9 C23 in orange, S6C in red b) shows the
raw 4 pulse PELDOR data. c) shows the PELDOR experiment after background subtraction in navy with
the fitting made by DeerAnalysis is red. d) Shows the DeerAnalysis Tikhonov derived distance distribution
in navy with the MMM predicted distance distribution in red. 50 K , 20 hours collection (~ 2500 scans),
4 shots/point, 428 points, 12.0 dB attenuation, 20 MHz video bandwidth, 69 dB video gain and 10000
s shot rep. time, ~9.70 GHz, 342.60 mT . 1= 380 ns, 2= 3200 ns, ELDOR pulse step 8 ns, no nuclear
modulation suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
This experiment shows a noisy PELDOR trace, but this is be expected given the labelling
efficiencies of all of these sites. A single oscillation is evident, which after a high frequency
noise filter to remove frequencies associated with distances less than 1.0 nm and back-
ground subtraction using E9 DNase S3CIA1 with unlablled Im9 yields figure 7.15.c. Notice
again that the renormalized signal intensity puts this single oscillation depth at around 3 %
of the signal representing a very low number of spins contributing to the dipolar oscillation.
In this first experiment with 4 spin label sites, with resolved distances there would still be
an expected minimum of 6 distances. With the splitting in population evidenced in §7.2.1
between at least two positions in the E9 DNase S3CIA1/S80CIA1 this becomes extends the
number of expected, individual distances to at least 13. In figure 7.15.d the distance distri-
bution shows 12 distinct peaks; most distinctive of which being the clearly present long E9
DNase S3CIA1/S80CIA1 at 5.40 nm.
Whether these peaks are artifacts from noisy data or genuine peaks is not possible to dis-
cern. The Tikhonov regularisation of such weak data results in an L-curve (appendix D.2.13)
that shows no significant discontinuity. Bymoving to higher regularisation parameter values
on the L-curve results in all of these peaksmelding into one broad peak ofmany features and
a total width of over 4 nm. MMM analysis of the highest populated rotamers of each spin
label suggests individual distances between of 3.19, 3.48, 3.83 and 4.09 nm. Clearly these
distances are too close to each to distinguish when individual peak broadening is consid-
ered, resulting in a large, 2 nm wide peak in the MMM prediction.
It is clear that 4 spin labels in a single sample is detrimental to analysis, and in this case
would be impossible to analyse without first analysis of the 2 spin systems, rendering the 4
spin label experiment useless.
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7. Pulsed Investigation
7.2.14. Colicin E9 DNase S30CIA1/S80CIA1 - Im9 C23IA1
(a) Protein structure
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Figure 7.16 PELDOR experiment results for colicin E9 DNase S30CIA1/S80CIA1 - Im9 C23IA1. a) shows the
PELDOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9 in
cyan). Spin labels are highlighted in coloured ball and stick representation showing highest populated
MMM rotamer. E9 DNase S30C shown in blue, S80C in black, Im9 C23 in orange. b) shows the raw 4
pulse PELDOR data. c) shows the PELDOR experiment after background subtraction in navy with the
fitting made by DeerAnalysis is red. d) Shows the DeerAnalysis Tikhonov derived distance distribution
in navy with the MMM predicted distance distribution in red. 50 K , 20 hours collection (~ 2500 scans),
4 shots/point, 428 points, 10.0 dB attenuation, 20 MHz video bandwidth, 63 dB video gain and 10000
s shot rep. time, ~9.70 GHz, 342.50 mT . 1= 380 ns, 2= 3200 ns, ELDOR pulse step 8 ns, no nuclear
modulation suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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7.2. Distance measurement
Withmore than 2 spin label sites comes greater complication in the spin label distance anal-
ysis. Undoubtly, due to the high labelling efficiency of the colicin E9DNaseS30CIA1/S80CIA1
protein, this distance dominates this spectrum. However, with such a strong signal, even a
small interaction from Im9 should differentiate it. Indeed, figure 7.16.d shows high similarity
with the very strong signal seen from the E9 DNase S30CIA1/S80CIA1 with some additional,
but weaker signals.
Unsurprisingly, with such a strong signal analysis is not difficult. In the raw trace the first
modulation shows a depth of 15 % of the total signal. After background subtraction (no
high frequency noise filter was required), Tikhonov regularisation produces a characteristic
L-curve (appendix D.2.14) with obvious discontinuity.
Again peaks at 3.9 and 5.4 nm can be seen from the colicin E9 DNase S30CIA1/S80CIA1
interaction, but crucially a shoulder at 3.0 nm becomes more pronounced, as well as the
appearance of the short E9 DNase S80CIA1 to Im9 C23IA1 distance, predicted to be only
1.70 nm by MMM. This peak however has a much lower intensity than predicted, reflecting
the spin labelling efficiencies of the different sites.
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7.2.15. Colicin E9 DNase S30CIA1/S80CIA1 - Im9 S6CIA1/C23S
(a) Protein structure
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(b) Raw PELDOR trace
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(c) Background subtracted PELDOR trace
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Figure 7.17 PELDOR experiment results for colicin E9 DNase S30CIA1/S80CIA1 - Im9 S6CIA1/C23S. a) shows
the PELDOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9
in cyan). Spin labels are highlighted in coloured ball and stick representation showing highest populated
MMM rotamer. E9 DNase S30C shown in blue, S80C in black, Im9 S6C in red. b) shows the raw 4 pulse
PELDOR data. c) shows the PELDOR experiment after background subtraction in navy with the fitting
made by DeerAnalysis is red. d) Shows the DeerAnalysis Tikhonov derived distance distribution in navy
with the MMM predicted distance distribution in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/-
point, 428 points, 8.0 dB attenuation, 20MHz video bandwidth, 63 dB video gain and 10000 s shot rep.
time, ~9.79 GHz, 345.50 mT . 1= 380 ns, 2= 3200 ns, ELDOR pulse step 8 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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From visual inspection of the cartoon representation of the protein complex in figure 7.17.a
it would be expected that this experiment has 3 inter-spin distances of approximately the
same distance. If it were not for the 5.20 nm rotamer spin distance of colicin E9 DNase
S30CIA1/S80CIA1 then all 3 distances could not easily be distinguished from one another.
In earlier experiments it was easy to establish peaks at 3.9 and 5.4nm from colicin E9 DNase
S30CIA1/S80CIA1.
Once again, thanks to the strong labelling efficiency of colicin E9 DNase S30CIA1/S80CIA1
a PELDOR trace was easy to optimise and collect. Whilst this distance still dominates
the distance distribution, when compared with figure 7.4.d of just the colicin E9 DNase
S30CIA1/S80CIA1 shoulders to the main peak are evident. The signal strength also allows
for easy background subtraction and Tikhonov regularisation (figure 7.17.a, 7.17.b and ap-
pendix D.2.14).
The longer distance previously associated with colicin E9 DNase S30CIA1/S80CIA1's longer
distance conformation, now appears in the predicted by MMM. Individually in this experi-
ment, MMMwould predict distances of 3.68, 4.78 and 4.83 nm when using only the highest
populated rotamers, yet when the entire rotamer population is considered the prediction
aligns very well with the experimental data.
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7.2.16. Colicin E9 DNase S30CIA1/S80CIA1 - Im9 S6CIA1/C23IA1
(a) Protein structure
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Figure 7.18PELDOR experiment results for colicin E9DNase S30CIA1/S80CIA1 to Im9 S6CIA1/C23IA1. a) shows
the PELDOR experiment distance superimposed onto PDB structure 2K5X (colicin E9 DNase in grey, Im9
in cyan). Spin labels are highlighted in coloured ball and stick representation showing highest populated
MMM rotamer. E9 DNase S30C shown in blue, S80C in black, Im9 C23 in orange, S6C in red. Distances
from E9 DNase S30C shown in blue, E9 DNase S80C shown in black, intramolecular Im9 distance (not
obvious, behind black lines) is in red. b) shows the raw 4 pulse PELDOR data. c) shows the PELDOR
experiment after background subtraction in navywith the fittingmade byDeerAnalysis is red. d) Shows the
DeerAnalysis Tikhonov derived distance distribution in navy with theMMMpredicted distance distribution
in red. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 428 points, 12.0 dB attenuation, 20MHz
video bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.70GHz, 346.30mT . 1= 380 ns, 2=
3200 ns, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100 M in
D2O and 50 % glycerol-d8.
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With 4 spin label sites yields a theoretical 6 distances producing complex PELDOR data
sets, pushing the limits of deconvolution. Unfortunately, due to the various spin labelling
efficiencies at different sites it also means that some of the distances are drowned out by
others. But for such a complicated experiment most of the experimental data corresponds
well with the MMM prediction.
Like previous experiments using E9 DNase S30CIA1/S80CIA1 the signal strength makes for
easy optimisation of the experiment to collect practically noise free data. The high signal
to noise ratio and modulation depth of nearly 25 % in the raw spectrum (8 % after back-
ground renormalization) makes Tikhonov regularisation easy with a strong L-curve (ap-
pendix D.2.16).
As with other experiments the strong signal from colicin E9 DNase S30CIA1/S80CIA1 cor-
responding to distances at 3.68 and 5.20 nm can be seen. However, the short (1.71 nm)
intramolecular distance between the poorly labelling Im9 sites S6CIA1 and C23IA1 has been
lost, almost certainly due to the very low labelling efficiency of these labelling sites in com-
parison to the colicin E9 DNase S30CIA1/S80CIA1 protein. The other distances have either
adopted distances too similar or have been drowned out to be seen, this results from the
low Im9 labelling but notice the main peak's shoulder at 3.20 nm is significantly larger than
in the previous two experiments, as well as a very small peak appearing at 2.60 nm. Simply,
there are too many distance of approximately similar ranges to deconvolute.
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7.3. Orientation selection
The PELDOR experiment is designed to measure a vector between 2 points, which by def-
inition, has a distance and direction. A spin label frozen in solution and bound to a protein
will have molecular directionality relative to the external magnetic field. When considering
2 spin labels, each with anisotropy, in order to transfrom between one position and other
requires both a transformation in space and orientation [45].
In analysis of the PELDOR spectrum it is possible to deconvolute both the distance between
points and the the angle of the vector, , from the external magnetic field, B0. By repeating
the PELDOR experiment across the field swept echo spectrum, sampling all orientations and
detecting at different g positions it is possible to build up a vector model from these angles.
Typically at X-band the g values from the nitroxide are not sufficiently resolved to accurately
determine eachof the required angles, though in colicin samples someamount of orientation
selection can be seen. Bymoving to higher fields, such as Q orW-band the g tensors resolve
and such angles can be deconvoluted more easily. Moving to higher fields also has the
additional benefits of far greater sensitivity and requiring far smaller sample sizes (due to
dielectric lose of samples in aqeuous buffers).
Through funding from a COST short term scientific mission grant, time could be spent at
Prof. R. Bittl's group at Freie Universität Berlin, Germany using thier Q-band pulsed spec-
trometer. Due to the short time available on this machine, it was decided to investigate the
colicin E9 DNase S30CR1A to Im9 C23R1A as the colicin E9 DNase S30CR1A sample was
very limited and could not provide any more experiments at X-band and had proved very
successful at X-band.
Figure 7.19.a shows the field swept echo of the colicin E9 DNase S30CR1A/Im9 C23R1A
complex at Q-band. Notice that at the higher magnetic field associated with Q-band that
the g tensors have begun to seperate.
PELDOR experiments were methodically taken across the field swept spectrum with the
most important positions being sampled first. In figure 7.19.a the experiment pump posi-
tions have been highlighted. To ensure the best data acquisition initially the observation
position was kept to the maximum signal intensity position within the spectrometer band-
width to the pump position. Ideally, 6 PELDOR experiments should be conducted in total
such that the each of the three tensor orientations is recorded to every other.
In the corresponding PELDOR traces (figure 7.19.b) field dependence can be seen first by
differences in modulation depth - this is the same sample simply with excitation occuring
in different orientations. This means that there is a difference in populations between the
different orientations corresponding to an orientation dependence. Further, whilst the oscil-
lation periodicity does not vary significantly between black, green and blue traces (gxy , gy , gx
pump positions respectively) the magenta trace (gz pump position), shows a very shallow
modulation depth due to the small number of spins in this orientation but also the oscillation
periodicity varies slightly. This suggests that the distance in the gz frame is slightly longer
than that in the gx or gy frames.
Indeed, in figure 7.19.d where the distance distributions are calculated using a Tikhonov
regularisation approach that the gxy-gz distance distribution is split into two peaks. The
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upper peak matches the other orientations well but a significant peak also appears at a
shorter distance of 2.7 nm.
In figure 7.20 a comparison of the same sample run at X and Q-band can be seen. The
X-band experiment (figure 7.20.a-c) shows observation at the low field peak with ELDOR
pumping of the centre peak, marked with navy arrow. Total experiment time was 23 h to
give a measured distance of 3.84 nm with a half height width of 0.5 nm. A secondary ghost
peak is shown at 5.20 nm.
The Q-band experiment (figure 7.20.d-f) shows the extremes in PELDOR experiments with
high field excitation (corresponding to gz) (blue) and low field peak (corresponding to gxy)
(black). Both of these experiments shows a good SNR after only 90 min acquisition time,
and show oscillations of similar periodicity but distinctly different modulation depths. In
figure 7.20.f the distance distributions of the PELDOR traces show a slight differing in ghost
peaks but the main peaks are almost identical at 3.75 nm for the high field spectrum with a
half height width of 0.3 nm, whilst the low field peak shows a distance of 3.97 nm and a half
height width of 0.7 nm.
Unfortunately, DeerAnalysis was used to calculate these distances in which zero orientation
dependency is assumed. Whilst these distances can be assumed to be correct, DeerAnaly-
sis is not the program to analysis the angular information contained within these spectrum.
Additionally, to fully deconvolute the angular transformation would require 6 PELDOR exper-
iments (gx-gy , gx-gz , gy-gz , gx-gx, gy-gy , gz-gz) and specially designed software. At Q-band in
this case it proved difficult to resolve all of the g tensors due to a strong mixing of gx and gy
into gxy and despite the strength of the signal, measurements with gz proved difficult due to
lowspin population, particularly in gz-gz where noPELDORcould be seen. Perhaps by further
increasing the field further to W-band would provide sufficient resolution of the g tensors to
easily measure each orientation. However, with no freely available analysis software data
analysis would remain extremely difficult and time consuming.
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Figure 7.19 Q-band PELDOR experiment results for colicin E9 DNase S30CR1A to Im9 C23R1A. a) shows the
field swept echo repeated 4 times, in 4 experiment colours, open each field sweep spectrum the pump
and observe position for the PELDOR experiment is shown. The pump position is highlighted by a solid
arrow in the experiment colour. The observe position is highlighted by a dashed arrow in red. b) shows
the PELDOR experiment after a 3 dimensional homogenious model background subtraction. Experiment
colours remain in the same colour, DeerAnalysis fits are shown in red. c) shows the PELDOR traces Fourier
transformed into the frequency domain, known as a Pake pattern. d) Shows the DeerAnalysis Tikhonov
derived distance distributions, maintaining experiment colours. All experiments 50K , 0.0 dB attenuation,
20MHz video bandwidth, 30 dB video gain and 1000 s shot rep. time, ~33.74GHz. a) 4 shots/point, 10
scans, 512 points, 20mT sweepwidth, 1000s shot rep. time, 1202.40mT . 1= 180ns. b) 30 shots/point,
260 points, 4.0 dB attenuation, 20MHz video bandwidth, 60 dB video gain and 2000 s shot rep. time.
1= 380 ns, 2= 3000 ns, ELDOR pulse step 60 ns, no nuclear modulation suppression. 4 hours collection
per experiment, except magenta trace that required 36 hours. Protein concentration 100 M inD2O and
50 % glycerol-d8.
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7.4. Summary
After 16 unique sample PELDOR experiments, numerous repeats, optimizations, 2 spin la-
bels and 2 differentmicrowave frequencies a database of distance constraints could be built
using 5 of the original 7 designed labelling sites, graphically presented in figure 7.22. This
database does not contain a fixed point distance, but, utilising a combination of peak width
and multiple peak analysis creates an allowed region. A distance constraint with upper and
lower limits (discussed later in §8.4).
Some experiments gave clear and easily interpertable data with obvious, concise distances.
Others gave ambigous results, where rotamer populations were giving rise to significant
peaks in the distance distribution that were not anticipated frommodelling of the spin labels.
In this investigation, a significant amount of protein was able to be produced allowing for a
long time to be spent ensuring that the highest possible spin labelling efficiencies for each
sitewas obtained. Despite, this effort the protein concentration before precipitationwas little
more than 200 M making stock solutions of any concentration difficult. This, combined
with the much lower than expected labelling efficencies meant that many of the PELDOR
experiments were always going to be challenging. With careful sample preparation and ex-
perimental setup it was possible to observe dipolar oscillations in some experiments.
Notable, the synthetic colicin E9 DNases E9 S3CIA1/S80CIA1 and S30CIA1/S80CIA1 with
theirmuch higher labelling efficiency gave clear dipolar oscillationswhichwhilst should have
yielded easy analyse the apparent mobility of the S80CIA1 site split both experiments into
an expected, highly populated distance and a longer, less populated, but significant, longer
distance. Unfortunately, as these mutants labelled approximately eight times better than
the Im9 proteins the effect upon the distance distribution on addition of the Im9 was only
slight. However, as the colicin E9 DNase in this case was providing so much signal that the
Im9 could be seen, but only as shoulders to the intramolecular colicin E9 DNase distance,
rather than themore useful to docking intermolecular distance. This made deconvolution of
the exact distances much more difficult than had the labelling efficiencies of both proteins
been approximately equal and provided equal intensity in the distance distributions.
In many experiments the combination of two proteins with low spin labelling efficiencies
meant that the effective concentration of complex contributing to the sought after dipolar
oscillations was very low and often sub-micromolar. In some instances this amounted to
PELDOR traces that lifted only slightly from the background decay rather than giving a clear
oscillation as was the case with experiments to the colicin E9 DNase S3CIA1. In other in-
stances, as with the colicin E9 DNase E66CIA1 to Im9 C23IA1, the signal was so weak that
all that could be detected was deuterium ESEEM modulations.
In themost extremecases detectionwasalmost impossible. The colicin E9DNaseD20C/E66C
with spin label efficiency of 1.4 % meant that no echo could be detected to even begin the
PELDOR experiment. In the case of the colicin E9 DNase S80CIA1, the protein labelling was
so low as to not be detectable with cw EPR above background noise of the instrument.
The labelling efficiencies were incredibly frustrating to work with significantly hampered the
investigation. It was the original intention of this investigation to produce far more inter-
molecular distances to triangulate the position of the docking partners in the complex than
were required. This would thereby allow an investigation to bemade into theminimumnum-
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ber of distance restraints to come to an unique solution, and compare the result in biology
to the theoretical basis that would require 6 distances, 1 for each motion of freedom.
The idea to engineer double mutations was also a mixed result. In most cases the mobility
of the spin label gave rise to broad distance distributions. Given the size of the proteins in
question, these broad peaks occur in a relatively similar distance range making deconvo-
lution of each distance difficult had the structure of the complex not already been known.
With less mobile spin label sites it was hoped that by simply running a PELDOR experiment
of the doubly labelled protein with and without the complex partner would be sufficient to
deconvolute the complex spectrum. To an extent this was shown and distances that could
not be obtained via singly labelled mutants (such as colicin E9 DNase S30C and S80C) were
obtained. However, recent work has shown that in systems with more than two spins show
some multiple spin effects which may distort the distance distributions. The resulting spin
interactions can sum and difference in the dipolar frequency contributions giving rise to ad-
ditional peaks in the distance distribution which do not correspond to real distances. It has
been shown that in some circumstances that these interspin effects can result in ghost
peaks so prominent that they may bemistaken for real distance peaks or that the real peaks
may move or disappear entirely [35, 95]. This ghost peak could perhaps explain why some
of the later experiments, particularly those with 4 spin labels, such as the colicin E9 DNases
E9 S3CIA1/S80CIA1 to Im9 S6CIA1 /C23IA1, showed such convoluted spectra with somany
peaks, even despite so many distances expected to be obtained from this experiment.
Until these effects have been investigated further the doubly labelled mutant intermolecular
distances need to be carefully scrutinised. As a result of this new information doubly labelled
mutants would not be undertaken if this investigation were to start now.
Despite the failure of colicin E9 DNase S30C and S80C proteins to be expressed in any quan-
tity or the colicin E9 DNase D20C/E66C to label, 11 distance constraints still remain to be
taken forward to modelling.
To further aid the reader on the next page two summary figures are presented. In figure
7.21 the spin labelled colicin E9 mutants are plotted against the spin labelled Im9 proteins
in a grid fashion showing the resulting distance distribution. The top row and first column
are blank as a result of doubly labelled proteins being tested in isolation. Blank panels are a
result of experiments that failed to yield results.
In figure 7.22, the highest probability peak from figure 7.21 for each distance is displayed
upon a cartoon representation of the colicin E9 DNase / Im9 complex.
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Figure 7.21 A binding cross summary of distance distributions from all PELDOR experiments. Presented hori-
zontally are the spin labelled colicin E9 mutants plotted against the spin labelled Im9 proteins. The top
row and first column are blank as a result of the protein being run in isolation.
Figure 7.22 Graphical summary of PELDOR experiments with final distances superimposed onto the protein
structure of PDB file, 2K5X. In grey, colicin E9 DNase, in light cyan, Im9. Dashed lines and labels are
coloured by the origin of the distance. In ball and stick representation, the spin labels upon the colicin E9
DNase the blue is S3C, magenta is D20C, yellow is S30C, green is E66C black is S80C. Upon the Im9 red
is S6C, orange is C23.
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8. Protein - protein docking with HADDOCK
Reported structural binding sites for colicins in general, but specifically non-cognate binding
partners, are very limited. Their transitory, dynamic nature and low Kd values has made
NMR structural studies difficult and, as yet, crystalisation unsuccesful. Reflected by the low
numbers of deposited complexes in the Protein Data Bank.
Traditionally the NMR approach to solving protein-protein complexes requires the lengthy
measurement of nuclear Overhausser effects (NOEs) whereby spin coupling of electron or-
bitals in close proximity transfer nuclear spin polarisation from one nucleus to another by
cross-relaxation. This typically requires atomic level assignment of side chains for sufficient
accuracy requiring excellent protein purity and stability.
With the use of 1H- 15Nheteronuclear single-quantumcorrelation (HSQC)NMRexperiments
changes in the chemical shift can be detected upon binding. Typically this is achieved by
isotope labelling each protein in turn and titrating in the unlabelled binding partner and ob-
serving the change, or perturbation. Residues that are observed to have a chemical shift
pertubation (CSP) have undergone a change in environment and can be used to identify
regions of intermolecular interaction and thus can be used to map an interaction surface.
In figure 8.1 the residues with a perturbation of greater than one standard deviation have
been drawn showing the side chains in line format and each atom's Van der Waal radius
drawn; the colicin E9 DNase shows a definite binding surface whilst the strongly  helical
Im9 shows a spread of residues (as a conformational shift that moves one end of an  helix
will alter all residues on that helix).
As computational power has become more available several in silico methods for the pre-
diction of protein-protein complexes have been developed. Some operate through ab initio
procedures requiring no experiment data, whilst othersmake use of various biochemical and
(a) Immunity protein, Im9 (b) Colicin E9 DNase
Figure 8.1 Residues with significant chemical shift perturbations mapped onto the NMR structure of the colicin
E9 DNase / Im9 complex (PDB ID: 2K5X), side chains are coloured by atom (oxygen red, nitrogen blue)
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biophysical techniques such as mutagensis studies (including fluorescene and isothermal
titration calorimetry), bioinformatics and, of course, NMR.
8.1. Docking principles
Docking methodologies assume that the lowest possible free energy state of a protein-
protein system represents the structure of the complex. Therefore to find the lowest possible
energy state a number of energy states need to be sampled and the free energy calculated.
Early methods of docking used low resolutions (residue scale) [107] but as sampling meth-
ods have become more efficient and energy calculations can be evaluated more accurately
the resolution ofmethods has been improved to the extent thatmatching of complementary
shapes of partner molecules can be matched although the flexibility of such areas is often
not adequately accounted for. As a result molecular dynamics and incremental simulated
annealing techniques were later introduced [28, 26, 31, 14].
All docking procedures consist of at least two steps and usually three. First the molecules
are randomly orientated, rotated and translated about each other. Using some form of scor-
ing criteria, such as energies of electrostatic interaction, Van der Waal's (VdW) repulsion or
other effect that is heavily weighted toward shape complimentarity. A number of candidate
structures are identified and are taken forward to the second round of optimisation whereby
each structure is reranked according to the energy of association usingmore realistic energy
functions, reflecting better native conditions. Finally the remaining structures are considered
at the atomic level with rotation allowed on side chains and the protein backbone to further
optimise the free energy.
The energy-score landscape, like the protein-folding landscape is full of local minima in
which optimisation can easily get stuck. For this reason it is important to start with many
random positions and to introduce experimental restraints as early as possible to improve
the efficiency of low energy structure discovery. Literature reviews of in silico, NMR based,
docking studies show that valuable information can be ascertained in this way, particularly
useful in high molecular weight or dynamic systems [9, 92].
8.2. HADDOCK overview
For the docking calculations described henceforth the data driven programHADDOCK (High
Ambiguity Data-driven biomolecular DOCKing) [26, 28] will be used. Whilst other programs
are available, none provide the ability to useNMRdata as docking constraints and include the
simulated annealing permitting the rearrangement of both backbone and side chain atoms
required for the optimisation of interface packing. The algorithms which underpin HAD-
DOCK have been well tested and shown to perform well in CAPRI1 evaluations [26]. In these
evaluations various protein-protein complex prediction software packages are entered into a
competition to evaluate the performance of various approaches upon a blind protein-protein
experiment of, as yet, unpublished X-ray crystal or NMRstructures. HADDOCKdistinguishes
1Critical Assessment of PRediction of Interactions - http://www.ebi.ac.uk/msd-srv/capri/
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itself from most other ab initio complex docking packages as it uses an information driven
docking approach, whereby the available information is used from the earliest possible point
in time. This minimises the required computation time as opposed to generating a large
sample space and then filtering those solutions that do not match the available information.
As a result, HADDOCK has become the de facto standard in the NMR field with over 3200
registered users2.
Since the original HADDOCK release in 2006, HADDOCK has been in constant development
and has been subsequently expanded to include docking from proteins to and with DNA,
RNA, select unnatural amino acids, cofactors (including hemes) and pharmaceutical based
small ligands, to name but a few. This represents no small feat as the intrinsic flexibility of
poly-nucleotide chains has often hampered the development of effective protein-nucleotide
docking methods.
Importantly, HADDOCK is a high level programconsisting of several programming languages,
that uses many of its own scripts to generate a fast and userable interface for the complex
docking. It originally evolved from several scripts in the Ambiguous Restraints for Itera-
tive Assignment program (ARIA) (Institut Pasteur, FR), a program designed to automate the
nuclear Overhauser effect assignments in NMR. The actual process of moving and rotating
proteins in a virtual space aswell as the important task of energetically scoring a structure is
performed by calls to the Crystallography and NMR System (CNS) program CNSsolve (Yale
University, US). CNS itself is an offshoot of X-PLOR (Yale University, US) as a result of X-
PLOR development all-but stopping in the long-term stable release XPLOR-NIH. Of course
X-PLOR itself was an offshoot of the much earlier Chemistry at Harvard Macromolecular
Mechanics (CHARMM) package (Harvard University, US) which was originally released in
1983. As a result all four of these programs have a large amount of crossover in their pro-
gramming languages and syntax.
HADDOCK consists of three stages similar to that described previously (summarised in fig-
ure 8.2). In the first stage the two or more molecules are positioned 25 A apart in a vir-
tual Cartesian coordinate with each dimension theoretically extending between -99,999 and
99,999 A. In this virtual space eachmolecule is freely rotated about its centre of mass. Each
random rotation step is followed by cycles of rigid body intermolecular energy minimsation
where themolecules aremoved together before allowing simultaneously rotation and trans-
lation to produce a complex. 1000 Monte-Carlo generated model structures are generated
and are subsequently ranked according to a weighted sum of the model's Van der Waal's
energies, electrostatic energies, buried surface area (hydrophobic energies) and ambiguous
interaction restraints (AIRs).
The top 200 scoringmodels are taken forward into the second stage of dockingwheremodel
in turn is subjected to three simulated annealing routines, whereby themodel is heated in the
virtual space and allowed to cool. With each annealing step it is assumed that themolecules
will cool into the lowest possible energy state as they collapse down the energy landscape
to the minimum, which likely represents the biological solution. Initially, in the first anneal-
ing step each docking object is considered as a rigid body. In the second annealing the
side chains that are defined as being active residues are allowed some freedom of move-
ment as well as the side chains of within two residues either side of the active residue. In
this instance an active residue is one that is considered to have a large perturbation upon
2At August 2013, http://haddock.science.uu.nl/enmr/services/HADDOCK/
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Figure 8.2 Flowchart representation of the HADDOCK modelling process, model restraints are applied at with
each of the four energy optimisation steps
the creation of the complex. Typically, these are obtained from chemical shift perturbation
measurements in NMR, but HADDOCK also allows for the random generation of restraints.
In the third stage the entire protein backbone and side chain atoms are allowed freedom of
movement - allowing for conformational rearrangement at the interface.
In the final stage of docking eachmodel is energyminimised in explicit water or other solvent
such as DMSO. For ease of analysis the final structures are typically clustered according to
the pairwise backbone root mean squared deviation (RMSD). This means that each model
is compared to every other model and the backbone atoms are aligned with the difference
in space between them calculated. A cluster is defined by default as consisting of at least
4 structures with a backbone average RMSD of less than 7.5 A from one another. In a good
docking model with high confidence there will be few clusters, perhaps only one cluster
containing most, if not all, of the final 200 models.
NMR chemical shifts have long been considered too unreliable and poorly understood to
be used in structural information although with the advent of ab initio modelling they are
now being used often as the only constraint in three dimensional structural determinations.
However, this technique only measures a change in chemical environment and so a certain
amount of attention needs to be paid such that long range conformational changes, remote
from the binding surface typically through hinges or helices, do not have an unfair bias in
the calculations.
8.2.1. Docking methodology
Both X-ray and NMR structures of the cognate colicin - immunity protein complexes have
shown that neither molecule undergoes significant structural changes upon binding [7, 27]
with backbone RMSDs between the free and bound colicin E9 DNase of 1.7 A (X-ray only)
and 1.6 A for Im9. Furthermore there are minimal differences in inter-helix angles between
free and bound forms suggests that the two proteins are interacting fundamentally as rigid
bodies, and by extension it is assumed that the weaker binding of non-cognate partners be-
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haves in the same way which allows us to justify our usage of CSPs as the driving restraints
in docking.
After assignment of HSQC and triple resonance experiments a table of chemical shifts for
each residue of eachproteinwith andwithout the binding partner canbe constructed. Residues
that are considered as active in docking are defined as those with a calculated difference in
chemical shifts outside of normal range associated with binding. Typically residues that
are outside 1 standard deviation of the average chemical shift value are defined as active to
binding.
These residues are refined such that only residueswith greater than 50% solvent accessibil-
ity are classified as active residues, whilst residues that are within 3 A of active residues and
have less than 50 % solvent accessibility are considered to be passive residues to binding.
Together these active and passive residues make up the ambiguous interaction restraints
(AIRs), where an AIR is defined as an intermolecular distance between any atom (m) of an
active residue (i) of molecule A (miA) and any atom (n) of either active or passive residues
(k) (Nres in total) of the partner molecule B (nkB) and similarly for molecule B giving the
effective distance calculated for each restraint as:
deffiAB =
"
NatomsX
miA=1
NresBX
k=1
NatomsX
nkB
1
d6miA:nkB
# 1
6
(8.1)
WhereNatoms is all given atoms of a residue andNres the total number of active and passive
residues for a givenmolecule. Passive residues as such do not constrain the partner protein
but they do allow for the fulfilment of active restraints. An upper limit of 3.0 A is imposed
by HADDOCK on the effective distance as a compromise between minimum hydrogen -
hydrogen and heavy atom - heavy atom Van der Waal distances whilst the 1
r6
averaging
guarantees that an AIR is fulfilled once any two atoms of the proteins are in contact.
8.2.2. Colicin protein structure
Any docking solution is only as good as the quality of the information put into the model.
For this reason it is essential to consider all of the currently available information. Several
different structures for colicin E9 DNase and Im9 have been published as work upon the
system was conducted, and are accepted by the field as being of high quality.
A NMR structure for colicin E9 DNase alone does not exist, in solution there is too much
intrinsic dynamic movement between at least two different states which broadens all peaks
and makes assignment impossible. This dynamicity made crystalisation difficult and could
only be achieved in 30%PEG 5000, 0.1M sodium acetate, at pH 5.4 and at 285K , conditions
far removed from those found in vivo. Nevertheless, upon binding, the states of colicin E9
DNase collapse, which have allowed for successful NMR assignment. Fortunately the NMR
structure of the complexed colicin E9 DNase agrees favourably with the crystal structures
(see figure 8.3).
Of course any structural solution for either binding partner when put through the docking
process should ideally generate the same docking solution. The quality of docked models
was assessed by comparison to that of the NMR structure of the complex (PDB: 2K5X) by 1)
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PDB (chain) Type Methodology Experimental Date of publication
2K5X (B) Complex NMR Minimized average July 2008
1FSJ Free X-ray 1.8 A resolution September 2000
1EMV (B) Complex X-ray 1.8 A resolution March 2000
(a) Colicin E9 DNase structures
PDB (chain) Type Methodology Experimental Date of publication
1IMP Free NMR 21 conformers May 1996
1IMQ Free NMR Minimized average of 1IMP May 1996
2K5X (A) Complex NMR Minimized average July 2008
1E0H Complex NMR 20 conformers March 2000
1EMV (A) Complex X-ray 1.8 A resolution March 2000
(b) Im9 structures
Table 8.1. Available PDB structures for the cognate pairing Colicin E9 DNase - Im9
(a) Overlay of PDBs 2K5X (NMR) (E9 DNase (light
grey), Im9 (pale cyan)) and 1EMV (X-ray) (E9
DNase (black), Im9 (blue))
(b) Overlay of E9 DNase PDBs 2K5X(B)(NMR:
complex) (blue), 1EMV(B)(X-ray: com-
plex, 1.7 A) (red) and 1BXI(B)(X-ray 2.1
A) (orange)
(c) Overlay of E9 DNase PDBs 2K5X(B)(NMR:
complex) (blue) and 1FSJ (X-ray: free
1.7 A) (red)
(d) Overlay of Im9 PDBs 1IMQ (NMR: free)
(blue) and 1EMV(A)(X-ray: complex, 1.8
A) (red)
Figure 8.3 Visual overlays of various cognate partner strucutre files
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the overall and interface RMSDs 2) backbone RMSDs of Im9 when the DNase co-ordinates
are overlaid and 3) the fraction of native contacts.
8.2.3. HADDOCK's application to colicins
Performing a HADDOCK calculation using only the raw, unpublished CSPs fromNMR exper-
imentation (one standard deviation threshold) and Naccess to calculate the solvent acces-
sibility, an interesting result occurs. In figure 8.4.a the HADDOCK score plot is seen, where
the HADDOCK score (more negative is a better docking model) is plotted against the RMSD
of each cluster from the average HADDOCK structure, where the average is calculated by the
superimposing of each structure on to the backbone atoms of the flexible interface defined
by the active residues calculated by CSP threshold and Naccess analysis. Here, almost all
200 final structures have an RMSD over 12 A away from the average HADDOCK run solu-
tion. The reason for this does not become obvious until the protein complex solutions are
plotted when it becomes apparent that there is an almost 50:50 split in models between Im9
sitting to the side of colicin E9 DNase (cyan in figure 8.4.b) and Im9 sitting to the back (blue
in figure 8.4.b).
In figure 8.4.b the DNase activity loop has been highlighted with the black arrow, so it makes
biological sense that the immunity protein directly sits in front of the active site in a compet-
itive inhibition fashion. However, it is not beyond the realms of possibility that Im9 binding
upon the back surface of E9 DNase, interact with the highlighted helix (red arrow), which
could cause changes in dynamicity and binding functionality of the DNase activity loop and
thus cause inhibition in a non-competitive fashion.
This model was never published or discussed in publications for a number of reasons. First,
biologically considering the strength of the interaction between colicin and immunity protein
it would be very unusual for this to be a non-competitive inhibition. Second, at the time of
this NMR investigation the X-ray crystal structure had been in the public domain for over 5
years and had never been challenged by any other biochemical investigation. Third, using
homology models of the full length colicin E9 it is likely that the other domains of the colicin
E9would prohibit the binding of the immunity protein at the back position, and that the dock-
ing process has noticed some weakly hydrophobic resides that would otherwise normally
reside within the inner surface of the protein.
Colicin E9 is one of nine E-group colicins in a much larger family of bacteriocin proteins.
Each with a unique immunity protein but due to common ancestry high homology, yield-
ing some cross-protection. Colicin E9 can be inhibited by immunity proteins Im2, Im7 and
Im8. Molecular structures for many immunity proteins have already been elucidated as well
as several of the more common colicins. By combining the existing structures with only a
few site-directed spin labelling protocols and PELDOR experiments the structure of many
of these non-cognate complexes could be solved using EPR on a much faster and cheaper
time scale than would be practical for NMR or X-ray crystallography.
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(a) HADDOCK run results, HADDOCK score plotted
against the RMSD of the cluster to the HAD-
DOCK run average structure. Blue open cir-
cles are individual models, red filled circles are
cluster averages.
(b) Overlay of E9 DNase PDBs 2K5X(B)(NMR: com-
plex)(black/grey) with HADDOCK cluster 1
best model (cyan) and HADDOCK cluster 2
best model (blue). E9 DNase active site high-
lighted by the black arrow.
Figure 8.4 Results of HADDOCK run using PDB entry 2K5X structures and NMR CSP data from 1H - 15N HSQC
and triple resonance experiments.
8.3. in silico spin labelling of proteins
EPR fundamentally uses paramagnetic centres as sites of investigation, asmost native pro-
teins have no paramagnetic centres (with the notable exception of somemetaloproteins) the
addition of paramagnetism is required, typically through the introduction of spin labels. The
most commonly used in the study of proteins is that of nixtroxide radical spin label com-
pounds, of which the most commonly used are the spin labels S-(2,2,5,5-tetramethyl-2,5-
dihydro-1H-pyrrol-3-yl)methylmethanesulfonothioate (MTSL) and3-(3-(2-iodo-acetamido)-
propyl-carbamoyl)-PROXYL (IA-PROXYL).
With the addition of spin labels to proteins the three dimensional structure is changed or
rather more atoms are present. These changes must be taken into account when experi-
mental data is to be interpreted. For calculations to accurately represent and be comparable
with experimental data the in silico protein must also be spin labelled.
MTSL whilst giving paramagnetism to a structure does not place it at a fixed position even
when attached to a rigid part of the protein. In fact, the majority of the time a fixed spin
label is undesirable as it has the potential to distort the protein structure. The flexibility in
MTSL is as a result of free rotation about the C-C , C-S , S-S , S-C, C-C , C-C3 bonds
(visualised in figure 8.5). Using Ramachandran plot parameters and steric hindrances, or
more correctly, torsion angle dynamics simulation, MTSL attached to a free cysteine has a
rotamer library of 210 discreet conformations (at 175 K) with the nitroxide radical ~10 A
from the C of the protein backbone.
IA-PROXYL has an additional atom in the flexible linker, making the label slightly longer with
typical nitroxide radical ~11 A from the C. Free rotation is given by 5 bonds (C-C , C-S ,
S-C , C-C and N-C3 bonds) with only partial rotation across the C-N as a result of bond
dissociation of the formal C=Obond. This single bond restriction results in a rotamer library
of 108 discreet conformations (at 175 or 298K) by torsion angle dynamics simulation to a
free cysteine.
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Figure 8.5 Structures of spin labels IA-PROXYL andMTSL attached to a cysteine residue with bond angle motion
highlighted.
8.3.1. MMM
Obviously all 210 rotamers of MTSL will not be available to every SDSL site due to steric
hindrance with the protein backbone or other side chains. To calculate which rotamers are
thermodynamically acceptable the program MMM3 is used.
MMM takes a protein coordinate file (in protein data bank (PDB) format) and assumes that
the protein is a rigid body and all atom positions absolute. A residue is selected andmutated
to a cysteine, if required, assuming that the backbone atoms' co-ordinates do not change,
which may not be the case biologically especially if the mutation involves bulky or charged
amino acids. MMM then applies the rotamer library to the cysteine mutant and calculates
the energy of each rotamer outputting the allowed rotamers into a pseudo-PDB format.
This assumes that the underlyingmodel is correct, in that there is no difference between the
EPR sample and model arrising from crystal data versus solution or lipid environment, etc.
and that the EPR distribution is free from experimental artefacts.
For the purposes of this investigation it is not sufficient to have seperate rotamer libraries
and protein co-ordinate files. Insteadwhat is required is PDB files eachwith a single rotamer,
an in silico snapshot in time.
Initially, this was achieved throughmanually cutting rotamers from the pseudo-PDB file and
inserting them into the original protein PDB file detailed elsewhere4, 5. However, this method
was extremely time consuming and an automated method was sort.
Through personal communication with Dr. Y. Polyhach (ETH Zurich, CH), a script was at-
tempted which systematically scanned through the rotamer file, read each rotamer, opened
the protein PDB file and overwrote the original residue, saved the new PDB file sequentially
3http://www.epr.ethz.ch/software/
4http://morganbye.net/research
5http://wiki.uea-epr.eu/index.php?title=Adding_a_spin_label_to_a_PDB
149
8. Protein - protein docking with HADDOCK
(a) pseudo-PDB output from MMM (b) Rotamers displayed within MMM
Figure 8.6Graphical representation of colicin E9 S30C's 62 rotamer library calculated byMMMat 298K, showing a
variation of 4.7 Å radical position. (a) the pseudo-PDB displayed in PyMOL (stick representation). (b) is the
MMM display where the residue is shown in ball and stick format with opacity proportional to probability,
the location of the nitroxide radical is shown by a purple sphere, with the size of the sphere proportional
to probability.
beforemoving to the next rotamer. Instead Polyhachmodified a series of his own old scripts
to write out individual PDB files instead of writing the rotamer atom coordinates to the ro-
tamers file6.
The problemwith this approach was that the PDB file format had for a number of years been
poorly enforced. As a result PDB files generated from one program are not guaranteed to
work with all others. Many software approaches to clean PDB files have been implemented,
whilst most developers resort to programming elaborate solutions with a large number of
switches based upon the origin of the PDB file and include a number of safety features lead-
ing to large footprints to simply open a file7.
8.4. Conversion of distance distributions to distance
restraints
The single most important part of modelling is the quality of the data that is used, therefore
the conversion of the experimentally derived distance distributions into distance restraints is
an important consideration. Unfortunately due to the constraints of the modelling software
distance distributions can not be directly used, nor can multiple distance restraints exist
between individual atoms.
HADDOCK uses amanipulation of CNS's unambiguous distance restraints input, initially de-
signed for NMRNOE distance restraints. This requires that each restraintmust be presented
in CNS format8; naming the atoms involved in the distance restraint (which requires a pro-
tein chain and residue number for both). The distance constraint itself is presented as the
distance (d), with additional parameters for dminus and dplus; the allowed distances from
d.
6A total of 557 lines of code across 7 .m files
7The current PDB guidelines are a 191 page document available here: http://www.wwpdb.org/docs.html
MatLab's pdbread function is 1366 lines of code
8http://cns.csb.yale.edu/v1.1/tutorial/formats/noe/text.html
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Using inspiration from both DeerAnalysis [47] and DEFit [84], a distance between two points
can be thought of as a normal distributionwhenmeasured using amethod, where the uncer-
tainty causes the single distance to broaden into a distance measurement. As a result, even
complex distance distribution peaks can be thought of as the sum of many superimposed
Gaussian peaks, such that conversely a strong peak can be fitted using a Gaussian distri-
bution with any shoulders being fitted with their own Gaussian distributions. If the shoulder
peaks are close in proximitity and intensity then the distance distribution will appear to be
broadened.
Gaussian distributions have the form:
y = a  exp
"
 1
2

x  b
c
2#
(8.2)
Where a is the amplitude, b is the centre and c is the width (standard deviation). These com-
mon features have been shown in figure 8.7.a, additionally Gaussian distributions are dis-
cussed in terms of the full width at half height (FWHM), as well as the range at two standard
deviations representing 95 % data coverage, these are also shown.
For strong signals, in a single conformation then the distance distribution obtained should be
close to a pure Gaussian distribution. In this case, such as figure 8.7.b showing the distance
distribution of E9 DNase S30CR1A - Im9 C23R1A, the distance distribution was fitted to a
Gaussian model using a Levenberg-Marquardt non-linear least squares fitting algorithm.
Here, a good fit to themain peak of interest can be seen, whilst the single standard deviation
represents the data well. In this instance the dplus and dminus values are set symmetrically
about d.
However, the Gaussian distribution here perhaps over-represents longer distances, whilst
the shorter distance shoulder is under-represented. Here a multivariate normal or split nor-
mal distribution would yield a better fit to the data. In figure 8.7.c the symmetric Gaussian
is shown in red, whilst the asymmetric Gaussian is shown in green. Here a clear increase in
dminus is seen as well as a decrease in dplus however, the reality of the difference here is
less than 0.1 A which makes the increased computation impractical.
In the final scenario for this investigation there were scenarios where two peaks existed
and shown to be significant such as in the colicin E9 DNase S3CIA1/S80CIA1 experiment.
Ideally an AND or OR statement would be introduced into the constraints file such that the
constraint is for only the peaks and not the null space between them. As this is not possible,
compromise was struck whereby the both the peaks in question were fitted using a sym-
metrical Gaussian method and each peak's integral was used to weight the overall result.
For example in figure 8.7.d assume that the green peak has a quarter the integral of the red.
In this instance, the distance would be weighted 75 % toward the red peak. dminus was then
set as the distance from d to the lower standard deviation of the red peak whilst dplus was
set to the upper standard deviation of the green peak.
In the instance of very broad or asymmetric peaks with non-Gaussian like distributions a
similar single standard deviation approach would be used, in which 68.2 % of the peak area
either side from the peakwould be sampled. In such unsymmetrical, non-Gaussian systems
the full width half height or standard standard deviation analysis would yield lessmeaningful
boundaries as opposed to this approach which relies less upon peak shape.
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(a) Definition of a Gaussian distribution (b) Single peak, symmetric fit
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Figure 8.7Graphical representation of the distance distribution fittingmechanism employed. a) defines the com-
mon terms in a Gaussian distribution, with the centre point (d), the full width at half height, and the first
two standard deviations of data in red and green, representing 68 % and 95 % of the data. b) shows the
symmetrical fitting of the single, largest peak to a Gaussian distribution in colicin E9 DNase S30CR1A -
Im9 C23R1A, with the black lines highlighting the first standard deviation. c) shows the symmetrical fitting
in red and asymmetric fit in green of colicin E9 DNase S30CR1A - Im9 C23R1A. d) shows themultiple peak
fitting using symmetrical fitting upon colicin E9 DNase S3CIA1/S80CIA1, the first standard deviation for
each peak is shown in the peak colour, whilst the overall d position is shown as a vertical black line with
dplus and dminus highlighted as black, dashed arrows.
This broad distance range would cover most of the distance distribution with reasonable
probability but also account for uncertainties arising in the dynamics in the spin label as
well as in data analysis. Uncertainties can appear during analysis as broadened wings in
the distance regularisation due to Tikhonov regularisation and low amplitude artifacts at the
end of the distance distributions [47, 115]. This method could equally be used to multiple
peak analysis with careful implementation. In this investigation, each distance distribution
analysis was conducted manually using a Gaussian approximation, though an automated
system using this final described method would be desireable and likely implemented later.
Using a combined approach of these described methods the PELDOR results of chapter 7
were analysed to yield table 8.2.
By contrast and for further investigation, MMM was used to generate a complete restraint
list for every spin label site used in this investigation with the IA-PROXYL label from the NMR
complex structure (PDB: 2K5X) shown in table 8.3. The distance distributions generated by
MMMwere analysed in exactly the samemanner as the experimental distance distributions.
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Protein, labelling position Distance restraints / A
from to d dminus dplus
E9 DNase S3CIA1 E9 DNase S80CIA1 3.23 0.85 1.15
E9 DNase S30CIA1 E9 DNase S80CIA1 3.96 0.98 1.65
Im9 C23IA1 Im9 S6CIA1 2.58 0.88 0.83
E9 DNase S3CIA1 Im9 S6CIA1 3.62 0.63 1.03
E9 DNase S30CR1A Im9 C23R1A 3.70 0.50 0.50
E9 DNase E66CIA1 Im9 S6CIA1 4.85 0.78 0.82
E9 DNase E66CIA1 Im9 C23IA1 2.80 0.10 0.10
Table 8.2. Tabulated summary of the distance constraints generated as a result of PELDOR experimentation
and processing.
Protein, labelling position Distance restraints / A
from to d dminus dplus
E9 DNase S3CIA1 E9 DNase S80CIA1 2.46 0.55 0.45
E9 DNase S30CIA1 E9 DNase S80CIA1 3.68 0.75 0.50
Im9 C23IA1 Im9 S6CIA1 3.21 0.33 0.20
E9 DNase S3CIA1 Im9 S6CIA1 3.89 0.87 1.41
Im9 C23IA1 4.10 0.30 0.92
E9 DNase D20CIA1 Im9 S6CIA1 5.37 0.93 0.20
Im9 C23IA1 3.75 0.30 0.30
E9 DNase S30CIA1 Im9 S6CIA1 4.28 0.89 0.42
Im9 C23IA1 1.55 0.25 0.60
E9 DNase E66CIA1 Im9 S6CIA1 5.27 0.87 0.18
Im9 C23IA1 2.48 0.22 0.39
E9 DNase S80CIA1 Im9 S6CIA1 5.25 0.65 0.30
Im9 C23IA1 2.43 0.28 0.32
Table 8.3. Tabulated summary of the distance constraints generated as a result of MMM rotamer analysis.
Even in the intramolecular distances, such as the colicin E9 DNase S3CIA1/S80CIA1 a dif-
ference of 0.77 A can be seen in the distance restraint with the constraint range varying by
1.00 A between prediction and experimental result. Most of the intermolecular distance re-
straints vary by less than 0.50 A between prediction and experimental data. However, the in
silico spin labels, unhampered by protein concentration, labelling efficiencies or experimen-
tal convolution yield far more distinct distance restraints.
8.5. MISHAP
MISHAP is the open-source MMM in silico simulated spin label to HADDOCK program. It
combines several MatLab scripts, functions, programs and user interfaces as well as a set
of additional parameter files for HADDOCK.
MISHAP aims to take spin labelled proteins and the distance distributions between labels
from in silico (MMM) calculations or experimental data (from pulsed electron-electron dou-
ble resonance experiments which have been analysed with DeerAnalysis) and pass them to
the biomolecular docking program HADDOCK as docking restraints.
153
8. Protein - protein docking with HADDOCK
Figure 8.8 MISHAP PDB Creator user interface with 2K5X parameters loaded
8.5.1. Implementation of MMM rotamers into PDB format
With the PDB file format being so ill-defined, or rather, not strictly enforced, it is very un-
usual for a PDB file, even those obtained from pdb.org to be compatible with HADDOCK.
Furthermore, HADDOCK expects PDB files in a particular way, for example a PDB file can
only contain one amino acid chain, it cannot contain a segment identifier andmust end with
a correct END statement. These constraints rule out almost every published PDB file. Whilst
HADDOCK provides some basic scripts to strip PDB files such as pdb_blank_segid the user
is still left with a lot of manual work.
Furthermore, it is required not only to have PDB files compatible with HADDOCK but also
to have PDB files including spin label attached residues. As a result MISHAP provides the
ability to generate HADDOCK compatible PDB files of single chains of amino acids where
one or more residues have been substiuted for a nitroxide spin label attached to a cysteine
residue.
At this time it is not known how successful HADDOCK is at optimising rotamer populations
of amino acid side chains, particularly for unnatural amino acids. For this reason, MISHAP
allows for the generation of a single MMM rotamer PDB file - which should be sufficient for
HADDOCK. However, if more methodical work is required, functionality has been built in to
generate rotamer PDB files for all MMM rotamers or for rotamers over a user defined thresh-
old, such as only generating PDB files of MMM rotamers with greater than 5 % occupancy.
This method utilises HADDOCK's ensemble structure input functionality, as would be com-
monly used by NMR users with an ensemble of structures rather than a minimized average
structure.
This is implemented in MISHAP's PDB file creator graphical user interface, seen in figure 8.8
and further discussed in chapter 12 and appendix B.
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8.5.2. Acquiescence of HADDOCK to spin labels
Since the original HADDOCK publication in 2003 by Dominguez et al. [28], HADDOCK has
been extended to deal with a large varity of data and complexes including protein-DNA,
protein-RNA, protein-oligosaccharides and protein-ligand complexes. Traditional docking
methodologies are based upon a combination of energetics and shape complementarity.
Instead, HADDOCK was initially designed differently from using a biochemical/biophysical
experimental data approach using data resulting fromNMR titration experiments, mutagen-
esis data or bioinformatic predictions and introducing it as ambiguous interaction restraints.
The use of spin labels as unnatural amino acids is not a problemwith HADDOCK. HADDOCK
is simply a complex top layer that drives docking whilst structural calculations are called
by HADDOCK using HADDOCK-specific parameter files from the Crystallography and NMR
System (CNS) program CNSsolve9. HADDOCK contains a series of files which contain all
of the necessary parameters for amino acid residues, ligands, DNA, etc. These parameters
largely are default parameters for CNS that have been extensively modfied and added to for
the purposes of HADDOCK.
8.5.2.1. Topology
In order to define a molecule or amino acid in CNSsolve requires the explicit definition of
every atom type, atom size, atom charge, bond, bond energy, bond length, dihedral angle
and improper dihedral angle in the molecule. Furthermore, in the case of amino acids the
way in which the amino acid links to the i  1 and i+ 1 residues, as well as its behaviour as
at the terminus of an amino acid chain requires defining.
topallhdg5.4.pep allows the labels to exist in a peptide, and defines how the peptidewould
bind to surrounding amino acid residues
topallhdg5.4.pep-noCter allows the labels to exist and bond to it's neighbours in a pep-
tide where no C-terminus exists
topallhdg5.4.pep-noNter allows the labels to exist and bond to it's neighbours in a pep-
tide where no N-terminus exists
topallhdg5.4.pep-noter allows the labels to exist and bond to it's neighbours in a peptide
where neither a N nor C -termini exists
topallhdg5.4.pro defines themass and charge of each atom, as well as each bond, angle,
improper angle, dihedral angle and hydrogen bond acceptor/donor site
9CNSsolve, Yale University, USA, http://cns-online.org
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8.5.3. Distance distributions and HADDOCK restraints
With the results of the PELDOR investigation of chapter 7, several distance distributionswere
generated between multiple sites across the colicin E9 DNase - Im9 complex.
These distance distributions require conversion into docking constraints that can be used by
HADDOCK. To do so, manipulation of HADDOCK's/CNS's unambiguous distance restraints,
initially designed for NMR NOE distance restraints are required. Restraints must be pre-
sented in a seperate file, following CNS format10; naming the atoms involved in the distance
restraint (which requires a protein chain and residue number for both). The distance itself is
presented as the distance (d), with additional parameters for dminus and dplus (the extents
either side of the distance, d)
For example, this line defines the distance between Im9 S6CIA1 and Im9 C23IA1 nitroxides
as 3.21 A with a lower limit of 2.88 A and a higher limit of 3.41 A.
assign (name "O1" and resid "6" and segid "A") ...
(name "O1" and resid "23" and segid "A") ...
3.21 0.33 0.20
MISHAP implements the generation of unamiguous distance restraints in a MatLab graph-
ical user interface (shown in figure 8.9). The user loads a distance distribution from Deer-
Analysis or MMM, the distribution is displayed, automatically scanned for peaks and a dis-
tance value presented. The user is free to change the automatically detected values and add
more spin label sites (for 3 or 4 spin label experiments) before generating the constraint file.
If the MISHAP constraint generator is used in conjunction with the MISHAP PDB generator
then the atom address and label information will automatically completed for the user as
well.
Figure 8.9 MISHAP distance constraint generator user interface
10http://cns.csb.yale.edu/v1.1/tutorial/formats/noe/text.html
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8.6. HADDOCK runs
HADDOCK developers pride HADDOCK's ability to accept ambiguous data, small amounts
of data or data from various different sources; including in silicomethods. This means that
HADDOCKcan be run, and give resultswith little, if any, experimental data. As a starting posi-
tion and example of HADDOCK's flexibility, the colicin E9 DNase and Im9 structures from the
PDB entry, 2K5X were taken and run through HADDOCK using no restraints. It was expected
that in the first stage of docking (solid body), when both molecules are randomly orientated
and combined with no restraints, that there should equal sampling across the molecular
surfaces, which after energy minimisation should yield little clustering of structures.
Next ambiguous interaction restraints derived from a typical NOE perturbation based NMR
titration assay would be introduced to replicate the process used to derive the published
complex structure. Having verified that the NMR complex is repeatable, spin labels were
introduced and docking rerun with no further restraints to ensure that the small spin labels
made no significant difference to the docking procedure. With the spin labelled proteins
confirmed to be representative of the natural proteins then additional EPR derived restraints
could be introduced.
Each HADDOCK run in this investigation was conducted using the same parameters such
that no run should be unfairly biased. In addition, several parameters as a result of the small
size of the docking molecules were adjusted such that a sufficient number of structures
completed the docking calculations. Namely the molecular dynamics time step between
energies calculation was reduced from 2.0 fs to 0.5 fs as well as reducing the anneal-
ing temperatures which the molecules are raised to before being allowed to cool. Without
these adjustments the molecules would often move too far between molecular dynamics
calculations allowing atoms moving toward each to clash. In the next round of calculations
the massive potential energy from the repulsion of atoms is resolved by moving the atoms
quickly far apart, often outside the calculation co-ordinate space (> 99,999 A) causing the
structure to fail.
In this section HADDOCK run results are displayed as both a statistical and graphical sum-
mary. In the statistical summary the structures that complete the docking process are su-
perimposed onto the backbone atoms of the flexible interface before they are aligned and
averaged to give an ``average structure''. The interface is defined by the atoms from the am-
biguous interaction restraints (AIRs), though if AIRs are not available then the entire protein
backbone is used. This average structure then serves as the basis of several calculations
that compare each model of the ensemble in terms of both energies and spatial deviation.
Each structure has several bonded and non-bonded energies calculated, including the total
complex energy, the bond energies, the bond angle energies, the dihedral angle energies,
the Van der Waal's energies, the electrostatic energies, the buried surface area (and thus the
desolvation energy). Finally, with consideration of hydrogen bonding, intermolecular hyrdo-
phobic contacts and violation analysis a HADDOCK score is generated.
In the visual statistical analysis the RMSD of each structure from the average structure is
plotted against the structure's HADDOCK score. Each structure is shown as an open blue
circle upon the axes. During analysis, as discussed in §8.2, structures of close RMSDs are
grouped into clusters. In the statistical analysis the cluster averages are shown as closed
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red circles with error bars showing the average for the best four structures in that cluster. A
gooddocking runwill show few, if not only a single clusterwith small error bars. Poor docking
runs with multiple solutions will show many clusters with all the structures showing a high
RMSD from the average structure. Whilst a very bad docking run will show few structures
complete annealing with almost no clustering as none of the results are close enough to be
considered a cluster.
The graphical analysis shows the published NMR structure for the colicin E9 DNase - Im9
complex (PDB: 2K5X) in cartoon format. As with previous diagrams in this investigation the
colicin E9 DNase remains in grey and Im9 remains in pale cyan, though the rotation has been
altered slightly to allow full view of the binding interface. All HADDOCK runs maintain the
same perceived orientation so that each run is visually directly comparable with all others.
The HADDOCK structures are represented in line format, for the sake of clarity only the back-
bone atoms (N , C , C, O) are shown. In black, the top scoring structure's colicin E9 DNase
is plotted after alignment to the reference structure. Other structures were considered how-
ever, the very low RMSDs upon the colicin E9 DNase only confuse the image and as a result
are omitted from the visual representation. Each HADDOCK structure is then aligned to the
top scoring structure. The Im9s from each HADDOCK structure is then shown in line for-
mat and coloured in a spectrum manner according to their scoring position with blue being
the best scoring and red being the lowest scoring structure. By default, the top 4 structures
from the top 4 scoring clusters are displayed. In later HADDOCK runs additional figures
are presented where more structures from fewer clusters are displayed, as this becomes
more appropiate given the cluster population. For some HADDOCK runs additional figures
are included which remove the reference structure and reorientate the co-ordinate system
to better show the Im9 positions, in these cases the cartoon model replaces the black line
representation for the top scoring colicin E9 DNase.
When comparing the positions of proteins, such as comparing the position of a HADDOCK
calculated structure to that of the published structure a two step analysis is performed. In
the first the colicin E9 DNase is aligned using a root mean squared deviation minimisation
method of C atoms, where matching atoms, v and w are superimposed such that
RMSD(v; w) =
vuut 1
n
nX
i=1

(vix   wix)2 + (viy   wiy)2 + (viz   wiz)2

(8.3)
Where x, y and z are the principle co-ordinate system. In the second step the distance
between Im9 positions is analysed by taking the translational component of an ordinary
Procrustes analysis for each C atom and averaging for the entire molecule. Using this
method removes any bias from rotation and molecular orientation that would be present
from using single representive atoms from the binding interface or a protein centre of mass
pseudoatom based approach.
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8.6.1. Without constraints
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary (c) Reorientated visual summary
Figure 8.10 HADDOCK run results with no restraints, and only minimal, randomly generated AIRs. a) statistical
summary, open blue circles show aHADDOCK solution structure, closed red circles show cluster averages
with error bars showing the cluster average of the top 4 scoring structures. b) visual summary in fixed
rotation showing the published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin
E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in
black after structure alignment to the reference structure. Im9s in line format are coloured by HADDOCK
score from blue to red. c) reorientated version of panel b) maximising visualisation of all Im9 structures.
The reference structure is removed and top scoring colicin E9 DNase structure is shown in grey cartoon
representation.
In figure 8.10.a we see a statistical summary of the HADDOCK run whereby each of the
completing 200 structures taken forward from solid body analysis is plotted as a blue circle.
Each structure's HADDOCK score (more negative is a better model) is plotted against the
RMSD distance of that structure from the average structure of the 200 models.
In HADDOCK, by default, structures are pooled into a cluster if, four or more structures have
an RMSD of less than 7.5 A. In figure 8.10.a the top 4 scoring structures of any cluster are
averaged and represented by filled red circles. A strong cluster should showmany structures
with similar RMSDs and HADDOCK score, thus small error bars. A perfect model of absolute
certainty therefore should have only one cluster.
With no restraints in place the energy optimisation docking procedure proves difficult. On a
protein with few solvent exposed charged residues and a small cross-sectional surface area
in many models entropy drives the system such that the binding partners are infinitely sep-
arated. Figure 8.10.a shows far less than 200 blue circles as these structures are removed
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from further calculation after failure.
Figure 8.10.b shows the visual summary of the HADDOCK run. In this instance the top scor-
ing structure has had the colicin E9 DNase aligned to the NMR reference structure using
a RMSD refinement process, after which all other HADDOCK models are aligned to the top
scoring HADDOCK structure. As the colicin E9 DNase conformation varies little between
structures, only the colicin E9 DNase of the top scoring structure is shown in black line for-
mat, whilst the reference structure is shown in cartoon format. The top 4 structures from the
top 4 clusters have their Im9 structure shown in backbone line format. The Im9 structures
have been colour coded such that blue is the best HADDOCK scoring structure and red is
the fourth structure from the fourth cluster.
Visually from figure 8.10.b little can be seen of the position of the Im9. However, when the
reference structure is removed and reorientated, as in figure 8.10.c, it can be seen that whilst
there has been some clustering into 3 positions (blue, green and yellow/red) the spread is
almost entirely spaced across the colicin E9 DNase's surface. Remember also that these
representations only present the top 4 structures from the top 4 clusters, when more struc-
tures are considered the image becomes considerably more distorted, with the apparent
clustering becoming less obvious.
When both figures 8.10.a and 8.10.c are considered together then no docking solution is
within 8 A of the average HADDOCK structure. From the visualisation it can be imagined
that the average position of the Im9 is to be almost directly superimposed on top of the
colicin E9 DNase with these structures having and RMSD to the reference structure of 1.45
and 1.98 A. However, there are a number of structures with a distance over 15 A from the
average structure representing approximately half the width of the protein.
8.6.2. With chemical shift perturbation constraints
To investigate whether EPR distance restraints could be used to elucidate models that re-
main ambiguous from only NMR experiments requires an investigation into how CSP data
influences the docking procedure.
In figure 8.11 we see a repetition of figure 8.4 now using experimentally derived ambiguous
NMR restraints. In figure 8.11.a, more structures can be seen to complete the docking trials.
In addition, a far greater clustering of structures can be seen whereby almost all 200 struc-
tures fall in a narrow 4 A range from the average structure. However, almost all of these
structures fall at least 12 A from the average structure. Due in no small part to the split-
ting of the top scoring structures into 2 distinct positions, highlighted in figure 8.11.c as the
blue/green and orange/yellow populations. As further, lower scoring, structures are intro-
duced to the analysis the visual representation distorts as the populations show a broader
interaction area.
Key to this docking procedure are the AIRs, which not only keep a far greater number of
structureswithin the confines of the virtual docking space, but also generate distinct clusters
opposed to the random spreading of structures that was seen when these restraints were
not present. In figure 8.11.a this causes the top scoring structures to have a greater RMSD
from the average structure, when compared to figure 8.10.a but the top structure docking
scores vary little.
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary (c) Reorientated visual summary
Figure 8.11 HADDOCK run with NMR AIRs restraints. a) statistical summary, open blue circles show a HADDOCK
solution structure, closed red circles show cluster averages with error bars showing the top four scoring
structures range. b) visual summary in fixed rotation showing the published colicin E9 DNase - Im9 com-
plex (PDB: 2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N,
C, C, O) for the top scoring colicin E9 DNase in black after structure alignment to the reference structure.
Im9s in line format are coloured by HADDOCK score from blue to red. c) reorientated version of panel b)
maximising visualisation of all Im9 structures. The reference structure is removed and top scoring colicin
E9 DNase structure is shown in grey.
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary (c) Reorientated visual summary
Figure 8.12HADDOCK runwith NMRAIRs restraints uponMISHAP generated proteinswith all spin labels present.
a) statistical summary, open blue circles show a HADDOCK solution structure, closed red circles show
cluster averages with error bars showing the cluster average of the top 4 scoring structures. b) visual
summary in fixed rotation showing the published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon
format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring
colicin E9 DNase in black after structure alignment to the reference structure. Im9s in line format are
coloured by HADDOCK score from blue to red. c) reorientated version of panel b) maximising visualisation
of all Im9 structures. The reference structure is removed and top scoring colicin E9 DNase structure is
shown in grey.
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8.6.3. With CSP constraints and spin labels
Through the use of site directed spin labelling the physical properties of the protein are
changed, especially in the case where the spin label locations are deliberately designed to
be upon the surface or inside of the protein. Whilst the spin labels are attached by a flexible
linker, they still have more bulk than a traditional cysteine or serine which they replace, this
could influence docking. Whilst each site was chosen to be away from the docking interface
in the published X-ray crystallography and NMR structures, it may still influence the docking
procedure. To test whether the spin labels influenced docking a HADDOCK run was con-
structed using only the AIRs from NMR using MISHAP generated proteins with spin labels
at every labelling position used in this investigation.
Figure 8.12 shows that the flexibility in the spin label linker means that the spin label makes
little difference to the protein structure or the docking behaviour. Here the colicin E9 DNase
with 4 spin labels and Im9 with 2 spin labels has given a near identical spread of structures
and clusters as those shown in figure 8.11.
On detailed analysis without spin labels present, the top cluster of 50 structures (42.0 % of
structures completing the run) have a backbone RMSD to one another of 2.22  1.74 A.
With spin labels present the top cluster of 34 structures (36.9 % of structures completing
the run) have a slightly increased RMSD 2.78  1.61 A.
Visualisation of the top structures in figure 8.12.b shows an identical representation as pre-
viously in figure 8.11.b. This confirms that the spin labels are away from the docking surface
in the top scoring structures, and that the spin label presence does not unfairly bias one of
the potential binding sites.
8.6.4. With intramolecular PELDOR restraints
Having established that the presence of spin labels across the docking partners made little
difference to their docking behaviour the next step was to begin introducing distance re-
straints derived from the PELDOR experiments. The proteins in question are small, globular
and delivered to HADDOCK as rigid bodies. As such, the introduction of intramolecular dis-
tance restraints to already restrained models should not yield any significant difference to
the docking process. The restraint may ultimately allow less flexibility in the energy optimi-
sation as domains and secondary structures will be restricted in their movement, but as the
first step in HADDOCK assumes rigid bodies the overall docking should not vary greatly.
8.6.4.1. Colicin E9 DNase S3CIA1/S80CIA1
In figure 8.13, the unmodified Im9 protein from the NMR complex structure is docked with
colicin E9 DNase with a single distance restraint between the terminal side chain oxygen
atom upon the S3CIA1 and S80CIA1 residues.
The statistical summary (figure 8.13.a) here shows little variation from an unconstrained run
with a great number of structures completing the docking procedure. However, all structures
remain over an RMSD of 11 A from the average run structure. The number of clusters also
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remains high with the error bars of each cluster covering a wide range of RMSD distances
and HADDOCK scores.
When the top structures are visualised in figure 8.13.c a clear splitting in the clusters is seen
again, with the top scoring structures (blue) sitting at the back of colicin E9 DNase in this
orientation (with an RMSD of the Im9 72 A from the reference structure). However a number
of good scoring structures adopt the previously seen position on top of the colicin E9 DNase,
which is also slightly closer to the reference position of the Im9 with a C average RMSD of
53 A.
However, when figures 8.12.b and 8.13.b are directly compared in the same orientation to the
reference structure it can be seen that the restraint in the colicin has a profound effect. The
best scoring structures (blue) move to the opposite side of the colicin but also constrain the
model such that the Im9s presented appear less distorted and almost approaching discrete
conformations.
8.6.4.2. Colicin E9 DNase S30CIA1/S80CIA1
In the case of the docking with the colicin E9 DNase S30CIA1 to S80CIA1 distance restraint
(figure 8.14) a shift in docking structures is seen. Figure 8.14.a shows a number of structures
in one cluster is seen to move just below an RMSD of 12 A from the average structure. 3
more small clusters with an RMSD from average in the range of 6 - 8 A also appear, but
these are not particularly well scoring.
By inspecting the clusters visually in figure 8.14.b, the spreading of structures across a
greater RMSD range from the average structure is related to the spreading of clusters from
the 2 distinct sites to an entire side of the colicin E9 DNase. This presents as a mix of situa-
tions between when no NMR AIRs and when no long range distance restraints are included.
It could simply be a case that the single long range distance restraint is causing less flexi-
bility in the colicin E9 DNase which causes unusual preferences upon introduction of Im9.
Notice however that the vast majority of structures lie in the 11 A cluster and that the HAD-
DOCK scores of this cluster are significantly better than the clusters closer or further away
from the average structure. This cluster is represented in blue in figure 8.14.b and has a top
scoring cluster of over -115. The fourth best scoring cluster (RMSD 8.5 A, HADDOCK score
-75 in figure 8.14.a) is shown in red in 8.14.b shows an ordinary HADDOCK score but a low
RMSD. If the high RMSD structures are orientated on the opposite face as the red cluster it
would artifically generate an average structure on top of colicin E9 DNase. Making the high
scoring cluster at an RMSD of 11 A the most relevant.
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary (c) HADDOCK visual summary
Figure 8.13HADDOCK runwith NMRAIRs and colicin E9 DNase S3CIA1/S80CIA1 PELDOR restraint. a) statistical
summary, open blue circles show aHADDOCK solution structure, closed red circles show cluster averages
with error bars showing one standard deviation. b) visual summary in fixed rotation showing the published
colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in
pale cyan. Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in black after structure
alignment to the reference structure. Im9s in line format are coloured by HADDOCK score from blue to
red. c) reorientated version of panel b) maximising visualisation of all Im9 structures. The reference
structure is removed and top scoring colicin E9 DNase structure is shown in grey.
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(a) HADDOCK statistical summary (b) HADDOCK visual summary
Figure 8.14 HADDOCK run with colicin E9 DNase S30CIA1/S80CIA1 PELDOR restraint. a) statistical summary,
open blue circles show a HADDOCK solution structure, closed red circles show cluster averages with error
bars showing one standard deviation. b) visual summary in fixed rotation showing the published colicin
E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in pale cyan.
Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in black after structure alignment to
the reference structure. Im9s in line format are coloured by HADDOCK score from blue to red.
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8.6.4.3. Im9 S6CIA1/C23IA1
Figure 8.15 shows the reverse situation of figures 8.13 and 8.14. Here the colicin E9 DNase
remains without mutation or label whilst the Im9 has been restrained with an intramolecular
distance between the terminal side chain oxygen of the S6CIA1 and C23IA1 residues.
Figure 8.15.a shows a greater spread of structures than when there are no constraints. No-
ticeably, 3 cluster averages are below the 12 A RMSD from average structure limit seen with
no restraints. However, at the same time a significant number of structures are above the
upper 16 A RMSD from average structure limit seen with no restraints.
Figure 8.15.b confirmswhat is shown in figure 8.15.a, and the best scoring clusters all collect
to the same side of the colicin E9 DNase, but a large distribution is still seen in these 16
structures. Translation of the top scoring clusters visualised here yields an average RMSD
of the Cs in the Im9 of approximately 75 A.
8.6.5. With intermolecular PELDOR restraints from colicin E9
DNase S3CIA1
Figure 8.16 shows the first HADDOCK run using both NMR AIRs and an experimentally de-
rived, intermolecular spin label, PELDOR distance restraint. From visual inspection of the
top scoring structures (figure 8.16.b) we see that from introducing a single EPR distance
restraint that the structures fall into 3 prominent clusters. The yellow structure remains in
a similar position at the back of the colicin E9 DNase (in this orientation) as has been seen
previously in other HADDOCK runs.
However, the visual representation here is misleading when considered with the statisti-
cal summary (figure 8.16.a). Here we can see that 6 structures deviate from the average
structure by less than 2 A, and the lowest cluster average is ~ 4 A from the average struc-
ture despite variation. However, as the structures under an RMSD of 2 A from the average
structure do not form a cluster they can be assumed to coincidentally close to the aver-
age structure but not to each other. If the top 4 scoring structures all fell within the same
cluster then only the blue/green distribution of figure 8.16.b is of interest whilst the others
presented are by HADDOCK score and RMSD much further from the average. This is not to
say that those results are the biological solution, it could be that the single structure at RMSD
= 13.8 A, HADDOCK score = -78, is the biological significant result and the other structures
are simply calculation artifacts as a result of the energy folding landscape. When the low
from average RMSD structures are calculated against the reference position of Im9 then it
is found that they have large translation values varying between 65 and 80 A.
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(a) HADDOCK statistical summary (b) HADDOCK visual summary
Figure 8.15 HADDOCK run with Im9 S6CIA1/C23IA1 PELDOR restraint. a) statistical summary, open blue circles
show a HADDOCK solution structure, closed red circles show cluster averages. b) visual summary in fixed
rotation showing the published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin
E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in
black after structure alignment to the reference structure. Im9s in line format are coloured by HADDOCK
score from blue to red.
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Figure 8.16 HADDOCK run with NMR AIRs and colicin E9 DNase S3CIA1-Im9 S6CIA1 PELDOR restraint. a) sta-
tistical summary, open blue circles show a HADDOCK solution structure, closed red circles show cluster
averages. b) visual summary in fixed rotation showing the published colicin E9 DNase - Im9 complex
(PDB: 2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C,
C, O) for the top scoring colicin E9 DNase in black after structure alignment to the reference structure.
Im9s in line format are coloured by HADDOCK score from blue to red. c) reorientated version of panel b)
maximising visualisation of all Im9 structures. The reference structure is removed and top scoring colicin
E9 DNase structure is shown in grey.
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(a) HADDOCK statistical summary (b) HADDOCK visual summary
Figure 8.17 HADDOCK run with NMR AIRs and colicin E9 DNase E66CIA1-Im9 C23IA1 PELDOR restraint. a)
statistical summary, open blue circles showaHADDOCKsolution structure, closed red circles showcluster
averages. b) visual summary in fixed rotation showing the published colicin E9DNase - Im9complex (PDB:
2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for
the top scoring colicin E9 DNase in black after structure alignment to the reference structure. Im9s in line
format are coloured by HADDOCK score from blue to red.
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary (c) Reorientated visual summary
Figure 8.18HADDOCK run with colicin E9 DNase E66CIA1-Im9 S6CIA1 PELDOR restraint. a) statistical summary,
open blue circles show a HADDOCK solution structure, closed red circles show cluster averages with error
bars showing one standard deviation. b) visual summary in fixed rotation showing the published colicin
E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in pale cyan.
Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in black after structure alignment to the
reference structure. Im9s in line format are coloured by HADDOCK score from blue to red. c) reorientated
version of panel b) maximising visualisation of all Im9 structures.
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8.6.6. With intermolecular PELDOR restraints from colicin E9
DNase E66CIA1
Figure 8.17 shows the results of a HADDOCK run with NMR AIRs and a PELDOR restraint
between colicin E9 DNase E66CIA1 and Im9 C23IA1. As the colicin E9 DNase E66CIA1 po-
sition is located almost centrally to the globular protein domain it was expected that this
single distance would give the most ambiguous docking results in such a small, spherical
protein as the docking would be driven almost exclusively by protein surface interactions.
In figure 8.17.a an almost identical distribution of structures to that of figure 8.11.a where
docking was conducted with no distance restraints can be seen. On closer inspection of
figure 8.17.b the top 4 clusters have shifted such they all reside on the same side of the
protein, simply with a wide distribution. This could however simply be a result of the con-
straints as the experimental data could only resolve to 2.80 0.50 nm. Again the top scoring
structures would appear to show a relatively narrow distribution of structures, but as lower
scoring structures are considered then the image distorts. The translation value though of
the modelled Im9 positions to the reference position remains in the 65-80 A range, showing
that these structures are placing the Im9 on almost exactly the opposite side of the colicin
E9 DNase.
The PELDOR distance restraint between colicin E9 DNase E66CIA1 and Im9 S6CIA1 whilst
being longer could also be resolved to a narrower range of 4.65 0.30 nm. This again splits
the top 4 clusters such that no discernible position of the Im9 upon the colicin E9 DNase can
be seen, as highlighted in figures 8.18.b and c. Crucially however, the Im9 now appears to
be on the front side of the colicin (in the reference orientation shown in figure 8.18.b), close
to the position of Im9 in X-ray crystallography and NMR structures.
Most interestingly this distance restraint causes a dramatic shift in structures and clusters
in the statistical summary (figure 8.18.a). A large number of structures remain above 12 A
from the average structure but there seems to be definite blocks in the ranges 6-8 A and 10-
12 A. Most significantly there is a single cluser under 2 A, with 1 structure having not only
the best HADDOCK score but a near zero RMSD from the average structure. The top scoring
structure (blue) can even be seen in figure 8.18.c to have some backbone overlapping with
helical structure of the NMR reference structure. The translation average of Cs between
modelled and reference Im9 positions remains quite high for these top scoring structures
in the range of 10 A, despite the structural overlap. The reason for this is simple, in the
docking process for this docking run almost all of the structures resulted in the Im9unfolding
and rearrangement of the tertiary structure (as can be particularly evidenced in the yellow
structure of figure 8.18.c). With the docking run repeated with lower annealing temperatures
the same result was achieved as soon as the proteins were no longer treated as solid bodies
and backbone freedom was allowed, perhaps suggesting a problem with the restraints.
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8.6.7. With intermolecular PELDOR restraints to Im9 C23IA1
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Figure 8.19 HADDOCK run with NMR AIRs and colicin E9 DNase S3CIA1/S30CIA1/E66CIA1/S80CIA1- Im9
C23IA1 PELDOR restraint. a) statistical summary, open blue circles show a HADDOCK solution struc-
ture, closed red circles show cluster averages with error bars showing one standard deviation. b) visual
summary in fixed rotation showing the published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon
format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring
colicin E9 DNase in black after structure alignment to the reference structure. Im9s in line format are
coloured by HADDOCK score from blue to red.
In this docking run all experimentally derived intermolecular long range distance restraints to
Im9 C23IA1 were combined (3 in total) with both colicin E9 DNase intramolecular distances.
Dockingmodels typically are at their best when there aremultiple distance restraints across
multipe sites on both docking partners. However, here it was investigated whether trian-
gulation of distances to a single point on a docking partner would be sufficent to refine a
model.
Most striking of this docking run is the visualisation in figure 8.19.b where the top 8 scoring
structures (blue/green) almost exactly lie on top of one-another (RMSD < 2 A to each other).
Further clusters (yellow/red) show a distinct second orientation of the Im9 to the colicin E9
DNase but still very much in the same location upon the surface of the colicin E9 DNase.
As with previous runs, especially those using intramolecular distance restraints there is a
strong cluster of many structures with good HADDOCK scores at an RMSD of ~11 A from
the average structure. A spread of clusters is seen at a slightly shorter and longer distance
from the average. This suggests a distribution of sites where Im9 can dock and perhaps
causes an unexpected average structure leading to artifically inflated RMSDs of the struc-
tures. What is clear, is that the single cluster not only scores the best structures within a
very tight RMSD range of one another but (< 1.2 A), this structure contains 40.4 % of the
total structures for the run. This cluster, however remains upon the opposite side of colicin
E9 DNase with a translation distance of the Im9 from modelled to reference of 68 A.
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8.6.8. With intermolecular PELDOR restraints to Im9 S6CIA1
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Figure 8.20 HADDOCK run with NMR AIRs and colicin E9 DNase S3CIA1/S30CIA1/E66CIA1/S80CIA1- Im9
S6CIA1 PELDOR restraint. a) statistical summary, open blue circles show a HADDOCK solution struc-
ture, closed red circles show cluster averages with error bars showing one standard deviation. b) visual
summary in fixed rotation showing the published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon
format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring
colicin E9 DNase in black after structure alignment to the reference structure. Im9s in line format are
coloured by HADDOCK score from blue to red.
This docking run, similar to the previous docking calculation to Im9 C23IA1, takes every
intermolecular long range distance restraint from colicin E9 DNase to the Im9 S6CIA1 site
(3 in total) with addition restraint within the colicin E9 DNase by 2 intramolecular distances.
As with figure 8.19, figure 8.20 shows amuchmore restricted system than in previous dock-
ing runs without long range distance restraints. In figure 8.20.b the top 3 clusters again are
located upon a single side of the colicin E9 DNase (at the back in this reference orientation).
The fourth cluster (orange/red) adopts the previously seen position on top of the colicin E9
DNase. Whilst the top clusters see a splitting of positions, the degree to which structures in
a cluster of overlay is very high, and higher than was seen in the previous docking run. Im9
again assumes two orientations about the same sites on the surface of colicin E9 DNase,
with the blue and yellow/green clusters 68 and 65 A respectively from the reference position
of Im9, whilst the lower scoring red/orange cluster is a slightly closer 53 A.
Whilst visually not as good as the Im9 C23IA1 site, the statistical summary of S6CIA1 shows
even greater clustering of structures. There remains a few outlying structures which score
poorly but the vast majority of structures fall into the 2 orientations of Im9 shown in figure
8.20.b.
The five best scoring structures at an RMSD from the average structure of approximately 9
A, are not significant. Whilst appearing to at a similar HADDOCK score and RMSD from the
average structure, when visualised, they have very different conformations to one another
and cannot be considered a cluster and as a result need to be treated with suspicion as
outliers.
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary, 1 cluster, 16 structures
(c) HADDOCK visual summary, 2 clusters, 8 structures
from each
(d) HADDOCK visual summary, 4 clusters, 4 structures
from each
Figure 8.21 HADDOCK run with AIRs and colicin E9 DNase S3CIA1/S30CIA1/E66CIA1/S80CIA1- Im9
S6CIA1/C23IA1 PELDOR restraints. a) statistical summary, open blue circles show a HADDOCK solu-
tion structure, closed red circles show cluster averages with error bars showing the average of the top
four scoring structures in that cluster. b), c) and d) visual summary in fixed rotation showing the pub-
lished colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin E9 DNase in grey, Im9 in
pale cyan. Im9s in line format are coloured by HADDOCK score from blue to red. b) shows 16 structures
from the top scoring cluster c) shows 8 structures from each of the top two scoring clusters d) shows 4
structures from each of 4 top scoring clusters.
172
8.6. HADDOCK runs
8.6.9. With all PELDOR restraints and CSPs
Figure 8.21 shows the docking results when all four IA-PROXYL spin label sites on the col-
icin E9 DNase are used in combination with both sites on Im9. The run consists of 2 colicin
E9 DNase intramolecular restraints, 1 Im9 intramolecular restraint and 4 intermolecular re-
straints. It was hoped that more intermolecular restraints could be used but the protein
expression levels and labelling efficency eliminated certain positions. Whilst doubly labelled
proteins helped elucidate some restraints despite this, distances were often too similar to
accurately restrain.
The statistical summary of the run shown in figure 8.21.a shows that there is one structure,
with the highest score sitting almost exactly upon the average structure at 0 A. With the
addition of restraints the number of structures within cluster with a backbone RMSD of less
than 2 A from the average is very high. After this the clusters become somewhat cluttered
with a large number of clusters and structures sitting in the RMSD from average structure
range of 4-12 A.
The first cluster contains 70 structures (35 % of the docking run), as a result figure 8.21.b
shows the visual summary of only that cluster, showing the top scoring 16 structures. With
the exception of the protein tails on the yellow structure, a near perfect overlay of the Im9
structures can be seen.
The second cluster contains a further 34 structures, and its cluster average HADDOCK score
is slightly better than the first cluster. However, the cluster has a much large RMSD range
from the average structure. Figure 8.21.c, shows the top 8 structures from each of the first
2 clusters, the first cluster remains tightly formed in black/red/orange. The second cluster
in blue and green shows that whilst the absolute HADDOCK score is margainly better, the
spread of structures narrows docking down to little more than an entire side of the colicin
E9 DNase.
In figure 8.21.d we see a visual representation more in keeping with previous figures where
the top 4 structures from each of the top 4 clusters are presented. Here cluster 3 has 20
structures (10 %) and cluster 4 has 12 structures (6 %). With the addition of 2 poorly scoring
clusters with large RMSDs simply distorts the image. However at no point does the Im9 ever
move to the other side of the colicin E9 DNase seen when the model was without PELDOR
derived distance restraints.
Crucially, this docking run with experimental PELDOR restraints shows only structures upon
one surface of the colicin E9DNase and distinguishes betweenmodels fromwhen only NMR
data is used.
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(a) HADDOCK statistical summary
(b) HADDOCK visual summary - reference orienta-
tion
(c) Reorientated visual summary
(d) HADDOCK visual summary - Im9 orientation optimised
Figure 8.22 HADDOCK run without AIRs, only colicin E9 DNase S3CIA1/S30CIA1/E66CIA1/S80CIA1- Im9
S6CIA1/C23IA1 PELDOR restraints. a) statistical summary, open blue circles show a HADDOCK solu-
tion structure, closed red circles show cluster averages with error bars showing one standard deviation.
b) visual summary in fixed rotation showing the published colicin E9 DNase - Im9 complex (PDB: 2K5X)
in cartoon format with colicin E9 DNase in grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the
top scoring colicin E9 DNase in black after structure alignment to the reference structure. Im9s in line for-
mat are coloured by HADDOCK score from blue to red. c) reorientated version of panel b). d) reorientated
version of b) maximising visualisation of all Im9 structures. The reference structure is removed and top
scoring colicin E9 DNase structure is shown in grey.
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8.6.10. With only PELDOR restraints
Using only 2 colicin E9 DNase intramolecular, 1 Im9 intramolecular and 4 intermolecular
long range PELDOR derived distance restraints, could docking be successful? This was
the question asked in the last experimentally obtained data driven docking run. From prior
docking runs it was unclear as the number of long range restraints increased whether the
remaining uncertainty was as a result of long range, unambiguous restraints or as a result
of the ambiguous interaction restraints from the NMR experiment. A threshold of one stan-
dard deviation, in the NOE experiments means that 32 % of residues will be considered as
important to binding, which in protein as small as Im9, 28 of the 86 residues will be active to
binding before passive residues are considered.
In figure 8.22.a the statistical summary is presented, notice the difference in scale compared
to previous figures. In this docking run all 200 structures have completed the docking pro-
cedure and have formed into a single cluster. The RMSD of every amino acid's C has been
aligned to the top scoring structure and the RMSD averaged, with each structure having an
average RMSD of less than 1 A from the docking run average structure.
When this result is visually plotted, in figure 8.22.b the result is initially not clear, for this rea-
son figure 8.22.c shows figure 8.22.b rotated approximately 90° clockwise. In these figures
it can be seen that the top 16 scoring structures from this single cluster almost perfectly
overlay, with only slight variation in the loop sections, whilst the central helices can still be
seen even in this line representation of the backbone. Figure 8.22.d removes the reference
structure and optimises the view upon the Im9 solutions to docking.
From this it is clear, in this case, that the ambiguity from using NMR derived ambiguous
interaction restraints is hampering the collapsing of docking solutions to a single solution.
Despite this the location of the Im9 is drastically different to that of the published X-ray
crystallography and NMR structures and
By default, HADDOCK gives equal weighting to ambiguous interaction restraints as it does
unambiguous, in this case the PELDOR derived distances. Clearly a stronger weighting to
the unambiguous restraints would be beneficially. However, this assertation only holds true
in a scenario where there are a sufficient number of distances in place to create a good
model, with fewer distances then maintaining equal weighting would be prudent.
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8.6.11. With a MMM derived restraint
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(a) HADDOCK statistical summary (b) HADDOCK visual summary
Figure 8.23 HADDOCK run with NMR AIRs and colicin E9 DNase S3CIA1-Im9 C23IA1 MMM restraints. a) sta-
tistical summary, open blue circles show a HADDOCK solution structure, closed red circles show cluster
averages with error bars showing the top 4 structures average. b) visual summary in fixed rotation show-
ing the published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin E9 DNase in
grey, Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in black after
structure alignment to the reference structure. Im9s in line format are coloured by HADDOCK score from
blue to red.
Figure 8.23 shows aHADDOCK run usingNMRderived AIRs and anMMMpredicted distance
distribution restraint using the published colicin E9 DNase - Im9 complex (PDB: 2K5X) be-
tween positions colicin E9 DNase S3CIA1 and Im9 C23IA1. The initial purpose of this run
was to investigate whether in silico derived EPR distance restraints could be successfully
integrated into a HADDOCK run and whether these restraints could yield useful data that
could not otherwise be obtained experimentally.
UsingMMMand theNMRcomplex structure (PDB: 2K5X) IA-PROXYL labelswere introduced
to the colicin E9 DNase S3C and Im9 C23IA1 positions at 175 K . The rotamer ensembles
were then used to calculate a distance distribution in MMM before being converted to a
single MMM derived, MISHAP generated distance restraint of 4:10 +0:92−0:30 A.
From visual inspection of the top scoring structures (figure 8.23.b) it can be seen that from
introduction of a single, long range, intermolecular distance restraint the top scoring struc-
tures have collapsed onto a single side of the colicin E9DNase. This however, is on the oppo-
site side of the colicin E9 DNase than the published However, on inspection of the statistics
presented (figure 8.23.a) whilst the spread of RMSDs from the average structure has re-
duced to ~ 2 A the actual distances of all structures have increased from docking without
restraint (as shown in figure 8.11) to between 16 and 18 A. Figure 8.23.b shows a spread
of Im9 positions amongst the top scoring structures, but it is unreasonable to think that the
average structure could be over 16 A away without a significant number of structures being
upon the other side of the colicin E9 DNase. However these structures must obviously be of
a much lower HADDOCK score to not be be presented in the visual summary.
Most importantly, the capacity of MMM derived in silico distance restraints to be used in
MISHAP and passed to HADDOCK has proved to yield meaningful results that were other-
wise not possible to obtain experimentally.
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8.6.12. With MMM derived restraints for all spin labels
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(a) HADDOCK statistical summary (b) HADDOCK visual summary
Figure 8.24 HADDOCK run with NMR AIRs and MMM derived distance restraints between every spin label. a)
statistical summary, open blue circles showaHADDOCKsolution structure, closed red circles showcluster
averages with error bars showing one standard deviation. b) visual summary in fixed rotation showing the
published colicin E9 DNase - Im9 complex (PDB: 2K5X) in cartoon format with colicin E9 DNase in grey,
Im9 in pale cyan. Backbone atoms (N, C, C, O) for the top scoring colicin E9 DNase in black after structure
alignment to the reference structure. Im9s in line format are coloured by HADDOCK score from blue to
red.
Figure 8.24 shows a HADDOCK run using NMR derived AIRs as well as 3 intramolecular and
10 intermolecular long distance restraints from MMM calculation upon the NMR complex
structure. Here IA-PROXYL labels were introduced to the 5 colicin E9 DNase sites and 2
Im9 sites in MMM at 175K . The purpose of this docking run was to conclude whether with
all these docking restraints in place whether there would still be uncertainty in the docking
calculation and if the published structure would be achieved.
In figure 8.24.b it can be seen that despite having all of these restraints from the published
structure themodelling fails to yield the top scoring structures in the same position. Instead
the top scoring structures (blue) are favoured to be at the back of the colicin E9DNase, whilst
a notable amount are located in the previously seen position on top of the colicin E9 DNase.
Figure 8.24.a shows that a great deal of the structures complete the docking process with
over half having a RMSD of less than 8 A from the average structure. None of these struc-
tures score very highly and the cluster averages are shown to have both broad RMSD and
HADDOCK score ranges.
The results here elude to two possibilites. First, the selection of labelling positions was not
appropiate to give sufficient sampling of the protein structures and therefore enough re-
straint in the modelling. Alternatively, the ambiguous interaction restraints from NMR being
given equal weighting to the unambiguous long range distance restraints creates artifically
high levels of uncertainty. These uncertainties yield the possibility of poorly scoring struc-
tures in positions thatwould usually be prohibitive in the initial stages of the docking process.
Additionally, it remains important to remember that colicin E9 DNase is only one domain of
a multidomain, globular protein.
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8.7. Summary and conclusions
In this chapter it has successfully been shown that using experimentally derived long range
distance distributions between spin label sites can effectively restrict docking models. The
extent of restriction varies greatly upon the position and environment of the spin labels in
question.
The colicin E9 DNase E66CIA1 labelling position being almost central within the globular
protein and having restricted movement yielded a sharper PELDOR derived distance distri-
bution. With a narrow range upon the long distance restraint yielded less uncertainty within
the docking models. However, in such a small, globular and largely spherical protein hav-
ing a distance from close to the centre of mass does little to discriminate structures in the
docking process. Of course, when using spin labels placed upon an internal protein surface
the risk of distorting the protein secondary and tertiary structure is greatly increased, and
without careful experiment design could yield many proteins inactive or unable to refold.
Using solvent exposed labelling positions, allows a higher probability of spin label - protein
interaction and as a result makes for greater labelling efficiencies. Using solvent exposed
residues also allows for the protein to be labelled without first having to unfold the protein
chemically with the use of a denaturant. In this study the refolding of the colicin E9 DNase
was carefully monitored using circular dichroism, but not all proteins would allow as such.
The largest cost of using solvent exposed labelling positions is that a far the spin label is typ-
ically much less sterically hindered. This removal of hinderance by the protein itself allows
the spin label much more freedom of movement, which computationally can be calculated
as allowing a larger rotamer population. The additional mobility ultimately is averaged in
the PELDOR experiment as the experiment samples all molecules within the sample, result-
ing in broader PELDOR distance distributions. These broader distance distributions in turn
result in less restriction during docking. However, by placing spin labels upon the protein
surface the risk of distortion to the protein secondary and teritary structure is minimised.
Care must be taken such that the labels do not directly inhibit binding or that key residues
are not mutated away rendering the protein insoluble.
In an idealised situation the protein in question could be roughly approximated as cubic and
a restricted spin label placed upon the eight corners in seperate protein mutants. In this
situation it is easy to visualise the six degrees of freedom in which each cube can be rotated
in x, y or z before translation onto each other. With suitable narrow distance distribution
ranges a unique solution could be quickly and accurately could be found requiring only a
single PELDOR target on the opposing docking partner yielding position and orientation.
The same result could be achieved using less sites if the sites were suitably restricted and
showed suitable orientation dependence (whichmay require higher frequency experiments).
Replacing the cubes with theoretical spheres, with ideal conditions and distances, it should
be possible to define an interface with four distances.
From the final experiments, particularly §8.6.9 and 8.6.10 where the docking procedure was
conducted with all the PELDOR derived distance restraints with and without the NMR de-
rived ambiguous interaction restraints it is apparent that the weighting of each data source
needs to be carefully examined. When both NMR and EPR restraints are combined then the
modelling process completes with many structures adopting a very close position on one
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surface of the colicin E9 DNase but with several site orientation rotations of the Im9. These
structures form many clusters but with low RMSD from each other and crucially there is a
single cluster at less than a RMSD of 2 A from the average structure and comprises 35 %
of all solutions. However, with the removal of the NMR derived AIRs the docking process
reduces to a single cluster comprising all structures with an RMSD of less than 1 A.
The difference between the top scoring cluster of the docking run with AIRs and the single
cluster of PELDOR only derived restraints is slight. When figures 8.21.b and 8.22.b are di-
rectly compared it can be seen in the visualisations that with the AIRs the Im9 sits mainly to
the right and slightly behind the colicin E9 DNase but without the AIRs the Im9 position can
hardly be seen as it is almost directly behind the colicin E9 DNase. The distance between
the Im9 positions is only 9.8 Awhen the top scoring structure from each run is translated in
space. Here the docking run without CSPs is closer at 46.8 A to the reference Im9 position
than with AIRs (68.2 A). Whilst both are in similar range from the reference position, these
values speak little other than to informwhat can be seen visually that the Im9 positions from
modelling are significantly different than the reference structure.
Finally, in this investigation (§8.6.11), it was shown that it is perfectly possible to useMMM to
in silico spin label proteins. This labelling procedure creates rotamer clouds which can then
calculate an expected distance distributions for a PELDOR experiment, subject to variations
in the protein and rotamer populations. Using the computing toolbox developed in this in-
vestigation these predicted restraints could be incorporated as long distance restraints and
docking parameters in the same way as experimentally derived restraints.
Careful consideration of computed parameters should always be used as the simulation
will only ever be as good as the information that is fed into it. In this instance, the proteins
are considered to be rigid bodies and each rotamer is assumed to be largely equally popu-
lated. Obviously, proteins are not fixed in space and routinely undergo molecular breathing,
conformational exchange as well as structural rearrangement upon docking.
In the final docking run (§8.6.12) it was hoped that with the use of idealised long distance re-
straints from MMM, including several of which could not be obtained experimentally, would
restraint the model sufficiently to obtain the reference complex from which the distance
restraints were calculated. The result of this docking procedure generated a rather ambigu-
ous picture which echoed many of the previous docking runs. Statistically none of the final
structures scored very well, with nine clusters - each with a varied spread of scores and
RMSDs. On visual inspection of the better scoring clusters a clear split of populations is
seen between the Im9 sitting on the right and slightly behind and on top of the colicin E9
DNase (in the reference orientation). These positions almost identically match those seen
when the docking was conducted with experimentally derived distance restraints. This al-
lows for a conclusion to be drawn that the curious nature of placing the Im9 in the right and
top positions is as a result of the docking procedure and not the experimental data. In fact,
the position of Im9 to the right of the colicin E9 DNase appeared even in the first HADDOCK
run where no restraints of any sort were used, appearing in figure 8.10.b as the red/orange
cluster. Clearly this surface of the colicin E9 DNase contains residues that are energetically
favourable to be hidden fromwater. Im9 appearing on top of colicin E9 DNase also appeared
early in the investigationwhen in figure 8.11.b, using only NMRderived AIRs, the Im9 position
was clearly split between the reference position and on top of the colicin E9 DNase.
As a result then, it can be assumed that the top position of the Im9 in relation to the colicin
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E9 DNase is as a result of the docking procedure's use of the AIRs. Whilst the right position
is energetically favourable enough to occur in almost each docking run, especially in those
runs where the long range distance restraints are not sufficient to discriminate and exclude
it.
At this time, HADDOCK only provides the facility to turn on or off ambiguous or unambiguous
restraints at each stage of docking. So that, for example, ambiguous results could be used
during rigid body structure generation and then only unambiguous restraints are used during
energy optimisation to discriminate models. This is not the same as having both restraints
present but unambiguous restraints favoured. Nor is there a way to specify the tolerance of
AIRs, so that AIRs could be abused if a favourable unambiguous restraint is nearly fulfilled.
However, in each docking run a user definable fraction of AIRs are randomly deleted (20
% by default) to assist in ensuring random sampling. If this fraction of randomly deleted
restraints was increased, with the docking process repeated several times from different
initial seed values and results combined in some way then this could perhaps provide an
inelegant solution.
Using only NMR derived AIRs of the final 200 structures calculated by HADDOCK there was
a near 50% split in structures between 2 sites upon the surface of the colicin E9 DNase.
That in which the Im9 directly inhibits the colicin E9 DNase activity by binding directly to
the DNase activity region. Alternatively, that in which the Im9 approaches from behind the
DNase activity region but could cause some conformational rearrangement and inhibit the
DNase activity flexible region from binding DNA. It was hoped that with the introduction of
increasing number of long distance restraints that one population would be increasingly
favoured over the other. Instead, as a result of the poor spin labelling, poor PELDOR traces
were obtained, which translated into poor and broad distance distributions. Rather than dis-
criminating between the two Im9 binding positions, thismodelling would suggest an entirely
different site.
It is key to remember that in this docking we consider both binding partners to be rigid, solid
bodies. In reality, the colicin E9 DNase domain in solution is shows enough intrinsically dis-
ordered character and dynamicity to stop the elucidation of its three dimensional structure
by NMR. A X-ray crystallography structure of the colicin E9 DNase was obtained in 2000
(1FSJ) using conditions far from that found in vivo, whilst it does align well with complexed
colicin E9 DNase structures, recent studies would suggest that this level of structure is un-
likely in solution [43] with the structure arising as a result of crystal lattice stabilisation. The
crystal structure (1EMV) is that of cocrystalised colicin E9 DNase / Im9 complex, whilst the
NMR structure (2K5X) was collected and assigned in complex. The binding event then, with
such a strong dissociation constant, must coincide with a massive conformation change in
the colicin E9 DNase. It is reasonable then to assume that the colicin E9 DNase structure is
induced by and forms around the Im9.
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9.1. Protein production
When the investigation began, the vast majority of DNA work was thought to be already
available after years of extensive investigation of the colicin E9 DNase system by NMR and
X-ray crystallography groups at UEA. Unfortunately, much of the DNA stocks had been badly
maintained and contaminated, resulting in several frame shifts whichmade a practical solu-
tion of fixing the genes with primers and PCRwork impractical. Wherever possible DNAwas
sought fromsite active colicin research groups at the Universities of Nottingham, Oxford and
York such that as many genes as possible in the investigation would be derived from natu-
rally occuring gene. These groups, despite their generousity, did not have the desired genes
or themselves only had copies of the contaminated genes from UEA.
Rather than attempting a time consuming and costly site-directed mutagensis approach
beyond the focus of this investigation and available facilities a synthetic gene approach was
chosen. Here a desired protein has the amino acid sequence reverse translated into a simple
DNA sequence, with certain optimisations made for species, codon usage and G/C content.
The DNA is then produced in an oligonucleotide synthesis with appropiate ends to ensure
the correct reading frame and insertion into a vector. The synthetic genes arrived delivered
in a suitable cloning vector within 2 weeks of order at a financial cost comparable with DNA
primers, cloning vectors and restriction enzymes. As the genes were being synthesised fully
the codons could be optimised for maximum protein expression in an E. coli expression
strain. In the case of the colicin E9 DNase S3C/S80C and S30C/S80Cmutants, the resulting
protein expression yielded excellent results, yet the whilst the naturally derived colicin E9
DNase S30C and S80C mutants barely expressed any significant amount of protein.
The constructed geneswere designed such that they either the protein themselves or the co-
expression partner contained a poly-histidine tail. Purification using an immobilised metal
ion chromatography method proved a successful way of separating the protein of inter-
est from the cell lysate, with only very minor contamination. A polishing purification step
was completed using size exclusion chromatography to ensure a high quality final product.
During size exclusion chromatography in the case where cysteines were highly solvent ex-
posed, the necessity of using a gentle reducing agent to stop the formation of protein-protein
homo-dimers was apparent.
Each purified proteinwas subjected to several tests to confirmboth its identity and ensure its
suitability for further investigation. Spectrophotometry confirmed protein concentration by
measuring the absorbance of light at 280 nm. Circlular dichromism confirmed the proteins'
major secondary structure features as well as confirming that the protein had folded cor-
rection, especially important later in the spin labelling of somemutants. Mass spectrometry
confirmed the proteinmass in the gas phase. Fluorescence enhancement assays confirmed
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that the colicin E9 DNase was indeed binding to Im9 in both naturally and synthetically de-
rived mutants of both proteins. Finally enzymatic assays were performed to confirm the kill
ability to the colicin E9 DNase molecules, as well as the ability of the Im9 mutants to inhibit
the action of the DNase activity.
As a result of many months hard work, 2 mutants of naturally derived Im9 were produced
in high yields (C23, S6C/C23S), 1 synthetic mutant of Im9 (S6C) was produced in moderate
yield, 3 naturally derived colicin E9 DNase mutants (S3C, E66C, D20C/E66C) were produced
in high yields, 2 synthetic mutants of colicin E9 DNasemutants (S3C/S80C and S30C/S80C)
were produced in high yields and 2 synthetic mutants of colicin E9 DNase mutants (S30C
and S80C) were produced in poor yields.
9.2. cw-EPR
The process of spin labelling proteins was to use a slow and methodical approach to try to
find the best labelling yields. It was known that any mutant moving forward to PELDOR ex-
periments would require high labelling efficiencies as 2 proteins at 90 % labelling efficencies
yields 81 % (0:92) of protein complexes contributing to the PELDOR signal. Whereas a com-
plex of proteins with 10 % labelling would yield 1 % (0:12) of those complexes contributing
to the signal.
The spin labelling investigation tested multiple pHs, in aerobic/anaerobic environments, at
multiple labelling concentrations, for various times, at different temperatures, with andwith-
out a reducing agent, with 2 different spin labels (MTSL and IA-PROXYL) and using three
different seperation methods (PD-10 columns, Amicon stirred cells and spin concentrators
(must use Hydrosart membrane, not polyethersulphone as colicin E9 inversibly binds to it)).
Despite all of this, labelling efficiencies were still lower than would have been desired. For
most mutants the labelling efficiencies of greater than 15 % were achieved, when before
optimisation a 1 % labelling efficiency was typical.
The largest problem that was encountered in spin labelling was the proteins themselves.
The proteins used in this investigation are relatively small, globular proteins and due to their
tight folds it was deliberately avoided to place spin label sites on the inside of the protein -
with the exception of the colicin E9 DNase D20C and E66C positions that are inside a small
pocket. It was also expected that by placing spin labelling targets in solvent exposed posi-
tions would allow access of free spin label to react with the exposed cysteine side chains.
However, in such small, globular proteins exposed cysteines allowed the spontanious for-
mation of homo-dimers. The only way to remove the disulphide linked homo-dimers was
with the use of a reducing agent, but this reducing agent would indiscriminately reduce the
cysteine - spin label bond that was being attempted to be formed by the MTSL. Alternative
stratergies such as very low protein concentrations thereby minimising protein-protein in-
teractions, anaerobic environments to minimise oxidation of formed disulphide bonds, pH
shifts to move the reaction equilibrium, reaction time and reaction temperature did little to
increase the labelling efficiency with MTSL. IA-PROXYL with its iodo leaving group however,
reacts with the exposed cysteine sulphur atom in a non-reversible manner and greatly in-
creased the labelling efficiency. The IA-PROXYL spin label also merited special attention
as the labelling efficiency was independent of oxygen and yielded 90 % reaction completion
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in one hour on the laboratory bench. It could also be used safely in a ten molar excess to
the protein to encourage the labelling reaction without unspecific binding to the protein and
washed away quickly as it passed through spin concentrator membranes.
Accessibility / power saturation experiments showed that the expected colicin E9 DNase
S3C and S30C and Im9 C23 labelling sites which are highly solvent exposed in both X-ray
crystallography and NMR structures were greater than 60 % solvent exposed. The expected
internalised site, such as that of colicin E9 DNase E66C position showed less than 3 %
aqueous accessibility. These accessibility measurements worked well to confirm that the
spin labelling positions matched well with how they were expected to behave from previous
structural studies, indictating that the protein production and spin labelling procedures were
successful.
When the power saturation experiments were repeated in the presense of the complex bind-
ing partner the accessibility values did not change by any significant amount and in doing so
proved that each labelling site was indeed away from the binding interface. Equally, low tem-
perature line broadening experiments were attempted but showed no dicernible broadening
of the centre peak, indicating that the labels were at least 16 A apart in the complex, agreeing
with the NMR and X-ray crystallography structures. Had the colicin E9 DNase D20C/E66C
double mutant expressed and labelled successfully it would have been a good candidate
for seeing line broadening effects and in doing so allowed this investigation to incorporate
two different EPR derived distance restraints. Continous wave line broadening for distances
under 15-20 A and PELDOR for distances in the 15-80 A regime.
9.3. Pulsed EPR
Time was spent in optimising every conceivable parameter to ensure the greatest possible
transverse relaxation time required to keep spin coherence and maintain the longest pos-
sible observation window for PELDOR oscillations. Strong spin coherence also yields large
signals which maximises the signal to noise ratio and reduces the required experiment time
to achieve a good quality of data.
Simultaneously, a compromise was sought to maintain the shortest possible spin-lattice
relaxation time. Such that the shot-repetition, the time inwhich the systemwaswait until it is
fully relaxed andmagnetically at equilibriumbefore it can be pulsed again, is kept low thereby
minimising experiment length. In any investigation this optimisation is prudent. However,
in this investigation with so many PELDOR experiments to be conducted an optimisation of
a few hours per sample would quickly multiply. Additionally, from the cw-EPR investigation,
the protein concentrations and labelling efficiencies were known to be very low and little
above the detectable limit of the spectrometer. In order to obtain data of any significance it
was known from the outset that optimisation herewould be crucial to avoid huge experiment
times from the required amounts of signal averaging.
Using a two pulse ESEEM pulse sequence to report the transverse relaxation time and an
inversion recovery sequence to report the spin-lattice relaxation time, temperature was the
first parameter to be optimised. Using a liquid helium flow cryostat samples from 4K were
tested until no further echo could be detected.
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The transverse relaxation time showed a maximum at 4 K , with signal still being recorded
after 1 s. As the temperature increased, so did the relaxation time in a linear fashion. At
30 K the transverse relaxation time remains at 94 % of that seen at 4 K. Rising further to
50K sees the relaxation time drop to 86 % of that at 4K , this is still a strong signal but the
observable window had reduced by 100 ns. At 90 K a phase transition between ice states
caused a large absorption of energy which generated an anomalous data point upon fitting.
Across this same range the spin-lattice relaxation sees a near exponential decay in length.
At 4 K the spin-lattice relaxation stands at nearly 5.5 ms, at 30 K this has reduced to less
than a third of what it was at 4 K to 1.4 ms. At 50 K the spin-lattice has reduced to a
quarter of that seen at 4 K. No further data points could be recorded above 90 K as the
signal became so weak.
As a result of these experiments a compromise was struck at 50K between having a strong
signal with a reasonable transverse relaxation time and having a reasonably short spin-
lattice relaxation time. Had time been an infinite resource or the signal from the sample so
strong as to require only a few scans then 4 K would have been used. Working at temper-
atures above 50 K would have been impractical as the spin coherence time would start to
become so short as to not give a sufficient window in which to observe dipolar oscillations
in the PELDOR experiment.
The pH of the protein was shown to have little bearing on the experiment in terms of the
transverse relaxation time, though a small maximum is seen around pH 7.5. As the cytosolic
pHof E. coli is 7.6 and the optimumconditions for colicin E9 activity is pH7.4 an experimental
pH of pH 7.5 was considered an acceptable compromise between biological relevances and
spectroscopic desirability.
The deuteration assay showedanalmost exponential increase in transverse relaxation times
with deuterium composition of the buffer. Whilst some quirkswere found here due to a com-
plex mix of different relaxation methods, hyperfine interactions of protons and deuteron ES-
EEM, ultimately the greater the level of deuteration the better. As a result all protein samples
were concentrated in deuterated buffers such that all labile protons were exchanged. This
simple exchange of buffers increased the transverse relaxation time by 300 ns from 500 ns.
One of the greatest increases found to the transverse relaxation timewas found in the use of
a glass forming agent. Glyercol interupts the hydrogen bonding network of water and, when
frozen quickly, stops the formation of crystaline ice - instead forming a glass. Physically
this glass behaves more like a very slow moving liquid than a solid and crucially removes a
large proportion of the crystal lattice and with it one of the major spin diffusion pathways.
With a reduced crystal lattice, the energy and spin coherence lost by spin-lattice relaxation
is greatly reduced. The glycerol also increases the viscousity of the solution, which at a
given temperature greatly reduces the molecular tumbling time (correlation time). Even the
small addition of 10 % glycerol increased the transverse relaxtion time from 2.77 to 3.71
s. With further additions of glyercol the transverse relaxation time increased further but
at a much reduced rate. It was decided that in future samples that 50 % glyerocl would be
used. Working with high glyercol concentrations is difficult as it requires that the protein
be concentrated to very high levels nearing saturation before being added to the glycerol
or require the difficult process of resuspending freeze-dried protein in glycerol. The high
viscosity solutions associated with high glyercol concentrations also generate sample han-
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dling problems when requiring small volumes to be accurately measured and placed inside
narrow bore sample tubes.
The use of glyercol meant that the whilst the sample would now no longer form a large
crystal lattice structure, it was now no longer completely deuterated. The effect of glyercol
deuteration in both protonated and deuterated solvents was tested for completeness.
In protonated solvent environments the addition of glyercol increased the transverse relax-
ation time, with increased deuteration levels of the glycerol, with the relaxation time doubling
from approximately 3 s between no glycerol and 50 % glycerol-d8. Most impressive in this
investigation was the dramatic effect of a fully deuterated sample of deuterated solvent and
50 % glycerol-d8 which increased the transverse relaxation time from approximately 3 s to
22 s (a 7.8 increase). It was concluded that the additional cost associatedwith deuterium
oxide and glycerol-d8wasworth the increased gain in signal. However, themain contribution
to relaxation was now deuterium ESEEM and not proton hyperfine. The deuterium ESEEM
modulations are approximately 500 ns in period and have a huge range in signal intensity
which require careful consideration in setting up the PELDOR experiment to ensure that the
observation is made upon a ESEEM modulation maximum.
It was found that a small increase could also be gained by taking the flash frozen sample and
raising it in temperature to just below the glass transition before a slow drop in temperature.
This resulted in a better glass being produced within the test tube with even less crystal
characteristic, but the additional time required in warming and slowly cooling the sample
again was decided against as the time could be better spent on signal averaging.
Finally a small investigation into pulse length was conducted to see whether short, high
power hard pulses would yield a better signal than longer, soft pulses of greater length. It
was found that longer pulses yielded longer transverse relaxation times as a result of amuch
greater signal intensity. However, this increased signal came with at a cost as the spin echo
increased in spectral width, in the case of a 72ns /2 pulse the echo increased to over 300ns.
Intergrating over the entire echo yielded a large signal, but the spins show weak coherence
to each other and would prove difficult when introducing more pulses as in the four pulse
PELDOR sequence. Particularly, in the PELDOR experiment only a small part of the echo is
integrated over to ensure minimal spin orientation dependence. Integrating over only the
central 12 ns of the echo showed that using hard echoes and the resulting narrow echo of
around 150 ns gave greater signal.
Equally moving to very short pulses meant that the spectrometer was unable to provide
sufficient power to move the entire spin population. As a result with only some spins being
correctly moved into the xy plane, with most still somewhere between the z axis and xy
plane after the /2 pulse, the detected echo was very weak and even distorted the deuterium
ESEEM modulations seen in the decay. A compromise was made by using 16 ns /2 pulses
as this gave an additional 300 ns to the transverse relaxation time over a 10 ns /2 pulse (the
shortest pulse without distortion) whilst still giving a sharp echo of full width 140 ns.
With all of this optimisation the colicin E9 DNase S3CIA1 transverse relaxation time was
increased from 0.45 s in water at 50 K , to 2.37 s in D2O / glyercol-d8 at 50 K , a 527 %
increase. At the same time, themaximumspin-lattice relaxation timewas 5.51ms (recorded
at 4 K), was reduced to 3.81 ms by increasing the temperature and addition of a glassing
agent, a decrease of 31 %.
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The increased transverse relaxation time allowed for a suitable dipolar observation window
in the PELDOR experiment. The optimisations also allowed the PELDOR experiments to
be reduced to a reasonable time frame of approximately 24 hours per sample, with some
samples requiring 48 hours of signal averaging.
Ultimately, many of the PELDOR experiments are of very poor quality and low signal to noise.
Unfortunately a number of less than ideal factors combined to cause issue with the experi-
ment. First the low protein concentrations required to stop protein precipitation meant that
no concentrated protein solutions could be made from which the EPR samples are usually
made. Without these concentrated samples after mixing of two protein samples and addi-
tion of glyercol the protein concentration was further reduced. Any attempt at protein con-
centration, after purification, spin labelling or buffer exchange into deuterated solvents re-
sulted in huge losses of protein as the protein precipitated against themembrane. A change
of membrane material to Hydrosart helped, but concentrations were forced to be kept low
and any concentration had to be conducted at a low spinning speed.
Second, the often poor spin labelling efficienciesmeant that whilst the protein concentration
may be approximately 100 M the amount of protein molecules that were contributing to
the EPR signal were significantly less. In the case of the Im9 samples the C23 positioned
labelled with only 5 % efficiency, so even with 100 M protein the effective sample concen-
tration seen by the spectrometer was 5 M . This problem is amplified when the PELDOR
experiment will only show dipolar oscillations from complexes where both proteins are la-
belled. In the case of the colicin E9 DNase S3CIA1 (33.6 %) with Im9 C23IA1 (5.3 %) only 1.8
% of the sample will be contributing to the dipolar oscillations whilst the remaining 98.2 % of
the sample is unused or worse contributes to the background only hiding the desired dipolar
oscillations.
As a result of these factors long experiment times with huge signal averaging were required
often before anything could be seen and even then the dipolar oscillations were often only
just detectable from the background decay. Through careful analysis and background sub-
traction of the data, most experiments could yield some information. Far fewer experimen-
tal intermolecular distance restraints were obtained than had been hoped for, and fewer still
were of the desired quality.
The quality of any modelling is a direct result of the parameters initially given. With such
poor quality of data and often ambiguous distance distributions spanning almost 2 nm, the
suitability of the experimental data was of constant concern. In proteins of less than 6 nm in
diameter, a distance restraint of range 2 nm seemed hardly informative. Nevertheless, the
only way to test such these constraints was to conduct the docking regardless.
9.4. Docking methodology
HADDOCK has one of the largest user bases of any biomolecular docking programs in the
world and has constantly performed well in blind test evaluations [26]. Its design was origi-
nally for systems where high ambiguity is common such as in NMR experimentation, but it
was also built with inherent flexibility to accept data from various sources both experimental
and computational.
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In order for HADDOCK to perform docking with EPR restraints, two approaches were re-
quired. First, in the PELDOR experiments conducted in this investigation the dipolar coupling
measured is a vector between paramagnetic electron spins. These paramagnetic sources
were introduced through the use of spin labels which do not occur naturally in the protein.
Instead, the spins are located upon the nitroxide of a spin label that has been covalently
attached to a cysteine residue.
Here two approaches could be used. Using a detailed rotamer analysis of each of the spin
label sites an attempt could be made to convert the vector between electron spins on the
N-O bond of the nitroxide into a distance between Cs on the protein backbone. This long
range backbone distance could then be introduced into HADDOCK inmuch the sameway as
any other distance restraint. The disadvantage of this method is that careful analysis of the
rotamer ensemble requires a lot of processing power and detailed information of the three
dimensional environment about the spin label site to accurate calculate theC-C distance.
This calculation without huge amounts of supercomputer time would also likely be limited
to considering the area within a narrow area around the spin label and consider all atoms
except the spin label in that space as fixed points in space. Also there would be no way
of telling whether the C-C distance would remain valid as HADDOCK allows backbone
flexibility in later docking steps.
In the second approach, MMM is used to generate a rotamer cloud at the spin label site us-
ing knowledge of the entire protein (still as a rigid body), with some calculation as to which
rotamers will likely be the most populated. The resulting MMM rotamer file could be taken
with the most populated rotamers being merged with the protein coordinate file to generate
a protein coordinate files where the spin label present in one of the many rotamer positions.
These merged files are exported in a compatible HADDOCK format, and using HADDOCK's
inbuilt ensemble functionality each rotamer could be loaded as a model of an ensemble.
However, HADDOCK would require additional parameters such that new spin-labelled cys-
teine residues would be accepted as allowed amino acid residues. These parameters woud
require complete definition of every atom, bond length, bond angle, bond rotation and charge
for each spin labelled residue. With HADDOCK now able to recognise and work with spin
labelled residues, the PELDOR derived vector could be introduced as a distance between
atoms upon the spin label. Combination of the initial ensemble of rotamers for the rigid body
docking with nitroxide sidechain chracteristics as well as inter-nitroxide distances would al-
low HADDOCK to optimise the distance restraint at every stage of docking. All that would
remain is to convert the distance distributions fromEPR experiments into distance restraints
compatible with HADDOCK.
It was decided that the second approach would be computationally less demanding as well
as give more representative docking. The first approach requires simulation of complex
parameters to give a distance unrelated to that seen experimentally. These calculations
would then be fed into a second calculation where the rigidity and isolation of atoms in
the first calculations would be removed and flexibility allowed to the whole system in the
second calculation process. In the second approach, a set of likely protein structures are
given - which are nothing more than slightly editted original protein coordinate files, as well
as a distance restraint between atoms reflecting an experimental observation. The docking
calculation then proceeds allowing rotamer rotation, backbone flexibility and conformational
rearrangement whilst maintaining the experimentally observed distance restraint.
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Graphical user interfaces were generated for both the spin labelled protein generation and
the conversion of PELDOR derived distance distributions such that future compatibility with
users with little experience with coding could use this methodology.
WithHADDOCK suitably prepared for spin labelled proteins andPELDORderived distance re-
straints docking could be conducted. The investigation showed the various resulting dock-
ing solutions when various degrees of restraint were applied. From absolutely no restraints,
to ambiguous restraints from NMR titrations, to fully restrained models using multiple PEL-
DOR derived distances.
With increasing restraints, it was shown that the sample space of each docking run reduced
to an extent where the final 200 structures after energy minimisation collapsed to a single
solution with an RMSD of less than 1 A. The final docking model, using only EPR restraints,
showed a different docking site upon the surface of the colicin E9 DNase than in the pub-
lishedNMRand X-ray crystallography structures. The site of Im9 bindingwas still very close
to theDNase activity region of the colicin E9DNase but distinctly different. With the inclusion
of NMRAIRs and EPR restraints the previous site was still by far preferential, in terms of total
energy and docking score, but the published docking site could be seen in the structures of
other clusters.
Despite the large experimentally derived dissociation constant of the colicin E9 DNase / Im9
complex (9.310 17 M ), the docking procedure here reports time and time again a better
scoring site upon the opposite surface of the colicin E9 DNase than published NMR and
X-ray crystallography structures. In fact this site came out scoring well in the very first
HADDOCK runwhenno restraintswere used at all. This is not to say that the docking process
here is wrong, as with all modelling, the resulting model is only as good as the data that is
passed into it. In this case the startingmaterial was a rigid, folded structure of the complexed
colicin E9 DNase that had been seperated from Im9 computationally in vacuo.
Colicin E9 DNase is a protein that has been shown to be intrinsically disordered in solution
[43]. This disorder is required for the colicin E9 to cross through the small OmpF pores in the
target cell's cell membrane, a pore so small that aromatic amino acids are almost too large
to pass through [22]. It is naive to think that an intrinsically disordered protein would spon-
taneously fold and form a rigid teritary structure, before complexing with a binding partner,
especially given the cytotoxic nature of the protein in question. It is more likely then that a
small region of a few amino acids, likely within the flexible region of residues that contain the
key DNase activity residues of the H-N-H motif, first bind the Im9 with the remaining colicin
E9 DNase structure forming about the contact site. The associated protein folding and drop
in enthalpy likely creates an artifically high dissociation constant. This is confirmed to some
extent in the literature where despite the avidity of the interaction the binding of colicin E9
DNase has only a marginal effect on Im9 [40]. If it is the case that the colicin E9 DNase folds
around Im9 then the fact that when NMR AIRs are maintained in the docking calculations
the published structure is still found is impressive.
Of course, in this investigation we are also considering the DNase domain of colicin E9 to be
representative of the domain within the full length protein. When the X-ray crystallography
structure of the colicin E9 homology model, colicin E3 bound to Im2 is considered (shown
in figure 9.1) the immunity protein can clearly be seen it site inside a pocket of the colicin
E3. The translocation domain (black) appears to largely be unaffected by the presense of
the immunity protein and remains globular. The cytotoxic domain (grey) has a long flexible
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Figure 9.1 Comparison of colicin E9 DNase to the homology model colicin E3. On the left is the NMR complex
structure of colicin E9 DNase (in grey) bound to the cognate immunity protein Im9 (in cyan), shown in
the same orientation as earlier chapters (PDB 2K5X). On the right is the X-ray crystallography structure
of the full length colicin E3, used as a homology model for the full length colicin E9, bound to the non-
cognate immunity protein Im2 (PDB 1JCH). The colicin E3, cytotoxic (ribonuclease) (C) domain is shown
in grey (matching the colicin E9 DNase), the receptor (R) domain is shown in white and the transloaction
(T) domain in black. Im2 is shown in cyan. Both proteins are scaled equally.
Figure 9.2 Colicin E9 DNase and Im9 complex structure from NMR (PDB 2K5X) has been superimposed onto
the X-ray crystallography derived homology model colicin E3 structure (PDB 1JCH). Here the colicin E3
homodimer bound to the non-cognate immunity protein Im2, has had the colicin E3 ribonuclease domain
and Im2 hidden. The colicin E9 DNase domain has been aligned using a RMSD minimisation routine to
an average C distance of 0.56 A. The NMR complex structure of colicin E9 DNase (in grey) bound to the
cognate immunity protein Im9 (in cyan), is shown in approximately the same orientation as all previous
docking figures. Colicin E3, bound to the non-cognate immunity protein Im2 has the receptor (R) domain
shown in white and the transloaction (T) domain in black.
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linker to the receptor domain (white) and wraps around the immunity protein. Alignment
between these models is difficult, and visually messy, due to the smaller size and sequence
diversity in the domains of colicin E3 ribonuclease domain compared to the colicin E9 DNase
and Im2 compared to Im9.
When the colicin E9 DNase domain is superimposed upon the colicin E3 structure, as shown
in figure 9.2, the docking solutions becomemore obvious. In this figure the colicin E3 bound
to Im2 has been used as a reference structure but the colicin E3 ribonuclease domain and
Im2 have been removed. The colicin E9 DNase has been aligned using a RMSDminimisation
procedure to place the colicin E9 DNase domain in the position of the colicin E3 ribonuclease
domain. This model is not flawless, as there is now a small pocket above the Im9 which
would likely cause the colicin E9 DNase domain and Im9 tomove up and closer to the colicin
E3 receptor domain (black). The figure is displayed in the same orientation as the reference
structure used to display the protein-protein docking chapter results. In this orientation, it is
clear that the docking results that place the Im9 to the right and slightly behind the colicin E9
DNase domain would not exist without steric clashes to the receptor domain of the colicin.
Equally the docking results that place the Im9 on top of the colicin E9 DNase could not exist
in the full length versionwithout steric clashes to the translocation domain of the colicin. It is
not unreasonable to think that these surfaces have residues which are designed to interact
with the other colicin domains and maintain the colicin tertiary structure. It is likely then
that these residues are sampled during the docking process and during energy calculations
behave favourable when not exposed to water.
Somewhat peculiarly, maintaining NMR AIRs gave less certainty in the final model than an
EPR constraint only docking calculation. From the HSQC experiment, a suprising number of
residues showed significant perturbation resulting in an extensive AIRs list, far more than
would be expected for proteins of this size. The decision to take residues beyond one stan-
dard deviation from the mean is an arbitrary one. By using one standard deviation results in
32 % of the molecule being considered as active to binding before passive residues are even
considered. In the case of Im9 28 residues are defined as having greater than one standard
deviation from average CSP, in such a small molecule a large number of these will be solvent
accessible defining them as active residues to binding. Referring back to figure 8.1 (page
141) it can be see that Im9 has active residues acrossmost of the protein. Colicin E9 DNase
shows active residues much more to one side of the protein. If the threshold was raised, to
2 standard deviations for example, only the key residues would be used in formation of the
AIRs, making the ambiguous interaction restraints much less ambiguous. With less ambi-
guity the docking results may lose some of the lower scoring structures away from themain
scoring clusters.
9.5. Outlook
This investigation has conclusively shown that EPR derived distance restraints can be used
to restrain dockingmodels and presents a practical user interface for the use of the nitroxide
spin labels MTSL and IA-PROXYL with the docking program HADDOCK.
From a programming perspective MISHAP could easily be expanded to facilitate other ni-
troxide spin labels such as TOAC, TEMPOL and PYC derivatives, common paramagnetic
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metal cofactors such asMn2+, Fe2+, Co2+, Ni2+, Cu2+, paramagnetic structures such as
Fe   S clusters or even newly developed nucleotide labels for measurement of distances
in DNA or RNA binding proteins. Greater integration with MMM has also been designed but
as yet not implemented, such that users could send structures created in MMM directly to
MISHAP for exporting to HADDOCK without having to seperately save the PDB and rotamer
files.
From an experimental view, having more spin labelling sites across the complex and hav-
ing each site label efficiently would allow for a more accurate mapping of docking to be
built. With increased labelling efficiency, would come PELDOR traces with far better signal
to noise ratios with clear dipolar oscillations. These higher quality PELDOR traces would
have far greater certainty and likely yield better resolved distance distributions and in turn
better docking restraints. With more labelling positions it would allow a detailed investiga-
tion into the exact number of intermolecular distances and the ideal locations that are re-
quired to establish a well resolved docking model. Careful selection of the sites could have
also allowed a comparison between solvent accessibility (and therefore label rigidity) and
distance distribution broadening; in the current investigation only two environments, that of
fully solvent exposed and solvent hidden, were available and with the labelling efficienies as
they were little could be distinguished.
Biologically, the project still has much scope for expansion. Collaborators at the University
of Oxford have DNA constructs for full length colicin E9 and are routinely generatingmutants
for X-ray crystallography and mass spectrometry investigations. A small amount of protein
was provided in the course of this investigation corresponding to full length equivalents of
colicin E9 DNase S3C, S30C and S80C. Unfortunately, the samples provided proved to yield
little more than cw-EPR spectra, as once again the protein concentration and labelling effi-
ciencies inhibited any PELDOR experiments. However, a PELDOR investigation into the full
length colicin E9 would yield useful information. Currently, it is accepted that the DNase do-
main is an accurate model of the full length colicin E9 in terms of interaction and binding to
immunity proteins, however as no full length colicin E9 has yet beenmade publicly available,
it cannot be certain.
As the proteins used in this investigation are small with only a single naturally occuring cys-
teine upon the Im9 the spin labelling could be greatly improved by moving to a cell-free pro-
tein expression system. In these systems the desired gene is placed into a reaction vessel of
cell extract that contains the energy source, cofactors and organelles required to generate
simple proteins. As each amino acid is placed individually into the reaction vessel the spin
label could be added to free cysteine before being added. With careful preparation, it could
be that all cysteines added to the reaction vessel are already spin labelled. Thiswould ensure
that all protein synthesised has a 100 % labelling efficiency. The limitations of this method
are the initial cost of the required equipment and the relatively small batches of protein that
are produced. However, the typical protein production yields are enough for an EPR sample
and a typical cell-free expression system takes one day to produce the protein, requiring
only a very simple one step purification process.
The initial hope for this investigation was to establish a protocol for docking proteins on
an established system where the outcome was known by both X-ray crystallography and
NMR. With an established and tested protocol then the methodology could be extended to
non-cognate colicin-immunity protein interactions. Im2, Im7 and Im8 are known to bind
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and inhibit colicin E9's biological activity, just with a much reduced dissociation constant.
Likewise, Im9 can give cross-protection to other E-group colicins. By generating a few cys-
teine mutants for each E-group colicin and immunity protein the structures of tens of non-
cognate complexes could be solved using only a few weeks of PELDOR experiments and
existing NMR structures.
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10.1. General techniques
10.1.1. SDS-PAGE
Asodiumdodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) ismade of two
parts; a running and a stacking gel. The running gel was made by mixing 15 % acrylamide
(7ml) with 10 % ammonium persulphate (AMPS) (700 l) and N,N,N’,N’-tetramethylene di-
amine (TEMED) (70l), which was mixed then poured between BioRad glass plates and al-
lowed to polymerise and set. This gel was topped with ethanol to ensure a flat surface. The
stacking gel was prepared by mixing 5 % acrylamide (5 ml) with 10 % AMPS (50 l) and
TEMED (3 l). The ethanol on top of the running gel was removed once the gel had set and
the stacking gel was then poured on top. A Teflon comb was added to the stacking gel and
allowed to set. The BioRad glass plates and gel within were moved into the running tank
and filled with running buffer (12.1 g Tris base, 17.9 g Tricine, 10ml of 10 % SDS, ddH2O to
a total volume of 1 l). Upon removal of the Teflon comb from the gel wells were produced,
approximatel y 15 l in size, giving the origin of the lanes. Protein samples (10 l) were
combined with 2×SDS loading buffer (10 l) (100 mM Tris-HCl, pH 6.8, 20 % glycerol, 4 %
SDS, 0.2 % bromophenol blue, 200mM dithiothreitol) and the protein denatured by heating
on a mantle (95 C , 5min). Samples (10 l) were then loaded into the wells of the stacking
gel, ensuring that one well was left empty and later filled with lowmolecular weight markers
(10 l) (Sigma-Aldrich, 66, 45, 36, 29, 24, 20, 14.2 kDa). Electrophoresis was run at 200 V for
approximately 1 hour until the visible bands had progressed to the bottom of the gel. The
gel was stopped and removed from the BioRad glass, before being stained in Coomassie
Brilliant Blue (1 hour), before being placed in destainer (25% methanol, 10% glacial acetic
acid). When sufficiently destained the gel was visualised using a standard PC scanner.
10.1.2. UV/Vis Spectroscopy
Optical densities of 1 ml protein samples were measured at 595 nm using a PerkinElmer
Lambda Bio+ photometer. When used in conjunction with a LB broth blank, taken from the
reading, concentration was calculated using the Beer Lambert Law:
Optical density = " c l (10.1)
Where " is the extinction coefficient, c is the concentration and l is the path length of the
sample.
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10.1.3. Dialysis
Dialysis is conducted to gradually lower the salt concentration of a solution, thereby desalt-
ing protein solutions. In Gdm solutions this results in refolding the protein back to native
conformations. Dialysis was conducted by placing the protein solution elutant from the
affinity chromatography inside Thermo Scientific SnakeSkin Pleated Dialysis Tubing (3500
Damolecular weight cut off) (catalogue number 68035) (1 cm tube for approximately every
3.5ml), and sealing the ends before adding to dialysis buffer (5 l) (5mM EDTA). The dialysis
buffer is advantageous as the EDTA also acts as ametal chelator removing any excessmet-
als that could shorten relaxation times in EPR experiments. The buffer solution was left with
gentle stirring overnight to equilibrate; any sediment that formed overnight was discarded.
10.2. DNA
10.2.1. General DNA techniques
10.2.1.1. Agar plates
Agar plates were created by taking LB broth (400 ml, 25 g/l (10 g/l tryptone, 5 g/l micro
granulated yeast extract, 10 g/l sodium chloride) and combining with agar (15 g/l (6 g))
before autoclaving. Whilst the solution was still warm (~ 50-60 C) ampicillin (100 l/ml)
was added and the solution was poured onto a plate under sterile conditions and allowed to
set. Once set the plates were stored upside down to minimize contamination.
10.2.1.2. Transformation of DNA plasmid into E. coli
On ice, 10 l of Escherichia coli BL21 (DE3) cells were added to 1 l of plasmid DNA. The
solution was mixed in an eppendorf with a flick and left on ice for 30 min. Samples were
then heatshocked (45 seconds, 42 C) before being returned to ice (2 min). Samples were
made up to 1 ml with LB broth (25 g/l) and incubated (1 h, 37 C) before being plated (50
l/plate). Plates were incubated overnight (37 C) and a single, isolated colony selected to
proceed to large scale expression.
10.2.1.3. Glycerol stocks
A single colony was picked from §10.2.1.2 and was added to LB broth (5ml, 25 g/l) contain-
ing ampicillin (50 l/ml) and incubated overnight (180 rpm, 37 C). 1.5ml of the suspension
was centrifuged and the supernatant discarded. The cell pellet was resuspended in 50:50
LB media:glycerol to produce a working glycerol stock if later required.
10.2.1.4. DNA sequencing
A single colony was picked from §10.2.1.2 and was added to LB broth (5 ml, 25 g/l) con-
taining ampicillin (50 l/ml) and incubated overnight (180 rpm, 37 C). 1.5 ml of the sus-
pension was centrifuged and the supernatant discarded. The cell pellet was resuspended
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in GTE buffer (100 l, (50 mM Glucose, 25 mM Tris-Cl, 10 mM EDTA, pH 8)), vortexing if
necessary. Once resuspended lysis solution was added (200 l, (0.2 M NaOH, 1 % SDS))
and the tube inverted 6 - 8 times to ensure good mixing. Potassium acetate solution (150
l, 5M , pH 4.8) was immediately added to neutralise the NaOH whilst the DNA preciptates.
The solution was spun (10000 g, 1 min) and the supernatant transfered to a new tube.
The nucleic acids were precipitated with isopropanol (0.5ml, on ice, 10mins) before being
spun again (10000 g, 1 min). The supernatant was discarded and the pellet dissolved in
TE buffer (0.4ml, (10 mM Tris-Cl, 1 mM EDTA, pH 7.5)) to which RNAse A solution (10 l, 20
mg/ml) was added and incubated (30min, 37 C) to remove any remaining RNA. Proteins
were then extracted from the plasmid using PCIA (0.3 ml, (equal parts phenol/chlorofor-
m/isoamyl alcohol)), the solution was quickly vortexed and then spun (10000 g, 5 mins).
The upper aqueous layer was removed from the organic PCIA layer at the bottom, carefully
avoiding the white precipitated protein. The remaining solution was added to ammonium
acetate solution (100ml, 7.5M ) and absolute ethanol (1ml) to precipitate the plasmid DNA
(on ice, 10min). The solution was spun again (10000g, 5mins) and the DNA pellet resus-
pended in pure water (to a total volume ~ 15 l). 5 l of DNA solution was taken and made
up to 1 ml and the optical density recorded at 260 nm (measured as described in §10.1.2)
giving a DNA concentration.
The samples were then sent for DNA sequencing at The Genome Analysis Centre, Norwich,
UK1. The results of which were analysed using a combination of FinchTV2, T-COFFEE3, Ex-
PASY4 and UniPROT5.
10.3. Plasmids
All protein samples were produced from plasmid DNA using similar growing and purification
procedures (§10.4). Plasmids were kindly provided by N. Cull, University of East Anglia, UK
or Dr. M. Vankemmelbeke, University of Nottingham, UK.
Naturally derived proteins were available from several sources, but not all were viable. For
example Colicin E9 DNase S3C was available from plasmid pTG2 (pET21d based) (UEA) or
pMV45 (Nottingham); the Nottingham plasmid being viable. Colicin E9 DNase S30C avail-
able from plasmid pTG5 (pET21d based) (UEA) or pMV46 (Nottingham); neither was viable.
Colicin E9 DNase S80C from plasmid pTG6 (pET21d based) (UEA); not viable. Colicin Immu-
nity Protein Im9 from plasmid pRJ345 (pTrc99a based) or pSE10 (both UEA); only pRJ345
viable.
In addition to the naturally derived mutants that were available through discussion with col-
laborators at the Universities of East Anglia, Nottingham and York more were designed and
created using a standard procedure.
The desired protein sequence was reverse translated into a DNA sequence that was opti-
mised for codon expression in E. coli. To the 5' end a NcoI restriction site was added (CC)
1http://www.tgac.bbsrc.ac.uk
2http://www.geospiza.com/finchtv/
3http://www.tcoffee.org
4http://expasy.org/tools/blast/
5http://www.uniprot.org/
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Protein, mutant Origin Plasmid name Base plasmid Cell line
E9 DNase S3C Natural, Nottingham pMV45 pET21d BL21 (DE3)
E9 DNase S30C Synthetic pMB4 pEX-A BL21 (DE3)
E9 DNase S80C Synthetic pMB5 pEX-A BL21 (DE3)
E9 DNase S3C / S80C Synthetic pMB1 pET21d BL21 (DE3)
E9 DNase S30C / S80C Synthetic pMB2 pET21d BL21 (DE3)
E9 DNase E66C Natural, UEA pAK4 pTrc99a BL21 (DE3)
E9 DNase D20C / E66C Natural, UEA pAK5 pTrc99a BL21 (DE3)
Im9 C23 Natural, Nottingham pRJ345 pTrc99a BL21 (DE3)
Im9 C23S / S6C Natural, Nottingham pMV16 pTrc99a BL21 (DE3)
Im9 S6C Synthetic pMB3 pET21d BL21 (DE3)
Im2 Natural, UEA pCD01 pTrc99a JM109
Im7 Natural, UEA pRJ347 pTrc99a JM109
Im8 Natural, UEA pKL340 pTrc99a JM109
Table 10.1. Listings of all proteins, their derived plasmids and plasmid sources
and a XhoI (CTCGAG) to the 3' end. This sequence was then checked using the software
package - GENEius6 - to avoid repeats or hairpin structures and to ensure that guanines
and cytosines are equally distributed throughout the sequence; thus ensuring DNA stability
and longevity.
The sequencewas then passed to EurofinsMWGGmbH, Ebersberg, Germanywho artifically
synthesised the gene using overlapping oligonucleotides, employing ligase chain reaction
(LCR) and polymerase chain reaction (PCR) technologies. The gene was then subcloned
into a standard commerically available pET21-d vector (Merck KGaA, Darmstadt, Germany),
before being mini-prepped to a suitable concentration. The gene was finally sequenced (in
both directions) to ensure quality of gene and surrounding restriciton map.
Once the plasmid was received from Eurofins it was transformed into viable E. coli BL21
(DE3) cells (as per §10.2.1.2) grown up and split, half forming a glycerol stock with the other
half being miniprepped to reform a plasmid stock.
The proteins (as a result of the expression vector) were all His6-tagged, which allowed for a
simple purification procedure. Raw, sonicated cell lysate could be passed over a nickel affin-
ity column, which removed most of the impurities, with a secondary size exclusion column
to give maximum purity.
10.3.1. Synthetically derived plasmids
10.3.1.1. Colicin E9 DNase S3C / S80C / H127A - pMB1
The double Colicin E9 DNase mutants could not be produced in isolation as they would kill
the host cell, instead they are usually co-expressed with the immunity protein Im9. How-
ever, the start of the immunity protein Im9 gene overlaps the end of the colicin E9 gene in
a different reading frame [19]. This proved very difficult to try to create a viable colicin E9
mutant whilst keeping immunity protein Im9 functional.
As a result of previous work [34] a further point mutation was introduced. The colicin E9
DNase H127A mutant has been shown to still bind DNA and the immunity protein Im9 but
6GENEius - for optimising synthetic genes [online], Available: http://www.geneius.de/ (Accessed 3 June 2011)
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shows noDNase action. With thismutation it is possible to overexpress the colicin E9DNase
in E. coliwithout killing the host cell. TheHis6 tag and stop codons are included in the pET21-
d vector and were ensured to be in the same reading frame as the insert.
Amino acid sequence
MEC KRN KPG KAT GKG KPV GDK WLD DAG KDS GAP IPD RIA DKL RDK EFK SFD DFR KAV WEE VSK DPE
LSK NLN PSN KSS VCK GYS PFT PKN QQV GGR KVY ELH HDK PIS QGG EVY DMD NIR VTT PKR AID IHR GK
DNA sequence (with restriction site tags)
cc ATG GAA TGC AAA CGC AAC AAA CCG GGC AAA GCT ACC GGG AAA GGC AAA CCA GTT GGC GAT AAA
TGG CTG GAT GAT GCC GGC AAA GAT TCA GGT GCA CCA ATT CCT GAT CGC ATT GCC GAC AAG TTA CGC
GAC AAA GAG TTC AAG TCG TTT GAC GAT TTC CGG AAA GCG GTT TGG GAA GAA GTG TCC AAA GAT CCC
GAA TTG AGC AAG AAT CTG AAT CCG AGC AAC AAA AGC TCT GTC TGT AAG GGG TAT TCG CCG TTT ACG
CCG AAG AAT CAG CAA GTA GGA GGT CGC AAA GTG TAT GAG CTG CAT CAC GAC AAA CCG ATC AGT CAG
GGT GGT GAA GTG TAC GAT ATG GAT AAC ATC CGT GTC ACT ACC CCT AAA CGT GCG ATT GAC ATC CAT
CGT GGC AAA ctcgag
10.3.1.2. Colicin E9 DNase S30C / S80C / H127A - pMB2
This mutant was also designed with the H127A mutation to stop DNase activity.
Amino acid sequence
MES KRN KPG KAT GKG KPV GDK WLD DAG KDC GAP IPD RIA DKL RDK EFK SFD DFR KAV WEE VSK DPE
LSK NLN PSN KSS VCK GYS PFT PKN QQV GGR KVY ELH HDK PIS QGG EVY DMD NIR VTT PKR AID IHR GK
DNA sequence (with restriction site tags)
cc ATG GAA TCC AAA CGG AAC AAA CCA GGC AAA GCA ACC GGT AAG GGC AAA CCT GTT GGG GAT AAA
TGG CTG GAT GAT GCG GGC AAA GAC TGT GGT GCT CCA ATT CCC GAT CGT ATT GCG GAC AAA TTG CGC
GAT AAA GAG TTC AAA TCG TTC GAT GAT TTT CGC AAA GCC GTT TGG GAA GAA GTC AGC AAA GAT CCG
GAG TTA AGC AAG AAC CTG AAT CCG TCA AAC AAG AGC TCT GTG TGC AAA GGC TAT TCG CCT TTT ACC
CCG AAG AAT CAG CAA GTG GGA GGT CGT AAG GTC TAT GAA CTG CAT CAC GAC AAA CCG ATT AGT CAG
GGT GGC GAA GTG TAC GAC ATG GAC AAT ATC CGC GTA ACG ACT CCG AAA CGT GCC ATC GAT ATC CAT
CGC GGG AAA ctcgag
10.3.1.3. Colicin Immunity protein Im9 S6C - pMB3
Mireille Vankemmelbeke provided DNA for Im9 S6C / C23S, a single cysteine mutant with a
spin label site at a different location. In addition an immunity protein mutant with two spin
label sites was designed for improved docking triangulation.
Amino acid sequence
MEL KHC ISD YTE AEF LQL VTT ICN ADT SSE EEL VKL VTH FEE MTE HPS GSD LIY YPK EGD DDS PSG IVN
TVK QWR AAN GKS GFK QG
DNA sequence (with restriction site tags)
cc ATG GAG TTG AAA CAC TGC ATT TCG GAC TAT ACC GAA GCG GAA TTT CTG CAG TTA GTG ACT ACG ATC
TGT AAT GCC GAT ACA TCC AGC GAA GAA GAG CTG GTT AAA CTG GTA ACC CAT TTC GAG GAA ATG ACC
GAA CAT CCG TCT GGA AGC GAT CTC ATC TAC TAT CCG AAA GAA GGT GAC GAT GAT TCG CCA TCA GGC
ATT GTC AAC ACG GTG AAA CAA TGG CGC GCT GCA AAC GGC AAA AGT GGG TTT AAG CAG GGT ctcgag
10.3.1.4. Colicin E9 DNase S30C / H127A - pMB4
Amino acid sequence
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MES KRN KPG KAT GKG KPV GDK WLD DAG KDC GAP IPD RIA DKL RDK EFK SFD DFR KAV WEE VSK DPE
LSK NLN PSN KSS VSK GYS PFT PKN QQV GGR KVY ELH HDK PIS QGG EVY DMD NIR VTT PKR AID IHR GK
HHHHHH
DNA sequence (with restriction site tags)
cc ATG GAG TCC AAA CGA AAC AAA CCA GGA AAA GCA ACG GGC AAA GGC AAA CCA GTT GGG GAT AAA
TGG CTG GAT GAC GCT GGG AAA GAC TGC GGC GCG CCC ATT CCG GAT CGT ATT GCG GAC AAG CTC CGC
GAT AAA GAA TTT AAA TCG TTC GAT GAT TTT CGT AAG GCC GTA TGG GAA GAA GTG TCG AAA GAT CCT
GAA TTA AGC AAG AAC CTG AAC CCG AGT AAT AAA AGT TCA GTG AGC AAA GGC TAT AGC CCT TTC ACC
CCG AAA AAT CAG CAG GTG GG CGG TCG GAA AGT CTA CGA ATT GCA CCA TGA CAA GCC GAT CTC TCA
AGG TGG TGA GGT CTA TGA CAT GGA TAA TAT TCG TGT TAC TAC CCC GAA GCG CGC CAT CGA TAT CCA
TCG CGG TAA A ctcgag
10.3.1.5. Colicin E9 DNase S80C / H127A - pMB5
Amino acid sequence
MES KRN KPG KAT GKG KPV GDK WLD DAG KDS GAP IPD RIA DKL RDK EFK SFD DFR KAV WEE VSK DPE
LSK NLN PSN KSS VCK GYS PFT PKN QQV GGR KVY ELH HDK PIS QGG EVY DMD NIR VTT PKR AID IHR GK
HHHHHH
DNA sequence (with restriction site tags)
cc ATG GAG TCT AAA CGA AAC AAA CCA GGC AAG GCC ACC GGC AAA GGT AAG CCT GTC GGG GAT AAA
TGG TTA GAC GAC GCT GGT AAG GAC AGC GGA GCC CCC ATC CCA GAT CGC ATC GCG GAT AAG TTG CGC
GAC AAG GAA TTC AAA TCC TTC GAC GAT TTT CGG AAA GCG GTC TGG GAG GAA GTA AGC AAA GAT CCG
GAA CTC AGC AAA AAT CTG AAC CCG TCG AAC AAA TCG AGT GTT TGC AAA GGC TAC TCA CCT TTT ACT
CCG AAA AAT CAA CAG GTT GGT GGG CGC AAA GTG TAT GAA CTG CAT CAT GAT AAA CCG ATC AGT CAG
GGT GGC GAA GTG TAT GAT ATG GAT AAT ATT CGT GTG ACG ACC CCG AAA CGT GCA ATT GAT ATT CAC
CGT GGC AAA ctcgag
10.4. Protein production
10.4.1. Colicin E9 DNase production
10.4.1.1. Large scale over-expression
E. Coli BL21 (DE3) cells were transformed with the constructed E9 plasmid (§10.2.1.2) and
then grown overnight in LB broth (2x 5ml, 25 g/l) with ampicillin (5 l, 100mg/ml) (37 C ,
180 rpm, 5 h). 400 l was taken from the initial growth of 5 ml and added to 40ml LB and
grown overnight (37 C , 180 rpm, 16 h) with the addition of ampicillin (40 l, 100 mg/ml).
20 ml was taken from the overnight culture and added to LB broth (4x 500 ml) mixed with
ampicillin (500 l, 100mg/ml) and incubated with shaking (37 C , 180 rpm) until reaching
an optical density (less LB) at 595 nm of approximately 0.6 (~ 4 h) (measured as described
in §10.1.2), at which the culture is considered to be at the middle of the log growth phase.
More ampicillin (500 l, 100 mg/ml) was added along with isopropyl--D-thiogalactoside
(IPTG) (5 ml, 100 mM ) which activates the lac operon and induces gene expression of the
desired E9 gene. The culture was further incubated with shaking (37 C , 180 rpm, 4 h). 1
ml samples were taken from the culture at hourly intervals after induction with IPTG, the
OD595nm measured, then analysed by SDS-PAGE to monitor protein expression (§10.1.1).
The remaining culture after 6 h was centrifuged (7000 g, 15 min), the supernatant was
discarded and the pellets, containing cells were resuspended in Tris buffer (10 mM Tris-
HCl, minimum required) and stored overnight at -4 C .
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10.4.1.2. Liberation of protein from cells
The resuspended pellets were thawed slowly on ice. The solution was sonicated on ice
(2 runs of 500 second length with 50% power, half second bursts every second with a 5
minute on ice rest between runs) using a Homogenisers Status 200 sonicator. This process
destroyed the cell walls releasing the protein into solution. The solution was centrifuged
(45,000 g, 45 min, 4 C) the supernatant containing soluble protein was removed and
placed on ice, the pellet containing cell remnants was discarded. A sample was taken from
the supernatant for SDS-PAGE analysis and comparison with various purification stages.
10.4.1.3. Immobilised metal ion affinity chromatography
GE Healthcare Life Sciences HisTrap HP columns with bed volume 5ml were washed with
10 column volume equivalents (CV) (ie 50ml) water, then activated with charge buffer (5 CV,
50 M Ni2SO4), then rewashedwith water (5CV ). The columnwas then run into the binding
buffer (5 CV, 20mM Tris, 500mM NaCl, 50mM imidazole). The protein was directly loaded
onto the column in one movement. The column and bound protein were further washed
with binding buffer (10 CV) to remove any none specific binding. Elution was conducted by
titrating in elution buffer elution buffer to the column (4 CV , 20mM Tris, 500mM NaCl, 50
mM imidazole, 6M GdmCl). The GdmCl was required to unfold the colicin E9 and unbind it
from the Im9, as it is one of the few ways to seperate the complex; the Im9 with its His6 tag
remained bound to the column. The column was finally stripped of Im9 using strip buffer (4
CV , 20mM Tris, 500mM NaCl, 100mM EDTA) before being stored in 20% ethanol at 4 C .
Chromatography was conducted using a GE Healthcare Life Sciences Äkta Explorer FPLC
system.
10.4.1.4. Dialysis
Dialysiswas conducted overnight as per §10.1.3 to lower and removeGdm from the solution,
allowing the colicin to refold.
10.4.1.5. Lyophilisation
The protein solution was placed inside a large round bottom flask; this was then placed in a
carbon dioxide (s) / ethanol (l) bath and flash frozen with rotation to ensure the maximum
possible surface area. The top of the flask was then sealed with parafilm and electrical tape
before being pierced with a surgical needle. The flask was then placed in a Thermo Sovant
MicroModuly vacuum desiccator, brought to vacuum and left > 48 h.
The protein was then resuspended in gel filtration buffer (2.5 ml, 50 M potassium phos-
phate (4.21 g/l KH2PO4, 3.32 g/l K2HPO2), potassium chloride (200 M ), pH 7.00).
10.4.1.6. Size exclusion chromatography
Size exclusion chromatography was conducted using a self poured 26/60 column constiut-
ing Amersham Pharmacia Biotech glassware, connectors and 350ml of GE Health Life Sci-
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ences Superdex 200 connected to aGEHealth Life Sciences Äkta Explorer FPLC system. The
column was equilibrated by running through gel filtration buffer (300ml, (50 M potassium
phosphate (4.21 g/l KH2PO4, 3.32 g/l K2HPO2), potassium chloride (200 M ), pH 7.00)).
The concentrated protein (less than 2.5ml) was injected onto the column and the progress
of protein elution wasmonitored by measuring the UV absorption at 280 nm. Relevant frac-
tions with UV absorption had samples (10 l) taken for SDS-PAGE analysis (§10.1.1). Rele-
vant fractions, as determined by SDS-PAGE were pooled and taken forward.
10.4.1.7. Purification and concentration
The protein was twice dialysed to pH adjusted water to remove any salt (§10.1.3). The final
volume (~ 50 ml) was reduced to usable concentrated sample stock volume of approxi-
mately 3 ml by a combination of Amicon filtering and lyophilization (§10.4.1.5). Filtering
was conducted using a Millipore Amicon Stirred Cell (model 8050), using a Y3K micro-filter
(3 kDa molecular weight cut off). The filter was loaded into the cell and stirrer added, the
volume to be concentrated was added. The cell was closed and sealed before being pres-
surised under argon (3 atmo) with gentle stirring until final volume was ~5 ml. The flow
through was discarded.
10.4.1.8. Protein concentration determination
Protein concentration was determined using a modified method as described in §10.1.2
(page 195).
Optical density = " c l
The molar extinction efficient, " in equation 10.1 (repeated above) is unique to every macro-
molecule at differing wavelengths and is characteristic of concentration. It was found from
extensive studies that at 280 nm the molar extinction coefficient comes almost exclusively
from aromatic amino acids [36, 71]. Thus from knowing the sequence the extinction coeffi-
cient can be found according to:
"280nmM
 1cm 1 = x:Trp (5500) + y:Tyr (1490) + z:Cys (125) (10.2)
Giving wild type colicin E9 DNase a molar extinction coefficient of 15470 M 1cm 1 (cy-
tosolic), single mutant 15595 M 1cm 1 (cytosolic) and double mutant 15620 M 1cm 1
(cytosolic). Single cysteine Im9, 9970M 1cm 1 (cytosolic) and double cysteine Im9, 10095
M 1cm 1 (cytosolic)
10.4.1.9. Protein storage
After the protein concentration was determined the protein solution was aliquoted into 1ml
amounts in 1.5ml eppendorfs. These were flash frozen in liquid nitrogen and stored in a -80
C freezer.
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10.4.2. Colicin E9 production
Full length Colicin E9 mutants S451C, S478C and S528C (corresponding to E9 DNase do-
main S3C, S30C and S80C) were produced and purified by Dr. N. Housden (University of
Oxford, UK) from his own gene construct.
10.4.3. Im9 production
10.4.3.1. Large scale over-expression
Escherichia Coli BL21 (DE3) cells were transformedwith the desired Im9 plasmid (§10.2.1.2)
and grown up as described for E9 (§10.4.1.1).
10.4.3.2. Liberation and purification
Liberation of Im9 was conducted by sonication, as described in §10.4.1.2. IMAC and size
exclusion chromatography were conducted as described in §10.4.1.3 and 10.4.1.6, except
that the IMAC did not require the GdmCl wash. Instead the protein, without unfolding, could
be liberated as the imidazole concentration was increased.
10.4.3.3. Purification, concentration and storage
Theproteinwasdesalted by dialysis (§10.1.3) and concentrated by lyophilisation (§10.4.1.5).
Protein concentration was determined using the method outlined in §10.4.1.8 concluding in
Im9 having amolar extinction coefficient of 9970M 1cm 1 (cytosolic). Again sampleswere
flash frozen for long term storage, as described in §10.4.1.9.
10.5. Spin labelling
10.5.1. MTSL
Inside of a low oxygen glovebox (~1 ppm O2) 13.5 mg of protein was dissolved into 2.0 ml
of degassed potassium phosphate buffer (50 mM (4.21 g/l KH2PO4, 3.32 g/l K2HPO2) pH
7.00). The protein solution was added to dithiothreitol (DTT) solution (1mg in 2.5ml), a re-
ducing agent to ensure that no formation of disulphide bridges. The combined solution was
passed down an GE Healthcare PD-10 column per manufactures instructions, to remove
any excess DTT.
A five fold excess of S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesul-
fonothioate (MTSL) (50 mM in acetonitrile) was added to the elutant of the PD-10 column
(90.4 l E9 mutants, 134.1 l Im9). The solution was covered in aluminium foil (as the re-
action is light inhibited) and left for 3 h at room temperature (298 K) with stirring every 30
min.
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After the reaction time, the solution could be removed from the glovebox. The protein was
desalted and excess label removed using 2 sequential PD-10 columns (equilibrated as be-
fore in potassium phosphate buffer).
The protein concentration was then evaluated using UV/Vis (as described in §10.1.2) using
a 10 l sample being diluted to 1ml in postassium phosphate.
10.5.2. IA-PROXYL
10.0 mg of protein was dissolved into chelexed and autoclaved metal free buffer (1 ml, 50
mM (4.21 g/l KH2PO4, 3.32 g/l K2HPO2), 2mM EDTA, pH 7.00), to which a 5molar excess
of IA-PROXYL was added (50mM in DMSO).
Colicin E9 DNase D20C/E66C and E66C due to the labelling sites required the addition of
6 M GdmCl to the buffer to unfold the protein, and due to the inhibiting effect of GdmCl to
labelling a 10molar excess of IA-PROXYL was added.
Solutions were wrapped in foil, to stop any light inhibition and left overnight at 4 C.
The samples were made up to 15 ml with further buffer and added to a VivaSpin 15R spin
concentrator and spun (3000 g) until the volume reached 1ml (~ 2 h). The samples were
again made up to 15ml and spun again until the volume reached 1ml.
Samples were taken before spinning as well as after spinning from the retained volume and
flow through. Each sample was evaluated by UV/Vis (as per §10.1.2) and cw-EPR (X-band),
to ensure that free label was removed from the sample and to evaluate labelling efficiency
to the protein.
204
11. EPR and other spectroscopies
11.1. cw-EPR
11.1.1. X-band
Unless otherwise noted all X-band experiments (~ 9.5GHz) were conducted upon a Bruker
ELEXSYS E500 or Bruker ELEXSYS E680 instrument.
11.1.1.1. Room temperature continuous wave
Experiments were conducted using a Bruker ELEXSYS E500 running Bruker software Xepr
v2.6; with an X-band Bruker ER 041 MR microwave bridge, Bruker ER 4123D cw-Resonator
(with the cavity being flushed with nitrogen gas, except in aerobic power saturation exper-
iments), Bruker B-E251B9 magnet, Bruker ER 082 C magnet power supply, Marconi Instru-
ments 2440 Microwave Counter. Experiments were conducted in an environmentally con-
trolled room, where the temperature was maintatined at 298  1K .
Samples were initially tested at ~ 9.7 GHz, 0.63 mW microwave power (25 dB power at-
tenuation), 100 G sweep width (centered around the expected g = 2 position), 16 scans, 60
dB gain, 1 G modulation amplitude, 100 kHz modulation frequency, 20.48 ms conversion
time, 10.24ms correlation time. Any sample variation from these settings are noted as such
in the main text.
11.1.1.2. Low temperature continuous wave
Experiments were conducted using a Bruker ELEXSYS E500 as described in §11.1.1.1 how-
ever the resonator was replaced with a Bruker ER 4122 SHQ (Super High-Q) resonator in
combination with a Bruker ER 4112HV helium temperature control system.
Samples were initially tested at ~ 9.4 GHz, 1.997mW microwave power (20 dB power at-
tenuation), 100Gauss sweep width (centered around the expected g = 2 position), 32 scans,
60 dB gain, 1 G modulation amplitude, 100 kHz modulation frequency, 20.48 ms conver-
sion time, 10.24ms correlation time. Any sample variation from these settings are noted as
such in the main text.
Temperatures of 80K and above were obtained through liquid nitrogen cooling whilst tem-
peratures below 80 K were obtained through liquid helium cooling using an Oxford Instru-
ments 503S ITC and VC41 gas flow controller.
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11.1.2. S- and Q-band
S and Q-band experiments were conducted using a Bruker ELEXSYS E560 running Bruker
software Xepr v2.6; comprising a Bruker ER 023 M signal channel controller, Bruker ER 032
M field controller, Bruker ER 048 R microwave controller, Bruker magnet B-E251B9, Bruker
ER 083 Z magnet power supply and Hewlett-Packard 5352B frequency counter.
11.1.2.1. S-band
S-band measurements were performed using a Bruker ER 061 SR microwave bridge and
a Bruker ER 6103 S-MS5 resonator, initial room temperature experiments were conducted
inside a Bruker ER 4118CF cryostat.
Temperatures below room temperature were obtained using an American Research Sys-
tems closed cycle displex system comprising an ARS-4HW compressor, ARS-DE204SF-
FMX-19EC cryostat and LakeShore LS331S Intelligent Temperature Controller. The closed
cycle displex system is extensively evaluated in Appendix A.
Samples were initially tested at ~ 4.0 GHz, 0.63 mW microwave power (25 dB power at-
tenuation), 100Gauss sweep width (centered around the expected g = 2 position), 32 scans,
60 dB receiver gain, 1 G modulation amplitude, 100 kHz modulation frequency, 81.92 ms
time constant. Low tempature experiments were conducted at 80K. Any sample variation
from these settings are noted as such in the main text.
11.1.2.2. Q-band
Q-band measurements were performed with a Bruker ER 053 QRD microwave bridge and a
Bruker ER 5106 QTW resonator.
Temperature was controlled using using an American Research Systems closed cycle dis-
plex system comprising an ARS-4HW compressor, ARS-DE204SF-FMX-19EC cryostat and
LakeShore LS331S Intelligent Temperature Controller. The closed cycle displex system is
extensively evaluated in Appendix A.
Samples were initially tested at ~ 34.0 GHz, 0.63mW microwave power (35 dB power at-
tenuation), 450 Gauss sweep width (centered around the expected g = 2 position), 20 scans,
60 dB receiver gain, 1 G modulation amplitude, 100 kHz modulation frequency, 20.48 ms
time constant. Low tempature experiments were conducted at 80K. Any sample variation
from these settings are noted as such in the main text.
11.1.3. W-band
Experiments were conducted using a Bruker ELEXSYS E680 running Bruker software Xepr
v2.6; with an X-band Bruker XPB and Bruker W-band EC 01 (ESP 900-1041) microwave
bridge, a Varian 5T-EPR hybrid magnet fitted with a Bruker W-band resonator and cryostat.
Sampleswere initially tested at ~ 94.0GHz, 3.57 W microwave power (31 dB power atten-
uation), 280Gauss sweep width (centered around the expected g = 2 position), 32 scans, 60
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dB receiver gain, 1 G modulation amplitude, 100 kHz modulation frequency, 1.28 ms time
constant, 40.96ms conversion time. Any sample variation from these settings are noted as
such in the main text.
Temperatures below room temperature were obtained through liquid helium cooling using
an Oxford Instruments 503S ITC and VC41 gas flow controller.
11.2. Pulsed EPR
11.2.1. Sample preparation
All pulsed EPR experiments used samples of total volume 80l, and unless otherwise stated
final protein concentrations of 100 M . Where this involved mixing multiple components a
stock protein solution of 200 or 400 M were used.
All samples were extensively dialysised against high purity (Milli-Q) water (pH 7.5) and 5
mM EDTA to remove all salt and metal from the samples. Samples were then concentrated
using VivaSpin 15R spin concentrators until the sample absorbance at 280 nmmatched the
desired concentration.
All samples were prepared in 200 l centrifuge tubes, as per the following instructions, be-
fore being transferred using TPX tubing to Wilmad 707-SQ-250M 4mm, thin wall precision
quartz EPR tubes.
11.2.1.1. Protonated samples
At the final spin concentration stage, the sample was reduced to 0.5ml with spinning, made
up to 15ml with high purity water (pH 7.5) and reduced again. This was repeated 3 times to
remove any EDTA before final sample preparation.
11.2.1.2. Deuterated samples
At the final spin concentration stage, the sample was reduced to 0.5ml with spinning, made
up to 15ml with high purityD2O (>99.99 %)(pH 7.5) and reduced again. This was repeated
3 times to remove any EDTA and to ensure deuteration of the solvent and all labile protons
of the protein in the final sample.
11.2.1.3. pH shifted samples
Samples were prepared as per §11.2.1.1, but solutions were made back up with buffered
solution at the desired pH. 25mM Tris (tris(hydroxymethyl) methylamine) was used for pHs
8.0 and above, 25mM HEPES (4-2-hydroxyethyl -1-piperazineethanesulfonic acid) for pHs
7.0 and 7.5 and 25mM MES (2-(N-morpholino) ethanesulfonic acid) for pH 6.5 and below.
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11.2.1.4. Samples with glycerol
Samples with glycerol were prepared from pure, unbuffered, high protein concentration so-
lutions. Typically, 40 l of a 200 M protein solution was added to a 200 l centrifuge tube
to which 40 l was added, to make a 50 % glycerol solution with final protein concentration
of 100 M .
In the case of §6.5, a 400 M stock protein solution was used (at the boundary of protein
precipitation) and in the case of the 90 % glycerol solution was used directly to give a final
40 M protein concentraion. For lesser glyercol concentrations the protein solution was
first diluted with high purity water before addition of glyercol to give the same final protein
concentraion.
11.2.1.5. Sample mixing
Samples once prepared requiredmixing to stop seperation into aqueous and organic layers.
Samples were sealed in 200 l centrifuge tubes and flicked by hand several times until dis-
tinct layers were no longer clear. Samples were further mixed with a benchtop vortex mixer
(300 rpm, 30 s), before being left at room temperature (10min) to allow diffusion of protein
throughout the solution.
11.2.1.6. Sample freezing
Typically, samples were desired to be in the glass phase. Glass samples were produced by
flash freezing the sample, inside the EPR tube by immersion in liquid nitrogen.
For §6.7, ice samples were produced by placing the sample inside a sample tube inside of
a cryostat at 298 K and then slowly cooling, inside the cryostat at 2 K/min to the experi-
mental conditions. Care needed to be ensure a high quality sample tube was used to avoid
the sample smashing the sample tube.
§6.7 reannealed samples were produced by flash freezing the sample in liquid nitrogen as
above before being transferred to a cold cryostat at 50 K. Once inside the cryostat the
temperature were raised at 5 K/min to just below the glass transition point (140 K [63])
and held for 20min before being returned to 50K at 2K/min.
11.2.2. General experimental setup
Experiments were conducted using a Bruker ELEXSYS E580/680 hybrid running Bruker soft-
ware Xepr v2.6; with an X-band Bruker XPB microwave bridge, Bruker ER 4118X-MD5 res-
onator inside a Bruker ER 4118CF cryostat, Bruker ER 073magnet, Bruker ER 083CSmagnet
power supply, Applied System Engineering 117X (1 kW) TWT amplifier. Experiments were
conducted in an environmentally controlled room, where the temperature was maintained
at 298  1K .
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11.2.3. T1
T1 experiments were conducted at 50 K , ~ 9.7 GHz, with the magnetic field optimised for
maximumsignal around g = 2, typcially 344mT . 2 scans, 1024 points, 4 shots/point, time in-
crement 12000 ns, 20MHz video bandwidth, 50000 s shot repetition time (approximately
4 the T2 time), 4 dB attenuation, 57 dB video gain. These settings were optimised on a
sample basis, particularly attenuation and video gain, any significant variation from these
settings being noted in the main text.
11.2.4. T2
T2 experiments were conducted at 50 K , ~ 9.7 GHz, with the magnetic field optimised for
maximum signal around g = 2, typcially 344mT . 4 scans, 16 shots/point, 1024 points, time
increment 4 ns, 10000 s shot repetition time, 8.0 dB attenuation, 45 dB video gain. These
settings were optimised on a sample basis, particularly attenuation and video gain, any sig-
nificant variation from these settings being noted in the main text.
11.2.5. FSE
FSEs were conducted at 50 K , ~ 9.7 GHz, 187.5 nW microwave power (60 dB power at-
tenuation), 100 G sweep width centred about g = 2, 4 scans, 2 shots/point, 512 points, time
increment 4 ns, 10000 s shot repetition time, 8.0 dB attenuation, 45 dB video gain. These
settings were optimised on a sample basis but matched the T2 experiment.
11.2.6. ELDOR nutation
ELDOR nutation experiments were conducted at 50 K , ~ 9.7 GHz, with the magnetic field
optimised for maximum signal around g = 2, typcially 344mT . 4 scans, 2 shots/point, 256
points, time increment 2 ns, 10000 s shot repetition time, 8.0 dB attenuation, 45 dB video
gain, ELDOR power optimised to give maximum inverse, typically 11 dB.
11.2.7. PELDOR
PELDOR experimentswere conducted at 50K , ~ 9.7GHz, with themagnetic field optimised
for maximum signal around g = 2, typcially 344mT . >2000 scans, 4 shots/point, points (op-
timised to experiment ~400), time increment 8 ns, shot repetition time - determined from
T1 experiment (typically 10000 s), attenuation and video gain - determined from T1 experi-
ment (typically 8.0 dB and 45 dB respectively), ELDOR power - optimised to give maximum
inverse (typically 11 dB).
Typically, the observer sequence was set to the low field peak of the FSE, whilst the ELDOR
channel was set to excite the centre peak. Observing with less signal intensity but stronger
ELDOR modulations was found to preferable than observing with more signal intensity and
less ELDOR modulation.
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PELDOR parameters were set according to prior FSE, T2, T1, ELDOR power and ELDOR nu-
tation experiments. These parameters were passed to a custom 4 pulse ELDOR program in
PulseSPEL which allows for independent control of each pulse. Phase cycling of the first 
pulse was employed to aid in noise suppression. Nuclear modulation suppression was not
employed for deuterated samples as the deuteron modulation time is near to the ELDOR
modulation time of a 3.0 nm distance.
11.3. Other spectroscopy
11.3.1. NMR
Standard 'BioPack' 1H - 15N HSQC and triple resonance (CBCACONH, HNCACB, CCONH and
HCCONH) NMR experiments were conducted at 1H frequencies of 500 and 600 MHz on
Varian Inova spectrometers by Dr. R. Boetzel (UEA). Binding experiments were conducted
using doubly labelled 15N/13C protein samples prepared by A. Reilly (UEA) at pH 6.2. Final
1H - 15N HSQC experiments were acquired at a molar ratio of immunity protein to DNase of
1.54:1.
11.3.1.1. Chemical shift pertubations
The assignments of the HSQC and triple resonance experiments were tabulated into chem-
ical shifts for each residue of each protein with and without the binding partner. Residues
with a difference outside 1 standard deviation of the average chemical shift were deemed
to be significant.
The structure of each protein was then run through the program Naccess1. This program
runs a virtual sphere over the surface of the structure and returns the solvent accessibility
of each residue. Any residues that had less than 50% solvent accessibility were considered
not relevant and disregarded.
The remaining residues were defined as active residues to docking whilst residues with <50
% solvent accessibility within 3 A to active residues were considered to be passive residues
in docking. Together these active and passive residues make up the ambiguous interaction
restraints (AIRs).
11.3.2. Ultra-violet / visible spectroscopy
Experiments were conducted using an Hitachi U2900 Spectrophotometer running Hitachi
UV solutions software (build: 461).
3ml of the sample was loaded into a Hellma Precision Cell of Quartz Suprasil (10mm light
path) and tested at 298 K , medium response, 1.5 nm slit width, over a range of 800 - 220
nm, at a scan rate of 200 nm/min.
1Hubbard,S.J. & Thornton, J.M. (1993), 'NACCESS', Computer Program, Department of Biochemistry and
Molecular Biology, University College London.
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On each day of testing blanks of an empty cavity, empty cuvette and buffer were taken, which
were post-experimentally taken from the signal.
11.3.3. Circular dichroism
Experiments were conducted using a Jasco J-810 Spectropolarimeter running Jasco CD
software (v1.24.00)
3ml of the sample was loaded into a Hellma Precision Cell of Quartz Suprasil (10mm light
path) and tested at 298 K , low sensitivity (1000 mdeg), data pitch 0.5, 1 s response, 2 nm
bandwidth, continuous scanning mode, over a range of 500 - 220 nm, at a scan rate of 100
nm/min.
On each day of testing blanks of an empty cavity, empty cuvette and buffer were taken, which
were post-experiment taken from the signal.
11.3.4. Fluorometry
Experiments were conducted using a Perkin Elmer LS 55 Fluorescence Spectrometer run-
ning FL WinLab software with thermostatted cell holder accessory.
3ml of the sample was loaded into a Hellma fluorescence cuvette of Suprasil quartz (path-
length 1010mm) and tested at 298K , continuous excitation mode with excitation at 295
nm, detection between 300 and 500 nm with a scan rate of 100 nm/min.
On each day of testing, blanks of an empty cavity, empty cuvette and buffer were taken,
which were post-experimentally subtracted from the signal.
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12.1. EPR toolbox
The EPR toolbox began as a simple collection of scripts written to streamline repetitive tasks
such as loading files into theMatLab workspace, autozeroing, normalization and the like. As
time has gone on the EPR toolbox has grown in complexitity and functionality. At the time
of writing (August 2013) the toolbox's key highlights include over 45000 lines of code (plus
extensive commenting), 21 public releases, over 30 months of development and over 1100
unique downloads from 41 countries.
12.1.1. cwViewer
cwViewer is a self contained program, included as part of the EPR toolbox, for the fast visu-
alisation and basic manipulation of cw-EPR, although over time basic functionality for the
pulsed EPR techniques of FSEs and PELDOR traces has been included.
cwViewer allows the user to quickly load a single file or folder of files into the workspace and
instantly visualise them. 3-dimensional Bruker BES3T files (.DTA/.DSC/.YGF) are supported
and can be plotted on top of one another or staggered in x and/or y axes.
The user can performa number of basicmanipulations upon the dataset including autozero-
ing, normalization (between 1 and -1), smoothing (by Savitzky-Golay, digital moving window
averaging or FFT methods) and roughening (single point within a range).
The abscissa can be toggled (in an appropiate dataset) between magnetic field and g value
through either an approximatation method or exactly, when a known standard (such as
DPPH) has been loaded.
Figure 12.1 Screenshot taken from cwViewer, showing the room temperature X-band spectrum of colicin E9
DNase S30CR1A.
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The dataset can then be exported in a variety of common file formats such as bitmap images
(.png), vector images (.eps), comma seperated value number tables, withmagnetic field and
g values (.csv) or to the MatLab workspace, for use with other MatLab programs.
In later versions, an option was given that allowed the user to pass the dataset after manip-
ulation directly to EasySpin for simulation through a simple graphical user interface (in that
it hides most of the complexity of EasySpin and limits the parameters available).
12.1.2. EasyRefiner
Figure 12.2 Screenshot taken from EasyRefiner, showing a file with default nitroxide system parameters loaded
In this investigation over 30 cw-EPR spectra were collected across different temperatures
and multiple frequencies. Each sample was broadly similar to every other sample at that
temperature and frequency, as all were nitroxide spin labels. Rather than attempt to manu-
ally fit each spectrum with EasySpin and reach the desired accuracy an automation facility
was built.
EasyRefiner, is a MatLab written graphical user interface that allows the loading of files and
folders to a queue list. The queuing functionality meant that fitting could be conducted upon
multiple spectra overnight.
Figure 12.3 Screenshot taken from EasyRefiner, showing fitting of a nitroxide system
The spin system is stated in the normal EasySpin syntax in the system box, or the user
can load defaults for nitroxides, Fremy's salt or DPPH. The experiment is defined in normal
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EasySpin syntax. EasyRefiner then allows up to 3 rounds of variables fitting, the idea is that
the first round of fitting gets variables that are roughly correct, which are passed to the next
rounds of fitting with finer variables. This allows the finding of very accurate g values in a
short computation time. Finally in the optionsmenu there are options to save each EasySpin
figure, the EasyRefiner log file and introduce a delay between fits (to prevent CPUoverheating
in long runs) as well as the EasySpin fitting options.
12.1.3. PowerSat
Figure 12.4 Screenshot taken from PowerSat, showing a Gaussian derivative fitting method
PowerSat is a self contained program written to quickly and efficiently evaluate power sat-
uration data. PowerSat is comprised of over 1500 lines of MATLAB code and has been
released under an open-source license to the public as part of the EPR toolbox and has
gained over 75 unique downloads (though its inclusion in the EPR toolbox prohibits exact
user numbers, but the PowerSat webpage has been accessed over 2000 times1).
PowerSat loads rawBruker EPRspectra, as either a folder of files in Bruker BES3T (.DTA/.DSC)
or Bruker EMX (.spc/.par) formats or as a single 3-dimensional Bruker BES3T file (.DTA/.DSC/.YGF).
A combination of these file formats can be used for each of the power saturation experi-
ments; oxygen (lipophilic), nitrogen (control), NiEDDA (hydrophilic) and DPPH (standard).
When files are loaded the program automatically finds the centre line peak and trough using
a search function for each power (though this can be specified by the user manually). The
centre line is described using either a simple point selection or by fitting. The fitting can
be completed quickly by splitting the peak and trough and fitting each using a Gaussian
or Lorentzian function. A more correct analysis can be made at the expense of computing
time by considering the peak and trough together and fitting first derivative Gaussian or
Lorentzian functions. The coefficients of the first derivative fit are then used to solve the
1as of 1st August 2013
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second derivative equation for zero to give the turning points (the peak and trough positions
in the first derivative spectrum).
The peak-to-trough height is then plotted against the square root of microwave power for
the spectrum to give the power saturation curve data points. Curve fitting of the data to:
y(x) = a  x  (1 + (((2(1/b))  1)  (x2))/P ))( b) (12.1)
yields the P1/2 (power at half of saturation) for that data set. With datasets and P1/2s for the
standard and control, the spin label accessibility parameter,  for lipophilic and hydrophilic
environments is calculated using the method outlined by Altenbach et al. [1].
12.2. NACCESS
Naccess is a program written in Fortran 77 code by Simon Hubbard2 which calculates the
atomic accessible area of a macromolecule by rolling a probe over the Van der Waal's sur-
face. The path of the probe's progress is traced out by its centre to give the accessible
surface. Typically the probe is set to 1.4 Å, the same radius as water, allowing for themacro-
molecule surface to be considered as the solvent accessible surface.
12.2.1. Define spin labels
Naccess by default has Van der Waal's parameters for all natural amino acids, stored within
the programs vdw.radii file, this however does not include the unnautral combined Cys
residue with MTSL (R1A) or IA-PROXYL (IA1).
To line 160 of vdw.radii the following was added (displayed in 2 columns for space)
160 RESIDUE ATOM R1A 18
161 ATOM C 1.87 0
162 ATOM CA 1.87 0
163 ATOM N 1.65 0
164 ATOM CB 1.76 0
165 ATOM SG 1.85 0
166 ATOM SD 1.85 0
167 ATOM CE 1.87 0
168 ATOM C3 1.70 0
169 ATOM C2 1.70 0
170 ATOM C9 1.70 0
171 ATOM C8 1.70 0
172 ATOM C4 1.70 0
173 ATOM C5 1.70 0
174 ATOM C7 1.70 0
175 ATOM C6 1.70 0
176 ATOM N1 1.65 1
177 ATOM O1 1.40 1
178 ATOM O 1.40 1
179
180 RESIDUE ATOM IA1 20
181 ATOM C 1.87 0
182 ATOM CA 1.87 0
183 ATOM N 1.65 0
184 ATOM CB 1.87 0
185 ATOM SG 1.85 0
186 ATOM CD 1.87 0
187 ATOM CE 1.87 0
188 ATOM OE 1.40 1
189 ATOM NZ 1.65 0
190 ATOM C3 1.87 0
191 ATOM C2 1.87 0
192 ATOM C9 1.87 0
193 ATOM C8 1.87 0
194 ATOM C4 1.87 0
195 ATOM C5 1.87 0
196 ATOM C7 1.87 0
197 ATOM C6 1.87 0
2of formerly UCL, UK, currently University of Manchester, UK
http://www.bioinf.manchester.ac.uk/naccess/
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198 ATOM N1 1.65 1
199 ATOM O1 1.40 1
200 ATOM O 1.40 1
Line 160: Residue identifier, instructions that the following are atom assignments, 3 letter
code for reside, number of atoms to expect.
Lines 161-178: Identifier, unique atom identifier within residue (corresponding to the third
column of a pdb file), Van der Waal radius in Angstroms corresponding to the sixth column
of a pdb file), indication of whether atom is charged (0 = false, 1 = true).
The Van der Waal radii are taken from Bondi's compilation [8].
12.3. MMM
MMM is an open-source program written initially by Prof. G. Jeschke and Dr. Y. Polyhach at
ETH Zurich, CH. Perhaps its most useful function is to take PDB files and in silico attaches
a spin label. These spin labels can then be evaluated by a simulated PELDOR experiment.
12.3.1. Selenomethionine
MMM by default was designed for proteins that were to be examined by EPR. Many PDB
files are from X-ray crystallography experiments which occassionally require heavy atoms
to start assignment; this is often achieved with the use of selenomethioine (MSE).
The original release of MMM (2009) did not have the Van der Waal terms for selenium in-
cluded, thus the following addition was proposed to get_simpleCH27forLJ.m file, line 60
60 % Selenium , 34
61 % we use sulphur values here , assuming tha t the p ro t e i n f o r spin l a b e l
62 % experiments i s made with na t i ve amino acids
63 vdw(34 )=1 . 80 ; % VdW rad ius
64 p_q (34 )=0 ; p_Rmin2 (34 )=2 .000 ; p_eps (34)= 0.450; % S " Su l f i d e Su l f u r "
65 % p_q (16 )=0 ; p_Rmin2 (16 )=1 .975 ; p_eps (16)= 0.380; % SM " D i s u l f i d e Su l f u r "%
In correspondence with Jeschke (February 2010) it was decided that whilst the actual VdW
distance for selenium is 1.9 Å, the value of 1.8 Å corresponding to sulphur would be used.
This is under the assumption that nomagnetic resonance experiment would use selenome-
thionine over methionine.
This addition appeared in MMM 2009 Patch 1 as
60 % Selenium , 34 ( taken EQUAL to Su l f u r ! )
61 vdw(34 )=1 . 80 ; % VdW rad ius
62 p_q (34 )=0 ; p_Rmin2 (34)= p_Rmin2 ( 1 6 ) ; p_eps (34)= p_eps ( 1 6 ) ;
This modification also required the residues.mat file to be updated with the addition of the
MSE residue to the residue_defs.hettags array.
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12.3.2. PDB file write function
MMM has the functionality to write out PDB files. Unfortunately, the PDB file format is old,
having undergone many revisions and is used by many programs that do not explicitly en-
force all PDB standards.
MMM versions 2009-2011.2 wrote out a PDB file a single line at a time using the file write
command fprintf, with no real control over line length instead using the new line character
``\n''. Some programs within the scope of this work, read PDB files on the older assumption
that every line is exactly 80 characters. Thus to make MMM PDB files more widely compat-
ible with these programs required a major rewrite of the MMM wr_PDB.m file. Each section
of the PDB file is now written using a subfunction to an output string with sprintf which
pads strings under 80 characters with spaces before a new line character.
The final wr_PDB.m file stands at 883 lines (too long to reasonable be shown here) and was
implemented in the next MMM release (2013).
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A. Useful references
Physical Constants
Name Symbol Value
Avogadro's number NA 6:02214 1023mol 1
Bohr Magneton B 9:27401 10 28 J:G 1
Boltzmann constant k 1:38065 10 23 J:K 1
Electron charge e  1:60218 10 19C
Electron mass me 5:486 10 4 amu
Free electron g-value ge 2:002319304
Gas constant R 8:31447 J:mol 1:K 1
Planck constant h 6:62607 10 34 J:s1
Speed of light c 2:99792 108m:s 1
EPR frequencies
EPR band Frequency / GHz Wavelength /mm
L 1 300
S 3 100
X 10 30
K 24 12.5
Q 35 8.5
W 95 3.2
J 263 1.0
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B. Closed cycle low temperature EPR
Following the development and design work of the Hinderberger group (MPIP Mainz, DE) in
2008 the EPR group at the University of East Anglia took delivery of 2 closed cycle cooling
cryostats in December 2011.
The Hinderberger group's system is used primarily in polymer research where experiments
are long and sample changes infrequent. In this instance, sample changing can occur by
turning the machine off, warming to room temperature and deconstruction of the cryostat.
At UEA the primary research is upon biological samples where experiment times are much
shorter and sample changes more frequent.
The primary benefit of moving to a closed cycle system is that the requirement of liquid
cryogens being passed over the sample is replaced by a cold environment beingmaintained
around the sample using only continuously recycled gaseous helium. Whilst the delivered
system pertains to a commerically available system it required adaption to the necessities
of EPR spectroscopy.
The following material is the documentation generated during the installation, calibration
and testing of the units. The version here is the 5th iteration and includes technical drawings
of all additionally required hardware and an ``Operator's guide'' detailing resonator installa-
tion, equipment turning on, standard operation, sample changing and safe turn off proce-
dures.
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Foreword
This manual is primarily concerned with the displex unit available from ARS Cryogenics
(arscryo.com). As such the installation section will only be valid for the specified dis-
plex unit. However, the calibration and operation sections should be relevent to any dis-
plex units including those available from SHI Cryogenics (shicryogenics.com), Cryogenic
(cryogenic.co.uk) or Bruker (bruker-biospin.com).
Each system manufacturer will have taken different approaches to overcome certain ex-
perimental problems. For example, Bruker systems operate with a much larger compres-
sor with the cryostat space at an overpressure of helium ensuring that any leaks in the
setup result in helium leaving and not air entering which minimises any icing of the cryo-
stat.
Finally, this documentation is the product of approximately 9 months of work. That is 9
months from point of delivery until continuous operation by non-development members
of the laboratory. A lot of this time was spent waiting, waiting for parts to turn up, waiting
for trades to install infrastructure and waiting for parts to be manufactured. However, at
time of writing the displex units in our laboratory have been operational for almost 2 years
with the only associated cost having been 2 gas cylinders of gaseous helium.
Not all points discussed in this material is significant to the operation of the displex units
and to most ordinary users they can move straight to chapter 3. However, a lot of what is
discussed in chapters 1 and 2 were unknown until they were tested.
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1 Installation
Upon delivery, the displex system from ARS Cryogenics arrives as one crate (containing
the compressor) and one palate of boxes containing everything else.
The system comprises:
 One compressor
 One LakeShore temperature controller
 One cryostat unit
 Two helium hoses
 One LakeShore to cryostat lead (2 pin banana plug to 9 pin DIN)
 One compressor to cryostat lead
1.1 Compressor
The compressor comes with a transformer and is quoted as suitable for single or three
phase electrical connections. In the UK single phase connections are rated to only 13 A,
whereas the compressor draws 25 - 30 A. For this reason the compressors were wired
into three phase sockets using only one of the phases and placed onto a 30 A riser.
The compressor cooling water requirements are <2.5 l/min at <24 C , which our building
supply more than covers. A spur was taken from themagnet cooling water and inline taps
added for ease of isolation.
The compression brass fittings for the supplied water cooling tubbing are very tight, and
require a heat gun to make the tubing pliable, as well as PTFE tape to ensure a water
tight seal. The tubing can then be attached to the taps and compressor using adjustable
spanners.
1.2 LakeShore intelligent temperature controller
The LakeShore should be completely unpacked and placed in an accessible location close
to the spectrometer.
The LakeShore requires a standard IECC13/C14 (kettle) lead for power and can be plugged
into a normal mains socket.
The lead from the cryostat splits into 3 connections 2 6 pin connectors. The leadmarked
“Control Sensor” goes to Input A on the LakeShore whilst the lead marked “Free Length
Sensor” goes to Input B
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He in
He out
DN25 -
vacuum shroud
Over-pressure
release valve
Optical window
4 pin adapter -
to compressor
10 pin adapter -
to LakeShore
Figure 1.1 A schematic diagram showing the connections on the cryostat
The other lead is a 2 pin banana plug type connection which goes to the “Heater Output”
of the LakeShore. IT IS VERY IMPORTANT YOU GET THIS CONNECTION THE RIGHT WAY
AROUND, yet it is not mentioned in any of the instructional material. The banana plug with
the white plastic lead goes to the “High” whilst the blue lead goes to “Low”. Getting this
wrong will see one of your heater coils receive 10 times the current it is designed for.
1.3 Cryostat
Whilst the displex system is sold as a complete system, several adjustments are required
to the cryostat to make the system operation.
1.3.1 Fitting the cryostat inside the magnet
Remove the rapid scan plates from the magnet. Remove the Hall probe from its casing
within the left rapid scan plate and put somewhere safe.
Get a set of calipers and accuratemeasure the diameter of the cryostat at itsmid-point (at
the optical window if you have one), and compare this to thewidth betweenmagnet shoes.
You may be able to convince the cryostat between the poles of the magnet, depending on
the combination of magnet and cryostat (and at which end of engineering tolerances they
lie).
In our case we had to get some fine grade sandpaper and slowly take back the shoes of
the magnet by 0.5 mm. We corresponded with Bruker first and were assured that this
“should be fine”.
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With Bruker supplied units, they have been designed to be used with rapid scan plates in
place and should not have this problem.
1.3.2 Cryostat height
The cryostat comes as a fixed size. Unfortunately, the size of the cryostat does not co-
inside with the sample height of the Bruker magnets (the older brown BE25 or newer
grey/white ER073). For this reason it was necessary for the cryostat to be raised off of
the ground to optimise the position such that with the addition of the resonator that the
sample would sit correctly between the poles.
To this end polymer plinths were constructed (see figure 1.11).
Note that, our pulsed magnet itself is on 100 mm girders so that the dual-doored console
can fit under the microwave bridge shelf. For this reason a second, wider plinth with a
larger recess was constructed to securely hold the first in place.
1.3.3 Vacuum shroud connections
Figure 1.2 A schematic of the cryostat situated inside the magnet
With the cryostat in place between the magnet poles, it quickly becomes apparent that
the vacuum connection (DN25) at the side of the cryostat (see figures 1.1, 1.2) points
straight into the magnet such that whilst an O-ring and clamp could be placed upon the
connection, no tubing could fit as well.
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For this reason, an adapter is required to turn the connection on the cryostat away from
magnet shoe, allowing for the vacuum tubing to come in from the front or rear of the
magnet. A technical drawing for such an adapter is enclosed as figure 1.12 on page 13.
Connect the right angle end of the adapter to the cryostat using a DN25 O-ring and clamp,
whilst the other end should be connected to a turbo-vacuum pump via DN25 vacuum
tubing and an isolation valve.
Rough pump on the vacuum shroud for 30-60 min to take the pressure to ~10 3 mbar.
Once down to pressure the turbo pump can be turned on, taking the vacuum shroud down
to high vacuum. The turbo pump should be left on overnight before the displex unit is
turned to completely degas the system.
1.3.4 Other connections
Once the cryostat is in place all the connections can be made (see figure 1.3). First make
the electrical connections to the LakeShore and compressor.
With all other connections made, take the protective screw caps off of the helium transfer
lines. WEARING EYE PROTECTION attach the helium transfer lines to the compressor us-
ing spanners, and ensure a firm connection. Repeat the connection of the helium lines to
the cryostat. This will take approximately 10-15min to attach the transfer lines, as once
within the magnet you can only use ~1/6 turns on the cryostat.
Figure 1.3 Photograph of the installed cryostat with all connections made
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1.4 Hall probe
The Hall probe that usually sits in the rapid scan plates needs to removed from the plate
and put back between the poles of the magnet, as the displex unit will not fit between the
magnet poles with them in place.
The power supply to the magnet is controlled via a feedback mechanism from the Hall
probe and without it in place the power supply will keep ramping up before it fail-safes.
The Hall probe needs to accurately reflect the magnetic field experienced by the sample.
For this reason it needs to be as close to the sample location as is physically possible.
For initial testing it is sufficient to align the Hall probe at the correct height with the sample
space (approximately the centre of the magnet shoe). Ensure that the Hall probe is flat
against the magnet shoe and the correct way around (it is directional) and Duct tape the
Hall probe in place.
This is not a long term solution, and certainly not suitable for magnetic field accuracy. For
this reason a Hall probe holder needs to be created, before the spectrometer is calibrated
using a known standard (such as DPPH), preferrably using a teslameter if possible.
Technical details of the created Hall probe holder are shown in figure 1.14, created using
3mm perspex sheets and brass connections. The base screws onto the magnetic pole of
the magnet with Teflon screws, using the same holes as the rapid scan plates. The Hall
probe is inserted into the gap, then the top plate (with padded foam tape) is screwed in
place on top holding the Hall probe safely and firmly in place.
(a) Base plate (b) Base plate with Hall probe (c) Complete holder
Figure 1.4 Photographs of the Hall probe holder in place
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1.5 Cryostat to DN40 adapter
Like most flow cryostats the displex cryostat comes blank with a flat top surface with 6
screw holes for flexible attachments (at 60° to each other of outer diameter 64.5 mm).
Bruker resonators use a standard DN40 connection and flow cryostats from Bruker come
with an adapter for this purpose.
Resonator
Displex header
Magnet 
- right
Magnet
- left
DN16 connection
- another at back
Figure 1.5 Schematic of cryostat in place, with cryostat header and resonator
However, we need access to fill and evacuate the sample space with resonator in place.
For this reason a cryostat header was designed andmanufactured of near identical design
to the standard Bruker cryostat header but with 2 DN16 connections, one for gas control
and one for an overpressure valve. Exact specifications can be seen in the technical draw-
ing in figure 1.13 on page 14. The cryostat was manufactured out of brass to minimize
interference with the magnetic field.
A 50 mm ID, 3 mm width O-ring is required between the cryostat and header, this can be
greased with high vacuum grease to ensure a good seal. The header is then sealed in
place with 6  5mm washers and screws.
Between the header and resonator a standard DN40 O-ring and placement ring can be
used in conjunction with a DN40 compression clamp.
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1.6 Gas line set up
The sample space requires to be filled with helium gas and held at an underpressure. For
this reason a simple system of vacuum parts was assembled such that the sample space
could be controlled and isolated.
Cryostat
Header
Overpressure
valve
Tubing
Underpressure
gauge
Isolation
valve
Helium in
Pump out
Helium
valve
Figure 1.6 Schematic for the gas line set up into the cryostat sample space
The system shown in figure 1.6 allows for the helium to be turned on and flood the sys-
tem. An overpressure valve (rated to 1150 mbar) stops any damage to the cryostat. The
helium flow can then be shut off and pump turned on to evacuate the sample space whilst
monitoring on the underpressure gauge (10-1000 mbar), the Oerlikon Leybold TM101 is
recommended by the author. The isolation valve then allows the sample space to be held
at this pressure even when the pump is turned off, allowing judgement as to whether there
are any leaks in the system.
Depending upon your system, you may find it easier to put isolation valves inline off of
the T-piece such that the pump and helium source can be isolated from one another. This
gives the benefit of not having to turn the pump off during flushing of the cryostat.
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1.7 Sample temperature sensing
To test the temperature at the sample it is necessary to construct a temperature sensor
that can sit in the same position as the samplewould and accurate report the temperature.
For this reason, a LakeShore Cernox CX-AA was purchased. A Cernox was chosen over
other cyrogenic temperature sensors due to its high temperature sensitivity and low re-
sponse to magentic fields. The relatively small size allowed the the Cernox to be placed
inside of a standard low temperature X-band EPR sample tube.
The sample tube was placed into a sample stick and wires run through, the challenge then
lay in making a connection through the sample stick end whilst maintaining the vacuum.
For this 10 pin cryogenic adapters (similar to that used by Oxford instruments) were used
with a hood being soldered onto the sample stick and a male connection screwed down
onto an O-ring inside the hood. The female connection was then run to a multimeter to
read the resistance, which could later be transformed into a temperature.
(a) Connector hood (b)Male connector (c) Female connector
(d) Complete temperature sensor on the bench
Figure 1.7 Cernox photographs
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1.8 Vibration dampening
Once the cryostat is in place with all necessary connections made for operation it is im-
portant to brace the cryostat in place so that vibrations are minimised during operation.
All vibrations from the valves on the cold head will be able to be seen on a cw experiment
(see figure 1.8), for strong signals this should not be a problem but may cause problems
for very weak signals; compare the intensities of figure 1.8a to 1.8b.
(a) The baseline taken from a non-signal part of the spectrum
(b) The full spectrum of the Mn/DPPH-KCl standard
Figure 1.8 Noise from the displex system shown in Xepr at Q-band
It is important to isolate the microwave bridge as much as is possible from the cryostat,
if the cryostat is in direct contact with the bridge platform it will be impossible for you to
lock your signal during tuning.
With no vibration protection there is a risk that the cryostat falls over, this should have
already been protected against through use of the heavy resin plinth. The most effective
solution however was to place both microwave bridge and cryostat on a cut-down yoga
mat. For further stabilisation (and thus reduce noise) it is recommended to surround the
base of the cryostat with sand bags.
Finally X-band waveguide stabiliser arms can be used to wedge the top of the cryostat
to the top of the magnet or the microwave bridge shelf cut out in the short term. A more
effective long termsolution, is to remove the cryostat fromanOxford flow cryostat system,
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which leaves a horse-shoe shaped platformwhich fits between themagnet poles. A brace
can then be constructed using padded tape and installed at the top of the cryostat, detailed
in figure 1.9.
Finally, it is important to remember that signal averaging is most beneficial here. For
pulsed experiments the timescale of the experiment is much shorter than the mechan-
ical action and so will not be a problem, but for cw a single scan will contain many pump
actions. The statisical chance that the spectrometer scan rate is exactly matched to the
mechanical action is remote, thus signal averaging will average away any remaining vi-
brational noise. This can clearly be seen in figure 1.10 where an ~10 M nitroxide spin
labelled protein is being run at S-band, 80 K. This is both a weak sample and a low res-
olution frequency and represents the worst possible situation, at X- and Q-band these
vibrations average away almost instantly.
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Figure 1.10 Signal averaging affect on noise from the displex system shown on a weak nitroxide labelled protein
at S-band, 80K
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1.8 Vibration dampening
(a) Cut down tape to correct width and fit
inside brace piece
(b) One half of brace shown from side
(c) Oxford flow cryostat with cryostat re-
moved
(d) Remove top screws and top ring
(e) Attach bottom brace piece to cryostat
holder
(f) Completed brace unit
(g) Brace in place - side view (h) Brace in place - top view
Figure 1.9 Construction and installation of vibration brace clamp
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1.9 Technical drawings
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Figure 1.11 Technical drawing of the cryostat plinth
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Figure 1.12 Technical drawing of the vacuum shroud adapter so that the cryostat can be attached to a vacuum
pump inside the magnet
13
1 Installation
4 10
3
⌀8 ⌀30
3
⌀7
⌀52.5
⌀75
⌀40
150
Top
Side
Grey shading indicates
a 2mm recess
⌀51
⌀57.5
⌀40
150
Bottom
30°
⌀5
⌀16
⌀30
20
⌀75
⌀62
0.75
Figure 1.13 Technical drawing of the displex header for conversion of the cryostat to a DN40 connection.
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Figure 1.14 Technical drawing of the Hall probe holder
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2 Calibration
2.1 Hall probe
Since the Hall probe has been relocated from within the rapid scan plates to a slightly
different position upon the magnet shoe (and thus within the magnetic field), it requires
to be calibrated again.
Ideally with the additional use of a Gaussmeter / Teslameter to accurately measure the
magnet field, insert an EPRstandard into the spectrometer and run a simple cwexperiment
to precisely find the field location of the standard centre line.
Using the spectrometers frequency counter and g-value of the standard calculate the ex-
pected peak position.
The relationship of magnetic field and radiation is given as
h = B:g:B0 (2.1)
Where h is Planck’s constant (6:626  10 34m2:kg:s 1),  the frequency of radiation, B
the Bohr magneton (9:274×10 24 J:T 1), g the g value of the standard andB0 the magnetic
field. Rearranging equation 2.1 gives:
Expectedmagnetic field =
6:626×10 34  Microwave frequency
gstandard  9:274×10 24 (2.2)
Calculate the field offset by taking the experimental magnetic field from the expected
magnetic field. In Xepr, go to Acquisitionmenu and select Spectrometer Configuration. In
the new window click on the Field tab and insert the calculated value into the Field Offset
field.
2.2 Pressure testing
ARS in their documentation state that the displex units should be operated at a 50 mbar
helium environment. Helium is required as at the very low temperatures (< 20K) expected
in the normal operating conditions normal laboratory gases such as nitrogen, oxygen,
carbon dioxide, compressed air, argon would all condense and freeze forming a solid layer
over the cold plate surface and minimise heat transfer.
Helium pressure needs to be carefully regulated within the displex cryostat as the helium
is the primary thermal energy transfer agent between the sample and cold plate. Too low a
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pressure and heat transfer wil take several hours to cool the sample. Too high a pressure
will allow for thermal transfer energy from through the resonator to the cold plate and
raise the base temperature.
2.2.1 Empty cavity testing
Upon initial investigation it was indeed found that the displex units cool the cold plate at
an optimum efficiency of 50mbar. Higher pressures of helium allow for a much increased
thermal energy transfer from the blanking plate on top of the cryostat; these convection
currents mean that the cold plate never reached temperatures below 20 K. Pressures
below 50 mbar whilst being acheivable are difficult to accurately control using standard
lab equipment and required the use of a turbo pump. Additionally the further dropping of
pressure provided little additional drop in base temperature due to the very little amount
of gaseous helium left to transfer thermal energy.
2.2.2 Leak testing
Fundamentally, trying to test the displex cryostat with a resonator in place at low pres-
sures causes problems from leaking. Operating at the recommeded 50 mbar means that
the inside of the cryostat is at 1/20th of atmospheric pressure and represents a large pres-
sure gradient.
S- and X- band resonators with their semi-flexible microwave connections showed ini-
tial leaking of > 50mbar/min from 50mbar, with a reduction to ~ 10 mbar/min at ~ 400
mbar. Q-band resonators with solid waveguides could only achieve 50mbar after exten-
sive pumping and leaked at a rate of over > 200mbar/minwith stabilisation at 1000mbar,
even with careful placement and replacement of mylar sheaths.
Clearly, leaks needed to be minimised. The following steps were required:
 Replacement and vacuum greasing of the O-ring between cryostat and cryostat
header
 Replacement and vacuum greasing of the O-ring between cryostat header and res-
onator
 Replacement and vacuum greasing of the O-ring at the entry port to the resonator
 Slight greasing of entry port, as the entry port blanking piece is slightly thinner than
a sample stick
2.2.3 Gas desorption
Despite all themeasures taken for leak testing, it remained very difficult to establish a sta-
ble under pressure within the cryostat. In the testing with S- and X- band resonators the
pressure stabilised around 400mbar after being pumped down to 50mbar. We needed to
test whether 400mbar represented a pressure gradient low enough between atmosphere
and cryostat not to leak further or whether there was no leak and that the 350 mbar in-
crease in pressure was from gas desorption of the cryostat walls.
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2.3 Pressure optimisation
In the first test under air the cryostat was pumped down to 50mbar on a rotary vein pump,
and the pressure traced for a minute. As expected it raised ~ 10 mbar/min, after the
minute the cryostat was pumped back down to 50 mbar and monitored. This time the
leak rate reduced to ~ 8mbar/min. After a further 4 pump downs, the pressure remained
steady at 50mbar for the minute. Leaving the cryostat overnight, the pressure crept up to
200mbar.
The second test was to leave the cryostat overnight attached to a rotary pump. After 15
hours the cryostat was isolated from the pump and the cryostat pressure returned to 50
mbar with gaseous helium. Over the next 24 hours, the cryostat showed no increase in
pressure. The same effect could be achieved using a turbo-pump in a much shorter time.
Further testing with helium pressurization shows that helium does not adsorb to the walls
of the cryostat. For this reason, when the cryostat is not in use it should be stored under
atmospheric helium to minimise air adsorption to the walls of the cryostat.
If the cryostat is unused for any extended period of time then it should be pumped on with
a rotary pump for at least 12 hours (overnight) before use.
2.3 Pressure optimisation
Charles’s and the ideal gas laws tell us that as the temperature of a closed systemchanges
the volume will also change or where the volume cannot change the pressure of the con-
tainer will. Thus, it follows that a pressure set for the cryostat at room temperature will
drastically reduce as the cryostat is cooled according to the rearrangement of the ideal
gas law
P =
nRT
V
(2.3)
Where, P is the pressure of the gas, V is the volume of the gas, n is the number of moles
of gas, T is the temperature of the gas and R is the ideal gas constant (8.31 J:K 1:mol 1
(3 sf)).
Taking the volume of the cryostat space to be ~ 4.89 10 4m3 (350 mm height  42
mm diameter). A room temperature pressure of 50 mbar becomes 1.68 mbar at 10 K
assuming an ideal gas. For this reason the gas pressure inside the cryostat needs to
careful monitored once the cold plate is down to temperature, so that the experimental
pressure reflects the desired.
The further addition of any helium, will bewarmheliumand so cannot be accurately judged
when adding. It is therefore recommended that the cryostat is cooled at a deliberately
higher pressure, allowed to cool to temperature before being pumped upon. The pumping
will result in a slight change in temperature but the result is negligible.
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2.4 Final calibration
Following optimisation of parameters a final calibration experiment was conducted in
which the set temperature of the LakeShore, reflecting the cold plate, was compared to
the temperature experienced at the sample. Temperatures were recorded using a pre-
calibrated Cernox semi-conductor from LakeShore. Details of the Cernox assembly con-
struction can be found in section 1.7.
Cryogenic temperatures (< 80 K) were allowed to equilibriate for 300 s before any mea-
surements were taken, at which point Cernox resistance and pressure were monitored for
30 s to ensure that they were both stable. For above cryogenic temperatures the Cernox
resistance and pressure were not stable after the 300 s and so were given 1200 s before
confirming stability and taking a measurement. These results hold true for the Bruker
pulsed ER 4118X-MD5 resonator.
LakeShore Cernox Pressure Gauge
Set /K Sensor A /K Sensor B /K Heater / % Resistance / 
 Temperature /K Pressure /mbar
8.0 7.94 8.18 3 2870.0 9.12 126.9
9.0 8.95 9.18 30 2523.0 10.14 138.2
10.0 9.99 10.24 45 2253.0 11.14 148.9
11.0 10.98 11.22 60 2042.0 12.13 158.4
12.0 11.98 12.24 75 1872.0 13.06 167.9
13.0 12.99 13.26 85 1718.0 14.10 176.9
14.0 14.00 14.28 88 1604.0 14.99 186.2
15.0 14.98 15.26 94 1492.0 15.98 194.7
17.5 17.48 17.73 30 1278.0 18.45 214.5
20.0 19.99 20.18 31 1125.0 19.78 232.6
25.0 25.01 25.11 37 895.0 25.63 265.6
30.0 30.00 30.16 39 741.6 30.71 296.8
35.0 35.00 35.20 41 633.0 35.35 324.1
40.0 40.00 40.22 42 551.3 40.41 348.8
45.0 45.00 45.22 44 488.0 45.20 371.8
50.0 50.03 50.02 45 444.0 49.60 393.7
55.0 55.00 55.18 45 398.4 54.94 422.5
60.0 60.00 60.14 46 365.1 59.54 449.7
70.0 70.02 69.97 48 320.7 67.34 486.3
75.0 75.00 74.97 48 292.9 73.32 511.0
80.0 80.00 79.00 49 274.1 77.94 529.5
85.0 85.00 84.73 50 264.0 80.88 544.1
90.0 90.01 89.70 50 245.0 86.89 563.0
100.0 99.87 99.16 53 227.0 93.31 588.7
150.0 150.00 148.08 63 149.7 138.54 703.0
293.0 292.94 293.37 0 72.4 278.00 1062.0
Table 2.1 Final calibration data table for the pulsed X-band resonator. The LakeShore columns show the set
temperature, readings from the 2 sensors inside the displex unit and the extent of heater current at each
temperature (temperatures in italics show the ``Medium'' heater range (8 - 15 K), normal type indicates
the ``High'' heater range. The Cernox columns show the experimentally measured resistance across the
semi-conductor as well as the transformed temperature.
2.4.1 Temperature offset
As previously explained, the temperature at the sample position will never completely
match that of the LakeShore sensors within the cold plate of the cryostat due to a slight
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temperature gradient across the cryostat and the fact that the sample is reliant upon the
passive cooling of cold helium removing the thermal energy.
The LakeShore had temperatures set such that areas of particular experimental interest
(<15K , ~50K and ~80K) were sampled more in the hope of giving a better local fit.
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Figure 2.1 Temperature offset between that set on the LakeShore and that measured at the sample
Fitting of the data yields f(x) = 0:9242x + 2:5535 (R2> 0.999) showing that across the
cryogenic range the relationship between the LakeShore set and sample temperature is
linear and almost 1:1 with an offset of 2.5K.
2.4.2 Temperature sensors and pressure
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Figure 2.2 The temperature from different sensors and pressure against the LakeShore set temperature. In black
the Cernox temperature, in red LakeShore Sensor A, in green LakeShore Sensor B, in blue the pressure.
The temperatures are fitted with a straight line, whilst the pressure is fitted with a first order exponential.
Fitting of the data yields Sensor A f(x) = 1:0000x   0:0128, Sensor B f(x) = 0:9889x +
0:4971, Cernox f(x) = 0:9242x+2:5535 (4 dp) andpressure f(x) = 70:96+387:57 exp x/89:96(2
21
2 Calibration
dp) (R2> 0.995 for all). This figure highlights the experimental range of certainty, as tem-
peratures rise above the cryogenic a greater discrepancy between the LakeShore sensors
within the cold plate and the sample is seen. This could be as a result of the increased
pressure of helium within the cryostat allowing for more transfer of thermal energy from
outside the cryostat to the sample.
The pressure recordings clearly show a curve that fits an exponential very well, and not
the linear relationship expected for an ideal gas.
2.4.3 Cooling time
The final experiment was to simulate a sample insertion or sample change. Samples will
be held in liquid nitrogen before being put into the cryostat to pre-cool the sample to 77
K , this ensures that the sample is flash frozen before entry and minimises the heat load
put onto the cryostat upon sample insertion. It is important that any sample has reached
thermal equilibrium before any experiment is conducted as physical magnetic properties
are heavily influenced by temperature.
For this experiment the cryostat was set to base temperature, representing the largest
temperature difference possible for the set up.
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(b) Pressure profile
Figure 2.3 Cooling profile of a simulated sample from liquid nitrogen into a cryostat running at base temperature,
shown from point of isolation of the system from the helium over-pressure immediately after sample
insertion
The figures show that the temperature of the systemdrops following an exponential decay
fashion whilst the pressure shows more of a reverse sigmoid profile. Suggesting that
the thermal energy in the sample is sufficent to keep the helium pressure high, and as
the energy in the sample is removed the helium pressure begins to drop rapidly. Both
temperature and pressure being to equilibriate after 300 s (5 minutes), with no further
changes after 400 s.
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Warning: displex units should never be in operation filled with anything other than high
purity helium
3.1 Installing a resonator
With the displex unit in place, prepare the resonator. S- and X-band resonators can use
semi-flexible waveguides and are not a problem. For Q-band resonators assemble the
waveguide before installation
(a) Before assembly (b) After assembly
Figure 3.1 Assembly of the waveguide to a Q-band resonator
Bruker resonators are not (despite appearances) circular, instead being elliptical in one
direction; with windowed displex systems (for use with optics/lasers) It is important to
rotate the resonator so that the black block (containing the modulation coils) on the bot-
tom so they can pass the window lip, whilst some resonators will be unable to be used in
their standard position.
3.1.1 S-band
TheS-band resonator is the easiest of resonators to install as the resonator is the smallest
and requires no rotation and can be simply slide straight into position.
Attach the clamp and tighten, so that the O-ring is compressed. Attach the semi-flexible
waveguide. Finally attach the modulation cable to the resonator.
On the console’s Microwave Bridge Controller set the pins to (pins 1-4 down, down, up,
up).
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(a) The bottom of the resonator (b) Insertion at 90° clockwise
(c) Turning back 45° at the window (d) Turned completely back at full insertion
Figure 3.2 Insertion of a Bruker Q-band resonator (Bruker ER 5106 QTW)
24
3.2 Turning the displex unit on
3.1.2 X-band
The X-band resonator needs to be inserted at 90° anticlockwise until past the window,
at this point the resonator needs to be rotated a further 90° anticlockwise such that it is
rotated 180° from the normal flow cryostat position (with modulation and temperature
connections at the back).
Attach the clamp and tighten, so that the O-ring is compressed. Attach the semi-flexible
waveguide. Finally attach the modulation cable to the resonator (remember that the res-
onator is now rotated 180°).
On the console that the Microwave Bridge Controller has the pins set to (pins 1-4 down,
down, up, up).
3.1.3 Q-band
The Q-band resonator is the trickiest of the resonators to install (and also the most ex-
pensive) and is shown pictorially in figure 3.2. It is recommended to attach the waveguide
to the resonator before insertion into the displex unit, as once in place access to the back
of resonator is very difficult.
The resonator is inserted at the 90° clockwise position. At the window, turn the resonator
anticlockwise 45° and lower to the bottom. At the bottom the resonator can be rotated a
further 45° anticlockwise so as to return to its normal, front facing position.
Attach the clamp and tighten, so that the O-ring is compressed. Attach the waveguide to
the bridge. Finally attach the modulation cable to the resonator.
On the console that the Microwave Bridge Controller has the pins set to (pins 1-4 down,
up, up, down)
3.2 Turning the displex unit on
Ensure that all O-ring connections are tight and air tight
Pressurize the helium bottle valves to approx. 0.5 bar
Open the helium bottle valves to a gentle flow, ensure that there is an overpressure on the
flow gauge
Open the displex isolation valve for 2-3 s filling the cavity space
Shut off the helium at the needle valve, and turn on the vacuum pump
Pump down the system to under 50mbar
Turn off the pump and open the needle valve and allow to fill to 1000mbar
Repeat, pumping and flushing of system 5 times to ensure high purity helium inside sam-
ple space
Mostly close the fine control on the flow gauge, turn on vacuum pump and pump down
sample space to exactly 50mbar
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Figure 3.4 The Advanced Research Systems ARS-2HW compressor, taken from arscryo.com
Close the sample space isolation valve
Turn on the intelligent temperature controller (LakeShore)
(a) The discontinued 332 front panel (b) The new 335 front panel
Figure 3.3 LakeShore front panel, taken from lakeshore.com
Press 6, “Set point” on model 332 or SETPOINT on the 335 model
Set temperature using the number pad and press Enter
Press Heater Range, using the arrow buttons select High and press Enter
The front panel should now read that A and B are room temperature (~298K), S the tem-
perature entered and in the bottom right “0% High”
Move to the compressor
Ensure the GAS SUPPLY PRESSURE gauge is at ~ 15 bar. Do not continue if it is signifi-
cantly lower than this
Ensure that the cooling water is flowing (open taps if necessary)
WEARING EYE PROTECTION: Press the green power button located at the top left of the
compressor unit
The unit will very rarely start on first press. Typically the compressor requires
up to 5 attempts to start. If it still will not start check the cooling water supply,
the unit has a built in safety feature that measures the water pressure and
temperature. The water must be below 35 C and free from air.
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3.3 Changing samples
Upon successful powering on of the compressor the characteristic valved system noise
will be audible and the GAS SUPPLY PRESSURE gauge will increase to ~ 20 bar.
Check the readings on the LakeShore to ensure that the heat stages are cooling
For a well constructed system during cooling at 200 K , isolate the vacuum shroud from
the turbo-pump.
At approximately 200K any remaining gaseous particles will condense to the
cold side of the shroud and create a near perfect vacuum. At this point even
a turbo-pump will not have enough draw to stop molecules being pulled back
through the pump into the vacuum shroud. This can potentially damage the
pump. Whilst 200K does not need to be strictly adherred too it certainly needs
to be done before 100 K (boiling points of common air components are: CO2
195 K , O2 90 K , N2 77 K). For systems with even slight leaks in the vacuum
shroud then the pump should be left open.
Wait for the displex unit to get to temperature by monitoring the LakeShore. 80 K ~ 90
min, 10K ~ 2 h.
3.3 Changing samples
Ensure the spectrometer is in a state suitable for changing of samples (tune mode).
Open the helium bottle valves so that the system is under pressure, open the needle valve
so that there is an helium overpressure.
Open the sample cavity isolation valve, allow pressure to raise from an underpressure to
an overpressure, with the overpressure audibly releasing the overpressure release valve.
If unfamiliar with the system it is better to extensively overpressure the system
to the extent that the overpressure valve on the can audibly be heard than risk
getting moisture in the system. This will freeze your next sample in place and
require warming of the system back to room temperature to remove.
Loosen the sample O-ring on top of the resonator (around the sample stick), and remove
the previous sample or resonator blanking piece.
Slide the sample stick into the correct position within the resonator.
Close the sample O-ring on the resonator.
Close the sample space isolation valve and monitor the pressure inside the cryostat as it
closely reflects the sample temperature.
Allow approximately 3 - 5 min for the sample to equilibriate to temperature before con-
ducting any experiments.
In the process of changing samples the LakeShore will read a jump in approx-
imately 10-30 K (depending upon the speed of switching). This is normal and
due to the increased amount of (warm) helium in the sample space. As soon
as the sample space has been isolated the LakeShore will stabilise again by
adjusting the heater current.
NOTE: As samples are maintained in an inert helium atmosphere, the samples should
never boil off liquid nitrogen on removal as would occur with traditional flow cryostats.
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3.4 Turning the displex unit off
Remove the sample and replace with the resonator cap as per §3.3.
Close the sample space isolation valve. It is not necessary to pump down the cavity, but
doing so will keep the displex unit cold for longer. Doing this ensures that no moisture
enters the cavity whilst it is still cold, else upon warming this moisture would condense
and sit on top of the copper heat stage and corrode it.
Go to the compressor and turn it off at the (green) main power switch. This should be
accompanied by a hiss as the pressure drops.
For a slow warm up the Lakeshore can simply be turned off.
For a quick warm up (for a change of resonator for example) then the best way is to use
the LakeShore’s ramping facility.
On the LakeShore 332:
1. Change the setpoint (press 6) to desired temperature (ie 80 K, 290 K). The ramp will
only go to the set point.
2. Press 1 “Control Setup”
3. Press Enter (5 times) until the display reads “Select for Loop 1, Setpoint Ramp Off”
4. Press the Up arrow so that the “Setpoint Ramp” is “On”, press Enter
5. Enter the ramp rate in Kelvin/minute on the number pad and press Enter. It is not
recommended to set this above 10 K/min as rapid heating could be dangerous to
the heater coil and cause rapid expansion in the displex unit.
6. To cancel the ramping press 1 “Control Setup” and immediately press 6 “Setpoint”,
this pauses the ramping. To completely turn it off press 1 “Control Setup”, press
Enter (5 times) until the display reads “Select for Loop 1, Setpoint Ramp On”, and
turn it off.
On the LakeShore 335:
1. Change the setpoint (press SETPOINT) to desired temperature (ie 80 K, 290 K)
2. Press 6 “RampRate”
3. Enter the ramp rate in Kelvin/minute on the number pad and press Enter. It is not
recommended to set this above 10 K/min as rapid heating could be dangerous to
the heater coil and cause rapid expansion in the displex unit.
4. To cancel the ramp press 6 “RampRate” and set it to 0 K/min
Finally turn the LakeShore off, the power switch is at the back (top right when viewed from
the front).
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4 Troubleshooting
During the course of installation and running of the displex units you will come across a
couple of common problems. The following section hopes to address and solve some of
these frequent problems.
Why can I not see any signal?
First of all check your sample, check it in a standard room temperature machine and see
that there is a signal there. If there is no signal, is the modulation cable attached to the
resonator.
If you are confident in your sample, then check your sample height. During the isolation
and cool down, if your sample was not completely secure then it may have been sucked
out of the holder and into the sample space. If adjusting your sample height shows no
movement in your tuning dip then this is likely your problem.
Remove your sample, if the sample is still there then try insertion, otherwise you need to
allow the sample space to warm to at least 80 K, remove the resonator and recover your
sample. Make sure the displex unit and resonator are completely dry before reinserting
the resonator and cooling down again.
The magnet power supply keeps overloading
The magnet power supply is controlled via direct feed back from the Hall probe. Check
that the Hall probe is still between the poles of the magnet and has not fallen off.
Samples keep freezing inside the resonator and cannot be removed
Ramp up the LakeShore to 80 K and quickly remove the resonator from the sample space
as you turn off the heater on the LakeShore.
As the resonator is removed does it drip? Does the LakeShore heat stages hold at 80 K
for a few minutes despite the system being open? If you look inside the sample space is
there any liquid boiling?
If yes, this is liquid nitrogen.
The cause of this is the O-rings and seals to the displex unit are not vacuum tight. Each
time the sample space is pumped down the underpressure is sucking in air, which is then
condensing and covering the base of the sample space. This effect is cumlative so often
only your 3rd or 4th sample will freeze in place.
If this only happens after many sample changes then your helium flow is not high enough
during sample changes, or the sample tubes have condensation over them when inserted
into the resonator.
The displex unit will not (/ is taking a long time) to get down to temperature
This is usually caused by the sample space containing some amount of nitrogen or air,
as the displex unit cools the gases will first condense and pool at the bottom of sample
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space as cooling continues the pool will freeze. This is potentially damaging for copper
heat stage and insulates the sample space from the cold.
Ramp up the LakeShore past 80 K, this should boil off any nitrogen, then pump-flush the
sample space with dry helium before pumping down and cooling down again.
The vacuum pump will not start
The vacuum pump has a safety feature where it will not spin up if the pressure is too low
as it may damage the pump.
Open the line to the helium cylinder and return it to atmospheric pressure (1000 mbar).
Start the pump.
After opening the needle valve it takes a long time for the pressure to rise
Are the other valves on the helium bottle open? Is the helium bottle empty (as shown by
zero pressure on the inlet pressure gauge)? Has the hosing between the bottle and system
come lose?
The compressor will not start
First check that the compressor is plugged in and turned on
Is the cooling water on? Are the taps open? Is the water cold? Is the system pressurized?
Are the helium lines securely attached?
Finely check the compressor fuses and the number of operational hours. If the operational
hours are~10,000 hours then the compressor needs a service. Consolt themanufacturers
instructions.
After pumping down the system there is a high pitched whine
After flooding the sample space with helium occasionally the overpressure valve can get
caught and stay slightly open. This can be verified by a lose in underpressure from the
sample space.
Simply pull on the overpressure valve and release, hopefully it should relocate into its
normal resting position.
The entire cryostat has visibly frosted up on the outside
This will occur when the vacuum shroud between the cavity space and outside world is
not at high vacuum. This will also be seen on the LakeShore, as the additional heat load as
heat enters the cavity spacewill cause the LakeShore struggle tomaintain the temperature
and may have crept up.
As we do not know the vacuum level, ensure that the turbo on the vacuum pump is off
and open the vacuum shroud to the vacuum pump. Once the vacuum pump has reached
a good vacuum again turn on the pump and turn the turbo back on, you can continue your
experiment with the turbo pump open.
If a good vacuum cannot be achieved, immediately stop the experiment and check the
fixtures between the vacuum shroud and pump. If these appear fine and but the problem
persists try the tubing and connectors on another systemwith a blanking plate to simulate
the cryostat. If they are fine, consult the manufacturer, it may be that there is a small leak
and that the cryostat simple needs to be run with the turbo pump constantly.
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The LakeShore seems to have no effect on temperature
Make sure that the LakeShore has a temperature set (the S value on the main display) and
that the heater is turned on (the main display does not show “Htr Open”). If the LakeShore
appears to otherwise be operational check that the connection to the displex unit is firmly
attached and clipped into position.
The LakeShore frequently displays the error “Htr Open”
The LakeShore 332 has a protection circuit that monitors the heater current and voltage
and shuts down the output when it detects a short or resistance that is less than 10 
 or
an open condition which is around 400 to 500 
.
First make sure that everything with the cryostat is fine.
 Check the pressure in the cavity space and ensure that is approximately correct or
at least dropping. If it is rising there is a leak and the heat load is causing the open.
 Feel the outside of the cryostat. The vacuum shroud should maintain that the out-
side of the cryostat is at room temperature. It will be a little cold, but should be
approximately the same as the magnet. If it is cold then the vacuum shroud is not
at high vacuum. Follow instructions for “The entire cryostat has visibly frosted up
on the outside”.
 Check that the connections between LakeShore and cryostat are firmly in place.
If the equipment appears fine, have you recently set a new temperature that is far from
the previous temperature? Having the heater on 100 % for more than a few seconds will
safety it.
The LakeShore can be prone to spikes on movement. For example if the LakeShore has
been on for a week with the heater at 29 % and the temperature is changed that a change
to the heater to 30 % may cause a spike and safety the heater open.
This can be tested by slowly stepping up the temperature and seeing if the error comes as
a result of crossing a particular temperature or heater current. Regretfully, thermal opens
are very difficult to troubleshoot as they close up almost immediately after the heater
current is removed.
With everything said above, it is possible that the protection circuit in the LakeShore is
defective. You can test the circuit using a fixed 50 Ω / 50W resistor in place of the heater.
Set the setpoint above the control temperature and let it run until the output reaches 100
% and if it does not shut off within 30min, the controller is OK. One word of caution is that
the resistor will become very hot and you must use caution if you try this test.
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Glossary
Base temperature the coldest possible temperature that the displex unit stabilises at
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C. MISHAP manual
MISHAP has been designed and built to be as intuitive as possible for a novice user. It is
intended that MISHAP be distributed with exemplary files and an user manual to facilitate
understanding of the software as well as provide some explanation as to core modelling
concepts and assumptions made in the modelling process.
The following material is the intended MISHAP user manual to be distributed with MISHAP.
The MISHAP manual is split into 3 key sections:
1. A general introduction to MISHAP, including what MISHAP does and the problem to
which it address. In addition, a getting started guide showing the installation and con-
figuration of MISHAP and HADDOCK is included.
2. The main documentation. A discussion of main graphical user interfaces used in
MISHAP (and MMM), including how each operates and common mistakes. Finally
a description and discussion of HADDOCK parameter files and how MISHAP adapts
them for the use of EPR.
3. A full worked example of using MISHAP in a docking run.
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1 General
1.1 Overview
1.1.1 What is MISHAP?
MISHAP is the open-source MMM in silico simulated spin label to HADDOCK program. It
combines several MatLab scripts, functions, programs and user interfaces as well as a set
of additional parameter files for HADDOCK.
MISHAP aims to take spin labelled proteins and the distance distributions between labels
from in silico (MMM) calculations or experimental data (from pulsed electron-electron dou-
ble resonance experiments which have been analysed with DeerAnalysis) and pass them to
the biomolecular docking program HADDOCK as docking restraints.
1.1.2 Functionality
MISHAP provides the ability to generate HADDOCK compatible PDB files of single chains
of amino acids where one or more residues have been substiuted for nitroxide spin label
attached cysteine residues.
MISHAPcangenerate distance baseddocking restraints frompulsed EPRexperiments (PEL-
DOR/DEER) when they have been analysed with DeerAnalysis or MMM.
The generated PDB files can be used in conjunction with or without the MISHAP generated
distance based docking restraints to help determine the docking of protein complexes.
Currently, MISHAPonly supports the generation ofmodels and restraints in proteins. Though
the open-source nature will allow for the expansion of MISHAP to accept non-nitroxide spin
labels, DNA, RNA and other common ligands.
1.1.3 Interface
The user interface of MISHAP initially consists of a simple installer that installs MISHAP as
well as modifying any existing installations of MMM and HADDOCK.
After installation the user interface largely consists of 2 windows. The first handles the
distance restraints whilst the second handles the generation of HADDOCK compatible PDB
files.
The changes to HADDOCK allow for the user to continue using HADDOCK normally via the
command line with the addition of being able to use the residues R1A (MTSL attached cys-
teine) and IA1 (IA-PROXYL attached cysteine).
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1.1.4 Help
MISHAP is designed to be as intuitive as possible whilst still maintaining user control. With
this in mind, all options are clearly labelled as well as extensively documented in this docu-
ment as well as online at morganbye.net/mishap
1.2 Getting started
1.2.1 Getting MISHAP
MISHAP is available online from 2 locations.
MISHAP general releases (for most users) should be downloaded from:
https://sourceforge.net/projects/mishap/
MISHAP developer releases (constantly updated and should be considered unstable) can be
obtained from the git repositary
https://github.com/morganbye/MISHAP
Alternatively, you can create a new git folder and pull the repository directly from the com-
mand line with:
git pull https://github.com/morganbye/MISHAP.git
1.2.2 Installing MISHAP
If MISHAP was downloaded from sourceforge then it will come as a ZIP file which includes
everything required. Simply unpack the ZIP file into a directory of your choosing. The folder
should contain several text files including; LICENSE.txt, README.txt and UPDATE.txt. There
will also be MISHAP.m; the main MatLab file and 2 directories: test_files containing some
example files (referenced later) and _private which contains all the files associated with
MISHAP.
The extracted folder needs to be added to the MatLab path with subfolders to the; this can
be done be navigating to the folder in the Current folder view, right clicking and selecting
Add to Path! with Selected folders and Subfolders
or by clicking from the main MatLab menu
File! Set Path
in the main MatLab window, then click Add folder with subfolders then Save and Close.
The MISHAP installer then needs to be run. This is detailed in §2.2, but simply in the MatLab
command window type
MISHAP
This begins the installation of MISHAP.
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1.3 Change history
Release v13.08 - BETA
v13.08 shows much improved error handling and allows for MISHAP generated PDBs be
reloaded in the PDB creator and have additional spin labels attached.
Release v13.06 - BETA
v13.06 is the first publicly viable release of MISHAP and marks the first build from alpha.
It shows far greater error handling, Windows compatibility and an improved graphical user
interface. MMM and MatLab programming is complete but significant errors still occur in
HADDOCK/CNS.
Build v13.05 - ALPHA
v13.05 is the first functional build ofMISHAP that generates distance distribution constraints
and MMM rotamer merged PDBs.
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2 User interface
2.1 MMM
MMM is an open-source program for the visualisation, inspection and improvement ofmod-
els of proteins and protein assemblies based on restraints frommultiple experimental tech-
niques, though primarily focussing on experimental techniques from electron paramagnetic
resonance1.
2.1.1 Save rotamers from MMM
Perhaps MMM's most useful feature is the ability to calculate the rotamer populations of
nitroxide spin labels attached to proteins.
For MISHAP we require these spin label attached protein models. To generate a rotamer
model first start MMM from the MatLab command window with the command
MMM
After the splash screen, load a PDB model using the Filemenu - more information available
in the MMMmanual §2.1.1.
Figure 2.1 Loaded protein model in MMM
The protein model should be visualised in the Model panel whilst the Message board should
update.
Next select a residue. To do this at the command line level type
select [structure](chain)residue
the strucutre option is not necessary depending upong the file (MMM §1.6). Residue selec-
tion can also be done graphically using:
1MMM - http://www.epr.ethz.ch/software/index
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Figure 2.2 Select a residue in the command line
Display! Hierarchy (MMMmanual §2.3 and 4.1.2)
However, the command line is superior as it allows the selection ofmultiple residues at once.
Figure 2.3 Message board update showing the select residue(s)
Once a residue is select the message board will update with the selection. If a selection is
made incorrectly use:
unselect [structure](chain)residue
Once happy with the selection we label the selected residues with:
EPR! Site scan/selected residues (MMMmanual §2.1.7)
Figure 2.4 MMMmenu showing the site scan option
This displays the Site scan setup window (MMM manual §4.1.2). It is imperative that Save
statistics and Save PDB rotamers are selected.
Selecting Save PDB rotamers will display a warning message. Ensure that you click Yes.
ClickingOKwill display the Set labeling conditions for selected residueswindow. Here select
the appropiate nitroxide spin label and temperature.
Finally a prompt appears to set the save path of the rotamer analysis files
The rotamer analysis can be tracked in the message board and once complete a prompt
appears to ask if the user wishes to view the results in a browser.
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Figure 2.5 MMM site scan setup window
Figure 2.6 MMM site scan warning dialogue
2.2 MISHAP Installer
Installation of MISHAP is kept as much as possible within the MatLab environment for sim-
plicity.
To install MISHAP, extract the MISHAP zip folder. Add the folder with subfolders to the Mat-
Lab path; this can be done be navigating to the folder in the Current folder view right clicking
and selecting
Add to Path! with Selected folders and Subfolders
or by clicking from the main MatLab menu or by clicking
File! Set Path
in the main MatLab window, then click Add folder with subfolders then Save and Close.
In the MatLab command window now type
MISHAP
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Figure 2.7 MMM site scan labelling conditions window
Figure 2.8 MMM site scan save dialogue window
This begins the installation of MISHAP. The installer addresses 3 different programs in turn.
First the installer looks to see if MISHAP has previously been installed, if so then the installer
aborts and simply loads MISHAP.
If MISHAP has not previously been installed then the installation begins looking first to see if
the user hasMMM installed (line 36). For safety the installer backs up MMM_prototype.m and
MMM_prototype.fig files to /.../MMM_path/old_files before copying across new ver-
sions of MMM_prototype, these versions allow you to access MISHAP from MMM.
At a later date this versionswill be submitted toMMMand this part of the installer
will be removed.
Next the installer asks the user if HADDOCK will be run locally, if so then the local copy of
HADDOCK requires some new parameter files. Again exisiting files are backed up first to
/.../HADDOCK_path/old_files before the new ones are copied across.
As HADDOCK is outside the MatLab environment a system search is required
and this may take some time. As a safety feature, the search for HADDOCK will
time out in 10 seconds and ask the user for the location instead.
The command window output from a typical installation should look something like:
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1 __ __ _____ _____ _ _ _____
2 | \/ |_ _|/ ____| | | | /\ | __ \
3 | \ / | | | | (___ | |__| | / \ | |__) |
4 | |\/| | | | \___ \| __ | / /\ \ | ___/
5 | | | |_| |_ ____) | | | |/ ____ \| |
6 |_| |_|_____|_____/|_| |_/_/ \_\_|
7
8 by
9 _ _
10 | | | |
11 _ __ ___ ___ _ __ __ _ __ _ _ __ | |__ _ _ ___ _ __ ___| |_
12 | '_ ` _ \ / _ \| '__/ _` |/ _` | '_ \| '_ \| | | |/ _ \ | '_ \ / _ \ __|
13 | | | | | | (_) | | | (_| | (_| | | | | |_) | |_| | __/_| | | | __/ |_
14 |_| |_| |_|\___/|_| \__, |\__,_|_| |_|_.__/ \__, |\___(_)_| |_|\___|\__|
15 __/ | __/ |
16 |___/ |___/
17
18
19 ============================================
20 STARTING INSTALLATION
21 ============================================
22
23 Installer version - 13.06
24 Build date - 04th May 2013
25
26 This installer will install
27 MISHAP version - 13.06
28 Release date - 04th May 2013
29
30 System - Linux - 64 bit
31
32 MatLab version - 7.12.0.635 (R2011a)
33
34 ============================================
35
36 Finding MMM installation...
37 MMM was located at:
38 /opt/matlab/MyScripts/MMM_2013
39
40 Backing up MMM files to:
41 /opt/matlab/MyScripts/MMM_2013/old_files
42
43 Files backed up!
44
45 Copying across new files...
46 Files successfully copied!
47
48 Installing...
49
50 Configuring...
51 MMM configured!
52
53 ============================================
54
55 MISHAP parameters are not yet compatible with the HADDOCK webservers,
56 though this should change shortly, MISHAP must be run locally in the mean time
57
58 Are you going to be using HADDOCK locally? Y/N [Y]: y
59
60 Finding HADDOCK installation...
61 detection will abort if nothing is found in 10 seconds...
62 HADDOCK was located at:
63 /opt/haddock
64
65 Backing up HADDOCK files to:
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66 /opt/haddock/old_files
67
68 Files backed up!
69
70 Copying across new files...
71 Files successfully copied!
72
73 Installing...
74
75 Configuring...
76 HADDOCK configured!
77
78 ============================================
79
80 Writing changes to MatLab...
81 MatLab configured!
82
83 ============================================
84
85 I hope you find MISHAP useful.
86
87 Documentation can be found at:
88 morganbye.net/mishap
89
90 Please address any feedback to:
91 morgan.bye@uea.ac.uk
92
93 ============================================
94 INSTALLATION COMPLETE
95 ============================================
With MISHAP installed, MISHAP can now be called from MMM using
Predict! Quaternary! HADDOCK!MISHAP
Figure 2.9 MMMmenu showing MISHAP
Or without MMM from the command window with the command:
MISHAP
This will launch the primary MISHAP window, the distance distribution window.
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2.3 MISHAP distance distribution window
2.3.1 Loading a distance distribution
Calling MISHAP will launch the primary MISHAP window, the distance distribution window.
Figure 2.10 MISHAP distance distribution window
From the distance distribution panel select whether the distance distribtion is from Deer-
Analysis orMMM and click Load.
If a DeerAnalysis or MMMwindow is open then MISHAP will try to pull the distance distribu-
tion information from the open window. If more than one is open then it will load whichever
was opened first. If no window can be found then a user interface for the selection of a
previously saved file is opened.
Figure 2.11 MISHAP distance distribution load interface
Once a file is selected MISHAP will automatically plot the distance distribution and search
it for any peaks. Peaks are marked with circles. The largest peak is selected as the peak of
interest and the peak location is updated into the r column of the table.
A s(r) of 0.5 nm is automatically set and the boundaries are plotted about the distance as
dotted lines in the same colour as the peak. At a later date the s(r) will be detected and
calculated from the plot using a half height analysis of a Gaussian fit to the peak.
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Figure 2.12 MISHAP distance distribution window showing a loaded distance distribution
2.3.2 Multiple spin systems
Currently MISHAP has support for systems with up to 4 nitroxide spin labels. By default it is
set for only 2 spins (1 distance), selecting 3 or 4 spin labels addsmore distances to the table
(3 distances for 3 labels, 6 distances for 4 labels). The distance distribution plot displays
each distance in a seperate coloured dashed line with the peak's s(r) dotted in the same
colour.
2.3.3 Protein information
If the distance distribution tool is being used without the protein PDB creator then the table
information needs to be completed with the appropiate information for the chain ID and
residue number of the spin label in the PDB.
However, it is recommended to generate the PDBs for HADDOCK with MISHAP before pro-
ceeding further. To do so click Generate to launch the PDB Creator (see §2.4).
2.3.4 Output location
Once happy with the information displayed in the table finally check the output location box.
This is the location and file name that the distance restraints file will be saved as.
By default the file name unambig.tbl will be used and the path will be that of the MatLab
path when MISHAP was first opened.
If this is not suitable simply click Change.
2.3.5 RUN!
When the information in the table is correct and the output location is set click RUN!
All information is passed out to theMatLab commandwindow. First the constraint generator
checks that the table is complete, then it checks that it can write to the selected location. If
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the folder does not exist or the user does not have permission to write to it then they will be
prompted.
Finally the file is created. This process should be very fast even on a slow computer, ensure
that RUN! is only pressed once.
Get distance distribution
Load distribution into memory
Find peaks
Lookup number of spin labels
Update UI table with detected peaks
Generate PDBs if necessary
Update UI table with PDB info
Select save location
Create export file
Write restraints to file
Close files from memory
User update UI table
Figure 2.13 Flowchart of the MISHAP distance distribution window process
On the next page is an example output from the command window.
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1 __ __ _____ _____ _ _ _____
2 | \/ |_ _|/ ____| | | | /\ | __ \
3 | \ / | | | | (___ | |__| | / \ | |__) |
4 | |\/| | | | \___ \| __ | / /\ \ | ___/
5 | | | |_| |_ ____) | | | |/ ____ \| |
6 |_| |_|_____|_____/|_| |_/_/ \_\_|
7
8 _____ _ _ _
9 / ____| | | (_) | |
10 | | ___ _ __ ___| |_ _ __ __ _ _ _ __ | |_
11 | | / _ \| '_ \/ __| __| '__/ _` | | '_ \| __|
12 | |___| (_) | | | \__ \ |_| | | (_| | | | | | |_
13 \_____\___/|_| |_|___/\__|_| \__,_|_|_| |_|\__|
14 _
15 | |
16 __ _ ___ _ __ ___ _ __ __ _| |_ ___ _ __
17 / _` |/ _ \ '_ \ / _ \ '__/ _` | __/ _ \| '__|
18 | (_| | __/ | | | __/ | | (_| | || (_) | |
19 \__, |\___|_| |_|\___|_| \__,_|\__\___/|_|
20 __/ |
21 |___/
22
23 ============================================
24 STARTING Distance Constraint Creation
25 ============================================
26
27 MISHAP version - 13.06
28 Release date - 16th May 2013
29
30 System - Linux - 64 bit
31
32 MatLab version - 7.12.0.635 (R2011a)
33
34 ============================================
35
36 Checking the data table...
37 Checking complete
38
39 Setting label variables...
40
41 Saving file...
42 File saved as
43 /opt/matlab/MyScripts/MISHAP/test_files/unambig.tbl
44
45 ============================================
46
47 MISHAP - distance constraint generator completed in 0.00589 seconds
48 Thank you for using MISHAP
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2.4 MISHAP PDB creator window
The MISHAP PDB creator window is launched from the MISHAP distance distribution win-
dow by clicking Generate.
Figure 2.14 MISHAP distance distribution and PDB creator windows
The purpose of the PDB creator is 2 fold. First is to ensure that PDB files are generated that
are compaitble with HADDOCK.
Unfortunately, the PDB format was first created in the 1970's and has been extensively de-
veloped, without any strict enforcement of the PDB format for many years meaning that it
is quite common for PDB files generated in one program to not be compatible with a differ-
ent PDB handling program. MMM version 2013 after a major rewrite of the PDB file writing
functions now conforms fully. HADDOCK will only accept PDB files in a very explicit format,
which differs significantly from the PDB standard2.
The second purpose of the PDB creator is to combine a PDB file supplied froma local source,
from the PDB website (using an access number) or from a loadedMMMmodel with a MMM
rotamer analysis.
MMM provides some basic functionality for this but we require a single PDB file where an
amino acid residue has beenmutated to a spin label attached cysteine residue. Alternatively,
a set of PDB files and a list file that can be inserted into HADDOCK as an ensemble of starting
conformations - similar to an NMR ensemble.
2.4.1 Load a PDB file
For the first protein select the PDB file location. If the PDB is a local file click file this will
open a user interface for selecting the file from your computer.
The PDB can also be obtained directly from rcsb.org in which case selectweb and enter the
accession number when prompted.
If MMM is open, then the current model can be used by clickingMMM.
There will be a delay as the file is processed. Once processed the Structure box will update
with the PDB accession code, the Chain dropdown box will update with the chains found in
the PDB and the sequence of the selected chain will be shown in the Sequence preview.
2for more information see http://www.nmr.chem.uu.nl/haddock/pdb.html
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Figure 2.15 MISHAP PDB creator load PDB file selection
Figure 2.16 MISHAP PDB creator with loaded PDB file
2.4.2 Load a MMM rotamer file
For the first protein select the MMM rotamer file location. If the PDB is a local file saved
during the MMM site scan then click file this will open a user interface for selecting the file.
In a later release, it will be possible to click MMM and pull the rotamer information from
MMM.
Figure 2.17 MISHAP PDB creator load MMM file selection
It will take a little time to process the rotamer information. Once processed the Label box
will update with the 3 character amino acid residue code for the spin label, the Temp. box
will update with the labeling temperature used in the site scan, the Residue box will update
with the amino acid residue number of the labeling site and theRotamerwill update with the
selected rotamer number from the MMM rotamer analysis.
By default, the Rotamer box will default to rotamer 1 though this can be changed to any
rotamer. If a rotamer is selected that is outside the range of available rotamers then the box
will automatically default back to rotamer 1. If an ensemble style rotamer analysis is desired
16
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Figure 2.18 MISHAP PDB creator load with PDB and MMM file loaded
type in this box:
a l l
2.4.3 Output location
By default the protein PDB will be saved as:
P ro te in [ A/B ] _ [YYMMDD] . pdb
These can be changed freely with any operating system valid name. Do not include .pdb in
the file name, otherwise you will generate a file called ProteinA_YYMMDD.pdb.pdb
The output path is defined in the Output location box, the path will be that of the MatLab
path when MISHAP was first opened.
If this is not suitable simply click Change.
2.4.4 RUN!
When happy with the settings for Binding Partner 1 the PDB creator can be run or a PDB and
MMM rotamer analysis can also be loaded for Binding Partner 2.
Figure 2.19 MISHAP PDB creator showing 2 proteins loaded with MMM rotamer files
When all the information is loaded and set click RUN!
All information is passed out to the MatLab command window. Binding Partner 1 is ad-
dressed before Binding Partner 2 but in both the creator checks that a PDB and MMM ro-
tamer analysis is loaded, then it checks that it can write to the selected output location. If
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the folder does not exist or the user does not have permission to write to it then they will be
prompted.
Finally the creator merges the selected MMM rotamer(s) with the PDB file and the output
file is created.
Briefly, the creator essentially splits the PDB file before and after the select residue. It then
pastes in the rotamer residue andmerges the residues before the residue, the rotamer residue
and residues after the rotamer residue with appropiate linkers. All hydrogen atoms are then
removed as these are prone to causing problems in HADDOCK and CNS. Finally, every atom
is renumbered in the merged PDB so that read sequentially. The file is finally written out line
by line with space padding so that each line is exactly 80 characters.
Figure 2.20 Flowchart of PDB handling within the MISHAP PDB creator
On the next page is an example output from the command window.
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1 __ __ _____ _____ _ _ _____
2 | \/ |_ _|/ ____| | | | /\ | __ \
3 | \ / | | | | (___ | |__| | / \ | |__) |
4 | |\/| | | | \___ \| __ | / /\ \ | ___/
5 | | | |_| |_ ____) | | | |/ ____ \| |
6 |_| |_|_____|_____/|_| |_/_/ \_\_|
7
8 _____ _____ ____ _____ _
9 | __ \| __ \| _ \ / ____| | |
10 | |__) | | | | |_) | | | _ __ ___ __ _| |_ ___ _ __
11 | ___/| | | | _ < | | | '__/ _ \/ _` | __/ _ \| '__|
12 | | | |__| | |_) | | |____| | | __/ (_| | || (_) | |
13 |_| |_____/|____/ \_____|_| \___|\__,_|\__\___/|_|
14
15 ============================================
16 STARTING PDB Creation
17 ============================================
18
19 MISHAP version - 13.06
20 Release date - 15th May 2013
21
22 System - Linux - 64 bit
23
24 MatLab version - 7.12.0.635 (R2011a)
25
26 ============================================
27 Binding partner 1
28 ============================================
29
30 Finding the selected PDB...
31 Loading file...
32 /opt/matlab/MyScripts/MISHAP/test_files/2K5X.pdb...
33 Using structure 2K5X and chain A
34 PDB loaded!
35
36 Finding the selected MMM rotamer...
37 Loading file...
38 /opt/matlab/MyScripts/MISHAP/test_files/rotamers_[2K5X](A){1}23_IA1_175.pdb
39
40 Rotamers loaded!
41
42 Setting labelling conditions:
43 Label - IA1
44 Temperature - 175 K
45 Attaching to residue - 23
46 Using rotamer - 1
47
48 Adding rotamer to PDB...
49 Rotamer successfully added!
50
51 Saving file...
52 File saved as
53 /opt/matlab/MyScripts/MISHAP/test_files/ProteinA_130610.pdb
54
55 ============================================
56 Binding partner 2
57 ============================================
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58
59 Finding the selected PDB!
60 Loading file...
61 /opt/matlab/MyScripts/MISHAP/test_files/2K5X.pdb
62 Using structure 2K5X and chain B
63 PDB loaded!
64
65 Finding the selected MMM rotamer
66 Loading file...
67 /opt/matlab/MyScripts/MISHAP/test_files/rotamers_[2K5X](B){1}3_IA1_175.pdb
68 Rotamers loaded!
69
70 Setting labelling conditions:
71 Label - IA1
72 Temperature - 175 K
73 Attaching to residue - 3
74 Using rotamer - 1
75
76 Attaching rotamer to PDB...
77 Rotamer successfully added!
78
79 Saving file...
80 File saved as
81 /opt/matlab/MyScripts/MISHAP/test_files/ProteinB_130610.pdb
82
83 ============================================
84
85 MISHAP - PDB Creator completed in 0.79016 seconds
86 Thank you for using MISHAP
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HADDOCK (the high ambiguity data driven biomolecular docking program) is an approach
that makes use of biochemical and biophysical interaction data such as chemical shift per-
turbations from NMR titration experiments, mutagenesis data or bioinformatic predictions
to study protein complexes.
Traditionally, most approaches to protein complex formation relied upon a combination of
energetics and shape complementarity rather than experimental data. The previously men-
tioned experiments are presented to the HADDOCK program as ambiguous interaction re-
straints (AIRs) to drive the docking process. More formally, these are defined as an ambigu-
ous distance between all residues shown to be involved in the interaction.
Since the original 2003 JACS publication HADDOCK has been extended to deal with a large
varity of data and complexes including protein-DNA, protein-RNA, protein-oligosaccharides
andprotein-ligand complexes. HADDOCKhas consistently performedwell in the blind protein-
protein complex CAPRI competitions1.
HADDOCK remains a command line tool requiring the generation and configuration of many
files before a run can commence. HADDOCK consists primarily as a collection of python
scripts derived from ARIA written by Michael Nilges and Jens Linge and makes use for CNS
as structure calculation.
3.1 Spin label definitions
HADDOCK being designed to accept input data from several different sources already has
the facility to use several unnatural amino acids such as phosphorylated CYS, HIS, SER, THR,
several methyl variants such as mono-, di- and tri- methyl lysine, to name but a few.
Thus if correctly defined it is perfectly possible to add MTSL and IA-PROXYL labelled cys-
teines as an unnatural, but allowed, amino acid residue.
For an amino acid to be defined in HADDOCK and the underlying structural calculation pro-
gram, CNS, requires explicit definitions of all atoms, charges, bonds, bond lengths and al-
lowed bond angles (both dihedral and improper dihedral). When combined this gives the
modelling software not only the atomic position and bonding of the atoms, but also allows
for the rotation of bonds - which is essential in the final energy optimisation stage of HAD-
DOCK before the final energy optimisation in water.
1http://capri.ebi.ac.uk
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(b) IA-PROXYL
Figure 3.1 Atom naming convention used in MMM and MISHAP for nitroxide spin labels
3.2 Protocols
With MMM there is an increasing amount of published data that shows that rotamer pop-
ulation prediction from a rotamer library accurately reflects the experimental situation. It is
not known whether the bond rotation allowed in HADDOCK/CNS reflects well with that seen
experimentally. Previously, the authors of HADDOCK when performing paramagnetic relax-
ation enhancement studies take the spin label and during the early stages of docking spawn
4 structures with the spin label in different conformations. Docking is then performed in an
ensemble style analysis and it is hoped that during the allowed side chain freedom stage of
energy minimisation that starting from 4 random positions will find the overall position(s)
and not get caught in a local energy minima.
To this end, MISHAP provides the ability in the PDB creator to not only create a single PDB file
but automatically generate an ensemble folder of PDB files, with the appropiate HADDOCK
file list file, of rotamers from MMM with populations of greater than 1 %. Whilst a typical
MMM analysis can generate up to 100 rotamers on a greatly solvent exposed site from
the rotamer library most will have populations of below 1 %. In more rigidly located spin
label positions the rotamer population quickly reduces in numberwith the remaining allowed
rotamers covering a large proportion of the population, in some cases above 50 %, in these
cases an ensemble analysis may not be necessary and a single rotamer PDB file should be
sufficient for an accurate docking simulation.
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3.3 Topology parameters (toppar)
HADDOCK contains a series of files which contain all of the necessary parameters for amino
acid residues, ligands, DNA, etc. These parameters largely are default parameters for CNS
that have been extensively modfied and added to for the purposes of HADDOCK. HADDOCK
creates CNS scripts and then calls CNS in order to perform docking.
Note that HADDOCKmustmake use of topology version 5.4 formany of the features towork.
HADDOCKhowever by default uses version 5.3 - to ensure as broad compatibility as possible
the provided MISHAP files provide both 5.3 and 5.4 topology files. The following files from
the HADDOCK/toppar folder require updating in order for HADDOCK to accept nitroxide spin
labels:
topallhdg5.3.pep allows the labels to exist in a peptide
topallhdg5.3.pep-noCter allows the labels to exist in a peptide where the C-terminus
does not exist
topallhdg5.3.pep-noNter allows the labels to exist in a peptide where the N-terminus
does not exist
topallhdg5.3.pro defines themass and charge of each atom, as well as each bond, angle,
improper angle, dihedral angle and hydrogen bond acceptor/donor site.
topallhdg5.3.pro-caro defines the mass and charge of each atom, as well as each bond,
angle, improper angle, dihedral angle and hydrogen bond acceptor/donor site.
topallhdg5.4.pep allows the labels to exist in a peptide, and defines how the peptidewould
bind to surrounding amino acid residues
topallhdg5.4.pep-noCter allows the labels to exist and bond to it's neighbours in a pep-
tide where no C-terminus exists
topallhdg5.4.pep-noNter allows the labels to exist and bond to it's neighbours in a pep-
tide where no N-terminus exists
topallhdg5.4.pep-noter allows the labels to exist and bond to it's neighbours in a peptide
where neither a N nor C -termini exists
topallhdg5.4.pro defines themass and charge of each atom, as well as each bond, angle,
improper angle, dihedral angle and hydrogen bond acceptor/donor site
Whilst it is possible to create these topology parameter files by hand methodically, several
tools exist that can speed up the process. For example the PRODRG tool2 has a free web
server3 that can be used to generate CNS topology files. This tool is only designed to create
ligands and so to incorporate a structure as an amino acid requires some modification.
3.4 Run settings
run.cns is the primary file that HADDOCK runs a docking experiment from. When a run is
first generated it is imperative to change this file to reflect not only your own system but also
to ensure the correct settings are used.
2Acta Cryst. (2004). D60, 1355-1363
3http://davapc1.bioch.dundee.ac.uk/prodrg/
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3.4.1 CNS address
Despite what is set in the new.html when the run is generated the CNS address often does
not update and is often defaulted to:
/sw/nmr/cns_solve_1.2-para/mac-intel-darwin/bin/cns
This can be editted by hand or with the command:
sed 's,'/sw/nmr/cns_solve_1.2-para/mac-intel-darwin/bin/
cns', '/path/to/cns_solve_1.3/intel-x86_64bit -linux/
bin/cns',' run.cns > tmp ; mv tmp run.cns
Where the sed command searches for the string in the first quote and replaces it with the
second string. We then need to save to a temporary file and overwrite the original file with
the temporary one.
3.4.2 Topology selection
HADDOCKwill always by default use topology parameters v5.3, we require HADDOCK to use
version 5.4 when using CNS v1.3.
Update the version selection with:
sed 's,'topallhdg5.3','topallhdg5.4',' run.cns > tmp ; mv
tmp run.cns
3.4.3 Parallelisation
HADDOCK by default assumes only a dual cored processor. If you are using it upon a cluster
or server ensure that you update the run.cns file to take this into account; replacing 'XXX'
with the number available on your system.
sed 's,'cpunumber_1=2','cpunumber_1=XXX',' run.cns > tmp
; mv tmp run.cns
The number of CPU cores on a UNIX system can be easily found with the command:
grep "cpu cores" /proc/cpuinfo
or with the terminal command (available in most Linux distributions):
lscpu
3.4.4 Initial seed number
HADDOCK uses a random number generator to begin the structure formation in the rigid
body stage. However, this number generator requires a starting point and should be recorded
for reproducability. It is easiest to set this as a fixed number, though a random number gen-
erator could be piped into the argument.
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sed 's,'iniseed=917','iniseed=999',' run.cns > tmp ; mv
tmp run.cns
3.4.5 MD time step
The HADDOCK protocol uses a process of simulated heating and cooling for energy opti-
misation and minimisation. By default HADDOCK uses an molecular dynamics (MD) time
step of 2 fs, however, docking runs will often fail with this setting. With such a time step,
atoms that are moving toward each other in one time step can often jump on top of each
other, when HADDOCK then calculates the energy there is a massive potential energy in
these atoms. Entropy resolves this in the next time step by moving the atoms far apart, of-
ten outside the calculation co-ordinate space (> 99,999 A). This causes the structure to fail,
if more than 20 % of a run's structures fail then HADDOCK will abort the run.
By decreasing the time step reduces the risk of this scenario, however, to ensure a good fit
the total simulation cannot change, thus the number of steps increases, which increases
the experiment time.
# Change MD time step
sed 's,'timestep=0.002','timestep=0.0005',' run.cns > tmp
; mv tmp run.cns
# Increase MD iterations to maintain total simulation
time
sed 's,'initiosteps=500','initiosteps=2000',' run.cns >
tmp ; mv tmp run.cns sed 's,'cool1_steps=500','
cool1_steps=2000',' run.cns > tmp ; mv tmp run.cns
sed 's,'cool2_steps=1000','cool2_steps=4000',' run.cns >
tmp ; mv tmp run.cns
sed 's,'cool3_steps=1000','cool3_steps=4000',' run.cns >
tmp ; mv tmp run.cns
3.4.6 Annealing temperature
Energy optimisation in HADDOCK is conducted by raising the temperture in the system to
a high value and then allowing it to cool in vacuo. Reducing the time step described in the
previous section can help. However, if greater than 20 % of structures fail during it1 (energy
optimisation) step then HADDOCK will abort and solvent optimisation will not occur. First,
change the initial seed number and restart the run (this will require deletion of all it0 files, for
the creation of new structures). If however, the runs continue to fail then the structures have
too much energy and will fall to same problems discussed in the MD time step section.
The best solution is to lower the temperature that the system is raised to in each energy
optimisation step. This again is defined in run.cns and can be quickly changed using the
following commands.
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sed 's,'tadhigh_t=2000','tadhigh_t=500',' run.cns > tmp ;
mv tmp run.cns
sed 's,'tadinit1_t=2000','tadinit2_t=1000',' run.cns >
tmp ; mv tmp run.cns
sed 's,'tadinit2_t=1000','tadinit2_t=500',' run.cns > tmp
; mv tmp run.cns
sed 's,'tadinit3_t=500','tadinit3_t=250',' run.cns > tmp
; mv tmp run.cns
sed 's,'tadfactor=8','tadfactor=4',' run.cns > tmp ; mv
tmp run.cns
These temperatures can be dropped further, but should only be donewith considerable care.
3.4.7 Protocols
The run.cns in the run root is not the same run.cns file that is called when protocols are
run. To ensure that our changes are reflected throughout the entire HADDOCK run we need
to copy the run.cns root and replace the run.cns file in the protocols folder.
cp run.cns protocols/run.cns
3.4.8 Structure generation
Each amino acid chain or ligand is generated as a seperate structure, so for a docking ex-
periment the bear minimumwe will have is structure A and B, whilst HADDOCK supports up
to 6 structures.
For each structure to be used in the docking run requires that the structure generation script
be forced to use topology parameters v5.4.
sed 's,'hdg5.3','hdg5.4',' generate_A.inp > tmp ; mv tmp
generate_A.inp
Repeating this command but replacing generate_A.inp with generate_B.inp, ..., etc. for
every structure.
Also check that the generate_X.inp file has the correct file location, all to often it will default
to:
/home/abonvin/software/haddock/examples/e2a.pdb
3.5 Run analysis
If the HADDOCK run is not being performed upon the Utrecht University webserver then the
run needs to be manually analysed (detailed in the documentation4 and online tutorial5).
4http://www.nmr.chem.uu.nl/haddock/analysis.html
5http://www.wenmr.eu/wenmr/haddock-web-server-tutorial
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With CNS and HADDOCK programs sourced in your terminal session navigate to the run
then
cd structures/it1/water
In this directory run the HADDOCK tool ana_structures.csh
$HADDOCKTOOLS/ana_structures.csh
Move into the analysis directory
cd analysis
Now run:
cluster_struc RUN_NAME_rmsd.disp 7.5 4 > cluster.out
Where RUN_NAME is the name of the HADDOCK run, 7.5 is the RMSD distance cutoff to which
structures within an RMSD of 7.5 A are clustered, with a minimum cluster size of 4 struc-
tures.
Move back to the water (or other solvent) directory
cd ..
Now run ana_clusters.csh to perform cluster analysis on the structures (this requires
ProFit to be defined in the haddock_configure.csh file). This script will only analyse the
top 4 scoring structures in the cluster analysis, the best flag can be removed (but will in-
crease calculation time) or the number changed.
$HADDOCKTOOLS/ana_clusters.csh -best 4 analysis/cluster.out
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4 An example docking experiment
MISHAP comes with the folder test_files in the root directory. In this folder the user will
find all the files necessary to run their first MISHAP/HADDOCK docking experiment, without
performing any PELDOR experiments. It is assumed that the user is proficient in DeerAnaly-
sis andMMM and would be able to follow the instructions in chapter 2 to generate their own
files. If the user is not versed in these programs then it is recommended to read the freely
available user manuals12.
4.1 Example files
The test_files folder contains 2K5X.pdb the published NMR energy minimised structure
of colicin E9DNase bound to it's immunity protein, Im9 from rcsb.org. There are also the files
2K5X_ChainA.pdb and 2K5X_ChainB.pdb files created with the EPR toolbox's3 PDBSplitter
function, which simply splits the original PDB file into seperate chains.
Additionally in this folderwe have several fileswith the root 4PEL_[2K5X](A)23_[2K5X](B)3,
these files are saved DeerAnalysis results from a PELDOR experiment between the C23 po-
sition of the Im9 to the S3C position of colicin E9 DNase.
Finally we have the files:
rotamers_[2K5X](A){1}23_IA1_175.pdb
rotamers_[2K5X](B){1}3_IA1_175.pdb
These are the saved MMM site scan rotamer analysis files of the 2 sites using IA-PROXYL
at 175K.
4.2 MISHAP
Open MatLab and into the command window type
MISHAP
A splash screen will display briefly whilst MISHAP is loaded.
Initially only theMISHAPDistanceDistributionwindowwill be open. In theDistance Distribution
box, select DeerAnalysis from the menu and click the Load button.
A file selection window will appear. Navigate to the MISHAP test files folder and select the
DeerAnalysis file 4PEL_[2K5X](A)23_[2K5X](B)3__distr.dat. Click Open.
1http://www.epr.ethz.ch/software/DeerAnalysis2013_manual.pdf
2http://www.epr.ethz.ch/software/MMM_2013_manual.pdf
3morganbye.net/eprtoolbox
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Figure 4.1 MISHAP distance distribution window
Figure 4.2 MISHAP distance distribution load interface
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4.2 MISHAP
The distance distribution will be opened and displayed in the box in the top right of the win-
dow. The distribution will automatically be scanned for peaks and the best peak selected.
Notice that the r / nm column of the table has been updated with the peak information.
Figure 4.3 MISHAP distance distribution window showing a loaded distance distribution
In the PDBs box click the Generate button.
Figure 4.4 MISHAP distance distribution and PDB creator windows
This will open the MISHAP PDB creator window. First only consider the left hand side of the
window.
Click the file button next to Get PDB from, again a file selection window will appear. Nav-
igate to the MISHAP test files folder and select 2K5X.pdb
After a fewseconds the Sequence previewwill display an amino acid sequence theStructure
will update with 2K5X, and Chain with A
In the MMM rotamerbox click the filebutton, selecting rotamers_[2K5X](A){1}23_IA1_175.pdb
After a few seconds the boxes in MMM rotamers will update with the rotamer information
that has just been loaded.
Now repeat the process on the right hand side for Binding partner 2. This time however,
make sure to change the Chain with the dropdown menu to B and instead select the other
MMM rotamer file: rotamers_[2K5X](B){1}3_IA1_175.pdb
Check that the Output location is set to a suitable location, it can be changed by clicking
Change
Click RUN!
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Figure 4.5 MISHAP PDB creator load with PDB and MMM file loaded
The command window will update as the PDBs are generated.
The PDB generation will also update the table in the Distance distribution window.
Now click RUN! in the Distance distribution window.
The command window will update as the distance restraints file is generated.
4.3 HADDOCK run generation
Following HADDOCK documentation create a new folder that contains the 2 protein PDBs
(from MISHAP), ambig.tbl (NMR AIRs file, if available), unambig.tbl (from MISHAP) and a
new.html file.
The new.html file needs to be editted to reflect your personal settings regarding folder lo-
cation, HADDOCK location, run name, etc. Be sure to source HADDOCK with the MISHAP
parameter files.
Open a terminal.
Per HADDOCK documentation source CNS and HADDOCK.
Move to run directory.
Initialise HADDOCK with:
haddock2 .1
This will generate the HADDOCK run. Move into the run directory.
Edit run.cns as per requirements detailed in §3.4
Copy run.cns into /protocols
cp run . cns pro toco ls / run . cns
Copy restraints files (ambig.tbl and unambig.tbl) into /structures/it0, /structures/it1 and
/data/distances
Run HADDOCK with:
haddock2 .1
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4.4 HADDOCK run analysis
4.4 HADDOCK run analysis
Perform the data analysis outlined in §3.5.
Open MatLab, change directory to the run folder. Move to /structures/it1/water.
Run HADDOCK_CLUSTERS_PROCESSING.m and HADDOCK_CLUSTERS_TO_PYMOL.m scripts if de-
sired (detailed in §5.2).
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5 Other tools
5.1 Naccess
Naccess is a program that calculates the exposed surface area of a protein by running a
simulated sphere across the surface of a protein. By default the sphere radius is set to 1.4
A the approximate diameter of a water molecule.
Within the MISHAP/_private folder is the NACCESS folder, this folder contains MISHAP.radii,
a special file which allows Naccess to calculate the exposed surface area of a protein which
includes the residues R1A/CYM and IA1.
5.2 HADDOCK processing tools
5.2.1 HADDOCK cluster processing
Included is a MatLab script, HADDOCK_CLUSTERS_PROCESSING.m, for the processing of HAD-
DOCK clusters. It allows the user to select a cluster or to operate on all the final structures
and present themas a figure plottingHADDOCKscore against any of theHADDOCKparame-
ters (bsa, dH, Edesolv, rmsd, rmsd-Emin (default), ener (by default this is Einter), ener-Einter,
ener-Enb, ener-Evdw, ener-Eelec, ener-Eair, ener-Ecdih, ener-Ecoup, ener-Esani, ener-Evean,
ener-Edani), as shown in figure 5.1. Each structure that completed the docking run is shown
as a blue circle and the top 4 scoring structures from each cluster are averaged and shown
as closed red circles.
Scores can be saved to the workspace, if the script is called with output variables.
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Figure 5.1 A typical figure from the HADDOCK_CLUSTERS_PROCESSING script showing HADDOCK score plotted
against the RMSD of the structure from the average structure
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Figure 5.2 A typical figure from the HADDOCK_CLUSTERS_TO_PYMOL script showing chain B (in grey cartoon) plotted
against the top 4 structures of the top 4 clusters
5.2.2 HADDOCK clusters to PyMOL
PyMOL is a long establishedprogram for the three dimensional visualisation of protein struc-
tures and their ligands. Due to the nature of the program, PyMOL can easily be called from
the command line using Python code.
Included is a MatLab script, HADDOCK_CLUSTERS_TO_PYMOL.m, which when called from Mat-
Lab by default will take the top 4 structures from the top 4 clusters and align all of the chain
B's using an RMSD refinement process. The top result from chain B is displayed as a car-
toon model and all the chain A's backbones as colour coded lines, where blue is the best
scoring model and red is the 4th structure from the 4th cluster.
This script can be called with different input arguments to adjust the number of clusters and
structures from each cluster to be considered. This takes the general form:
HADDOCK_CLUSTERS_TO_PYMOL( number_of_c lusters , s t r uc tu res )
For example,
HADDOCK_CLUSTERS_TO_PYMOL(1 , 16)
Would present the top 16 structures from only the top scoring cluster.
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6.1 License
For a human-readable summary of the legal code below, please visit:
http://creativecommons.org/licenses/by-nc-sa/3.0/
This is a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
To use MISHAP assumes agreement with this license, and is repeated in LICENSE.txt in the
MISHAP root directory.
License
THEWORK (AS DEFINED BELOW) IS PROVIDEDUNDER THE TERMSOF THIS CREATIVE COMMONSPUBLIC LICENSE ("CCPL"
OR "LICENSE"). THE WORK IS PROTECTED BY COPYRIGHT AND/OR OTHER APPLICABLE LAW. ANY USE OF THE WORK
OTHER THAN AS AUTHORIZED UNDER THIS LICENSE OR COPYRIGHT LAW IS PROHIBITED.
BY EXERCISING ANY RIGHTS TO THE WORK PROVIDED HERE, YOU ACCEPT AND AGREE TO BE BOUND BY THE TERMS OF
THIS LICENSE. TO THE EXTENT THIS LICENSEMAY BE CONSIDERED TO BE A CONTRACT, THE LICENSORGRANTS YOU THE
RIGHTS CONTAINED HERE IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH TERMS AND CONDITIONS.
1. Definitions
"Adaptation" means a work based upon the Work, or upon the Work and other pre-existing works, such as a translation, adap-
tation, derivative work, arrangement of music or other alterations of a literary or artistic work, or phonogram or performance
and includes cinematographic adaptations or any other form inwhich theWorkmay be recast, transformed, or adapted includ-
ing in any form recognizably derived from the original, except that a work that constitutes a Collection will not be considered
an Adaptation for the purpose of this License. For the avoidance of doubt, where the Work is a musical work, performance or
phonogram, the synchronization of the Work in timed-relation with a moving image ("synching") will be considered an Adap-
tation for the purpose of this License. "Collection" means a collection of literary or artistic works, such as encyclopedias and
anthologies, or performances, phonograms or broadcasts, or other works or subject matter other than works listed in Section
1(g) below, which, by reason of the selection and arrangement of their contents, constitute intellectual creations, in which the
Work is included in its entirety in unmodified form along with one or more other contributions, each constituting separate and
independent works in themselves, which together are assembled into a collective whole. A work that constitutes a Collection
will not be considered an Adaptation (as defined above) for the purposes of this License. "Distribute" means to make available
to the public the original and copies of the Work or Adaptation, as appropriate, through sale or other transfer of ownership.
"License Elements" means the following high-level license attributes as selected by Licensor and indicated in the title of this
License: Attribution, Noncommercial, ShareAlike. "Licensor" means the individual, individuals, entity or entities that offer(s)
the Work under the terms of this License. "Original Author" means, in the case of a literary or artistic work, the individual,
individuals, entity or entities who created theWork or if no individual or entity can be identified, the publisher; and in addition (i)
in the case of a performance the actors, singers, musicians, dancers, and other persons who act, sing, deliver, declaim, play in,
interpret or otherwise perform literary or artistic works or expressions of folklore; (ii) in the case of a phonogram the producer
being the person or legal entity who first fixes the sounds of a performance or other sounds; and, (iii) in the case of broadcasts,
the organization that transmits the broadcast. "Work" means the literary and/or artistic work offered under the terms of this
License including without limitation any production in the literary, scientific and artistic domain, whatever may be the mode or
form of its expression including digital form, such as a book, pamphlet and other writing; a lecture, address, sermon or other
work of the same nature; a dramatic or dramatico-musical work; a choreographic work or entertainment in dumb show; a
musical composition with or without words; a cinematographic work to which are assimilated works expressed by a process
analogous to cinematography; a work of drawing, painting, architecture, sculpture, engraving or lithography; a photographic
work to which are assimilated works expressed by a process analogous to photography; a work of applied art; an illustration,
map, plan, sketch or three-dimensional work relative to geography, topography, architecture or science; a performance; a
broadcast; a phonogram; a compilation of data to the extent it is protected as a copyrightable work; or a work performed by a
variety or circus performer to the extent it is not otherwise considered a literary or artistic work. "You" means an individual or
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entity exercising rights under this License who has not previously violated the terms of this License with respect to the Work,
or who has received express permission from the Licensor to exercise rights under this License despite a previous violation.
"Publicly Perform" means to perform public recitations of the Work and to communicate to the public those public recitations,
by any means or process, including by wire or wireless means or public digital performances; to make available to the public
Works in such a way that members of the public may access these Works from a place and at a place individually chosen by
them; to perform the Work to the public by any means or process and the communication to the public of the performances
of the Work, including by public digital performance; to broadcast and rebroadcast the Work by any means including signs,
sounds or images. "Reproduce" means to make copies of the Work by any means including without limitation by sound or
visual recordings and the right of fixation and reproducing fixations of the Work, including storage of a protected performance
or phonogram in digital form or other electronic medium. 2. Fair Dealing Rights. Nothing in this License is intended to reduce,
limit, or restrict any uses free from copyright or rights arising from limitations or exceptions that are provided for in connection
with the copyright protection under copyright law or other applicable laws.
3. License Grant. Subject to the terms and conditions of this License, Licensor hereby grants You a worldwide, royalty-free,
non-exclusive, perpetual (for the duration of the applicable copyright) license to exercise the rights in theWork as stated below:
to Reproduce the Work, to incorporate the Work into one or more Collections, and to Reproduce the Work as incorporated
in the Collections; to create and Reproduce Adaptations provided that any such Adaptation, including any translation in any
medium, takes reasonable steps to clearly label, demarcate or otherwise identify that changes weremade to the original Work.
For example, a translation could be marked "The original work was translated from English to Spanish," or a modification
could indicate "The original work has beenmodified."; to Distribute and Publicly Perform theWork including as incorporated in
Collections; and, to Distribute and Publicly Perform Adaptations. The above rights may be exercised in all media and formats
whether now known or hereafter devised. The above rights include the right to make such modifications as are technically
necessary to exercise the rights in othermedia and formats. Subject to Section 8(f), all rights not expressly granted by Licensor
are hereby reserved, including but not limited to the rights described in Section 4(e).
4. Restrictions. The license granted in Section 3 above is expressly made subject to and limited by the following restrictions:
You may Distribute or Publicly Perform the Work only under the terms of this License. You must include a copy of, or the
Uniform Resource Identifier (URI) for, this License with every copy of the Work You Distribute or Publicly Perform. You may
not offer or impose any terms on the Work that restrict the terms of this License or the ability of the recipient of the Work to
exercise the rights granted to that recipient under the terms of the License. You may not sublicense the Work. You must keep
intact all notices that refer to this License and to the disclaimer of warranties with every copy of the Work You Distribute or
Publicly Perform. WhenYouDistribute or Publicly Perform theWork, Youmaynot impose any effective technologicalmeasures
on the Work that restrict the ability of a recipient of the Work from You to exercise the rights granted to that recipient under
the terms of the License. This Section 4(a) applies to the Work as incorporated in a Collection, but this does not require the
Collection apart from the Work itself to be made subject to the terms of this License. If You create a Collection, upon notice
from any Licensor You must, to the extent practicable, remove from the Collection any credit as required by Section 4(d),
as requested. If You create an Adaptation, upon notice from any Licensor You must, to the extent practicable, remove from
the Adaptation any credit as required by Section 4(d), as requested. You may Distribute or Publicly Perform an Adaptation
only under: (i) the terms of this License; (ii) a later version of this License with the same License Elements as this License;
(iii) a Creative Commons jurisdiction license (either this or a later license version) that contains the same License Elements
as this License (e.g., Attribution-NonCommercial-ShareAlike 3.0 US) ("Applicable License"). You must include a copy of, or
the URI, for Applicable License with every copy of each Adaptation You Distribute or Publicly Perform. You may not offer
or impose any terms on the Adaptation that restrict the terms of the Applicable License or the ability of the recipient of the
Adaptation to exercise the rights granted to that recipient under the terms of the Applicable License. You must keep intact
all notices that refer to the Applicable License and to the disclaimer of warranties with every copy of the Work as included
in the Adaptation You Distribute or Publicly Perform. When You Distribute or Publicly Perform the Adaptation, You may not
impose any effective technological measures on the Adaptation that restrict the ability of a recipient of the Adaptation from
You to exercise the rights granted to that recipient under the terms of the Applicable License. This Section 4(b) applies to the
Adaptation as incorporated in a Collection, but this does not require the Collection apart from the Adaptation itself to be made
subject to the terms of the Applicable License. You may not exercise any of the rights granted to You in Section 3 above in
any manner that is primarily intended for or directed toward commercial advantage or private monetary compensation. The
exchange of the Work for other copyrighted works by means of digital file-sharing or otherwise shall not be considered to be
intended for or directed toward commercial advantage or private monetary compensation, provided there is no payment of
anymonetary compensation in con-nection with the exchange of copyrighted works. If You Distribute, or Publicly Perform the
Work or any Adaptations or Collections, You must, unless a request has been made pursuant to Section 4(a), keep intact all
copyright notices for the Work and provide, reasonable to the medium or means You are utilizing: (i) the name of the Original
Author (or pseudonym, if applicable) if supplied, and/or if theOriginal Author and/or Licensor designate another party or parties
(e.g., a sponsor institute, publishing entity, journal) for attribution ("Attribution Parties") in Licensor's copyright notice, terms
of service or by other reasonable means, the name of such party or parties; (ii) the title of the Work if supplied; (iii) to the
extent reasonably practicable, the URI, if any, that Licensor specifies to be associated with the Work, unless such URI does
not refer to the copyright notice or licensing information for the Work; and, (iv) consistent with Section 3(b), in the case of an
Adaptation, a credit identifying the use of the Work in the Adaptation (e.g., "French translation of the Work by Original Author,"
or "Screenplay based on original Work by Original Author"). The credit required by this Section 4(d) may be implemented in any
reasonable manner; provided, however, that in the case of a Adaptation or Collection, at a minimum such credit will appear, if
a credit for all contributing authors of the Adaptation or Collection appears, then as part of these credits and in a manner at
least as prominent as the credits for the other contributing authors. For the avoidance of doubt, You may only use the credit
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required by this Section for the purpose of attribution in the manner set out above and, by exercising Your rights under this
License, You may not implicitly or explicitly assert or imply any connection with, sponsorship or endorsement by the Original
Author, Licensor and/or Attribution Parties, as appropriate, of You or Your use of the Work, without the separate, express prior
written permission of the Original Author, Licensor and/or Attribution Parties. For the avoidance of doubt:
Non-waivable Compulsory License Schemes. In those jurisdictions in which the right to collect royalties through any statutory
or compulsory licensing scheme cannot be waived, the Licensor reserves the exclusive right to collect such royalties for
any exercise by You of the rights granted under this License; Waivable Compulsory License Schemes. In those jurisdictions
in which the right to collect royalties through any statutory or compulsory licensing scheme can be waived, the Licensor
reserves the exclusive right to collect such royalties for any exercise by You of the rights granted under this License if Your
exercise of such rights is for a purpose or use which is otherwise than noncommercial as permitted under Section 4(c) and
otherwise waives the right to collect royalties through any statutory or compulsory licensing scheme; and, Voluntary License
Schemes. The Licensor reserves the right to collect royalties, whether individually or, in the event that the Licensor is amember
of a collecting society that administers voluntary licensing schemes, via that society, from any exercise by You of the rights
granted under this License that is for a purpose or usewhich is otherwise than noncommercial as permitted under Section 4(c).
Except as otherwise agreed in writing by the Licensor or as may be otherwise permitted by applicable law, if You Reproduce,
Distribute or Publicly Perform the Work either by itself or as part of any Adaptations or Collections, You must not distort,
mutilate, modify or take other derogatory action in relation to the Work which would be prejudicial to the Original Author's
honor or reputation. Licensor agrees that in those jurisdictions (e.g. Japan), in which any exercise of the right granted in
Section 3(b) of this License (the right to make Adaptations) would be deemed to be a distortion, mutilation, modification or
other derogatory action prejudicial to the Original Author's honor and reputation, the Licensor will waive or not assert, as
appropriate, this Section, to the fullest extent permitted by the applicable national law, to enable You to reasonably exercise
Your right under Section 3(b) of this License (right to make Adaptations) but not otherwise. 5. Representations, Warranties
and Disclaimer
UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING AND TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, LICENSOR OFFERS THE WORK AS-IS AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY
KINDCONCERNING THEWORK, EXPRESS, IMPLIED, STATUTORYOROTHERWISE, INCLUDING,WITHOUT LIMITATION,WAR-
RANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE
OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT DISCOVER-
ABLE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THIS EXCLUSION MAY NOT
APPLY TO YOU.
6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN NO EVENTWILL LICENSOR BE LIABLE
TO YOU ON ANY LEGAL THEORY FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES
ARISING OUT OF THIS LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY
OF SUCH DAMAGES.
7. Termination
This License and the rights granted hereunderwill terminate automatically upon any breach byYou of the termsof this License.
Individuals or entities who have received Adaptations or Collections from You under this License, however, will not have their
licenses terminated provided such individuals or entities remain in full compliance with those licenses. Sections 1, 2, 5, 6,
7, and 8 will survive any termination of this License. Subject to the above terms and conditions, the license granted here is
perpetual (for the duration of the applicable copyright in the Work). Notwithstanding the above, Licensor reserves the right to
release the Work under different license terms or to stop distributing the Work at any time; provided, however that any such
election will not serve to withdraw this License (or any other license that has been, or is required to be, granted under the terms
of this License), and this License will continue in full force and effect unless terminated as stated above. 8. Miscellaneous
Each time You Distribute or Publicly Perform the Work or a Collection, the Licensor offers to the recipient a license to the Work
on the same terms and conditions as the license granted to You under this License. Each time You Distribute or Publicly
Perform an Adaptation, Licensor offers to the recipient a license to the original Work on the same terms and conditions as the
license granted to You under this License. If any provision of this License is invalid or unenforceable under applicable law, it
shall not affect the validity or enforceability of the remainder of the terms of this License, and without further action by the
parties to this agreement, such provision shall be reformed to the minimum extent necessary to make such provision valid
and enforceable. No term or provision of this License shall be deemed waived and no breach consented to unless such waiver
or consent shall be in writing and signed by the party to be charged with such waiver or consent. This License constitutes
the entire agreement between the parties with respect to the Work licensed here. There are no understandings, agreements
or representations with respect to the Work not specified here. Licensor shall not be bound by any additional provisions that
may appear in any communication from You. This License may not be modified without the mutual written agreement of
the Licensor and You. The rights granted under, and the subject matter referenced, in this License were drafted utilizing the
terminology of the Berne Convention for the Protection of Literary and Artistic Works (as amended on September 28, 1979),
the Rome Convention of 1961, the WIPO Copyright Treaty of 1996, the WIPO Performances and Phonograms Treaty of 1996
and the Universal Copyright Convention (as revised on July 24, 1971). These rights and subject matter take effect in the
relevant jurisdiction in which the License terms are sought to be enforced according to the corresponding provisions of the
implementation of those treaty provisions in the applicable national law. If the standard suite of rights granted under applicable
copyright law includes additional rights not granted under this License, such additional rights are deemed to be included in
the License; this License is not intended to restrict the license of any rights under applicable law.
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6.2 Third-party software
6.2.1 Software within MISHAP
MISHAP makes use of the following freely available scripts from MatLab Central
Peak detection
fpeak.m by Geng Jun, 2003
Wrapping of strings
linewrap.m by Steve Eddins, 2006
6.2.2 MMM
MMM (Multiscale Modeling of Macromolecular systems) is an open-source program for the
visualization, inspection, and improvement of models of proteins and protein assemblies
based on restraints from multiple experimental techniques. Authored by Yevhen Polyhach
and Gunnar Jeschke, with design support by Enrica Bordignon from ETH Zurich, Switzerland
with additional development by Stefan Stoll, University of Washington, USA.
Available from: http://www.epr.ethz.ch/software
6.2.3 HADDOCK
HADDOCK (High Ambiguity Driven biomolecular DOCKing) is an information-driven flexible
docking approach for the modeling of biomolecular complexes. HADDOCK distinguishes
itself from ab-initio docking methods in the fact that it encodes information from identified
or predicted protein interfaces in ambiguous interaction restraints (AIRs) to drive the docking
process. Authored by Alexandre Bonvin, Utrecht University, NL.
Available from: http://www.nmr.chem.uu.nl/haddock/
With public webservers available at: http://haddock.science.uu.nl/
6.3 Acknowledgements
Morgan Bye - primary software writer, testing, documentation
Fraser MacMillan - head of Henry Wellcome Unit for Biological EPR
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6.4 Hardware and computation time
The vast majority of testing of MISHAP has been conducted upon a 64-bit Linux system
(Ubuntu 12.04 LTS), MatLab R2011a.
This system comprises an Intel Core 2 processor @ 2  2.40 GHz with 4 GB of RAM.
With this system generation of a distance restraint file is ~5 ms, PDB file load time is ~3
s (for a ~25 kDa protein with ~2500 atoms), MMM rotamer file load time is ~3 s, the PDB
creator running 2 proteins (~ 15 kDa) is ~1 s.
These timings will not vary much with newer machines as MatLab by default will not paral-
lelise tasks. If your version of MatLab is set up to use parrallelisation these times will drop
significantly.
TheMISHAPMatLab interface has been briefly tested upon aWindowsXPmachine (MatLab
2010a) and is shown to be functional. Though with the specifications of this machine (Intel
Celeron @ 1  2.00 GHz with 1 GB of RAM) loading of PDB files can take as long as 10 s.
HADDOCK runs were performed on a local computing cluster, a 16 core Intel Xeon server
node with 32 GB of RAM would complete a run in ~4 - 18 h. Whilst HADDOCK runs are
possible on a desktop computer the calculation time will be approximately a week and in
which time the machine will be otherwise unusable.
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D. Additional experimental figures
D.1. PELDOR setup experiments
Whilst every effort was made in chapter 6 to find the best experiment conditions for the
investigation, each individual PELDOR experiment was further optimised to yield the best
possible data.
Before each PELDOR experiment was started a series of small experiments were conducted
on each sample. First, a simple field swept echo using a 2 pulse ESEEM experiment with 22
ns 2/3 pulses with a 380 ns 1, typical for a deuterated protein sample. This allowed the
magnetic field to be set such that the maximum amount of signal could be detected, as
well as the difference required in the ELDOR pulse frequency. Second, a short T2 relaxation
experiment, again using a 2 pulse ESEEMpulse sequencewas conducted to gather themax-
imum PELDOR observation window. Next a T1 relaxation time experiment was conducted
to determine the minimum possible time between repeats in an experiment.
With the conditions in the primary channel optimised, the initial  pulse of the T1 relaxation
time experiment was replaced by a  pulse in the ELDOR channel. With the spectrometer
in transient mode the ELDOR power was increased to give maximum inversion of the echo.
With, the ELDOR channel power optimised an ELDOR nutation experiment was conducted to
determine optimum ELDOR pulse length, as this is not necessarily the same as the primary
channel.
All experiments showed very similar resultswith onlyminor variations in field position (within
10 G), T2 relaxation time (within ~ 1 s), T1 relaxation time (within ~ 1 ms), ELDOR pulse
power (within 3 dB) and ELDOR pulse length (within 4 ns). Shown here in figure D.1 are the
setup experiments for colicin E9 DNase S3CIA1/S80CIA1.
The initial parameter finding experiment consisted of a field swept echo, shown in figure
D.1.a, where the centre field positionwas set corresponding to a g = 2:022 for themicrowave
frequency and the field was swept 15 mT . Through experimentation it was found that it
was better to place the observation pulse sequence upon the low field peak, shown here at
343 mT , whilst pumping upon the centre peak, shown here at 346 mT . In strong samples
it made little difference which position was selected as the pump position, however with
peak samples it was more beneficial to sacrifice overall signal-to-noise in order to have
observable PELDOR oscillations.
Figure D.1.b shows the T2 relaxation experiment which allowed for the determination of the
maximum possible observation window. Here the clear deuterion ESEEM modulations can
clearly be seen, but despite sample and glycerol deuteration a small amount of proton hy-
perfine oscillations can be seen on the larger ESEEM oscillations. After 8 s the signal had
decayed to an extent making it indistinguishable from background noise.
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Figure D.1.c shows the T1 relaxation experiment which shows the time required for the sys-
tem to each magnetic equilibrium. The dotted red line represents the zero line. The exper-
iment was deliberately run for a long time as whilst the initial relaxation is fast, complete
relaxation takes a long time. The result was fitted using an inverse exponential decay and
the resulting relaxation time wasmultiplied by 2.5 to give the shot repetition time used in the
experiment, thereby ensure complete magnetic equilibrium before the next experiment.
Finally, figure D.1.d shows the ELDOR nutation experiment, where the ELDOR channel power
is first optimisedwith a 32ns pulse. Then the pulse length is set to 0ns and in the experiment
is increased. The maximum inversion of the ELDOR pulse can be seen here at 34 ns.
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(d) ELDOR nutation experiment
Figure D.1 Initial parameter finding experiments for colicin E9 DNase S3CIA1/S80CIA1. All experiments: 50 K ,
4 scans, 4 shots/point, 1024 points, 9.7047 GHz, 6.0 dB attenuation, 20MHz video bandwidth, 45 dB
video gain a) 12 mT sweep width, 10000 s shot rep. time b) 345.70 mT c) 50000 s shot rep. time,
345.70mT , 51 dB video gain d) 10000 s shot rep. time, 14.0 dB ELDOR attenuation, 345.70mT . Protein
concentration 100 M inD2O and 50 % glycerol-d8.
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D.2. PELDOR experiments
In the main body of text, chapter 7 diplays PELDOR experiments in a 4 panel system. In
this system the first panel shows a representation of the experiment superimposed onto
the protein structure to aid with visual understanding of that experiment in relation to the
others. However, the quality and confidence of the final distance distribution, p(r), from the
form factor, F (t), is subject to the quality of the Tikhonov regularisation.
Remember that extraction of the distance distribution is an ill-posed problem where small
errors in fitting the form factor cangenerate large errors in the distance distribution. Tikhonov
regularisation requires the addition of extra constraints to stabilise the solution, these con-
straints are defined to be non-negative (as a distance cannot be negative) and must give a
smooth distribution. The subspace of possible values can be scanned to give data that is
smooth, without being over-smoothed and which still yields a good fit to the original data.
Plotting the log of each parameter in the result of the Tikhonov regularisation yields a charac-
teristically shaped L-curve. At the steep section of the curve a small increase in the smooth-
ing parameter yields a large increase in the quality of the fit. In the flat section of the curve
the data is over-smoothed and results in a poor fit to the original data. The best compromise
then is at the discontinuity of the L-curve. This appendix showss the Tikhonov regularisation
L-curve for each experiment as well as the point selected for the distance distribution.
Each experiment has an additional figure where the background trace is shown superim-
posed on top of the raw data. This allows for quick visual inspection of the strength of the
dipolar interaction. In the case of strong signals PELDOR oscillations deviate strongly from
the background decay, inweak signals the PELDORoscillations barely showmovement from
the background decay.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.2 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1. a) shows in navy the raw 4 pulse
PELDOR data of colicin E9 DNase S3CIA1/S80CIA1, in red the background data, from running colicin E9
DNase S3CIA1 under identical experimental parameters. b) shows the DeerAnalysis L-curve Tikhonov
analysis of the background subtracted data. The data point highlighted in red shows the regularisation
parameter used in the final distance distribution. 50 K , 20 hours collection (~ 2500 scans), 4 shots/-
point, 276 points, 6.0 dB attenuation, 20MHz video bandwidth, 57 dB video gain and 10000 s shot rep.
time, ~9.70 GHz, 345.70mT . 1= 380 nm, 2= 2200 nm, ELDOR pulse step 4 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.3 PELDOR experiment results for colicin E9 DNase S30CIA1/S80CIA1. a) shows in navy the raw 4 pulse
PELDOR data of colicin E9 DNase S30CIA1/S80CIA1, in red the background data, from running colicin E9
DNase S30CIA1 under identical experimental parameters. b) shows the DeerAnalysis L-curve Tikhonov
analysis of the background subtracted data. The data point highlighted in red shows the regularisation
parameter used in the final distance distribution. 50K , 20 hours collection (~ 2500 scans), 4 shots/point,
193 points, 10.0 dB attenuation, 20 MHz video bandwidth, 69 dB video gain and 10000 s shot rep.
time, ~9.69 GHz, 346.00mT . 1= 380 nm, 2= 4160 nm, ELDOR pulse step 4 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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Figure D.4 The resulting distance distributions for the colicin E9 DNase S30CIA1/S80CIA1 PELDOR experiment
when the background subtraction time is moved. The black line represents the distance distribution pre-
sented in the main text, ending data consideration at 3000 ns. Using DeerAnalysis's Tikhonov validation
functionality the fitting window was moved to consider the difference in distance distributions when data
considerationwasmoved between 2500 and 3500ns. The grey shadder areas represent the certainty area
of the Tikhonov regularisation, with red representing upper bounds and blue representing lower bounds
(2 standard deviations).
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.5 PELDOR experiment results for Im9 S6CIA1/C23IA1. a) shows in navy the raw 4 pulse PELDOR data of
Im9 S6CIA1/C23IA1, in red the background data, from running Im9 /C23IA1 under identical experimental
parameters. b) shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted data.
The data point highlighted in red shows the regularisation parameter used in the final distance distribution.
50K , 20 hours collection (~ 2500 scans), 4 shots/point, 193 points, 10.0 dB attenuation, 20MHz video
bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.69GHz, 346.00mT . 1= 380 nm, 2= 4160
nm, ELDOR pulse step 4 ns, no nuclear modulation suppression. Protein concentration 100 M in D2O
and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.6 PELDOR experiment results for colicin E9 DNase S3CIA1 - Im9 C23IA1. a) shows in navy the raw 4
pulse PELDOR data of Im9 C23IA1, in red the background data, from running colicin E9 DNase S3CIA1
under identical experimental parameters. b) shows the DeerAnalysis L-curve Tikhonov analysis of the
background subtracted data. The data point highlighted in red shows the regularisation parameter used
in the final distance distribution. 50 K , 20 hours collection (~ 2500 scans), 4 shots/point, 414 points,
5.5 dB attenuation, 20 MHz video bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.69
GHz, 345.60mT . 1= 380 nm, 2= 3440 nm, ELDOR pulse step 8 ns, no nuclear modulation suppression.
Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.7 PELDOR experiment results for colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23S a) shows in navy the raw
4 pulse PELDOR data of Im9 S6CIA1/C23S, in red the background data, from running colicin E9 DNase
S3CIA1 under identical experimental parameters. b) shows the DeerAnalysis L-curve Tikhonov analysis
of the background subtracted data. The data point highlighted in red shows the regularisation parameter
used in the final distance distribution. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 20MHz
video bandwidth and 10000 s shot rep. time, ~9.69GHz, ELDOR pulse step 8 ns, no nuclearmodulation.
Data points, magnetic field, attenuation, video gain and delay times were optimised on a per experiment
basis suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.8 PELDOR experiment results for colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23IA1. a) shows in navy
the raw 4 pulse PELDOR data of colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23IA1, in red the background
data, from running colicin E9 DNase S3CIA1 under identical experimental parameters. b) shows the Deer-
Analysis L-curve Tikhonov analysis of the background subtracted data. The data point highlighted in red
shows the regularisation parameter used in the final distance distribution. 50 K , 20 hours collection (~
2500 scans), 4 shots/point, 602 points, 3.5 dB attenuation, 20MHz video bandwidth, 63 dB video gain
and 10000 s shot rep. time, ~9.74GHz, 347.30mT . 1= 380 nm, 2= 2580 nm, ELDOR pulse step 4 ns,
no nuclear modulation suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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Figure D.9 The resulting distance distributions for the colicin E9 DNase S3CIA1 - Im9 S6CIA1/C23IA1 PELDOR
experiment when the background subtraction time is moved. The black line represents the distance dis-
tribution presented in themain text, ending data consideration at 1750 ns. Using DeerAnalysis's Tikhonov
validation functionality the fitting window was moved to consider the difference in distance distributions
when data consideration was moved between 1000 and 2000 ns. The grey shadder areas represent the
certainty area of the Tikhonov regularisation, with red representing upper bounds and blue representing
lower bounds (2 standard deviations).
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.10 PELDOR experiment results for colicin E9 DNase S30CR1A - Im9 C23R1A. a) shows in navy the
raw 4 pulse PELDOR data of colicin E9 DNase S30CR1A - Im9 C23R1A, in red the background data, from
running colicin E9 DNase S30CR1A under identical experimental parameters. b) shows the DeerAnalysis
L-curve Tikhonov analysis of the background subtracted data. The data point highlighted in red shows
the regularisation parameter used in the final distance distribution. 50 K , 20 hours collection (~ 2500
scans), 4 shots/point, 253 points, 4.0 dB attenuation, 20 MHz video bandwidth, 60 dB video gain and
10000 s shot rep. time, ~9.66GHz, 344.70mT . 1= 380 nm, 2= 3000 nm, ELDOR pulse step 12 ns, no
nuclear modulation suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.11 PELDOR experiment results for colicin E9 DNase E66CIA1 - Im9 C23IA1. a) shows in navy the raw
4 pulse PELDOR data of colicin E9 DNase E66CIA1 - Im9 C23IA1, in red the background data, from Deer-
Analysis homogenious background fitting model. b) shows the DeerAnalysis L-curve Tikhonov analysis
of the background subtracted data. The data point highlighted in red shows the regularisation parame-
ter used in the final distance distribution. 50 K , 20 hours collection (~ 2500 scans), 4 shots/point, 352
points, 6.0 dB attenuation, 20MHz video bandwidth, 60 dB video gain and 10000s shot rep. time, ~9.71
GHz, 348.00mT . 1= 380 nm, 2= 2600 nm, ELDOR pulse step 8 ns, no nuclear modulation suppression.
Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.12 PELDOR experiment results for colicin E9 DNase E66CIA1 - Im9 S6CIA1/C23S. a) shows in navy the
raw 4 pulse PELDOR data of colicin E9 DNase E66CIA1 - Im9 S6CIA1/C23S, in red the background data,
from DeerAnalysis homogenious background fitting model. b) shows the DeerAnalysis L-curve Tikhonov
analysis of the background subtracted data. The data point highlighted in red shows the regularisation
parameter used in the final distance distribution. 50 K , 20 hours collection (~ 2500 scans), 4 shots/-
point, 500 points, 5.5 dB attenuation, 20MHz video bandwidth, 60 dB video gain and 10000 s shot rep.
time, ~9.71 GHz, 348.00mT . 1= 380 nm, 2= 4160 nm, ELDOR pulse step 8 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.13PELDOR experiment results for colicin E9DNase E66CIA1 - Im9S6CIA1/C23IA1. a) shows in navy the
raw 4 pulse PELDOR data of colicin E9 DNase E66CIA1 - Im9 S6CIA1/C23IA1, in red the background data,
from DeerAnalysis homogenious background fitting model. b) shows the DeerAnalysis L-curve Tikhonov
analysis of the background subtracted data. The data point highlighted in red shows the regularisation
parameter used in the final distance distribution. 50K , 20 hours collection (~ 2500 scans), 4 shots/point,
428 points, 10.0 dB attenuation, 20 MHz video bandwidth, 66 dB video gain and 10000 s shot rep.
time, ~9.71 GHz, 348.00mT . 1= 380 nm, 2= 3200 nm, ELDOR pulse step 8 ns, no nuclear modulation
suppression. Protein concentration 100 M inD2O and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.14PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1- Im9 C23IA1. a) shows in navy the
raw 4 pulse PELDOR data of colicin E9 DNase S3CIA1/S80CIA1- Im9 C23IA1, in red the background data,
from running Im9 C23IA1 with unlablled colicin E9 S3C/S80C under identical experimental parameters.
b) shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted data. The data point
highlighted in red shows the regularisation parameter used in the final distance distribution. 50 K , 20
hours collection (~ 2500 scans), 4 shots/point, 428 points, 10.0 dB attenuation, 20MHz video bandwidth,
69 dB video gain and 10000 s shot rep. time, ~9.68GHz, 342.60mT . 1= 380 nm, 2= 3200 nm, ELDOR
pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100 M in D2O and 50 %
glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.15 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1- Im9 S6CIA1/C23S. a) shows in
navy the raw 4 pulse PELDOR data of colicin E9 DNase S3CIA1/S80CIA1- Im9 S6CIA1/C23S, in red the
background data, from running colicin E9 DNase S3CIA1 with unlablled Im9 under identical experimental
parameters. Here the fit has been artifically extended back to before the zero time using linear extrap-
olation. b) shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted data. The
data point highlighted in red shows the regularisation parameter used in the final distance distribution.
50K , 20 hours collection (~ 2500 scans), 4 shots/point, 428 points, 11.0 dB attenuation, 20MHz video
bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.71GHz, 346.30mT . 1= 380 nm, 2= 3200
nm, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100 M in D2O
and 50 % glycerol-d8.
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(b) DeerAnalysis L-curve results of Tikhonov regu-
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Figure D.16 PELDOR experiment results for colicin E9 DNase S3CIA1/S80CIA1- Im9 S6CIA1/C23IA1. a) shows in
navy the raw 4 pulse PELDOR data of colicin E9 DNase S3CIA1/S80CIA1- Im9 S6CIA1/C23IA1, in red the
background data, from running colicin E9 DNase S3CIA1 with unlablled Im9 under identical experimental
parameters. Here the fit has been artifically extended back to before the zero time using linear extrap-
olation. b) shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted data. The
data point highlighted in red shows the regularisation parameter used in the final distance distribution.
50K , 20 hours collection (~ 2500 scans), 4 shots/point, 428 points, 12.0 dB attenuation, 20MHz video
bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.70GHz, 342.60mT . 1= 380 nm, 2= 3200
nm, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100 M in D2O
and 50 % glycerol-d8.
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D.2.14. Colicin E9 DNase S30CIA1/S80CIA1 - Im9 C23IA1
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(b)DeerAnalysis L-curve results of Tikhonov regular-
isation
Figure D.17 PELDOR experiment results for colicin E9 DNase S30CIA1/S80CIA1- Im9 C23IA1. a) shows in navy
the raw 4 pulse PELDOR data of colicin E9 DNase S30CIA1/S80CIA1- Im9 C23IA1, in red the background
data, from running Im9 C23IA1 with unlablled colicin E9 S3C/S80C under identical experimental param-
eters. Here the fit has been artifically extended back to before the zero time using linear extrapolation. b)
shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted data. The data point
highlighted in red shows the regularisation parameter used in the final distance distribution. 50 K , 20
hours collection (~ 2500 scans), 4 shots/point, 428 points, 10.0 dB attenuation, 20 MHz video band-
width, 63 dB video gain and 10000 s shot rep. time, ~9.70GHz, 342.50mT . 1= 380 nm, 2= 3200 nm,
ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100 M in D2O and
50 % glycerol-d8.
D.2.15. Colicin E9 DNase S30CIA1/S80CIA1 - Im9 S6CIA1/C23S
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.18 PELDOR experiment results for colicin E9 DNase S30CIA1/S80CIA1- Im9 S6CIA1/C23S. a) shows in
navy the raw 4 pulse PELDOR data of colicin E9 DNase S30CIA1/S80CIA1- Im9 S6CIA1/C23S, in red the
background data, from running Im9 S6CIA1/C23S with unlablled colicin E9 S30C/S80C under identical
experimental parameters. Here the fit has been artifically extended back to before the zero time using
linear extrapolation. b) shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted
data. The data point highlighted in red shows the regularisation parameter used in the final distance
distribution. 50 K , 20 hours collection (~ 2500 scans), 4 shots/point, 428 points, 8.0 dB attenuation, 20
MHz video bandwidth, 63 dB video gain and 10000 s shot rep. time, ~9.79 GHz, 345.50mT . 1= 380
nm, 2= 3200 nm, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100
M inD2O and 50 % glycerol-d8
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D.2.16. Colicin E9 DNase S30CIA1/S80CIA1 - Im9 S6CIA1/C23IA1
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(b) DeerAnalysis L-curve results of Tikhonov regu-
larisation
Figure D.19 PELDOR experiment results for colicin E9 DNase S30CIA1/S80CIA1- Im9 S6CIA1/C23IA1. a) shows
in navy the raw 4 pulse PELDOR data of colicin E9 DNase S30CIA1/S80CIA1- Im9 S6CIA1/C23IA1, in
red the background data, from running Im9 C23IA1 with unlablled colicin E9 S30C/S80C under identical
experimental parameters. Here the fit has been artifically extended back to before the zero time using
linear extrapolation. b) shows the DeerAnalysis L-curve Tikhonov analysis of the background subtracted
data. The data point highlighted in red shows the regularisation parameter used in the final distance
distribution. 50K , 20 hours collection (~ 2500 scans), 4 shots/point, 428 points, 12.0 dB attenuation, 20
MHz video bandwidth, 69 dB video gain and 10000 s shot rep. time, ~9.70 GHz, 346.30mT . 1= 380
nm, 2= 3200 nm, ELDOR pulse step 8 ns, no nuclear modulation suppression. Protein concentration 100
M inD2O and 50 % glycerol-d8.
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UNIX based operating system
OriginPro - originlab.com
Graph creation
PDF-Shuffler - sourceforge.net/projects/pdfshuffler
PDF management tool
ProFit - bioinf.org.uk
Protein structure comparison program
PyMOL - pymol.org
pdb visualiser and figure creation
Roboto - developer.android.com/design/style/typography
open-source font used here
Shutter - shutter-project.org
Screenshot grabber
Thunderbird -mozilla.com/thunderbird
Email solutions
Ubuntu - ubuntu.com
UNIX based operating system
VMware Player - vmware.com
Virtual machine environment
Xepr - bruker-biospin.com/xepr
EPR equipment control and data capture
XeTex - scripts.sil.org/xetex
Font control for LATEX
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